{"version": "v1.0", "data": [{"id": "8908396_3_0", "context": "OBJECTIVE: To test the hypothesis that tumor necrosis factor (TNF)-alpha may mediate the loss and the dedifferentiation of subcutaneous fat tissue in the insulin-induced lipoatrophies of a diabetic patient who presented extensive lesions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] insulin [Effect] lipoatrophies"}, {"id": "10891991_1_1", "context": "An evaluation of ovarian structure and function should be considered in women of reproductive age being treated with valproate for epilepsy, especially if they develop menstrual cycle disturbances during treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] women of reproductive age [Treatment] valproate for epilepsy [Effect] menstrual cycle disturbances"}, {"id": "2332596_1_2", "context": "Phenobarbital hepatotoxicity in an 8-month-old infant.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] an 8-month-old infant [Treatment] Phenobarbital [Effect] hepatotoxicity"}, {"id": "12552054_1_3", "context": "The authors report a case of Balint syndrome with irreversible posterior leukoencephalopathy on MRI following intrathecal methotrexate and cytarabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] intrathecal methotrexate and cytarabine [Effect] Balint syndrome with irreversible posterior leukoencephalopathy on MRI"}, {"id": "19531695_12_4", "context": "According to the Naranjo probability scale, flecainide was the probable cause of the patient's delirium; the Horn Drug Interaction Probability Scale indicates a possible pharmacokinetic drug interaction between flecainide and paroxetine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] the patient [Treatment] flecainide [Effect] delirium"}, {"id": "8002140_2_5", "context": "Contact dermatitis due to budesonide: report of five cases and review of the Japanese literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] budesonide [Effect] Contact dermatitis"}, {"id": "8586895_3_6", "context": "Prolongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with halofantrine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a Japanese patient with vivax malaria [Treatment] halofantrine [Effect] Prolongation of the QT interval"}, {"id": "7776854_3_7", "context": "We report three cases of severe hepatotoxicity related to benzarone, a benzofuran derivative.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] three cases [Treatment] benzarone [Effect] severe hepatotoxicity"}, {"id": "8024670_1_8", "context": "Four patients who manifested symptoms of the antiepileptic drug (AED) hypersensitivity syndrome during therapy with carbamazepine are reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] symptoms of [Subject] Four patients [Treatment] antiepileptic drug (AED); during therapy with carbamazepine [Effect] hypersensitivity syndrome"}, {"id": "11026106_1_9", "context": "Minocycline as a cause of drug-induced autoimmune hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Minocycline [Effect] autoimmune hepatitis"}, {"id": "19434733_1_10", "context": "Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] etoposide therapy [Effect] Secondary acute myeloid leukemia"}, {"id": "16882109_1_11", "context": "Allergic contact angioedema to benzoyl peroxide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] benzoyl peroxide [Effect] Allergic contact angioedema"}, {"id": "1244265_1_12", "context": "A 60-year-old white man with chronic bronchitis was noted to develop acute respiratory failure and metabolic acidosis four days after being started on methazolamide (Neptazane) for an ophthalmologic problem.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] A 60-year-old white man with chronic bronchitis [Treatment] methazolamide (Neptazane) [Effect] acute respiratory failure and metabolic acidosis"}, {"id": "14557583_2_13", "context": "L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] L-DOPA [Effect] daytime sleepiness"}, {"id": "8384030_1_14", "context": "CONCLUSIONS: It is probable that foscarnet contributed to the electrolyte disorders and symptomatology in this patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] contributed [Subject] this patient [Treatment] foscarnet [Effect] electrolyte disorders and symptomatology"}, {"id": "17228132_1_15", "context": "Acute drug induced hepatitis due to erlotinib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] erlotinib [Effect] Acute drug induced hepatitis"}, {"id": "9804082_2_16", "context": "We observed 3 diabetic patients with intolerable dizziness followed by nausea and vomiting immediately after an initial administration of the alpha-glucosidase inhibitor, voglibose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] 3 diabetic patients [Treatment] an initial administration of the alpha-glucosidase inhibitor, voglibose [Effect] intolerable dizziness followed by nausea and vomiting"}, {"id": "9184269_1_17", "context": "Although risk factors for MTX-induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre-existing lung disease, represented by diffuse interstitial changes on chest X-ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of MTX pneumonitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] the presence in 3 out of 5 of our patients of pre-existing lung disease, represented by diffuse interstitial changes on chest X-ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA [Treatment] MTX [Effect] pulmonary toxicity"}, {"id": "8936932_1_18", "context": "Acute esmolol toxicity may be self-limiting because of its extremely short half-life.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] be [Treatment] esmolol [Effect] toxicity"}, {"id": "7835785_2_19", "context": "The association with prolonged unopposed estrogen-like stimulation with tamoxifen as a possible factor in the development of ovarian endometrioid carcinoma is discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] prolonged unopposed estrogen-like stimulation with tamoxifen [Effect] development of ovarian endometrioid carcinoma"}, {"id": "7019786_2_20", "context": "The other woman had rheumatoid arthritis and developed acute tubular necrosis after treatment with gentamicin and cefoxitin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] The other woman had rheumatoid arthritis [Treatment] gentamicin and cefoxitin [Effect] acute tubular necrosis"}, {"id": "8053440_2_21", "context": "One patient who received clindamycin had liver biopsy findings of marked cholestasis, portal inflammation, bile duct injury and bile duct paucity (ductopenia).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] One patient [Treatment] clindamycin [Effect] marked cholestasis, portal inflammation, bile duct injury and bile duct paucity (ductopenia)"}, {"id": "19531695_11_22", "context": "A MEDLINE search (1966-January 2009) revealed one in vivo pharmacokinetic study on the interaction between flecainide, a CYP2D6 substrate, and paroxetine, a CYP2D6 inhibitor, as well as 3 case reports of flecainide-induced delirium.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] 3 case reports [Treatment] flecainide [Effect] delirium"}, {"id": "11250985_1_23", "context": "As these cases revealed, close monitoring of blood chemistry is mandatory after starting spironolactone, and patients should be advised to stop spironolactone immediately if diarrhoea develops.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develops [Subject] patients [Treatment] spironolactone [Effect] diarrhoea"}, {"id": "21045170_9_24", "context": "When these cells are exposed to nicotinic acid, an exaggerated immune response is produced that may lead to pain, redness, and swelling at the injection site.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] produced [Treatment] nicotinic acid [Effect] exaggerated immune response; pain, redness, and swelling at the injection sit"}, {"id": "15107195_1_25", "context": "A case of heatstroke is reported in a 32-year-old man diagnosed with schizophrenia and on clozapine monotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Subject] a 32-year-old man diagnosed with schizophrenia [Treatment] clozapine monotherapy [Effect] heatstroke"}, {"id": "282937_2_26", "context": "Paraplegia following intrathecal cytosine arabinoside.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] intrathecal cytosine arabinoside [Effect] Paraplegia"}, {"id": "6733633_1_27", "context": "Cimetidine-induced fever.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Cimetidine [Effect] fever"}, {"id": "3470173_5_28", "context": "This case report illustrates the neurotoxicity unique to HDARAC.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Subject] This case [Treatment] HDARAC [Effect] neurotoxicity unique"}, {"id": "9433539_2_29", "context": "Agranulocytosis associated with ticlopidine: a possible benefit with filgastim.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] ticlopidine [Effect] Agranulocytosis"}, {"id": "16005413_10_30", "context": "Since SS is a clinical diagnosis, heightened clinician awareness of the possibility of SS among patients receiving SSRI or mirtazapine in combination with opioids may lead to earlier detection and avoidance of potentially lethal consequences.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] lead to [Subject] patients [Treatment] SSRI or mirtazapine in combination with opioids [Effect] potentially lethal consequences"}, {"id": "19499966_4_31", "context": "The mechanism by which sunitinib induces gynaecomastia is thought to be associated with an unknown direct action on breast hormonal receptors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induces [Treatment] sunitinib [Effect] gynaecomastia"}, {"id": "16463436_1_32", "context": "Some patients develop hypersensitivity rash in response to HCQ.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] Some patients [Treatment] HCQ [Effect] hypersensitivity rash"}, {"id": "18676387_2_33", "context": "To report a case of serotonin toxicity, presenting in the postoperative period, caused by an interaction between paroxetine (a selective serotonin reuptake inhibitor, SSRI) and fentanyl (a phenylpiperidine opioid).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] paroxetine; fentanyl [Effect] serotonin toxicity"}, {"id": "20367573_1_34", "context": "However, to our knowledge, in newborns there have been no reported cases to date of thrombocytosis induced by enoxaparin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] newborns [Treatment] enoxaparin [Effect] thrombocytosis"}, {"id": "9846036_7_35", "context": "The case presented here documents adverse cardiac effects in a 28-year-old man who intentionally ingested 24 mg of risperidone--4 times the recommended dose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] ingested [Subject] 28-year-old man [Treatment] 24 mg of risperidone [Effect] adverse cardiac effects"}, {"id": "12494253_2_36", "context": "Anaphylaxis to cisplatin following nine previous uncomplicated cycles.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] cisplatin following nine previous uncomplicated cycles [Effect] Anaphylaxis"}, {"id": "14746605_3_37", "context": "To the best of the authors' knowledge, this is the first reported case of Propecia-associated cataract.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Propecia [Effect] cataract"}, {"id": "17381671_1_38", "context": "Serotonin syndrome caused by interaction between citalopram and fentanyl.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] citalopram and fentanyl [Effect] Serotonin syndrome"}, {"id": "8149366_2_39", "context": "We report on three observations of parkinsonian patients with levo-dopa-induced diphasic dyskinesias, who received subcutaneous apomorphine to reduce the duration of abnormal movements.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] parkinsonian patients [Treatment] levo-dopa [Effect] diphasic dyskinesias [Potential therapeutic event] reduce [Subject] parkinsonian patients [Treatment] subcutaneous apomorphine"}, {"id": "11757641_3_40", "context": "This report presents a case of acute lung injury developing within hours after administration of mefloquine for a low-level Plasmodium falciparum malaria, which was persistent despite halofantrine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] administration of mefloquine for a low-level Plasmodium falciparum malaria; halofantrine therapy [Effect] acute lung injury; persistent despite halofantrine therapy"}, {"id": "11837564_3_41", "context": "Warfarin-associated bleeding generally is considered deleterious; however, in our patient it unmasked an early stage of colon cancer and thus may have saved the patient's life.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Warfarin [Effect] bleeding"}, {"id": "20076952_11_42", "context": "The clinical use of itraconazole in patients receiving multiple doses of oxycodone for pain relief may increase the risk of opioid-associated adverse effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increase [Subject] patients [Treatment] itraconazole; receiving multiple doses of oxycodone [Effect] opioid-associated adverse effects"}, {"id": "6251941_2_43", "context": "Three cases of gold-related neuropathy are reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] Three cases [Treatment] gold [Effect] neuropathy"}, {"id": "17224428_2_44", "context": "We report the case of a man, treated with mesalazine for Crohn's disease who developed drug-induced pericarditis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a man [Treatment] mesalazine [Effect] drug-induced pericarditis"}, {"id": "11483161_3_45", "context": "We report the occurrence of spontaneous intracranial bleeding in an human immunodeficiency virus (HIV)-infected adolescent with hemophilia A who was receiving amprenavir (APV).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurrence [Subject] an human immunodeficiency virus (HIV)-infected adolescent with hemophilia A [Treatment] amprenavir (APV) [Effect] spontaneous intracranial bleeding"}, {"id": "17352036_3_46", "context": "Under the suspicion of amiodarone-induced acute pancreatitis, amiodarone was substituted by propafenone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] amiodarone [Effect] acute pancreatitis"}, {"id": "7661076_1_47", "context": "Evidence is shown in this report that adenosine was associated with dangerous worsening of arrhythmia in patients with atrial flutter.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] patients with atrial flutter [Treatment] adenosine [Effect] dangerous worsening of arrhythmia"}, {"id": "6197014_1_48", "context": "Salicylate hepato toxicity in rheumatic fever.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] Salicylate [Effect] hepato toxicity"}, {"id": "17189581_2_49", "context": "A case of serotonin syndrome that developed during concurrent linezolid and fluoxetine is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] concurrent linezolid and fluoxetine [Effect] serotonin syndrome"}, {"id": "15866658_1_50", "context": "Herein we report four patients who underwent liver transplantation and developed neutropenia while receiving MMF.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] four patients who underwent liver transplantation [Treatment] MMF [Effect] neutropenia"}, {"id": "2931445_2_51", "context": "A study of in vitro reactivity to L-T4, as assessed by peripheral blood lymphocyte transformation, was carried out in a patient with Hashimoto's disease who developed leukopenia during treatment with L-T4.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with Hashimoto's disease [Treatment] L-T4 [Effect] leukopenia"}, {"id": "8792511_2_52", "context": "Methemoglobinemia is another common finding among patients receiving dapsone therapy, but rarely does it result in prominent symptoms other than transient pallor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] patients [Treatment] dapsone therapy [Effect] Methemoglobinemia; transient pallor"}, {"id": "3470173_3_53", "context": "During the first treatment, dysarthria and ataxia were seen after completion of the patient's eighth and final dose of HDARAC.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] seen [Subject] the patient's [Treatment] HDARAC [Effect] dysarthria and ataxia"}, {"id": "3143551_4_54", "context": "Four weeks earlier she had developed hepatopathy during a regimen of carbamazepine, lynestrenol and sodium valproate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] she [Treatment] carbamazepine, lynestrenol and sodium valproate [Effect] hepatopathy"}, {"id": "1420650_3_55", "context": "We consider asterixis to be an easily overlooked sign of neurotoxicity, which may occur even at low or moderate dosage levels, if certain drugs as lithium or clozapine are used in combination with CBZ.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Treatment] even at low or moderate dosage levels; certain drugs as lithium or clozapine are used in combination with CBZ [Effect] asterixis"}, {"id": "20178709_3_56", "context": "We report here a rare case of pleuropericarditis due to methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] a rare case [Treatment] methotrexate [Effect] pleuropericarditis"}, {"id": "3677571_2_57", "context": "A case of phenytoin-induced hepatitis with mononucleosis is reported, and syndromes associated with phenytoin hypersensitivity reactions are discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] phenytoin [Effect] hepatitis with mononucleosis"}, {"id": "10099659_14_58", "context": "We also discuss whether screening for DPD deficiency is warranted to identify patients at risk for severe toxicities from 5-FU treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Subject] patients [Treatment] 5-FU treatment [Effect] severe toxicities"}, {"id": "10102531_2_59", "context": "We report a case of reversible encephalopathy syndrome in a 16-year-old girl with acute myelogenous leukemia (AML), who is undergoing during consolidation chemotherapy composed of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosyl cytosine) and idarubicin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] undergoing [Subject] a 16-year-old girl with acute myelogenous leukemia (AML) [Treatment] consolidation chemotherapy composed of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosyl cytosine) and idarubicin [Effect] reversible encephalopathy syndrome"}, {"id": "24429012_10_60", "context": "Concurrent use of vismodegib and warfarin was deemed the probable cause of acute INR elevation in this case, suggesting the need for close monitoring of INR values in patients receiving this combination of drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] vismodegib and warfarin [Effect] acute INR elevation"}, {"id": "11834188_2_61", "context": "Captopril is an angiotensin-converting enzyme (ACE) inhibitor and their cutaneous side-effects are documented, but little has been published concerning the usefulness of patch test when they occur.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] documented [Treatment] Captopril [Effect] cutaneous side-effects"}, {"id": "18784429_3_62", "context": "High-dose methylprednisolone in a pregnant woman with Crohn's disease and adrenal suppression in her newborn.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a pregnant woman with Crohn's disease [Treatment] High-dose methylprednisolone [Effect] adrenal suppression in her newborn"}, {"id": "17224428_1_63", "context": "Cardiac hypersensitivity and myopericarditis have been reported during long-term treatment with mesalazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] long-term treatment with mesalazine [Effect] Cardiac hypersensitivity and myopericarditis"}, {"id": "6311654_6_64", "context": "It is concluded that 'cerebral atrophy' on CT scans may represent an accumulative effect of ACTH and that ACTH should be given with the utmost discretion, and in as low a dose as possible.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] represent [Treatment] ACTH [Effect] cerebral atrophy"}, {"id": "12135176_1_65", "context": "Two cases of polymorphic ventricular tachycardia induced by the administration of verapamil against paroxysmal supraventricular tachycardia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] verapamil [Effect] polymorphic ventricular tachycardia"}, {"id": "15162903_3_66", "context": "Fatal acute encephalomyelitis after a single dose of intrathecal methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] single dose of intrathecal methotrexate [Effect] Fatal acute encephalomyelitis"}, {"id": "18465737_2_67", "context": "The authors report one case of incomplete posterior hyaloid detachment (PHD) following intravitreal pegaptanib to treat DME.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] one case [Treatment] intravitreal pegaptanib [Effect] incomplete posterior hyaloid detachment (PHD)"}, {"id": "3612639_1_68", "context": "Pulmonary edema as a delayed complication of ritodrine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] ritodrine [Effect] Pulmonary edema"}, {"id": "15685264_1_69", "context": "Carbamazepine toxicity following Oxybutynin and Dantrolene administration: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] Oxybutynin and Dantrolene [Effect] Carbamazepine toxicity"}, {"id": "18633310_1_70", "context": "Multiple seizures after bupropion overdose in a small child.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a small child [Treatment] bupropion overdose [Effect] Multiple seizures"}, {"id": "19537383_2_71", "context": "Sorafenib, a multitargeted kinase inhibitor used for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinomas, received FDA approval in 2005.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Sorafenib; a multitargeted kinase inhibitor"}, {"id": "1174301_2_72", "context": "Triiodothyronine-induced thyrotoxicosis in ophthalmic Graves disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Triiodothyronine [Effect] thyrotoxicosis"}, {"id": "17526968_1_73", "context": "Bleomycin induced hyperpigmentation with yolk sac tumor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Bleomycin [Effect] hyperpigmentation with yolk sac tumor"}, {"id": "19034138_5_74", "context": "PURPOSE: To describe bilateral corneal endothelial dysfunction in a patient with Parkinson disease who was treated with long-term amantadine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient with Parkinson disease [Treatment] long-term amantadine [Effect] bilateral corneal endothelial dysfunction"}, {"id": "2140997_1_75", "context": "A case of severe acute hepatitis caused by cyproterone acetate in a 71 year old man with prostatic carcinoma is reported with a review of the literature on hepatic reactions to this drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] a 71 year old man with prostatic carcinoma [Treatment] cyproterone acetate [Effect] acute hepatitis"}, {"id": "2309833_2_76", "context": "Insulin-dependent diabetes mellitus associated with danazol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] danazol [Effect] Insulin-dependent diabetes mellitus"}, {"id": "10458196_4_77", "context": "CONCLUSIONS: Topical brimonidine may be associated with central nervous system depression in infants.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] infants [Treatment] Topical brimonidine [Effect] central nervous system depression"}, {"id": "10707759_1_78", "context": "Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a patient with the LEOPARD syndrome [Treatment] Flecainide [Effect] pneumonitis with acute respiratory failure"}, {"id": "1433432_1_79", "context": "Seizure with hyponatremia in a child prescribed desmopressin for nocturnal enuresis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a child [Treatment] desmopressin [Effect] Seizure with hyponatremia"}, {"id": "23624139_10_80", "context": "Risks and benefits of co-treatment should be carefully considered and therapeutic alternatives to NSAIDs should be recommended to patients with central DI in order to improve DDAVP safety.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] recommended [Subject] patients with central DI [Treatment] therapeutic alternatives to NSAIDs [Effect] in order to improve DDAVP safety"}, {"id": "15685264_6_81", "context": "She had been treated by Carbamazepine 1000 mg/day for neuropathic pain for 2 years without clinical or laboratory signs of toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] She [Treatment] Carbamazepine 1000 mg/day"}, {"id": "9509511_1_82", "context": "The chemotherapeutics, including vincristine, actinomycin D, and epirubicin in case 1 and vincristine and actinomycin D in case 2, were given before the hepatotoxicity developed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] given [Treatment] vincristine and actinomycin D [Effect] hepatotoxicity developed [Adverse event] given [Treatment] chemotherapeutics, including vincristine, actinomycin D, and epirubicin [Effect] hepatotoxicity developed"}, {"id": "11816261_1_83", "context": "After a second dose of metoclopramide, these symptoms recurred and were associated with confusion, agitation, fever, diaphoresis, tachypnea, tachycardia, and hypertension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] second dose of metoclopramide [Effect] confusion, agitation, fever, diaphoresis, tachypnea, tachycardia, and hypertension"}, {"id": "17364199_4_84", "context": "We report the first case of tuberculous uveitis due to etanercept.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Treatment] etanercept [Effect] tuberculous uveitis"}, {"id": "10516999_1_85", "context": "Acute hyperphosphatemia caused by sodium phosphate enema in a patient with liver dysfunction and chronic renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] a patient with liver dysfunction and chronic renal failure [Treatment] sodium phosphate enema [Effect] Acute hyperphosphatemia"}, {"id": "12757344_2_86", "context": "We discuss the association between carbamazepine and hyponatremia and the causes of hyponatremia after cardiopulmonary bypass.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] carbamazepine [Effect] hyponatremia"}, {"id": "16882112_7_87", "context": "Use of the Naranjo adverse drug reaction probability algorithm indicated a probable relationship between serotonin syndrome and treatment with lithium and venlafaxine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] a probable relationship between [Treatment] treatment with lithium and venlafaxine [Effect] serotonin syndrome"}, {"id": "19203515_3_88", "context": "The exact mechanism of IVIG-associated acute renal failure remains unclear.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] IVIG [Effect] acute renal failure"}, {"id": "1849334_2_89", "context": "We report on 7 patients (2 women, 5 men) with chronic renal failure, who developed under a high dosage of the new diuretic muzolimine (range 240 to 1440 mg per day) fatal neuromyeloencephalopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 7 patients (2 women, 5 men) with chronic renal failure [Treatment] a high dosage of the new diuretic muzolimine (range 240 to 1440 mg per day) [Effect] fatal neuromyeloencephalopathy"}, {"id": "1580986_2_90", "context": "Two renal transplant patients developed anemia during treatment of hypertension with enalapril medication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two renal transplant patients [Treatment] enalapril medication [Effect] anemia"}, {"id": "7787496_1_91", "context": "Sotalol-induced bradycardia reversed by glucagon.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] reversed [Treatment] glucagon [Adverse event] induced [Treatment] Sotalol [Effect] bradycardia"}, {"id": "9892272_4_92", "context": "The development of cutaneous ecchymosis associated with a sudden fall in hemoglobin after the administration of alteplase should strongly suggest the possibility of diffuse subfascial hematoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] alteplase [Effect] cutaneous ecchymosis; a sudden fall in hemoglobin; diffuse subfascial hematoma"}, {"id": "11545487_7_93", "context": "We report a case of papillary necrosis in a patient treated with indinavir.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] a patient [Treatment] indinavir [Effect] papillary necrosis"}, {"id": "9247841_3_94", "context": "Generalized maculopapular and papular purpuric eruptions are perhaps the most common thionamide-induced reactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] thionamide [Effect] Generalized maculopapular and papular purpuric eruptions; reactions"}, {"id": "8276031_6_95", "context": "Imidazoline intoxication due to overdose or accidental ingestion but also after normal therapeutic usage is frequent in children.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] children [Treatment] Imidazoline; overdose or accidental ingestion but also after normal therapeutic usage [Effect] intoxication"}, {"id": "12121061_2_96", "context": "A 50-year-old diabetic and hypertensive male patient is reported who had ticlopidine-induced marrow aplasia partially responsive to colony-stimulating factors and corticosteroids, but experienced complete recovery with cyclosporine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] 50-year-old diabetic and hypertensive male patient [Treatment] ticlopidine [Effect] marrow aplasia [Potential therapeutic event] with [Subject] 50-year-old diabetic and hypertensive male patient [Treatment] cyclosporine [Effect] experienced complete recovery"}, {"id": "2378415_2_97", "context": "A patient with intracranial osteosarcoma that arose 16 years after radiation therapy for hereditary retinoblastoma developed fatal cerebral edema and brainstem herniation after she received a single dose of intravenous methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient with intracranial osteosarcoma that arose 16 years after radiation therapy for hereditary retinoblastoma [Treatment] a single dose of intravenous methotrexate [Effect] cerebral edema and brainstem herniation"}, {"id": "8255797_2_98", "context": "Neutropenia is an infrequent complication following administration of the angiotensin-converting enzyme (ACE) inhibitor, captopril.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] the angiotensin-converting enzyme (ACE) inhibitor, captopril [Effect] Neutropenia"}, {"id": "17522786_1_99", "context": "INTRODUCTION: We describe the neurointensive care (NIC) management of a patient with severe cerebral swelling and raised intracranial pressure (ICP) after severe sodium valproic acid (VPA) intoxication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] patient [Treatment] sodium valproic acid (VPA) [Effect] severe cerebral swelling and raised intracranial pressure (ICP); intoxication"}, {"id": "8313300_7_100", "context": "Lithium therapy was discontinued because of poor compliance to the medication and intolerable polyuria.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] because [Treatment] Lithium [Effect] polyuria"}, {"id": "7594371_2_101", "context": "Both PAN and methotrexate have been independently demonstrated to cause sensorineural hearing loss.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] PAN and methotrexate [Effect] sensorineural hearing loss"}, {"id": "19667003_14_102", "context": "CONCLUSION: A 26-year-old man with bipolar disorder developed hyperammonemia three weeks after initiating carbamazepine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 26-year-old man with bipolar disorder [Treatment] three weeks after initiating carbamazepine therapy [Effect] hyperammonemia"}, {"id": "11034877_2_103", "context": "We report two adults who received gabapentin (GBP) and subsequently developed behavioural side effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two adults [Treatment] gabapentin (GBP) [Effect] behavioural side effects"}, {"id": "4038927_1_104", "context": "Atrial fibrillation was induced by diltiazem in two patients and verapamil induced syncope in one patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] two patients [Treatment] diltiazem [Effect] Atrial fibrillation [Adverse event] induced [Subject] one patient [Treatment] verapamil [Effect] syncope"}, {"id": "21448111_6_105", "context": "We can conclude that in this case, as in many others, akathisia as a possible adverse effect of psychopharmacs was very hard to identify.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse effect [Subject] this case [Treatment] psychopharmacs [Effect] akathisia"}, {"id": "18176653_12_106", "context": "Although HAART is very important in the treatment of HIV, its side effects are responsible for patients' non-adherence to medications.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effects [Subject] patients [Treatment] HAART [Effect] non-adherence to medications"}, {"id": "7668127_2_107", "context": "A case of acute subdural haematoma originating spontaneously from an angiomatous meningioma in a patient receiving prophylactic aspirin therapy is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] an angiomatous meningioma in a patient [Treatment] aspirin [Effect] acute subdural haematoma"}, {"id": "16529136_4_108", "context": "Long known to psychiatrists, monoamine oxidase inhibitors (MAOIs) and complications of their use may be unfamiliar to medical and surgical practitioners who may thus unwittingly precipitate a hypertensive crisis or serotonin syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitate [Treatment] monoamine oxidase inhibitors (MAOIs) [Effect] hypertensive crisis or serotonin syndrome"}, {"id": "18294121_1_109", "context": "According to the Naranjo adverse drug reaction probability scale, the likelihood that temozolomide was responsible for the adverse drug reaction of fever was probable (score of 6).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse drug reaction [Treatment] temozolomide [Effect] fever"}, {"id": "10891991_4_110", "context": "OBJECTIVE: To describe the development of valproate-related reproductive endocrine disorders in women with epilepsy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] women with epilepsy [Treatment] valproate [Effect] reproductive endocrine disorders"}, {"id": "2857534_1_111", "context": "Alprazolam-induced mania: two clinical cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] two clinical cases [Treatment] Alprazolam [Effect] mania"}, {"id": "10679548_2_112", "context": "Bronchiolitis obliterans organising pneumonia associated with the use of nitrofurantoin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] use of nitrofurantoin [Effect] Bronchiolitis obliterans organising pneumonia"}, {"id": "6692713_3_113", "context": "To our knowledge, this recurrence of amiodarone pulmonary toxicity has not been reported previously.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] amiodarone [Effect] pulmonary toxicity"}, {"id": "10660641_2_114", "context": "A patient treated with itraconazole (ITCZ) under the diagnosis of Aspergillus flavus-induced chronic hypertrophic pachymeningitis is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] A patient [Treatment] itraconazole (ITCZ)"}, {"id": "12802933_1_115", "context": "Severe autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a patient with a lymphoproliferative disorder [Treatment] rituximab therapy [Effect] Severe autoimmune hemolytic anemia"}, {"id": "11545487_6_116", "context": "The renal consequences of indinavir-associated nephrotoxicity are uncertain.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] indinavir [Effect] nephrotoxicity"}, {"id": "11834188_1_117", "context": "BACKGROUND: reports on delated cutaneous reactions to captopril have been seldom reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] captopril [Effect] delated cutaneous reactions"}, {"id": "24163322_7_118", "context": "Bismuth subsalicylate 30 mL every 4 hours was prescribed for diarrhea.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prescribed [Treatment] Bismuth subsalicylate 30 mL every 4 hours"}, {"id": "19382926_6_119", "context": "A drug interaction between the alpha(2)-adrenergic agonist medetomidine and lignocaine is suspected and highlights the potential for seizures following the subcutaneous administration of relatively large doses of lignocaine under medetomidine sedation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] subcutaneous administration of relatively large doses of lignocaine under medetomidine sedation [Effect] seizures"}, {"id": "7428724_2_120", "context": "Oesophageal ulceration due to emepronium bromide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Treatment] emepronium bromide [Effect] Oesophageal ulceration"}, {"id": "16432996_1_121", "context": "Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Development [Treatment] interferon alpha 2b and ribavirin [Effect] sarcoidosis"}, {"id": "9022114_2_122", "context": "CONCLUSION: The findings in these two patients suggest that colchicine may delay corneal wound healing.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] delay [Subject] two patients [Treatment] colchicine [Effect] delay corneal wound healing"}, {"id": "12324937_3_123", "context": "Gemcitabine-associated hemolytic-uremic syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Gemcitabine [Effect] hemolytic-uremic syndrome"}, {"id": "9100429_1_124", "context": "Case study: adverse response to clonidine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] clonidine [Effect] adverse response"}, {"id": "17163271_2_125", "context": "In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of cyclosporin, prednisone and azathioprine, developed thrombosis of the central retinal vein 5 years following the transplantation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] on immunosuppressive therapy consisting of cyclosporin, prednisone and azathioprine; undergone a renal transplantation as a result of malignant hypertension [Effect] thrombosis of the central retinal vein"}, {"id": "15300114_2_126", "context": "In each of the three reported patients, alteration of eyelid appearance with deepening of the lid sulcus was evident as the result of topical bimatoprost therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] evident [Subject] three reported patients [Treatment] topical bimatoprost [Effect] alteration of eyelid appearance with deepening of the lid sulcus"}, {"id": "16629074_1_127", "context": "PURPOSE: To report a case of traumatic flap dehiscence and Enterobacter keratitis 34 months after LASIK.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] 34 months after LASIK [Effect] traumatic flap dehiscence and Enterobacter keratitis"}, {"id": "9220046_2_128", "context": "CONCLUSIONS: The risk of drug-induced rhabdomyolysis due to the potential interaction between lovastatin and azithromycin or clarithromycin should be considered before the concomitant use of these agents.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] lovastatin; azithromycin; clarithromycin [Effect] rhabdomyolysis"}, {"id": "1509179_2_129", "context": "Ten years of behavioral data are presented to support the hypothesis that phenobarbital was exacerbating maladaptive behaviors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exacerbating [Treatment] phenobarbital [Effect] maladaptive behaviors"}, {"id": "8835752_2_130", "context": "Terbinafine-induced cholestatic liver disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Terbinafine [Effect] cholestatic liver disease."}, {"id": "21789791_2_131", "context": "The proteasome inhibitor Bortezomib has been identified as a potent enhancer of TRAIL-induced apoptosis in several human cancers.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] induced [Treatment] proteasome inhibitor Bortezomib has been identified as a potent enhancer of TRAIL [Effect] apoptosis in several human cancers"}, {"id": "19116715_2_132", "context": "METHODS: A retrospective report of the first case of gemcitabine-related HUS, in a patient with metastatic pancreatic adenocarcinoma, treated with a variety of standard therapies in addition to rituximab is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] a patient with metastatic pancreatic adenocarcinoma [Treatment] gemcitabine [Effect] HUS"}, {"id": "2595431_3_133", "context": "Their parkinsonism improved on discontinuation of metoclopramide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] improved [Subject] Their parkinsonism [Treatment] discontinuation of metoclopramide therapy"}, {"id": "15304176_1_134", "context": "Lichen planus induced by hepatitis B vaccination: a new case and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] hepatitis B vaccination [Effect] Lichen planus"}, {"id": "18453852_4_135", "context": "A total of 40 healthy volunteers were planned to start with 600 mg rifampicin once daily from days 1-5.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] start [Subject] 40 healthy volunteers [Treatment] 600 mg rifampicin once daily from days 1-5"}, {"id": "9366852_1_136", "context": "Skin necrosis secondary to low-molecular weight heparin in a patient with antiphospholipid antibody syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary to [Subject] a patient with antiphospholipid antibody syndrome [Treatment] low-molecular weight heparin [Effect] Skin necrosis"}, {"id": "20098333_1_137", "context": "Exacerbation of anthracycline-induced early chronic cardiomyopathy with ATRA: role of B-type natriuretic peptide as an indicator of cardiac dysfunction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] anthracycline; with ATRA [Effect] early chronic cardiomyopathy"}, {"id": "10395123_2_138", "context": "Fixed drug eruption in hands caused by omeprazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] omeprazole [Effect] Fixed drug eruption in hands"}, {"id": "12699871_1_139", "context": "FK506, which began to be administered 12 days earlier, rose to a level of 44 ng/mL (normal range, 10-20 ng/mL) 1 day before neurologic abnormalities began.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] before [Treatment] FK506, which began to be administered 12 days earlier, rose to a level of 44 ng/mL (normal range, 10-20 ng/mL) [Effect] neurologic abnormalities began"}, {"id": "15224368_2_140", "context": "Sweet's syndrome is an acute febrile neutrophilic dermatosis that is a known complication of the administration of filgrastim, a drug that causes increased neutrophil proliferation and differentiation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causes [Treatment] filgrastim [Effect] Sweet's syndrome is an acute febrile neutrophilic dermatosis; increased neutrophil proliferation and differentiation"}, {"id": "12811715_1_141", "context": "Although it would be expected that, like other type IA toxicities, diphenhydramine-induced cardiotoxicity could be responsive to hypertonic sodium bicarbonate, this finding is largely unappreciated.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] diphenhydramine [Effect] cardiotoxicity [Potential therapeutic event] responsive [Treatment] hypertonic sodium bicarbonate"}, {"id": "2016556_1_142", "context": "We describe a patient who experienced chronic nausea and an episode of confusion while treated with a small, stable dose of oral morphine in the setting of mild renal insufficiency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] a patient [Treatment] a small, stable dose of oral morphine [Effect] chronic nausea and an episode of confusion"}, {"id": "2011096_1_143", "context": "Bulbar and pseudobulbar palsy complicating therapy with high-dose cytosine arabinoside in children with leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicating [Subject] children with leukemia [Treatment] high-dose cytosine arabinoside [Effect] Bulbar and pseudobulbar palsy"}, {"id": "1068531_2_144", "context": "The development of erythroid leukemia plus carcinoma in these two men suggests mutagenic change secondary to cyclophosphamide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suggests [Subject] two men [Treatment] cyclophosphamide therapy [Effect] development of erythroid leukemia plus carcinoma; mutagenic change"}, {"id": "25538343_3_145", "context": "Administration of thiazide diuretics also has been the cause of hyponatremia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] thiazide diuretics [Effect] hyponatremia"}, {"id": "17122225_2_146", "context": "Serotonin syndrome is a potentially lethal adverse drug reaction that may occur in patients taking proserotoninergic medications.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Subject] patients [Treatment] proserotoninergic medications [Effect] Serotonin syndrome"}, {"id": "7519913_1_147", "context": "However, there remain questions concerning whether these drugs, especially methimazole (MMI), may be associated with aplasia cutis congenita (ACC) and how best to avoid impairment of fetal thyroid function during their use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] methimazole [Effect] aplasia cutis congenita"}, {"id": "17896898_2_148", "context": "An 18-year-old man with attention-deficit-hyperactivity disorder (ADHD) was prescribed varenicline for smoking cessation.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prescribed [Subject] An 18-year-old man with attention-deficit-hyperactivity disorder (ADHD) [Treatment] varenicline"}, {"id": "3878320_2_149", "context": "The condition should be suspected in patients who develop unexplained abdominal pain or collapse following vasopressin treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] patients [Treatment] vasopressin [Effect] unexplained abdominal pain or collapse"}, {"id": "10357715_3_150", "context": "The present observation suggests, that a batch of different testing doses, including lower testing doses may help to differentiate between an allergic type of contact dermatitis and an irritant type of reaction after treatment with calcipotriol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after treatment [Treatment] calcipotriol [Effect] an allergic type of contact dermatitis; an irritant type of reaction"}, {"id": "1068531_1_151", "context": "Acute erythroid leukemia after cyclophosphamide therapy for multiple myeloma: report of two cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] two cases [Treatment] cyclophosphamide therapy [Effect] Acute erythroid leukemia"}, {"id": "1642627_1_152", "context": "A combination of behavioural and cognitive adverse effects is illustrated in this case report of a recurrent triazolam-induced eating disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] triazolam [Effect] eating disorder"}, {"id": "15494638_2_153", "context": "5-fluorouracil (5-FU)-associated peripheral neuropathy is an uncommon event.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] 5-fluorouracil [Effect] peripheral neuropathy"}, {"id": "8908396_2_154", "context": "Insulin-induced lipoatrophy in type I diabetes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Insulin [Effect] lipoatrophy"}, {"id": "2327115_4_155", "context": "This article describes a patient with suspected ciprofloxacin-induced interstitial nephritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient [Treatment] ciprofloxacin [Effect] interstitial nephritis"}, {"id": "10607332_1_156", "context": "We report 3 cases of HIV-1 infected patients who experienced symptomatic angiolipomas shortly after starting antiretroviral therapy including the protease inhibitor indinavir.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] 3 cases of HIV-1 infected patients [Treatment] antiretroviral therapy including the protease inhibitor indinavir [Effect] symptomatic angiolipomas"}, {"id": "11093071_1_157", "context": "Depressive symptoms disappeared after interferon therapy was stopped.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] interferon therapy [Effect] Depressive symptoms"}, {"id": "12776809_2_158", "context": "Coumarin is reported to elevate liver function tests (LFT) values.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] Coumarin [Effect] elevate liver function tests (LFT) values"}, {"id": "9723127_3_159", "context": "Decreased plasma cortisol level during alprazolam treatment of panic disorder: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] alprazolam [Effect] Decreased plasma cortisol level"}, {"id": "8181372_1_160", "context": "Severe diffuse interstitial pneumonitis induced by carmustine (BCNU).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] carmustine (BCNU) [Effect] diffuse interstitial pneumonitis"}, {"id": "2394154_1_161", "context": "Fever, pulmonary infiltrates, and pleural effusion following acyclovir therapy for herpes zoster ophthalmicus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] acyclovir therapy for herpes zoster ophthalmicus [Effect] Fever, pulmonary infiltrates, and pleural effusion"}, {"id": "1584367_2_162", "context": "We propose a mechanism of vancomycin-induced mast cell degranulation and subsequent release of eosinophil chemotactic factor as a cause of CSFE.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] vancomycin [Effect] mast cell degranulation and subsequent release of eosinophil chemotactic factor as a cause of CSFE"}, {"id": "6837655_3_163", "context": "Within 3 weeks of beginning continuous daily isoniazid and rifampin therapy for pulmonary tuberculosis, a patient developed acute renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] Within 3 weeks of beginning continuous daily isoniazid and rifampin [Effect] acute renal failure"}, {"id": "8862924_5_164", "context": "We report four cases of severe corneal ulceration in methamphetamine abusers.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] four cases [Treatment] methamphetamine [Effect] corneal ulceration"}, {"id": "7375145_1_165", "context": "Diagnosis: practolol induced sclerosing peritonitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] practolol [Effect] sclerosing peritonitis"}, {"id": "19039026_2_166", "context": "We report the first biopsy confirmed occurrence of acute interstitial nephritis in a patient receiving treatment with Sunitinib for metastatic renal cell cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurrence [Subject] patient [Treatment] Sunitinib [Effect] acute interstitial nephritis"}, {"id": "12111771_3_167", "context": "Multiple pulmonary nodules: an unusual presentation of fludarabine pulmonary toxicity: case report and review of literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presentation [Treatment] fludarabine [Effect] Multiple pulmonary nodules"}, {"id": "19995222_1_168", "context": "Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] schizophrenic patients [Treatment] Clozapine [Effect] tardive dyskinesia"}, {"id": "9701106_4_169", "context": "Recently, her serum theophylline levels had increased to the toxic range (133.2 micromol/L [24 microg/mL]) shortly after the addition of zafirlukast (Accolate, Zeneca Pharmaceuticals, Wilmington, Del) to her regimen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] her [Treatment] zafirlukast [Effect] theophylline levels had increased to the toxic range"}, {"id": "2738729_2_170", "context": "Withdrawal emergent syndrome in an infant associated with maternal haloperidol therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] an infant [Treatment] maternal haloperidol therapy [Effect] Withdrawal emergent syndrome"}, {"id": "812008_1_171", "context": "Diphenylhydantoin apparently adversely affected both the clinical and biochemical parameters of the acute intermittent porphyria.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] affected [Treatment] Diphenylhydantoin [Effect] adversely affected both the clinical and biochemical parameters of the acute intermittent porphyria"}, {"id": "15852680_1_172", "context": "Successful recovery from interstitial pneumonitis, induced by bicalutamide and leuprorelin acetate given as treatment for prostate cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] bicalutamide and leuprorelin acetate [Effect] interstitial pneumonitis"}, {"id": "3438585_1_173", "context": "Gold-induced pneumonitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Gold [Effect] pneumonitis"}, {"id": "12921505_4_174", "context": "OBJECTIVE: To report a case of significant hepatic and renal failure with the use of argatroban in a patient with heparin-induced thrombocytopenia (HIT) requiring continuous veno-veno hemodialysis (CVVHD).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] use [Subject] a patient with heparin-induced thrombocytopenia (HIT) requiring continuous veno-veno hemodialysis (CVVHD) [Treatment] argatroban [Effect] significant hepatic and renal failure [Adverse event] induced [Treatment] heparin [Effect] thrombocytopenia"}, {"id": "20378385_2_175", "context": "Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] under [Subject] a patient with rheumatoid arthritis [Treatment] adalimumab [Effect] Visceral leishmaniasis and macrophagic activation syndrome"}, {"id": "11215836_1_176", "context": "He was diagnosed with possible serotonin syndrome; his symptoms resolved after clomipramine was stopped but before clozapine was restarted eight days later.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resolved [Subject] He [Treatment] clozapine [Effect] possible serotonin syndrome"}, {"id": "15878975_2_177", "context": "Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] Rh(0)(D) immune globulin intravenous [Effect] Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria"}, {"id": "6484655_3_178", "context": "Two patients had ampicillin-associated seizures.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] ampicillin [Effect] seizures"}, {"id": "15197722_1_179", "context": "A patient developed restless legs symptoms paralleling the course of interferon-alpha (IFN alpha) therapy for chronic hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient [Treatment] interferon-alpha (IFN alpha) therapy [Effect] restless legs symptoms"}, {"id": "16005413_9_180", "context": "While many can benefit from coadministration of serotonergic antidepressants and opioids, it appears that some individuals are at increased risk for SS.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Subject] some individuals [Treatment] coadministration of serotonergic antidepressants and opioids [Effect] SS"}, {"id": "10099659_3_181", "context": "Stomatitis, diarrhea, dermatitis, and myelosuppression are the main toxicities of 5-FU.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicities [Treatment] 5-FU [Effect] diarrhea; dermatitis; myelosuppression; Stomatitis"}, {"id": "8921647_1_182", "context": "After treatment with cimetidine, there was a rapid deterioration with decreased oxygen saturation and arterial PO2 values.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] was [Treatment] cimetidine [Effect] a rapid deterioration with decreased oxygen saturation and arterial PO2 values"}, {"id": "11487721_3_183", "context": "We describe a case of advanced ovarian carcinoma who developed difficulty walking because of marked pain in the lower extremities and loss of proprioception 25 days after treatment with weekly taxol (80 mg/m(2)x3).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a case of advanced ovarian carcinoma [Treatment] 25 days after treatment with weekly taxol (80 mg/m(2)x3) [Effect] difficulty walking because of marked pain in the lower extremities and loss of proprioception"}, {"id": "11722307_1_184", "context": "Agranulocytosis and granulocytopenia associated with quetiapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] quetiapine [Effect] Agranulocytosis and granulocytopenia"}, {"id": "16029707_3_185", "context": "The multiple comedones and ruptured epidermoid cysts are newly reported adverse effects of imiquimod therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] imiquimod therapy [Effect] multiple comedones and ruptured epidermoid cysts"}, {"id": "2305654_1_186", "context": "We conclude that neurosurgeons and neurologists should be aware of calcium antagonist--related ileus in patients treated with nimodipine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] patients [Treatment] calcium antagonist; nimodipine [Effect] ileus"}, {"id": "12932249_1_187", "context": "Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] interferon-alpha therapy [Effect] Hyperpigmentation"}, {"id": "6142995_1_188", "context": "Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Chlorambucil [Effect] chromosome damage"}, {"id": "17705565_1_189", "context": "Carbamazepine hypersensitivity syndrome is a rare, life-threatening condition.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] is [Treatment] Carbamazepine [Effect] hypersensitivity syndrome"}, {"id": "3195622_3_190", "context": "Case report: dapsone hypersensitivity syndrome associated with treatment of the bite of a brown recluse spider.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] dapsone [Effect] hypersensitivity syndrome"}, {"id": "11706664_1_191", "context": "Acute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and artesunate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exposed [Subject] a healthy normal volunteer [Treatment] 2 oral doses of amodiaquine and artesunate [Effect] Acute asymptomatic hepatitis"}, {"id": "3753891_3_192", "context": "The authors report a case of focal myocardial necrosis, presenting clinically as an acute myocardial infarction during the administration of the antineoplastic drug, amsacrine, in a patient without coronary artery disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a patient without coronary artery disease [Treatment] amsacrine [Effect] focal myocardial necrosis, presenting clinically as an acute myocardial infarction"}, {"id": "17420198_8_193", "context": "Baclofen and oxazepam were prescribed secondary to right-sided hemiparesis contractures.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prescribed [Treatment] oxazepam; Baclofen"}, {"id": "11918514_2_194", "context": "DISCUSSION: A review of the cases of SS with implication of mirtazapine as the cause was performed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] implication of [Treatment] mirtazapine [Effect] SS"}, {"id": "16968538_3_195", "context": "A small number of oxaliplatin-related hemolytic and/or thrombocytopenic reactions have been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] oxaliplatin [Effect] hemolytic and/or thrombocytopenic reactions"}, {"id": "10410183_3_196", "context": "CASE SUMMARY: A 39-year-old white Jewish schizophrenic man treated with olanzapine developed an elevated serum CK concentration with a peak concentration of 4000 IU/L (normal < 230).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 39-year-old white Jewish schizophrenic man [Treatment] olanzapine [Effect] an elevated serum CK concentration"}, {"id": "23624139_1_197", "context": "Severe water intoxication secondary to the concomitant intake of non-steroidal anti-inflammatory drugs and desmopressin: a case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary to [Treatment] the concomitant intake of non-steroidal anti-inflammatory drugs and desmopressin [Effect] Severe water intoxication"}, {"id": "17671884_3_198", "context": "An apparent link is described between the use of MMF with prednisone to treat pemphigus vulgaris and the development of red blood cell anemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] MMF with prednisone to treat pemphigus vulgaris [Effect] red blood cell anemia"}, {"id": "9256906_3_199", "context": "Other potential causes of renal failure were not present in our patient and his renal function gradually recovered with the cessation of suramin treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] recovered [Subject] our patient [Treatment] cessation of suramin treatmen [Effect] his renal function gradually recovered"}, {"id": "11435808_2_200", "context": "Massive CBZ OD may produce a reversible encephalopathy that includes cortical hyperexcitability, a profound burst-suppression EEG pattern, and cranial nerve areflexia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] produce [Treatment] Massive CBZ OD [Effect] reversible encephalopathy that includes cortical hyperexcitability, a profound burst-suppression EEG pattern, and cranial nerve areflexia"}, {"id": "10755579_3_201", "context": "This is the first report of a fluoxetine-related death in a child with a confirmed genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] a child with a confirmed genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism [Treatment] fluoxetine [Effect] death"}, {"id": "16025424_2_202", "context": "We report a case of reversible DKA and new-onset DM that developed in a demented patient who was treated with quetiapine for 14 days.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] demented patient [Treatment] quetiapine for 14 days [Effect] reversible DKA and new-onset DM"}, {"id": "12811715_4_203", "context": "We describe 3 cases of diphenhydramine-induced cardiac toxicity that were responsive to bicarbonate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] 3 cases [Treatment] diphenhydramine [Effect] cardiac toxicity [Potential therapeutic event] responsive [Subject] 3 cases [Treatment] bicarbonate"}, {"id": "17298107_1_204", "context": "The patient's arthritis flared after the second infusion of infliximab, which was discontinued.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] patient's [Treatment] second infusion of infliximab [Effect] arthritis flared"}, {"id": "11077455_1_205", "context": "CONCLUSION: Marked visual field constriction appears to be associated with vigabatrin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] vigabatrin therapy [Effect] Marked visual field constriction"}, {"id": "11215836_3_206", "context": "Possible serotonin syndrome associated with clomipramine after withdrawal of clozapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] withdrawal of clozapine [Effect] serotonin syndrome associated with clomipramine"}, {"id": "1295628_2_207", "context": "A 14-year-old female developed systemic lupus erythematosus (SLE)-like symptoms, rash, fever, leukopenia and positive anti-nuclear antibody (ANA) two weeks after administration of carbamazepine (CBZ; Tegretol) used against benign Rolandic epilepsy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 14-year-old female [Treatment] administration of carbamazepine (CBZ; Tegretol) used against benign Rolandic epilepsy [Effect] systemic lupus erythematosus (SLE)-like symptoms, rash, fever, leukopenia and positive anti-nuclear antibody (ANA)"}, {"id": "6236730_2_208", "context": "There was a clear relationship between restarting the Accutane and recurrence of the transient myopia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] a clear relationship [Treatment] Accutane [Effect] recurrence of the transient myopia"}, {"id": "7718983_3_209", "context": "Graves' hyperthyroidism following transient thyrotoxicosis during interferon therapy for chronic hepatitis type C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] interferon therapy [Effect] Graves' hyperthyroidism following transient thyrotoxicosis"}, {"id": "1445134_4_210", "context": "Masculinization of a female fetus occurred in 5 of 39 (12.8%) exposed to norethisterone; all were cases of clitoral hypertrophy not requiring surgical treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exposed [Subject] 5 of 39 (12.8%) [Treatment] norethisterone [Effect] Masculinization of a female fetus; clitoral hypertrophy"}, {"id": "9161656_16_211", "context": "She continued taking verapamil for 6 months, then, on her own, stopped all medications including the sustained-release verapamil, and her asthma symptoms disappeared.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] disappeared [Subject] She [Treatment] continued taking verapamil for 6 months, then, on her own, stopped all medications including the sustained-release verapamil"}, {"id": "9311175_2_212", "context": "Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to cisplatin: one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reactions [Subject] one [Treatment] cisplatin; involving intrahepatic artery infusion [Effect] manifested general erythema, dyspnea, and hypotension [Adverse event] reactions [Subject] the other [Treatment] cisplatin; involving intravenous infusion [Effect] manifested abdominal pain, general erythema, and fever"}, {"id": "12324937_2_213", "context": "CONCLUSION: There are only a few confirmed cases of gemcitabine-associated HUS despite the widespread use of the drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] gemcitabine [Effect] HUS"}, {"id": "19365885_3_214", "context": "In these patients, long-acting octreotide may trigger serious hypoglycemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] trigger [Subject] these patients [Treatment] long-acting octreotide [Effect] serious hypoglycemia"}, {"id": "1722991_1_215", "context": "Usefulness of antiplatelet drugs in the management of heparin-associated thrombocytopenia and thrombosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] heparin [Effect] thrombocytopenia and thrombosis [Potential therapeutic event] Usefulness [Treatment] antiplatelet drugs"}, {"id": "17039658_1_216", "context": "An intertrigo-like eruption from pegylated liposomal doxorubicin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] pegylated liposomal doxorubicin [Effect] intertrigo-like eruption"}, {"id": "14514135_2_217", "context": "We report a case of NEH masquerading as cutaneous vasculitis in a woman receiving cyclophosphamide for lupus nephritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a woman; for lupus nephritis [Treatment] cyclophosphamide [Effect] NEH masquerading as cutaneous vasculitis"}, {"id": "12621956_1_218", "context": "The diagnosis of hypothermia was delayed until it was apparent for several days but resolved with the discontinuation of risperidone and continuation of clozapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Treatment] discontinuation of risperidone and continuation of clozapine"}, {"id": "10048291_2_219", "context": "Unaccountable severe hypercalcemia in a patient treated for hypoparathyroidism with dihydrotachysterol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] patient [Treatment] dihydrotachysterol [Effect] Unaccountable severe hypercalcemia"}, {"id": "11022272_1_220", "context": "Anaphylaxis to calcitonin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] calcitonin [Effect] Anaphylaxis"}, {"id": "19764104_1_221", "context": "However, he developed acute renal failure, hyperkalemia, and hyperuricemia 30 d after receiving the sorafenib treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] he [Treatment] sorafenib [Effect] acute renal failure, hyperkalemia, and hyperuricemia"}, {"id": "17983451_1_222", "context": "Mycobacterium marinum infection complicating Crohn's disease, treated with infliximab.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Treatment] infliximab"}, {"id": "16649344_2_223", "context": "Current immunosuppressive therapies are effective but can be associated with significant adverse reactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Current immunosuppressive therapies [Effect] significant adverse reactions."}, {"id": "1977935_4_224", "context": "This report describes the first association (exclusive of drug overdose) of symptomatic torsades de pointes occurring with the use of terfenadine in a patient who was taking the recommended prescribed dose of this drug in addition to cefaclor, ketoconazole, and medroxyprogesterone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] a patient [Treatment] terfenadine; taking the recommended prescribed dose of this drug in addition to cefaclor, ketoconazole, and medroxyprogesterone [Effect] symptomatic torsades de pointes"}, {"id": "9232614_2_225", "context": "Tamoxifen is suggested to be carcinogenic both through direct genotoxic and epigenetic mechanisms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suggested [Treatment] Tamoxifen [Effect] carcinogenic both through direct genotoxic and epigenetic mechanisms"}, {"id": "14632592_3_226", "context": "DISCUSSION: Colchicine, the most important drug in treatment of FMF, can cause myopathy in patients with impaired renal and hepatic function.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] patients with impaired renal and hepatic function [Treatment] Colchicine [Effect] myopathy"}, {"id": "7673653_4_227", "context": "In the presented case fluvoxamine-induced akathisia in an OCD patient was partially resistant to the anticholinergic agent biperiden, and was successfully treated with the 5-HT2A/5-HT2C antagonist mianserin.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] fluvoxamine-induced akathisia in an OCD patient [Treatment] 5-HT2A/5-HT2C antagonist mianserin"}, {"id": "16225183_7_228", "context": "SUBSEQUENT COURSE: The nephrosis resolved almost completely once the interferon was stopped and after immunosuppressive treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Treatment] interferon was stopped and after immunosuppressive treatment"}, {"id": "8149366_1_229", "context": "In two patients, apomorphine remained effective in the morning, but increased the intensity of the dyskinesias in the afternoon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increased [Subject] In two patients [Treatment] apomorphine [Effect] intensity of the dyskinesias in the afternoon"}, {"id": "18079582_2_230", "context": "Transient asymptomatic bradycardia in patients on infusional 5-fluorouracil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] on [Subject] patients [Treatment] infusional 5-fluorouracil. [Effect] Transient asymptomatic bradycardia"}, {"id": "25515435_6_231", "context": "In 2006, he was diagnosed with deep vein thrombosis and pulmonary embolism and was started on warfarin.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] started [Subject] he [Treatment] warfarin"}, {"id": "17026827_1_232", "context": "Scleritis complicating zoledronic acid infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicating [Treatment] zoledronic acid infusion [Effect] Scleritis"}, {"id": "10467499_1_233", "context": "A 22-year-old black man developed fever, chills, fatigue, night sweats, tender lymphadenopathy, and a generalized, pruritic, macular eruption 3 weeks after starting minocycline therapy for acne.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 22-year-old black man [Treatment] minocycline therapy [Effect] fever, chills, fatigue, night sweats, tender lymphadenopathy, and a generalized, pruritic, macular eruption"}, {"id": "12221670_4_234", "context": "Ticlopidine-induced aplastic anemia: two new case reports, review, and meta-analysis of 55 additional cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Ticlopidine [Effect] aplastic anemia"}, {"id": "11757641_2_235", "context": "This is the second report of acute lung injury and diffuse alveolar damage caused by mefloquine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] mefloquine [Effect] acute lung injury and diffuse alveolar damage"}, {"id": "480917_1_236", "context": "A case of Erythema Multiforme Bullosum in patient of lepromatous leprosy with pulmonary tuberculosis due to Rifampicin is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Subject] patient of lepromatous leprosy with pulmonary tuberculosis [Treatment] Rifampicin [Effect] Erythema Multiforme Bullosum"}, {"id": "7661076_2_237", "context": "Life-threatening alterations in heart rate after the use of adenosine in atrial flutter.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] adenosine [Effect] Life-threatening alterations in heart rate"}, {"id": "9719245_4_238", "context": "We report a case of pancytopenia in a 23-year-old man with Crohn's disease who was treated with 5-aminosalicylic acid (Pentasa; Nisshin, Tokyo, Japan) 3.0 g/day.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated with [Subject] a 23-year-old man with Crohn's disease [Treatment] 5-aminosalicylic acid (Pentasa; Nisshin, Tokyo, Japan) 3.0 g/day [Effect] pancytopenia"}, {"id": "9169264_2_239", "context": "The ampicillin rash occurring in cases of infectious mononucleosis is well documented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Treatment] ampicillin [Effect] The ampicillin rash"}, {"id": "16204273_1_240", "context": "The major side effect of infliximab is infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] infliximab [Effect] infection"}, {"id": "11545487_1_241", "context": "An asymptomatic HIV-infected woman experienced right-sided renal colicky pain during treatment with indinavir.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] An asymptomatic HIV-infected woman [Treatment] indinavir [Effect] right-sided renal colicky pain"}, {"id": "6233326_3_242", "context": "The case resembles two previously reported cases of optic neuropathy which occurred in patients with Wilson's disease who were receiving penicillamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] patients with Wilson's disease [Treatment] penicillamine [Effect] optic neuropathy"}, {"id": "1743388_1_243", "context": "Cutaneous ulceration: an unusual complication of intravenous pentamidine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] intravenous pentamidine [Effect] Cutaneous ulceration"}, {"id": "8222875_3_244", "context": "Pulmonary hemorrhage is an uncommon feature in the HUS, and seems to appear especially in the HUS associated with MMC therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] appear [Treatment] MMC [Effect] Pulmonary hemorrhage"}, {"id": "9017913_1_245", "context": "Immunosuppression elicited by the extensive administration of prednisolone was suspected for the initiation of the generalized mite infestation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] generalized [Treatment] extensive administration of prednisolone [Effect] mite infestation"}, {"id": "6414095_4_246", "context": "The episode appeared to have been precipitated by toxicity due to ingestion of a large amount of phenytoin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] a large amount of phenytoin. [Effect] The episode appeared to have been precipitated by toxicity"}, {"id": "3370103_1_247", "context": "Cardiopulmonary arrest following intravenous phenytoin loading.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] intravenous phenytoin loading [Effect] Cardiopulmonary arrest"}, {"id": "11487721_1_248", "context": "Although taxol has shown significant activity in advanced ovarian cancer, peripheral neuropathy is likely to become the major dose-limiting toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] taxol [Effect] peripheral neuropathy"}, {"id": "19017039_2_249", "context": "Syringotropic hypersensitivity reaction associated with infliximab and leflunomide combination therapy in a child with psoriatic arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a child with psoriatic arthritis [Treatment] infliximab and leflunomide combination therapy [Effect] Syringotropic hypersensitivity reaction"}, {"id": "3438585_5_250", "context": "Corticosteroid therapy was continued for 8 months since there was still improvement of pulmonary function studies.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] improvement [Treatment] Corticosteroid; for 8 months"}, {"id": "19567656_3_251", "context": "OBJECTIVE: To describe a case of sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an elderly patient with dementia and comorbidities [Treatment] sertraline [Effect] rhabdomyolysis"}, {"id": "15028964_3_252", "context": "Beyond the predictable pharmacokinetic drug-drug interaction requiring a significant warfarin dose reduction, the iodine-rich amiodarone affects the thyroid gland, causing overt hypothyroidism or thyrotoxicosis in 14%-18% of cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causing [Treatment] iodine-rich amiodarone [Effect] overt hypothyroidism or thyrotoxicosis"}, {"id": "12086549_4_253", "context": "Toxic epidermal necrolysis associated with interleukin-2.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] interleukin-2 [Effect] Toxic epidermal necrolysis"}, {"id": "9840249_2_254", "context": "The pulmonary toxicity of gold salts is an uncommon cause of life-threatening respiratory failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] gold salts [Effect] pulmonary toxicity; life-threatening respiratory failure"}, {"id": "15383642_14_255", "context": "With its characteristics, tizanidine has the potential to compromise hemodynamic stability during concomitant angiotensin-converting enzyme inhibitor use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] compromise [Treatment] tizanidine; during concomitant angiotensin-converting enzyme inhibitor use [Effect] compromise hemodynamic stability"}, {"id": "17060191_1_256", "context": "Premature closure of the ductus arteriosus: variable response among monozygotic twins after in utero exposure to indomethacin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] monozygotic twins [Treatment] in utero exposure to indomethacin [Effect] Premature closure of the ductus arteriosus"}, {"id": "8239963_2_257", "context": "Possible mechanisms by which clonidine decreases spasticity are described, probable mechanisms of induced bradycardia are reviewed, and specific treatment recommendations for the use of clonidine in spinal cord injured patients are presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] clonidine [Effect] bradycardia"}, {"id": "10475726_3_258", "context": "This is the first report of a possible association between an acute cardiovascular event and venlafaxine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] venlafaxine [Effect] an acute cardiovascular event"}, {"id": "6830388_1_259", "context": "Since early symptoms of the toxic effects of theophylline can mimic peptic ulcer disease, cimetidine might be prescribed for the gastrointestinal symptoms with subsequent worsening of theophylline poisoning.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prescribed [Treatment] cimetidine"}, {"id": "9256906_1_260", "context": "Acute renal failure in a patient receiving treatment with suramin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient [Treatment] suramin [Effect] Acute renal failure"}, {"id": "6540393_1_261", "context": "A further case of anaphylactoid reaction to methylprednisolone is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] methylprednisolone [Effect] anaphylactoid reaction"}, {"id": "8222875_2_262", "context": "Pulmonary hemorrhage as a clinical manifestation of hemolytic-uremic syndrome associated with mitomycin C therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] mitomycin C therapy [Effect] Pulmonary hemorrhage; hemolytic-uremic syndrome"}, {"id": "4054170_3_263", "context": "EEG abnormalities were observed in two of the nine children during chlorambucil therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Subject] two of the nine children [Treatment] chlorambucil [Effect] EEG abnormalities"}, {"id": "9111724_1_264", "context": "Discontinuation of the itraconazole caused resolution of the drug eruption.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] itraconazole [Effect] drug eruption"}, {"id": "19307676_2_265", "context": "The addition of intrathecal methotrexate to treatment protocols has increased survival rates in children with acute lymphoblastic leukemia but is also associated with varying degrees of neurotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] in children with acute lymphoblastic leukemia [Treatment] The addition of intrathecal methotrexate to treatment protocols [Effect] varying degrees of neurotoxicity"}, {"id": "10473079_1_266", "context": "We conclude that the presence of this metabolic defect combined with topical 5-FU (a drug demonstrating a narrow therapeutic index) results in the unusual presentation of life-threatening toxicity after treatment with a topical drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] results in [Subject] this metabolic defect [Treatment] topical 5-FU (a drug demonstrating a narrow therapeutic index) [Effect] unusual presentation of life-threatening toxicity"}, {"id": "6958210_1_267", "context": "Six patients with rheumatoid arthritis developed a syndrome resembling lupus erythematosus while being treated with penicillamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Six patients with rheumatoid arthritis [Treatment] penicillamine [Effect] syndrome resembling lupus erythematosus"}, {"id": "12590235_3_268", "context": "This case highlights the need to monitor liver enzymes in patients treated with 6-TG and identifies the need for additional research focused on the mechanism of thiopurine-induced hepatic injury.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patients treated with 6-TG [Treatment] thiopurine [Effect] hepatic injury"}, {"id": "9347384_2_269", "context": "During clarithromycin coadministration, four out of the seven patients developed moderate-to-severe toxic symptoms of carbamazepine, such as drowsiness, dizziness, and ataxia, which resolved within 5 days after clarithromycin discontinuation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] four out of the seven patients [Treatment] During clarithromycin coadministration; carbamazepine [Effect] moderate-to-severe toxic symptoms of carbamazepine, such as drowsiness, dizziness, and ataxia [Potential therapeutic event] resolved [Treatment] 5 days after clarithromycin discontinuation"}, {"id": "10099659_2_270", "context": "5-Fluorouracil (5-FU) is an analogue of pyrimidine nucleosides that is widely used in the treatment of head and neck, breast, ovarian, and colon cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used [Treatment] 5-Fluorouracil (5-FU) is an analogue of pyrimidine nucleosides"}, {"id": "19782276_1_271", "context": "Fulminant fatal cardiotoxicity following cyclophosphamide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] cyclophosphamide [Effect] Fulminant fatal cardiotoxicity"}, {"id": "15383642_11_272", "context": "The reaction in our patient appeared after tizanidine initiation and improved after both lisinopril and tizanidine were discontinued.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] patient [Treatment] tizanidine initiation [Effect] reaction [Potential therapeutic event] improved [Subject] patient [Treatment] both lisinopril and tizanidine"}, {"id": "11142491_2_273", "context": "We describe the exceptional development of AML and lung cancer in a patient with previously diagnosed CLL in minimal residual disease status after fludarabine treatment followed by autologous peripheral blood stem-cell transplantation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] a patient with previously diagnosed CLL in minimal residual disease status [Treatment] fludarabine; autologous peripheral blood stem-cell transplantation [Effect] AML; lung cancer"}, {"id": "12095907_2_274", "context": "Valproate-induced hyperammonemia as a cause of altered mental status.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Valproate [Effect] altered mental status; hyperammonemia"}, {"id": "6353252_3_275", "context": "We report 5 cases of acute reversible renal failure coinciding with the onset of treatment with captopril in patients with severe drug-resistant hypertension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] onset of treatment [Subject] patients with severe drug-resistant hypertension [Treatment] captopril [Effect] acute reversible renal failure"}, {"id": "9375469_3_276", "context": "We report a case of contact dermatitis due to sodium bisulfite in Tathion eye drops.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] sodium bisulfite [Effect] contact dermatitis"}, {"id": "19815480_1_277", "context": "The first patient is undergoing hemodialysis and, though responding to sunitinib, is having significant fatigue and hypertension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] having [Subject] The first patient [Treatment] sunitinib [Effect] significant fatigue and hypertension"}, {"id": "17536204_4_278", "context": "CCBs should be considered in the treatment of 5-FU or capecitabine-induced headaches.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] CCBs"}, {"id": "9337441_8_279", "context": "Furosemide, spironolactone, allopurinol, and hydroxyurea were considered possible causes of the reaction and were discontinued.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causes [Treatment] Furosemide, spironolactone, allopurinol, and hydroxyurea [Effect] reaction"}, {"id": "11414270_5_280", "context": "PATIENTS: One patient with mucositis secondary to chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Subject] One patient [Treatment] chemotherapy [Effect] mucositis"}, {"id": "15266150_1_281", "context": "A patient with monocular open-angle glaucoma had trichiasis, a condition associated with the use of a prostaglandin analog.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] A patient with monocular open-angle glaucoma [Treatment] a prostaglandin analog [Effect] trichiasis"}, {"id": "21189363_3_282", "context": "A 53-year-old African American male with HIV was prescribed warfarin 5 mg/day for 12 months after diagnosis of idiopathic deep vein thrombosis and bilateral pulmonary emboli (target INR 2.5 [range 2.0-3.0]).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prescribed [Subject] A 53-year-old African American male with HIV [Treatment] warfarin 5 mg/day for 12 months"}, {"id": "18836269_1_283", "context": "After treatment with a beta-sympathomimetic drug (Partusisten) one fetus developed supraventricular tachycardia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] one fetus [Treatment] a beta-sympathomimetic drug (Partusisten) [Effect] supraventricular tachycardia."}, {"id": "17189581_16_284", "context": "Serotonin syndrome developed in a patient taking concurrent linezolid and fluoxetine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] concurrent linezolid and fluoxetine [Effect] Serotonin syndrome"}, {"id": "18533420_2_285", "context": "RESULTS: A male and a female patient with spasticity treated with intrathecal baclofen were recognized to have sexual dysfunction side effects from treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] A male and a female patient with spasticity [Treatment] intrathecal baclofen [Effect] sexual dysfunction"}, {"id": "8672829_5_286", "context": "OBJECTIVE: To describe a patient with ifosfamide-induced nonconvulsive status epilepticus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patient [Treatment] ifosfamide [Effect] nonconvulsive status epilepticus"}, {"id": "18252776_1_287", "context": "Upper gastrointestinal haemorrhage is a serious complication of aspirin and clopidogrel (dual) anti-platelet therapy with a high morbidity and mortality.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] aspirin and clopidogrel (dual) [Effect] Upper gastrointestinal haemorrhage"}, {"id": "17448102_2_288", "context": "Flecainide overdose can rapidly result in profound cardiovascular collapse, and is associated with a relatively high mortality.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] Flecainide overdose [Effect] profound cardiovascular collapse, and is associated with a relatively high mortality"}, {"id": "2894766_4_289", "context": "Sulfasalazine-induced lupus erythematosus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Sulfasalazine [Effect] lupus erythematosus"}, {"id": "4036917_2_290", "context": "Reye syndrome (RS) is believed to occur infrequently among children receiving long-term aspirin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Subject] children [Treatment] long-term aspirin [Effect] Reye syndrome (RS)"}, {"id": "14746605_2_291", "context": "Propecia-associated bilateral cataract.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Propecia [Effect] bilateral cataract"}, {"id": "12921505_1_292", "context": "After 39 hours on argatroban, the infusion was stopped when minor bleeding was observed with a concurrent activated partial thromboplastin time (aPTT) of 100 seconds.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] After [Treatment] argatroban [Effect] minor bleeding was observed with a concurrent activated partial thromboplastin time (aPTT) of 100 seconds"}, {"id": "6540393_2_293", "context": "Anaphylactoid reaction to methylprednisolone pulsed therapy for multiple sclerosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] methylprednisolone pulsed therapy [Effect] Anaphylactoid reaction"}, {"id": "17044380_2_294", "context": "Warfarin-induced skin necrosis and heparin-induced thrombocytopenia following mitral valve replacement for marantic endocarditis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Warfarin [Effect] skin necrosis [Adverse event] induced [Treatment] heparin [Effect] thrombocytopenia"}, {"id": "18020545_1_295", "context": "Surprisingly, we found that three patients appeared to develop tardive OGC while taking clozapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] three patients [Treatment] clozapine [Effect] tardive OGC"}, {"id": "11207969_4_296", "context": "We report a fatal case of toxic epidermal necrolysis (TEN) resulting from a high dose of cytosine arabinoside (ARA-C).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting from [Treatment] high dose of cytosine arabinoside (ARA-C) [Effect] toxic epidermal necrolysis (TEN)"}, {"id": "11207969_2_297", "context": "On the fifth day after administration of a high dose of ARA-C (2 g/m2 intravenously every 12 hours), she developed bullous lesions on the hands and soles that disseminated, evolving to necrosis, sepsis, and death on the 22nd day.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] high dose of ARA-C [Effect] bullous lesions on the hands and soles that disseminated, evolving to necrosis, sepsis, and death"}, {"id": "8730143_3_298", "context": "We describe 2 patients with cutaneous lupus erythematosus who developed severe dapsone reaction after low dose therapy, with a fatal outcome in one.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] 2 patients with cutaneous lupus erythematosus [Treatment] low dose therapy [Effect] severe dapsone reaction; with a fatal outcome in one"}, {"id": "1359782_1_299", "context": "A patient with ulcerative colitis developed skin pigmentation and diffuse pulmonary shadowing without respiratory symptomatology, while taking sulfasalazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient with ulcerative colitis [Treatment] sulfasalazine [Effect] skin pigmentation and diffuse pulmonary shadowing without respiratory symptomatology"}, {"id": "23552010_2_300", "context": "This is a case report involving a patient who was treated with topical 5-FU cream and subsequently developed a severe case of angioedema.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] topical 5-FU cream [Effect] a severe case of angioedema"}, {"id": "10555917_2_301", "context": "Cessation of D-Pen and the start of corticosteroid therapy were followed by recovery from bicytopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] followed [Treatment] Cessation of D-Pen and the start of corticosteroid therapy [Effect] recovery from bicytopenia"}, {"id": "21751666_3_302", "context": "Prevention of infection by immunization, together with early recognition and prompt antiviral treatment are critical.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] Prevention [Treatment] immunization, together with early recognition and prompt antiviral treatment"}, {"id": "10879669_1_303", "context": "A case of normotensive scleroderma renal crisis after high-dose methylprednisolone treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A case [Treatment] high-dose methylprednisolone treatment [Effect] normotensive scleroderma renal crisis"}, {"id": "16411025_3_304", "context": "OBJECTIVES: A delayed stroke-like leukoencephalopathy has been observed in patients receiving methotrexate (MTX) for childhood leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] has been observed [Subject] patients; childhood leukemia [Treatment] methotrexate (MTX) [Effect] delayed stroke-like leukoencephalopathy"}, {"id": "25538343_1_305", "context": "Duloxetine-induced hyponatremia in an elderly patient treated with thiazide diuretics.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an elderly patient treated with thiazide diuretics [Treatment] Duloxetine [Effect] hyponatremia"}, {"id": "16623611_2_306", "context": "The following is a case report analysis intended to draw attention to the need for better care coordination by describing the observed relationship of olanzapine to metabolic changes manifested as uncontrolled diabetes mellitus and weight gain.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] relationship [Treatment] olanzapine [Effect] metabolic changes manifested as uncontrolled diabetes mellitus and weight gain"}, {"id": "10466445_2_307", "context": "Arsenic trioxide has recently been introduced as a promising new agent to treat refractory acute promyelocytic leukemia (APL).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treat [Treatment] Arsenic trioxide"}, {"id": "10779995_1_308", "context": "Although the t-AML developed following oral etoposide therapy, the child had previously received high-dose, multiagent chemotherapy, and rearrangement of the MLL gene was not demonstrated.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] the child [Treatment] oral etoposide therapy; high-dose, multiagent chemotherapy [Effect] the t-AML"}, {"id": "15107195_2_309", "context": "Heat stroke in schizophrenia during clozapine treatment: rapid recognition and management.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] clozapine [Effect] Heat stroke"}, {"id": "25957434_4_310", "context": "The same symptoms recurred few days after taking nitrendipine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Treatment] nitrendipine; few days after [Effect] same symptoms"}, {"id": "16062101_3_311", "context": "The authors report two cases of acute dystonic reactions (ADRs) as a side effect of lamivudine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] effect [Subject] two cases [Treatment] lamivudine [Effect] acute dystonic reactions (ADRs)"}, {"id": "12751276_1_312", "context": "Isoniazid-induced anaphylaxis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Isoniazid [Effect] anaphylaxis"}, {"id": "18067642_3_313", "context": "Histopathology of the thyroid in amiodarone-induced hypothyroidism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] amiodarone [Effect] hypothyroidism"}, {"id": "15300114_1_314", "context": "Deepening of lid sulcus from topical bimatoprost therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] bimatoprost [Effect] Deepening of lid sulcus"}, {"id": "2979256_2_315", "context": "Gastro-oesophageal reflux associated with nifedipine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] nifedipine [Effect] Gastro-oesophageal reflux"}, {"id": "7919557_1_316", "context": "CASE SUMMARY: A 68-year-old woman developed a dry, irritating cough within one month of starting quinapril therapy for the treatment of essential hypertension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] starting [Subject] A 68-year-old woman [Treatment] quinapril therapy [Effect] a dry, irritating cough"}, {"id": "19567656_4_317", "context": "Sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an elderly patient with dementia and comorbidities [Treatment] Sertraline [Effect] rhabdomyolysis"}, {"id": "11431864_1_318", "context": "After the dose of methylprednisolone was reduced from 40 mg to 20 mg i.v. q6h and shifted to other anti-asthma treatment by procaterol metered dose inhaler via spacer, the psychotic reaction disappeared a few hours later.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] disappeared [Treatment] After the dose of methylprednisolone was reduced from 40 mg to 20 mg i.v. q6h and shifted to other anti-asthma treatment by procaterol metered dose inhaler via spacer; a few hours later"}, {"id": "16649344_3_319", "context": "Sirolimus works differently from the immunosuppressants currently available, and except for increased lipid levels, the adverse reaction profile of sirolimus does not appear to overlap to any great extent with that associated with cyclosporine or tacrolimus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] for [Treatment] Sirolimus works differently from the immunosuppressants currently available [Effect] increased lipid levels"}, {"id": "21512888_7_320", "context": "Patient was on warfarin for a prior deep venous thrombosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Treatment] warfarin"}, {"id": "15729090_1_321", "context": "Quetiapine-induced myoclonus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Quetiapine [Effect] myoclonus"}, {"id": "3391110_1_322", "context": "Dyspnea possibly associated with controlled-release morphine sulfate tablets.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] controlled-release morphine sulfate tablets [Effect] Dyspnea"}, {"id": "7496198_6_323", "context": "The incidence of ARE suddenly exceeded 10% of the patients treated by melarsoprol during August 1992 and September 1993.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] by [Subject] patients [Treatment] melarsoprol [Effect] ARE"}, {"id": "426502_1_324", "context": "A patient with disseminated herpes zoster developed a syndrome of inappropriate antidiuretic hormone and profound hyponatremia secondary to the administration of adenine arabinoside.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient with disseminated herpes zoster [Treatment] adenine arabinoside [Effect] syndrome of inappropriate antidiuretic hormone and profound hyponatremia"}, {"id": "2147700_1_325", "context": "One patient with systemic lupus erythematosus developed erythema multiforme after taking griseofulvin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] One patient with systemic lupus erythematosus [Treatment] griseofulvin [Effect] erythema multiforme"}, {"id": "19949685_4_326", "context": "We report a rare case of colonic mucosal necrosis following Kalimate (calcium polystryrene sulfonate), an analogue of Kayexalate without sorbitol in a 34-yr-old man.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a 34-yr-old man [Treatment] Kalimate (calcium polystryrene sulfonate), an analogue of Kayexalate without sorbitol [Effect] colonic mucosal necrosis"}, {"id": "18379937_1_327", "context": "Bilateral anterior uveitis associated with clomiphene citrate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] clomiphene citrate [Effect] Bilateral anterior uveitis"}, {"id": "15479299_1_328", "context": "Progressive anemia following combination therapy with interferon-alpha and interleukin-2 in a patient with metastatic renal cell carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a patient with metastatic renal cell carcinoma [Treatment] combination therapy with interferon-alpha and interleukin-2 [Effect] Progressive anemia"}, {"id": "2595431_2_329", "context": "Metoclopramide-induced parkinsonism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Metoclopramide [Effect] parkinsonism"}, {"id": "8461228_1_330", "context": "A 12 year old patient with atrial flutter is presented, in whom intravenous adenosine was followed by acceleration of the heart rate to a potentially dangerous arrhythmia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] followed by [Subject] 12 year old patient with atrial flutter [Treatment] intravenous adenosine [Effect] acceleration of the heart rate to a potentially dangerous arrhythmia"}, {"id": "17873198_3_331", "context": "Similar to reports in patients receiving gefitinib, those with pathologic findings of UIP on resected lung specimens or known pulmonary fibrosis may be at particular risk for erlotinib pulmonary toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] patients [Treatment] gefitinib [Effect] erlotinib pulmonary toxicity."}, {"id": "11144696_4_332", "context": "Eleven days after increase of the trimipramine dosage to 100 mg/d, she was hospitalized because of seizures suggesting a secondary generalized grand-mal episode.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] hospitalized [Subject] she [Treatment] Eleven days after increase of the trimipramine dosage to 100 mg/d [Effect] seizures suggesting a secondary generalized grand-mal episode"}, {"id": "19707032_3_333", "context": "AIM: To report a patient with diabetic rubeosis who suffered from acute retinal ischemic change and stroke after intravitreal injection of bevacizumab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suffered [Subject] patient with diabetic rubeosis [Treatment] intravitreal injection of bevacizumab [Effect] acute retinal ischemic change and stroke"}, {"id": "11174414_1_334", "context": "Stevens-Johnson syndrome caused by the antiretroviral drug nevirapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused by [Treatment] antiretroviral drug nevirapine [Effect] Stevens-Johnson syndrome"}, {"id": "9476721_2_335", "context": "From these data, acute generalized dystonia with brainstem and thalamic lesions may occur in WD patients after an initial d-penicillamine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] WD patients [Treatment] an initial d-penicillamine therapy [Effect] acute generalized dystonia with brainstem and thalamic lesions"}, {"id": "20412003_2_336", "context": "Although this combination agent has been associated with a hypersensitivity syndrome involving cutaneous skin eruptions, pediatric cases of TMP-SMX-induced hepatotoxicity are rare.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] pediatric cases [Treatment] TMP-SMX [Effect] hepatotoxicity"}, {"id": "21728158_4_337", "context": "Drug resistant tuberculosis requires more complex and longer treatment with alternative substances.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] requires [Treatment] complex and longer treatment with alternative substances"}, {"id": "7668127_1_338", "context": "Intracranial haemorrhage from a meningioma in a patient receiving aspirin prophylaxis: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient [Treatment] aspirin [Effect] Intracranial haemorrhage from a meningioma"}, {"id": "10395123_3_339", "context": "The objective of this report is to describe a case of fixed drug eruption that occurred during omeprazole treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] during omeprazole treatment [Effect] fixed drug eruption"}, {"id": "10803790_2_340", "context": "Case 2: A 43-year-old male alcoholic remained completely abstinent with cyanamide treatment for 5 years and complained of general fatigue.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complained [Subject] A 43-year-old male alcoholic [Treatment] completely abstinent with cyanamide treatment for 5 years [Effect] general fatigue"}, {"id": "9042097_1_341", "context": "Delayed hypersensitivity to flurbiprofen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] flurbiprofen [Effect] Delayed hypersensitivity"}, {"id": "10981493_3_342", "context": "Propafenone-induced ataxia: report of three cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] three cases [Treatment] Propafenone [Effect] ataxia"}, {"id": "11225565_6_343", "context": "Delavirdine and efavirenz (but not nevirapine) also were strong inhibitors of CYP3A, consistent with clinical hazards of initial cotreatment with either of these drugs and substrates of CYP3A.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] consistent with [Treatment] Delavirdine and efavirenz (but not nevirapine) [Effect] clinical hazards"}, {"id": "10688731_2_344", "context": "This is the first report of UFT-induced scleroderma-like reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] UFT [Effect] scleroderma-like reaction"}, {"id": "14526130_1_345", "context": "Can roxithromycin and betamethasone induce acute pancreatitis? A case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Treatment] roxithromycin and betamethasone [Effect] acute pancreatitis"}, {"id": "18362995_3_346", "context": "Up to four percent of patients treated with imatinib may develop hepatotoxicity, which usually resolves with discontinuation of the drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] Up to four percent of patients [Treatment] imatinib [Effect] hepatotoxicity"}, {"id": "12923827_1_347", "context": "Schneiderian first-rank symptoms associated with fluvoxamine treatment: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] fluvoxamine [Effect] Schneiderian first-rank symptoms"}, {"id": "17655517_5_348", "context": "Peripheral and optic neuropathy was usually seen after several months of linezolid therapy (median 5 mo), lactic acidosis after several weeks (median 6 wks), and serotonin syndrome after several days (median 4 days).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] several months of linezolid therapy (median 5 mo) [Effect] Peripheral and optic neuropathy; lactic acidosis after several weeks (median 6 wks), and serotonin syndrome after several days (median 4 days)"}, {"id": "1849334_1_349", "context": "Muzolimine-induced severe neuromyeloencephalopathy: report of seven cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Muzolimine [Effect] neuromyeloencephalopathy"}, {"id": "15494638_16_350", "context": "We conclude peripheral neuropathy with 5-FU is rare.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] 5-FU [Effect] peripheral neuropathy"}, {"id": "7962394_2_351", "context": "Additionally, danazol produces hepatocellular damage in approximately 10% of women.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] produces [Subject] 10% of women [Treatment] danazol [Effect] hepatocellular damage"}, {"id": "17188061_1_352", "context": "CONCLUSIONS: We report a typical symptoms of Charles-Bonnet syndrome (CBS) in patients with severe AMD after intravitreal Avastin-injections.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] patients with severe AMD [Treatment] intravitreal Avastin-injections [Effect] typical symptoms of Charles-Bonnet syndrome (CBS)"}, {"id": "11033734_3_353", "context": "Proconvulsive tendency of imipenem/cilastatin is one of its well-known side effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effects [Treatment] imipenem/cilastatin [Effect] Proconvulsive tendency"}, {"id": "9013348_1_354", "context": "A 49-year-old man with Crohn's disease treated with prednisone and mesalamine (5-ASA) developed worsening respiratory distress and fever.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 49-year-old man with Crohn's disease [Treatment] prednisone and mesalamine (5-ASA) [Effect] worsening respiratory distress and fever."}, {"id": "18721173_3_355", "context": "OBJECTIVE: This case report outlines a significant type of morbidity due to continued use of gabapentin during an episode of acute renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] use [Subject] This case [Treatment] gabapentin [Effect] a significant type of morbidity"}, {"id": "18585545_1_356", "context": "Acute delirium resulting from levofloxacin therapy is an exceedingly rare complication that has been thought to occur more commonly in elderly patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Subject] elderly patients [Treatment] levofloxacin [Effect] Acute delirium"}, {"id": "17473493_1_357", "context": "Selective estrogen receptor modulator raloxifene-associated aggravation of nonalcoholic steatohepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] raloxifene [Effect] aggravation of nonalcoholic steatohepatitis"}, {"id": "15162903_4_358", "context": "The day after methotrexate administration, the patient complained of severe back pain and urinary retention.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complained [Treatment] The day after methotrexate administration [Effect] severe back pain and urinary retention"}, {"id": "11943900_1_359", "context": "Pulmonary toxicity secondary to procarbazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] procarbazine [Effect] Pulmonary toxicity"}, {"id": "58443_1_360", "context": "In keeping with findings in the literature, the aortic wall in this case was damaged by secondary changes following irradiation and Bleomycin treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] irradiation and Bleomycin treatment. [Effect] aortic wall in this case was damaged"}, {"id": "12460237_3_361", "context": "It has been suggested that PPE caused by cytarabine does not recur with subsequent cytarabine re-challenge.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] cytarabine [Effect] PPE"}, {"id": "9205466_3_362", "context": "CONCLUSIONS: The value of multihormonal therapy in breast carcinoma is not established, and the addition of progestogens to tamoxifen may not reduce of developing endometrial lesions, including carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] may not reduce [Treatment] addition of progestogens to tamoxifen [Effect] endometrial lesions; carcinoma"}, {"id": "426502_2_363", "context": "Inappropriate antidiuretic hormone following adenine arabinoside administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] adenine arabinoside [Effect] Inappropriate antidiuretic hormone"}, {"id": "6484655_2_364", "context": "Ampicillin-associated seizures.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Ampicillin [Effect] seizures"}, {"id": "6692713_4_365", "context": "We describe a case of fibrosing alveolitis, diagnosed by lung biopsy, in a patient receiving amiodarone which responded to corticosteroid therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] a patient [Treatment] amiodarone which responded to corticosteroid therapy [Effect] fibrosing alveolitis"}, {"id": "7752014_1_366", "context": "Furosemide-associated fever.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Furosemide [Effect] fever"}, {"id": "18810448_2_367", "context": "Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a patient with juvenile idiopathic arthritis [Treatment] etanercept [Effect] Thymic enlargement"}, {"id": "24846936_1_368", "context": "Fatal methylene blue associated serotonin toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] methylene blue [Effect] serotonin toxicity"}, {"id": "7900744_4_369", "context": "Mannitol-induced ARF responds promptly to hemodialysis with rapid resolution of anuria and recovery of renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Mannitol [Effect] ARF; anuria; renal failure"}, {"id": "18665833_3_370", "context": "We report a rare case of recurrent (stuttering) priapism in a patient with protein C deficiency while maintained on Warfarin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] while [Subject] a patient with protein C deficiency [Treatment] maintained on Warfarin therapy [Effect] recurrent (stuttering) priapism"}, {"id": "16641839_1_371", "context": "Angioedema and maculopapular eruptions associated with carbamazepine administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] carbamazepine administration. [Effect] Angioedema and maculopapular eruptions"}, {"id": "9195619_2_372", "context": "Mental nerve neuropathy as a result of hepatitis B vaccination.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] hepatitis B vaccination [Effect] Mental nerve neuropathy"}, {"id": "12860350_2_373", "context": "We describe a premenopausal woman who, while having tamoxifen due to a diagnosis of in situ ductal carcinoma, developed endometriosis requiring surgery.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a premenopausal woman [Treatment] tamoxifen [Effect] endometriosis"}, {"id": "12773807_1_374", "context": "Disseminated cellulitic cryptococcosis in the setting of prednisone monotherapy for pemphigus vulgaris.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in the setting of [Treatment] prednisone monotherapy [Effect] Disseminated cellulitic cryptococcosis"}, {"id": "3417739_2_375", "context": "We describe a 63 year old woman with a suppurative mediastinitis, treated with continuous PI irrigation who developed an acute oliguric renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 63 year old woman with a suppurative mediastinitis [Treatment] continuous PI irrigation [Effect] acute oliguric renal failure"}, {"id": "3128415_1_376", "context": "A young woman with epilepsy had tonic-clonic seizures during antineoplastic therapy with adriamycin and cisplatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] A young woman with epilepsy [Treatment] antineoplastic therapy with adriamycin and cisplatin. [Effect] tonic-clonic seizures"}, {"id": "19567656_1_377", "context": "CONCLUSIONS: This patient's rhabdomyolysis was probably induced by sertraline therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] This patient [Treatment] sertraline [Effect] rhabdomyolysis"}, {"id": "16225183_1_378", "context": "Nephrotic syndrome in a multiple sclerosis patient treated with interferon beta 1a.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] a multiple sclerosis patient [Treatment] interferon beta 1a [Effect] Nephrotic syndrome"}, {"id": "7937287_8_379", "context": "In our patient, DIAN possibly was related to cefuroxime, but the patient did not experience associated allergic symptoms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related to [Subject] our patient [Treatment] cefuroxime [Effect] DIAN"}, {"id": "9642842_2_380", "context": "We describe the case of a nonatopic 17-year-old girl with bronchial asthma and aspirin intolerance who developed a dramatic anaphylactic reaction to oral prednisone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a nonatopic 17-year-old girl with bronchial asthma and aspirin intolerance [Treatment] oral prednisone [Effect] a dramatic anaphylactic reaction"}, {"id": "10772434_1_381", "context": "CASE SUMMARY: A 10-year-old white girl with bilateral optic glioma developed a hypersensitivity reaction to carboplatin after nine courses.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 10-year-old white girl with bilateral optic glioma [Treatment] carboplatin after nine courses [Effect] hypersensitivity reaction"}, {"id": "18453852_16_382", "context": "Liver function should be carefully monitored when rifampicin and lopinavir/ritonavir are combined in patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] when [Subject] patients [Treatment] rifampicin and lopinavir/ritonavir are combined [Effect] Liver function should be carefully monitored"}, {"id": "15504988_2_383", "context": "We report three patients, all of whom had preexisting diabetic dyslipidemia, who showed a profound reduction in plasma HDL cholesterol and apolipoprotein AI levels soon after the initiation of rosiglitazone therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] initiation [Subject] three patients [Treatment] rosiglitazone therapy [Effect] profound reduction in plasma HDL cholesterol and apolipoprotein AI levels"}, {"id": "12923827_4_384", "context": "This finding suggests that fluvoxamine can precipitate Schneiderian first-rank symptoms in some susceptible patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitate [Subject] some susceptible patients [Treatment] fluvoxamine [Effect] Schneiderian first-rank symptoms"}, {"id": "14960440_3_385", "context": "Warfarin-associated thoracic aortic dissection in an elderly woman.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] an elderly woman [Treatment] Warfarin [Effect] thoracic aortic dissection"}, {"id": "10774758_2_386", "context": "This is the first report of an adverse effect of fetal renal circulation by maternal ingestion of nimesulide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse effect [Subject] first report of an adverse effect of fetal renal circulation [Treatment] maternal ingestion of nimesulide; nimesulide [Effect] fetal renal circulation"}, {"id": "11111942_1_387", "context": "Diarrhea-associated over-anticoagulation in a patient taking warfarin: therapeutic role of cholestyramine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] over-anticoagulation [Subject] patient [Treatment] warfarin [Effect] Diarrhea-associated over-anticoagulation"}, {"id": "9876809_3_388", "context": "A 72-year-old white man suddenly developed combative behavior, refused to leave his room, stopped eating, and began falling to the floor 6 weeks after being given ticlopidine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 72-year-old white man [Treatment] 6 weeks after being given ticlopidine [Effect] combative behavior, refused to leave his room, stopped eating, and began falling to the floor"}, {"id": "71813_4_389", "context": "The case history confirms that gold treatment, even in the same patient, can give rise to a wide range of skin disturbances, which in many cases do not break out until long after the drug has been withdrawn.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] give rise [Subject] in the same patient, [Treatment] gold [Effect] wide range of skin disturbances, which in many cases do not break out until long after the drug has been withdrawn"}, {"id": "8828999_3_390", "context": "Lithium neurotoxicity should be considered in Creutzfeldt-Jakob disease differential diagnosis, serial electroencephalograms being the most valuable.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] considered [Treatment] Lithium [Effect] Lithium neurotoxicity"}, {"id": "7647084_1_391", "context": "The authors describe a case of neuroleptic malignant syndrome that occurred in a patient on amitriptyline and lithium carbonate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] a patient [Treatment] amitriptyline and lithium carbonate [Effect] neuroleptic malignant syndrome"}, {"id": "15239684_2_392", "context": "The findings were judged to be consistent with soft-tissue injury associated with intravenous administration of phenytoin, also termed purple glove syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] intravenous administration of phenytoin [Effect] soft-tissue injury"}, {"id": "10749332_1_393", "context": "However, as illustrated by these and other cases reported to date, the onset of troglitazone-induced liver injury is insidious and temporally variable.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] troglitazone [Effect] liver injury is insidious and temporally variable"}, {"id": "2887555_1_394", "context": "Soon after its introduction in 1952, chlorpromazine was noted to induce symptoms resembling Parkinson's disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Treatment] chlorpromazine [Effect] symptoms resembling Parkinson's disease"}, {"id": "9220046_4_395", "context": "Erythromycin is a macrolide antibiotic that may increase the risk of lovastatin-induced rhabdomyolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Erythromycin [Effect] ncrease the risk of lovastatin-induced rhabdomyolysis"}, {"id": "17189581_3_396", "context": "A 23-year-old white male patient was originally admitted to receive intravenous chemotherapy for acute myelogenous leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receive [Subject] A 23-year-old white male patient [Treatment] intravenous chemotherapy"}, {"id": "2768785_2_397", "context": "We present two children with acute lymphocytic leukemia who developed leukoencephalopathy following administration of a combination of intravenous ara = C and methotrexate during the consolidation phase of chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two children with acute lymphocytic leukemia [Treatment] administration of a combination of intravenous ara = C and methotrexate during the consolidation phase of chemotherapy [Effect] leukoencephalopathy"}, {"id": "2320800_1_398", "context": "Lethal anuria complicating high dose ifosfamide chemotherapy in a breast cancer patient with an impaired renal function.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicating [Subject] a breast cancer patient with an impaired renal function [Treatment] high dose ifosfamide chemotherapy [Effect] anuria"}, {"id": "15013892_2_399", "context": "CONCLUSIONS: Low dosages of quinacrine used for malaria prophylaxis can be associated with a delayed, severe maculopathy indistinguishable from chloroquine maculopathy in certain patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Low dosages of quinacrine used for malaria prophylaxis [Effect] a delayed, severe maculopathy [Adverse event] associated [Subject] certain patients. [Treatment] Low dosages of quinacrine used for malaria prophylaxis [Effect] chloroquine maculopathy"}, {"id": "10987357_7_400", "context": "When pilsicainide is prescribed in patients with coronary artery disease or renal dysfunction, close attention must be paid to avoid life-threatening arrhythmias due to high plasma concentrations of the drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] patients with coronary artery disease or renal dysfunction, [Treatment] pilsicainide [Effect] life-threatening arrhythmias"}, {"id": "19018868_3_401", "context": "We describe a case of severe aplastic anemia (AA) that was probably induced by lenalidomide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] lenalidomide [Effect] severe aplastic anemia (AA)"}, {"id": "3569037_4_402", "context": "We present a case report of a patient with typhoid fever who experienced a hypersensitivity reaction subsequent to the infusion of chloramphenicol sodium succinate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] subsequent to [Subject] a patient with typhoid fever [Treatment] the infusion of chloramphenicol sodium succinate [Effect] hypersensitivity reaction"}, {"id": "3310776_3_403", "context": "This confirmed the history of captopril-related asthma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] captopril [Effect] asthma"}, {"id": "9100429_3_404", "context": "Four cases of adverse experiences with clonidine are described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] Four cases [Treatment] clonidine [Effect] adverse experiences"}, {"id": "9972383_2_405", "context": "OBJECTIVE: To report a case of reversible nonthrombocytopenic palpable purpura associated with metoclopramide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] metoclopramide [Effect] reversible nonthrombocytopenic palpable purpura"}, {"id": "424824_6_406", "context": "Three patients received respectively 190 mg, 175 mg, and 196 mg of methotrexate and developed bilateral pulmonary infiltrates without evidence of peripheral blood eosinophilia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Three patients [Treatment] received respectively 190 mg, 175 mg, and 196 mg of methotrexate [Effect] bilateral pulmonary infiltrates without evidence of peripheral blood eosinophilia"}, {"id": "9876812_1_407", "context": "Clinicians should be aware of the possibility that vinorelbine may cause SIADH and possibly hypokalemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] vinorelbine [Effect] SIADH and possibly hypokalemia"}, {"id": "19995690_4_408", "context": "We report a case of a 34-year-old man on carbamazepine for complex partial seizures who developed acute liver and renal failure on less than 2.5 grams a day of acetaminophen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] on [Subject] a 34-year-old man [Treatment] carbamazepine; less than 2.5 grams a day of acetaminophen [Effect] acute liver and renal failure"}, {"id": "16935446_1_409", "context": "Fever and maculopapular rashes appeared at 10 days after phenytoin initiation, and then the drug was discontinued.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] appeared [Treatment] phenytoin [Effect] Fever and maculopapular rashes"}, {"id": "15628319_4_410", "context": "We report AZA-induced drug eruption that developed in two cases of systemic scleroderma with polymyositis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] two cases of systemic scleroderma with polymyositis [Treatment] AZA [Effect] drug eruption"}, {"id": "12776809_1_411", "context": "Safety aspects of a coumarin-troxerutin combination regarding liver function in a double-blind placebo-controlled study.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Safety aspects [Treatment] coumarin-troxerutin combination [Effect] liver function"}, {"id": "15580406_3_412", "context": "Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Treatment] interferon alpha [Effect] Vogt-Koyanagi-Harada disease"}, {"id": "11206417_1_413", "context": "Glucose and insulin exert additive ocular and renal vasodilator effects on healthy humans.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exert [Subject] healthy humans [Treatment] Glucose and insulin [Effect] additive ocular and renal vasodilator effects"}, {"id": "4025011_2_414", "context": "Two patients with osteomyelitis who developed reversible cholestatic jaundice during treatment with oxacillin derivatives are described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two patients with osteomyelitis [Treatment] oxacillin [Effect] reversible cholestatic jaundice"}, {"id": "1504404_3_415", "context": "DATA SYNTHESIS: A 49-year-old man developed symptoms of severe psychosis concomitant with ciprofloxacin (250 mg bid) treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 49-year-old man [Treatment] ciprofloxacin [Effect] psychosis"}, {"id": "7673653_1_416", "context": "Beneficial effect of low-dose mianserin on fluvoxamine-induced akathisia in an obsessive-compulsive patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] obsessive-compulsive patient [Treatment] fluvoxamine [Effect] akathisia [Potential therapeutic event] Beneficial [Subject] obsessive-compulsive patient [Treatment] low-dose mianserin"}, {"id": "8862924_3_417", "context": "Potential causes of methamphetamine-related keratitis can be divided into four categories resulting from (a) direct pharmacologic and physical effects of methamphetamine; (b) the toxic effects of diluting or \"cutting\" agents such as lidocaine and quinine; (c) effects related to the route of drug administration (intravenous, inhalation, smoking); and (d) manufacture-related effects of exposure to unintentional caustic contaminants in the final product.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] methamphetamine [Effect] keratitis"}, {"id": "2028358_2_418", "context": "Pulmonary oedema after hexoprenaline administration in preterm labour.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] hexoprenaline [Effect] Pulmonary oedema"}, {"id": "11144696_10_419", "context": "Venlafaxine-associated seizures at therapeutic doses have not been reported in the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Venlafaxine [Effect] seizures"}, {"id": "9184269_2_420", "context": "Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patients with rheumatoid arthritis and psoriatic arthritis [Treatment] Methotrexate [Effect] pneumonitis"}, {"id": "3677571_4_421", "context": "She was receiving phenytoin sodium 300 mg/day; carbamazepine 200 mg four times daily had been discontinued four days before admission because of leukopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] because [Treatment] carbamazepine 200 mg four times daily [Effect] leukopenia"}, {"id": "9211543_4_422", "context": "Thoracoscopic biopsy to confirm metastasis revealed instead fibrotic lesions apparently attributable to bleomycin or cyclophosphamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attributable [Treatment] bleomycin or cyclophosphamide [Effect] fibrotic lesions"}, {"id": "16968538_4_423", "context": "We present a case of hemolytic-uremic syndrome that developed during the 4th cycle of combination chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] during the 4th cycle of combination chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin [Effect] hemolytic-uremic syndrome"}, {"id": "16632429_1_424", "context": "We report the case of a lung cancer patient with bronquiloalveolar carcinoma (BAC) presenting with BOOP after chemotherapy with docetaxel and gemcitabine producing severe respiratory insufficiency, and simulating a progression of the tumor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] lung cancer patient with bronquiloalveolar carcinoma (BAC) [Treatment] chemotherapy with docetaxel and gemcitabine [Effect] producing severe respiratory insufficiency, and simulating a progression of the tumor; BOOP"}, {"id": "9240497_1_425", "context": "Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] treatment with all-trans retinoic acid [Effect] Relapse in the external auditory canal of acute promyelocytic leukemia"}, {"id": "10439378_1_426", "context": "Acute neutrophilic dermatosis induced by all-trans-retinoic acid treatment for acute promyelocytic leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced by [Treatment] all-trans-retinoic acid [Effect] Acute neutrophilic dermatosis"}, {"id": "15840734_1_427", "context": "Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a schizophrenic patient [Treatment] Fluphenazine [Effect] neuroleptic malignant syndrome"}, {"id": "19039026_1_428", "context": "Biopsy-proven acute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib: a class effect?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] tyrosine kinase inhibitor sunitinib [Effect] acute interstitial nephritis"}, {"id": "8222875_4_429", "context": "We describe two women who developed HUS after MMC therapy and presented massive pulmonary bleeding.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] two women [Treatment] MMC [Effect] HUS; massive pulmonary bleeding"}, {"id": "6529939_2_430", "context": "Alternating sinus rhythm and intermittent sinoatrial (S-A) block was observed in a 57-year-old woman, under treatment for angina with 80 mg propranolol daily.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment [Subject] a 57-year-old woman [Treatment] 80 mg propranolol daily. [Effect] Alternating sinus rhythm and intermittent sinoatrial (S-A) block"}, {"id": "9399776_4_431", "context": "These case reports provide evidence that 5-aminosalicylic acid may induce acute pancreatitis after long term treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Treatment] 5-aminosalicylic acid [Effect] acute pancreatitis"}, {"id": "17896898_4_432", "context": "During that time, he had also been taking amphetamine-dextroamphetamine (Adderall) on work days for his ADHD.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] taking [Subject] he [Treatment] amphetamine-dextroamphetamine (Adderall)"}, {"id": "9375469_2_433", "context": "Therefore, we diagnosed her eruption as contact dermatitis due to sodium bisulfite.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] diagnosed [Treatment] sodium bisulfite [Effect] r eruption as contact dermatitis"}, {"id": "3485422_1_434", "context": "Macular infarction after endophthalmitis treated with vitrectomy and intravitreal gentamicin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] endophthalmitis treated with vitrectomy and intravitreal gentamicin [Effect] Macular infarction"}, {"id": "11876387_2_435", "context": "Since tamoxifen therapy can induce endometrial disorders, surveillance schemes of women taking tamoxifen have been recommended.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Subject] women [Treatment] tamoxifen therapy [Effect] endometrial disorders"}, {"id": "11837564_2_436", "context": "Warfarin-associated bleeding complication saved life.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Warfarin [Effect] bleeding complication saved life"}, {"id": "8979664_1_437", "context": "METHODS/RESULTS: This paper presents a new case of rifabutin uveitis and a review of the various published reports to date.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presents [Subject] new case [Treatment] rifabutin [Effect] uveitis"}, {"id": "12860350_1_438", "context": "Acute abdomen due to endometriosis in a premenopausal woman taking tamoxifen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Treatment] tamoxifen [Effect] Acute abdomen due to endometriosis"}, {"id": "18094347_3_439", "context": "DISCUSSION: Methotrexate-induced papular eruption is rarely reported shortly after beginning methotrexate therapy in patients with acute exacerbation of collagen vascular diseases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patients with acute exacerbation of collagen vascular diseases [Treatment] Methotrexate [Effect] papular eruption"}, {"id": "15028964_5_440", "context": "We describe 3 patients on concomitant amiodarone and warfarin who developed amiodarone-induced thyrotoxicosis heralded by a significant decrease in warfarin requirements.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 3 patients [Treatment] concomitant amiodarone and warfarin [Effect] amiodarone-induced thyrotoxicosis [Adverse event] induced [Treatment] amiodarone [Effect] thyrotoxicosis"}, {"id": "25157214_3_441", "context": "The aim of this post-hoc analysis of data from a Phase III clinical trial (VISTA; NCT00298831) was to investigate the impact of antibiotics on recovery from rocuronium-induced NMB after administration of sugammadex for reversal, and compared the neuromuscular recovery in patients who received antibiotics preoperatively with those who did not.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] rocuronium [Effect] NMB [Potential therapeutic event] recovery [Treatment] antibiotics"}, {"id": "14693027_1_442", "context": "All patients had taken phenytoin for variable time periods (range 16-80 days; mean: 40) and were on the medication when the skin lesions first appeared.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] appeared [Subject] All patients [Treatment] phenytoin for variable time periods (range 16-80 days; mean: 40) [Effect] skin lesions"}, {"id": "9754850_3_443", "context": "One should therefore be aware of possible extrapyramidal side effects with olanzapine that are reduced compared to classical neuroleptic drugs but not completely eliminated.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] olanzapine [Effect] extrapyramidal side effects"}, {"id": "122410_1_444", "context": "A patient who had been treated with large doses of thyroid hormone for several years developed features of secondary hypothyroidism after thyroid hormone withdrawal.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient [Treatment] thyroid hormone withdrawal [Effect] secondary hypothyroidism"}, {"id": "18344455_5_445", "context": "This article discusses the possibility that simultaneous use of valproic acid, lamotrigine, and phenytoin could give this combination of toxicities and that concurrent viral infection may increase this risk.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] give [Treatment] valproic acid, lamotrigine, and phenytoin [Effect] toxicities; concurrent viral infection"}, {"id": "984862_2_446", "context": "A second patient with a similar glucose tolerance test result showed postprandial hyperglycemia when treated similarly with betamethasone valerate cream 0.1%.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] showed [Treatment] betamethasone valerate cream 0.1% [Effect] postprandial hyperglycemia"}, {"id": "3677571_1_447", "context": "Phenytoin-induced hypersensitivity reactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Phenytoin [Effect] hypersensitivity reactions."}, {"id": "9545161_1_448", "context": "A 54-year-old man developed TEN 4 weeks after beginning lamotrigine for complex partial seizures related to a glioblastoma multiforme brain tumor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 54-year-old man; complex partial seizures related to a glioblastoma multiforme brain tumor [Treatment] 4 weeks after beginning lamotrigine [Effect] TEN"}, {"id": "11881322_5_449", "context": "The occurrence of acute hepatitis is best known for ketoconazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] for [Treatment] ketoconazole [Effect] acute hepatitis"}, {"id": "6233326_2_450", "context": "Optic neuropathy developed in a patient with rheumatoid arthritis who had been receiving D-penicillamine for about 1 year.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with rheumatoid arthritis [Treatment] D-penicillamine for about 1 year [Effect] Optic neuropathy"}, {"id": "19520277_1_451", "context": "Stupor and fast activity on electroencephalography in a child treated with valproate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] a child [Treatment] valproate [Effect] Stupor; fast activity on electroencephalography"}, {"id": "7606071_5_452", "context": "During her third cycle, she again received cisplatin 100 mg/m2 over 30 minutes and developed palmar pruritus, urticaria, and edema.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] she [Treatment] cisplatin 100 mg/m2 over 30 minutes [Effect] palmar pruritus, urticaria, and edema"}, {"id": "9169264_3_453", "context": "The case of a patient with infectious mononucleosis treated with cephalexin who later showed a rash is presented and the previous literature is reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] showed [Subject] a patient with infectious mononucleosis [Treatment] cephalexin [Effect] rash"}, {"id": "9855339_1_454", "context": "After 1 week of nefazodone therapy the patient experienced headache, confusion, and \"gray areas\" in her vision, without abnormal ophthalmologic findings.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] patient; her [Treatment] After 1 week of nefazodone therapy [Effect] headache, confusion, and \"gray areas\" in her vision, without abnormal ophthalmologic findings"}, {"id": "8771575_4_455", "context": "Nitrofurantoin-induced pulmonary toxicity during pregnancy: a report of a case and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Nitrofurantoin [Effect] pulmonary toxicity"}, {"id": "18644535_1_456", "context": "Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Methylphenidate [Effect] enuresis"}, {"id": "14740795_4_457", "context": "To our knowledge, this is the first case report that demonstrates the occurrence of fever with low-dose amifostine therapy without the manifestation of accompanying rash or hypotension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurrence [Subject] the first case [Treatment] low-dose amifostine [Effect] fever"}, {"id": "3528096_1_458", "context": "Administration of excessive insulin induced hypoglycemia within 4 to 8 hours, followed by rebound hyperglycemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Administration of excessive insulin [Effect] hypoglycemia; rebound hyperglycemia"}, {"id": "17122225_5_459", "context": "In both cases, symptoms of autonomic instability and severe agitation started within hours of initiation of cyclobenzaprine and fully resolved within 3 days after discontinuing the proserotoninergic drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] started [Treatment] within hours of initiation of cyclobenzaprine [Effect] symptoms of autonomic instability and severe agitation"}, {"id": "10779995_2_460", "context": "Secondary leukemia in a child with neuroblastoma while on oral etoposide: what is the cause?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a child with neuroblastoma [Treatment] oral etoposide [Effect] Secondary leukemia"}, {"id": "20666169_1_461", "context": "Atorvastatin induced multiple organ failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Atorvastatin [Effect] multiple organ failure"}, {"id": "19697589_3_462", "context": "While serotonin syndrome has become more frequent in an overdose situation and when an interacting drug is given, the toxicity of SSIRs is less than that of most other psychiatric drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] SSIRs [Effect] serotonin syndrome"}, {"id": "7272895_1_463", "context": "A 73-year-old woman with non-Hodgkin's lymphoma had two episodes of severe, bilateral, sensori-neural hearing loss after vincristine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 73-year-old woman with non-Hodgkin's lymphoma [Treatment] vincristine therapy [Effect] two episodes of severe, bilateral, sensori-neural hearing loss"}, {"id": "10885900_2_464", "context": "Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] an advanced ovarian cancer patient [Treatment] carboplatin and gemcitabine [Effect] Severe hemolytic uremic syndrome"}, {"id": "2746565_2_465", "context": "Ulcerative proctitis in juvenile systemic lupus erythematosus after ibuprofen treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] ibuprofen [Effect] Ulcerative proctitis in juvenile systemic lupus erythematosus"}, {"id": "9161656_1_466", "context": "Acute asthma associated with sustained-release verapamil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] sustained-release verapamil [Effect] Acute asthma"}, {"id": "8749646_3_467", "context": "The renal insufficiency of three patients and the timing of the seizures implicate accumulation of ofloxacin as a contributing factor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] implicate [Subject] three patients [Treatment] accumulation of ofloxacin [Effect] renal insufficiency; seizures"}, {"id": "2413037_1_468", "context": "Hemolytic uremic syndrome in a patient on cis-platinum, vinblastine and bleomycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient [Treatment] cis-platinum, vinblastine and bleomycin [Effect] Hemolytic uremic syndrome"}, {"id": "15878975_1_469", "context": "A previous review described data on 15 patients who experienced acute hemoglobinemia or hemoglobinuria following anti-D IGIV administration for ITP or secondary thrombocytopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] 15 patients [Treatment] anti-D IGIV [Effect] acute hemoglobinemia or hemoglobinuria"}, {"id": "2042691_1_470", "context": "Amiodarone was discontinued, and thyrotoxicosis gradually abated.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] was discontinued [Treatment] Amiodarone [Effect] thyrotoxicosis gradually abated"}, {"id": "11700998_1_471", "context": "De novo absence status of late onset following withdrawal of lorazepam: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] withdrawal of lorazepam [Effect] De novo absence status of late onset"}, {"id": "19183077_1_472", "context": "Tenofovir-associated nephrotoxicity in two HIV-infected adolescent males.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] two HIV-infected adolescent males [Treatment] Tenofovir [Effect] nephrotoxicity"}, {"id": "17965530_1_473", "context": "Reports of colonic perforation as a result of the administration of calcium polystyrene sulfonate and sorbitol are rare.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] calcium polystyrene sulfonate; sorbitol [Effect] colonic perforation"}, {"id": "8749646_1_474", "context": "Improved awareness of and further investigation into the neurotoxic effects of ofloxacin may enhance its safe use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] ofloxacin [Effect] neurotoxic effects"}, {"id": "12013364_2_475", "context": "Atypical neuroleptic malignant syndrome associated with olanzapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] olanzapine [Effect] Atypical neuroleptic malignant syndrome"}, {"id": "20118434_4_476", "context": "OBJECTIVE: The authors described a case of interferon-induced psychosis as a framework to review the literature and discuss the decision to pursue antiviral treatment in psychiatrically ill patients with hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] psychiatrically ill patients with hepatitis C [Treatment] interferon [Effect] psychosis"}, {"id": "1495728_4_477", "context": "We believe that methotrexate represents a relatively effective alternative to surgery in patients with early unruptured tubal pregnancy, but suggest that it be used with caution in view of possible systemic toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caution [Subject] patients with early unruptured tubal pregnancy [Treatment] methotrexate [Effect] systemic toxicity"}, {"id": "16371793_12_478", "context": "After intravitreal injection of triamcinolone acetonide, cataract may rapidly develop in eyes that have been intensively treated, topically and systemically, by corticosteroids for several years.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Treatment] intravitreal injection of triamcinolone acetonide [Effect] cataract"}, {"id": "17277758_1_479", "context": "Acute endophthalmitis following intravitreal bevacizumab (Avastin) injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] intravitreal bevacizumab (Avastin) injection [Effect] Acute endophthalmitis"}, {"id": "25957434_3_480", "context": "We report a case of bullous eruption, one month after starting nicardipine and lercanidipine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] starting nicardipine and lercanidipine. [Effect] bullous eruption,"}, {"id": "1775411_2_481", "context": "Pulmonary fibrosis associated with nabumetone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] nabumetone [Effect] Pulmonary fibrosis"}, {"id": "19660974_2_482", "context": "The ability of tumor necrosis factor (TNF)-alpha inhibitors to impair pivotal pro-inflammatory host defenses may facilitate the development of disseminated cryptococcosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] tumor necrosis factor (TNF)-alpha inhibitors [Effect] disseminated cryptococcosis"}, {"id": "6529939_4_483", "context": "This was accepted as evidence for propranolol being the cause of this conduction disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] propranolol [Effect] conduction disorder"}, {"id": "1517501_4_484", "context": "We report a third case of a 6-week-old infant with Escherichia coli sepsis who received ampicillin and other antibiotics and subsequently developed TEN.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 6-week-old infant with Escherichia coli sepsis [Treatment] received ampicillin and other antibiotics [Effect] TEN"}, {"id": "18379937_2_485", "context": "PURPOSE: To report a case of bilateral anterior uveitis associated with ovulation induction therapy using clomiphene citrate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] case [Treatment] ovulation induction therapy using clomiphene citrate [Effect] bilateral anterior uveitis"}, {"id": "2979256_1_486", "context": "A 57-year-old woman presented with a 3-week history of dysphagia for solids, 6 months after starting treatment with nifedipine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] A 57-year-old woman [Treatment] nifedipine [Effect] dysphagia for solids"}, {"id": "15097937_1_487", "context": "Although combinations of belladonna, ergotamine, and phenobarbital have been used for medical treatment of menopausal symptoms since the 1960s, this is the first known case report of its association with anticonvulsant hypersensitivity syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] combinations of belladonna, ergotamine, and phenobarbital [Effect] anticonvulsant hypersensitivity syndrome"}, {"id": "2728526_2_488", "context": "Rifampin can be associated with severe adverse effects such as hepatitis, acute renal failure, hemolytic anemia, and thrombocytopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Rifampin [Effect] hepatitis, acute renal failure, hemolytic anemia, and thrombocytopenia"}, {"id": "2051906_2_489", "context": "It is believed that this is the first reported case of reversible azathioprine-induced cholestasis associated with histological evidence of bile duct injury.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] azathioprine [Effect] cholestasis"}, {"id": "9554064_4_490", "context": "We present a fatal case of subacute methanol toxicity with associated diffuse brain involvement, including bilateral putaminal necrosis and cerebral edema with ventricular compression.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] methanol [Effect] diffuse brain involvement, including bilateral putaminal necrosis and cerebral edema with ventricular compression"}, {"id": "9653495_6_491", "context": "Patients with inoperable or metastatic colorectal cancer were randomized to receive monthly FU 400 mg/m2/day plus LV 20 mg/m2/day as intravenous push daily for five days, or FU alone.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receive [Subject] Patients with inoperable or metastatic colorectal cancer [Treatment] monthly FU 400 mg/m2/day plus LV 20 mg/m2/day as intravenous push daily for five days"}, {"id": "9347384_3_492", "context": "The present report suggests that clarithromycin coadministration induces increased plasma carbamazepine concentrations, which may result in carbamazepine toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induces [Subject] carbamazepine [Treatment] clarithromycin; carbamazepine; carbamazepine [Effect] increased plasma carbamazepine concentrations; carbamazepine toxicity."}, {"id": "11850606_2_493", "context": "In this case, interferon alpha induced polymyositis and cardiomyopathy is diagnosed in a 33-yr-old male patient with history of chronic hepatitis B.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 33-yr-old male patient with history of chronic hepatitis B [Treatment] interferon alpha [Effect] polymyositis and cardiomyopathy"}, {"id": "16005413_2_494", "context": "To describe the potential for interaction between opioids and serotonergic antidepressants leading to the development of serotonin syndrome (SS), mechanism of the interaction, and the spectrum of SS in elderly residents of a long-term care facility.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] leading [Subject] elderly residents [Treatment] opioids; serotonergic antidepressants [Effect] serotonin syndrome"}, {"id": "480917_2_495", "context": "Erythema multiforme bullosum due to rifampicin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] rifampicin [Effect] Erythema multiforme bullosum"}, {"id": "2554727_4_496", "context": "We describe a patient with acute leukemia who developed Horner's syndrome and a severe demyelinating peripheral neuropathy leading to death after receiving high-dose cytosine arabinoside.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with acute leukemia [Treatment] high-dose cytosine arabinoside. [Effect] Horner's syndrome and a severe demyelinating peripheral neuropathy leading to death"}, {"id": "1509179_3_497", "context": "This profile should trigger a \"red flag\" as to the possibility of phenobarbital behavioral side effects or exacerbation of preexisting maladaptive behaviors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] trigger [Treatment] phenobarbital [Effect] behavioral side effects or exacerbation of preexisting maladaptive behaviors"}, {"id": "15580406_2_498", "context": "Retinal abnormalities, including retinal hemorrhage and \"cotton-wool\" spots, often occur within the first 8 weeks in the course of interferon therapy in patients with chronic hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Subject] patients with chronic hepatitis C [Treatment] interferon [Effect] Retinal abnormalities, including retinal hemorrhage and \"cotton-wool\" spots"}, {"id": "12581772_2_499", "context": "Rapamycin/sirolimus-induced pneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart-lung transplant recipient who developed a pulmonary infiltrate that reversed after ceasing SR therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Rapamycin/sirolimus [Effect] pneumonitis"}, {"id": "19104709_1_500", "context": "IFNalpha-induced recurrence of Graves' disease ten years after thyroidectomy in chronic viral hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] IFNalpha; ten years after thyroidectomy [Effect] recurrence of Graves' disease"}, {"id": "15795553_2_501", "context": "Risperidone withdrawal-related respiratory dyskinesia: a case diagnosed by spirography and fibroscopy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] Risperidone [Effect] respiratory dyskinesia"}, {"id": "17556909_2_502", "context": "Paralytic ileus in patients undergoing bortezomib treatment has been reported, although a definite attribution to bortezomib administration has not been established.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Subject] patients [Treatment] bortezomib treatment [Effect] Paralytic ileus"}, {"id": "11918514_4_503", "context": "Severe serotonin syndrome induced by mirtazapine monotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced by [Treatment] mirtazapine monotherapy [Effect] serotonin syndrome"}, {"id": "21712512_6_504", "context": "Three days after starting fluconazole, she developed polyuria and polydipsia and was found to have severe hyperglycemia, which led to the diagnosis of Cushing syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] Three days after starting fluconazole [Effect] polyuria and polydipsia and was found to have severe hyperglycemia, which led to the diagnosis of Cushing syndrome"}, {"id": "10566542_1_505", "context": "Postoperative hypocalcemic tetany caused by fleet phospho-soda preparation in a patient taking alendronate sodium: report of a case.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] patient [Treatment] fleet phospho-soda; alendronate sodium [Effect] hypocalcemic tetany"}, {"id": "7854541_3_506", "context": "Observations in our patient suggest that the leukoencephalopathy that developed in previously reported patients who received 5-fluorouracil and levamisole may have been caused at least partly by levamisole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] patients [Treatment] levamisole [Effect] leukoencephalopathy"}, {"id": "10589077_6_507", "context": "We describe the clinical response, as determined by increases in total Hb and decreased transfusion needs, in five patients with thalassemia intermedia treated with HU alone or in combination with SPB.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] in five patients with thalassemia intermedia [Treatment] HU alone or in combination with SPB [Effect] increases in total Hb and decreased transfusion needs"}, {"id": "19299370_1_508", "context": "According to the Naranjo et al. adverse-reaction probability scale, enoxaparin was the probable cause of hepatotoxicity in this patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] this patient [Treatment] enoxaparin [Effect] hepatotoxicity"}, {"id": "11788010_5_509", "context": "This is the first reported case of hepatolithiasis during octreotide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] octreotide [Effect] hepatolithiasis"}, {"id": "2781955_2_510", "context": "Treatment of amiodarone-induced thyrotoxicosis (AIT) with thionamide, lithium or radioactive iodine is ineffective.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] amiodarone [Effect] thyrotoxicosis (AIT) [Potential therapeutic event] Treatment [Treatment] thionamide, lithium or radioactive iodine"}, {"id": "2292051_2_511", "context": "Six patients with no previous signs or symptoms suggestive of coronary artery disease developed acute coronary ischemia/infarction shortly after cis-diamine-dichloroplatinum II (cisplatin) -based chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Six patients with no previous signs or symptoms suggestive of coronary artery disease [Treatment] cis-diamine-dichloroplatinum II (cisplatin) -based chemotherapy [Effect] acute coronary ischemia/infarction"}, {"id": "10891991_6_512", "context": "RESULTS: Replacing valproate with lamotrigine resulted in a decrease in serum testosterone concentrations in all 3 women.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Subject] all 3 women [Treatment] Replacing valproate with lamotrigine [Effect] a decrease in serum testosterone concentrations"}, {"id": "6744146_1_513", "context": "A 65-year-old woman, in the intensive care unit because of septic shock and acute renal failure, had a small-bowel obstruction due to Amphojel concretions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] A 65-year-old woman, in the intensive care unit because of septic shock and acute renal failure [Treatment] Amphojel [Effect] small-bowel obstruction; concretions"}, {"id": "1879988_3_514", "context": "After the first oral dose of propranolol, syncope developed together with atrioventricular block.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] oral dose of propranolol [Effect] syncope; atrioventricular block"}, {"id": "19764104_2_515", "context": "Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an advanced hepatocellular carcinoma patient [Treatment] Sorafenib [Effect] tumor lysis syndrome"}, {"id": "10660641_9_516", "context": "The symptoms did not recur during the 36 months of itraconazole treatment after discharge, and it was concluded that ITCZ was effective for A. flavus hypertrophic pachymeningitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] effective [Treatment] the 36 months of itraconazole treatment after discharge [Effect] The symptoms did not recur"}, {"id": "14679124_3_517", "context": "A prospective randomized clinical trial was implemented to assess whether the concomitant or the sequential addition of tamoxifen to chemotherapy provides improved clinical benefit in the adjuvant treatment of breast cancer in postmenopausal patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] provides [Subject] postmenopausal patients [Treatment] the concomitant or the sequential addition of tamoxifen to chemotherapy [Effect] improved clinical benefit in the adjuvant treatment"}, {"id": "11328247_2_518", "context": "Increased libido in a woman treated with fluvoxamine: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a woman [Treatment] fluvoxamine [Effect] Increased libido"}, {"id": "2935070_3_519", "context": "In the following case report, a patient developed acute interstitial nephritis with renal failure and exfoliative dermatitis following ampicillin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] patient [Treatment] ampicillin therapy [Effect] acute interstitial nephritis with renal failure and exfoliative dermatitis"}, {"id": "21417793_10_520", "context": "Severe symptoms associated with serotonin toxicity were shown to be uncommon in patients receiving linezolid and selected serotonin reuptake inhibitors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] patients [Treatment] linezolid and selected serotonin reuptake inhibitors [Effect] Severe symptoms associated with serotonin toxicity"}, {"id": "10099659_9_521", "context": "We describe the side effects of 5-FU in a colon cancer patient who suffered severe mucositis, desquamating dermatitis, prolonged myelosuppression, and neurologic toxicity that required admission to the intensive care unit.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Subject] colon cancer patient who suffered severe mucositis, desquamating dermatitis, prolonged myelosuppression, and neurologic toxicity that required admission to the intensive care unit [Treatment] 5-FU [Effect] side effects"}, {"id": "110153_1_522", "context": "There have been many reports of probable lithium-induced organic brain syndromes occurring when serum lithium levels are within or close to the therapeutic range.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] lithium; when serum lithium levels are within or close to the therapeutic range [Effect] organic brain syndromes"}, {"id": "16623611_3_523", "context": "The patient was enrolled in a weight-loss clinic, and his diabetes medications were adjusted.Subsequently, olanzapine was discontinued because of weight gain and uncontrolled diabetes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] because [Subject] patient [Treatment] olanzapine was discontinued [Effect] weight gain and uncontrolled diabetes"}, {"id": "4004433_4_524", "context": "While most physicians are aware of heparin-induced thrombocytopenia and skin necrosis, the association of heparin and hyperkalemia is less well recognized.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] heparin [Effect] thrombocytopenia and skin necrosis"}, {"id": "16176119_2_525", "context": "Gefitinib (IRESSA, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, has been approved in several countries for the treatment of advanced non-small-cell lung cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Gefitinib"}, {"id": "19520277_2_526", "context": "The case of a 4-year-old girl with valproate-induced stupor and electroencephalographic pattern of increased fast activity is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 4-year-old girl [Treatment] valproate [Effect] stupor and electroencephalographic pattern of increased fast activity"}, {"id": "16421117_2_527", "context": "Prior to surgery, levodopa induced dyskinesia had improved (< or = 50%) under treatment with amantadine (400 mg/day, po) in all three patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] improved [Subject] all three patients [Treatment] treatment with amantadine (400 mg/day, po) [Effect] levodopa induced dyskinesia"}, {"id": "8384030_3_528", "context": "Foscarnet-induced severe hypomagnesemia and other electrolyte disorders.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Foscarnet [Effect] hypomagnesemia and other electrolyte disorders"}, {"id": "667809_1_529", "context": "A case is reported of a child with fatal pulmonary fibrosis following BCNU therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] child with fatal pulmonary fibrosis [Treatment] BCNU therapy [Effect] fatal pulmonary fibrosis"}, {"id": "15729090_3_530", "context": "A 64-year-old man with schizophrenia developed myoclonic jerks when given higher doses of quetiapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 64-year-old man with schizophrenia [Treatment] higher doses of quetiapine [Effect] myoclonic jerks"}, {"id": "15494638_18_531", "context": "The etiology of neurotoxicity in our two patients remains unclear; however, as CAP is rapidly metabolized to 5-FU in patients with normal liver function, it is likely that 5-FU or its active metabolites (fluoro-beta-alanine) were contributing factors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] contributing [Subject] two patients [Treatment] 5-FU or its active metabolites (fluoro-beta-alanine) [Effect] neurotoxicity"}, {"id": "19034138_2_532", "context": "CONCLUSIONS: Amantadine can cause reversible corneal edema but can irreversibly reduce the density of endothelial cells.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Amantadine [Effect] reversible corneal edema"}, {"id": "1635565_1_533", "context": "After gastric-outlet obstruction was recognized in several infants who received prostaglandin E1, we studied the association between the drug and this complication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] received [Subject] several infants [Treatment] prostaglandin E1 [Effect] gastric-outlet obstruction"}, {"id": "10981493_2_534", "context": "A wide variety of adverse central nervous system effects have been reported in association with propafenone; dizziness is the most common.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] propafenone [Effect] adverse central nervous system effects; dizziness"}, {"id": "21712512_10_535", "context": "Iatrogenic Cushing syndrome has been reported in patients with CF treated concomitantly, and for extended duration, with inhaled corticosteroids and CYP3A4 inhibitors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Subject] patients with CF [Treatment] inhaled corticosteroids and CYP3A4 inhibitors [Effect] Iatrogenic Cushing syndrome"}, {"id": "17671884_1_536", "context": "Red blood cell anemia in a patient with pemphigus vulgaris induced by the use of mycophenolate mofetil and prednisone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with pemphigus vulgaris [Treatment] mycophenolate mofetil and prednisone [Effect] Red blood cell anemia"}, {"id": "1765991_1_537", "context": "Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] by [Subject] a patient with rheumatoid arthritis [Treatment] interferon-gamma [Effect] systemic lupus erythematosus"}, {"id": "16997047_2_538", "context": "In this case, unlike those previously reported, hyponatremia recurred 5 months after switching from citalopram to mirtazapine, which is believed to be a safe antidepressant.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] switching from citalopram to mirtazapine [Effect] hyponatremia"}, {"id": "16945058_2_539", "context": "This report describes a case of acute compromise of renal function associated with hypotension in a 7-year-old boy treated with the ACE inhibitor lisinopril and the ARB losartan.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a 7-year-old boy [Treatment] ACE inhibitor lisinopril and the ARB losartan [Effect] acute compromise of renal function; hypotension"}, {"id": "9302445_4_540", "context": "We report a male patient with advanced AIDS who developed hypercalcemia 2 weeks after institution of rhGH therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a male patient with advanced AIDS [Treatment] 2 weeks after institution of rhGH therapy [Effect] hypercalcemia"}, {"id": "1592841_2_541", "context": "RESULTS: Both patients experienced a previously unreported side effect--falling backward--associated with bupropion use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] Both patients [Treatment] bupropion [Effect] falling backward"}, {"id": "150825_2_542", "context": "A second episode of jaundice followed the intravaginal administration of a mixture of furazolidone and nifuroxime.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] followed [Treatment] intravaginal administration of a mixture of furazolidone and nifuroxime [Effect] jaundice"}, {"id": "18294121_2_543", "context": "Clinicians should be aware that an erythematous and exfoliative rash may be induced by temozolomide, and be familiar with the pharmacologic and supportive measures necessary for its treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] temozolomide [Effect] an erythematous and exfoliative rash"}, {"id": "8255797_1_544", "context": "Captopril-induced bone marrow suppression in two cardiac patients with trisomy 21.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] two cardiac patients with trisomy 21 [Treatment] Captopril [Effect] bone marrow suppression"}, {"id": "9796135_1_545", "context": "A 65-year-old woman with angina pectoris presented with syncope after sublingual ingestion of isosorbide dinitrate (5 mg).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] A 65-year-old woman with angina pectoris [Treatment] sublingual ingestion of isosorbide dinitrate (5 mg) [Effect] syncope"}, {"id": "1860779_1_546", "context": "The authors present a case study of a mentally healthy man who repeatedly experienced short-lived, obsessional-like suicidal ideas and images after ingestion of the anti-fungal drug ketoconazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] a mentally healthy man [Treatment] ingestion of the anti-fungal drug ketoconazole [Effect] short-lived, obsessional-like suicidal ideas and images"}, {"id": "1356045_2_547", "context": "Flaccid quadriparesis was noted after discontinuation of vecuronium.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] noted [Treatment] vecuronium [Effect] Flaccid quadriparesis"}, {"id": "17444802_2_548", "context": "AIMS: The aim of this study was to report on the effectiveness and tumor side effects of topical interferon (INF) alpha 2-beta in a case of conjunctiva-cornea intraepithelial neoplasia (CIN) of a patient that rejected any surgical procedure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effects [Subject] conjunctiva-cornea intraepithelial neoplasia (CIN) of a patient that rejected any surgical procedure [Treatment] topical interferon (INF) alpha 2-beta [Effect] tumor side effects"}, {"id": "17044380_1_549", "context": "Herein is reported an unusual case of coexistent warfarin-induced skin necrosis and heparin-induced thrombocytopenia following mitral valve replacement for thromboembolic phenomena associated with marantic endocarditis and bronchial adenocarcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] warfarin [Effect] skin necrosis [Adverse event] induced [Treatment] heparin [Effect] thrombocytopenia"}, {"id": "17026827_2_550", "context": "We present a case of severe unilateral posterior scleritis associated with zoledronic acid administration that was recognized and treated in a timely manner.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] zoledronic acid [Effect] severe unilateral posterior scleritis"}, {"id": "19567656_5_551", "context": "The patient's other comorbidities and medications have not been suggested as possible interactions with sertraline that can cause rhabdomyolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] sertraline [Effect] rhabdomyolysis"}, {"id": "11030530_1_552", "context": "L-asparaginase-provoked seizures as singular expression of central nervous toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] provoked [Treatment] L-asparaginase [Effect] seizures as singular expression of central nervous toxicity"}, {"id": "7351000_1_553", "context": "Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] patients with ovarian carcinoma [Treatment] long-term treatment with Treosulfan (= dihydroxybusulfan) [Effect] Acute non-lymphocytic leukemia"}, {"id": "15694139_7_554", "context": "Children treated with thalidomide should undergo regular neurophysiologic studies in order to detect presymptomatic or progressive peripheral neuropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] detect [Subject] Children [Treatment] thalidomide [Effect] presymptomatic or progressive peripheral neuropathy"}, {"id": "11174414_2_555", "context": "Nevirapine is a non-nucleoside reverse transcriptase inhibitor widely used in combination with other antiretroviral agents for the treatment of HIV infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Nevirapine is a non-nucleoside reverse transcriptase inhibitor widely used in combination with other antiretroviral agents"}, {"id": "17260498_4_556", "context": "The case is presented of a 72-year-old man with hormone-refractory prostate cancer and weekly administration of 30 mg/m2 docetaxel who developed subacute interstitial pneumonitis-related pulmonary fibrosis after seven doses and died despite mechanical ventilation and high-dose corticosteroid treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 72-year-old man with hormone-refractory prostate cancer [Treatment] weekly administration of 30 mg/m2 docetaxel; seven doses; despite mechanical ventilation and high-dose corticosteroid treatment [Effect] subacute interstitial pneumonitis-related pulmonary fibrosis; and died"}, {"id": "10732843_5_557", "context": "In this case, it was suspected that a combination of cigarette smoking, pulmonary fibrosis, and low-dose methotrexate therapy might have promoted the development of lung cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] promoted [Subject] pulmonary fibrosis [Treatment] low-dose methotrexate therapy [Effect] the development of lung cancer"}, {"id": "21712512_1_558", "context": "Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease treated with inhaled corticosteroids and a moderate CYP3A4 inhibitor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] onset [Subject] a patient with cystic fibrosis-related liver disease [Treatment] inhaled corticosteroids and a moderate CYP3A4 inhibitor [Effect] iatrogenic adrenal insufficiency"}, {"id": "1722991_2_559", "context": "Heparin-associated thrombocytopenia and thrombosis is a severe complication of systemic heparin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Heparin [Effect] thrombocytopenia and thrombosis"}, {"id": "10891991_7_560", "context": "The polycystic changes disappeared from the ovaries in 2 of the women after valproate therapy was discontinued, and the 2 women who had gained weight and developed amenorrhea while being treated with valproate lost weight and resumed menstruating after the change in medication.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] disappeared [Subject] 2 of the women [Treatment] after valproate therapy was discontinued [Effect] polycystic changes disappeared from the ovaries; lost weight and resumed menstruating [Adverse event] while [Subject] 2 women [Treatment] valproate [Effect] gained weight and developed amenorrhea"}, {"id": "11225532_2_561", "context": "The cause of his bleeding was a severe thrombocytopoaenia, induced by chronic ingestion of quinine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] chronic ingestion of quinine [Effect] thrombocytopoaenia"}, {"id": "16882112_3_562", "context": "The concomitant use of antidepressant drugs associated with lithium as a co-adjuvant seems to increase the risk of this adverse reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increase [Treatment] concomitant use of antidepressant drugs associated with lithium as a co-adjuvant [Effect] adverse reaction"}, {"id": "2554727_3_563", "context": "Peripheral nervous system disturbances caused by cytosine arabinoside have rarely been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] cytosine arabinoside [Effect] Peripheral nervous system disturbances"}, {"id": "9315405_1_564", "context": "We report an unusually short lived and asymptomatic episode of severe cisplatin-induced renal tubular salt wasting in a fit 41-year-old patient with malignant teratoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a fit 41-year-old patient with malignant teratoma [Treatment] cisplatin [Effect] renal tubular salt wasting"}, {"id": "10102531_1_565", "context": "This case suggests that BH-AC, a derivative of cytosine arabinoside (1-beta-D-arabinofuranosylcytosine) could be a cause of reversible encephalopathy syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] This case [Treatment] BH-AC, a derivative of cytosine arabinoside (1-beta-D-arabinofuranosylcytosine) [Effect] reversible encephalopathy syndrome"}, {"id": "11816261_5_566", "context": "She was administered metoclopramide because of nausea and, within 2 hours, developed agitation, dysarthria, diaphoresis, and a movement disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] metoclopramide [Effect] agitation, dysarthria, diaphoresis, and a movement disorder"}, {"id": "448845_4_567", "context": "This article describes two cases of aplastic anemia, at least one of which was almost certainly induced by the use of methazolamide, and one case of agranulocytosis related to the use of methazolamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] two cases [Treatment] methazolamide [Effect] aplastic anemia [Adverse event] related [Treatment] methazolamide [Effect] agranulocytosis"}, {"id": "12584153_3_568", "context": "Amprenavir is a human immunodeficiency virus-1 (HIV-1) protease inhibitor intended to be used to treat HIV-infected children.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treat [Subject] children [Treatment] Amprenavir"}, {"id": "18094347_4_569", "context": "Methotrexate-induced papular eruption following treatment of psoriasis has not been previously reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Methotrexate [Effect] papular eruption"}, {"id": "19733945_2_570", "context": "On day 7 of linezolid treatment, the patient developed severe pruritus, macular rash, facial edema, eosinophilia, marked increase in serum creatinine level, and mild hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] the patient [Treatment] linezolid [Effect] pruritus, macular rash, facial edema, eosinophilia, marked increase in serum creatinine level; hepatitis"}, {"id": "8181372_2_571", "context": "We report a fatal case of acute interstitial pneumonitis in a patient treated with carmustine (BCNU) for a brain tumor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated with [Subject] a patient; for a brain tumor [Treatment] carmustine (BCNU) [Effect] acute interstitial pneumonitis"}, {"id": "10749332_4_572", "context": "The three reported cases demonstrate that troglitazone is an idiosyncratic hepatotoxin that can lead to irreversible liver injury.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] lead [Subject] three reported cases [Treatment] troglitazone [Effect] irreversible liver injury"}, {"id": "7814182_1_573", "context": "High-grade atrioventricular block during dipyridamole stress testing.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] dipyridamole stress testing [Effect] High-grade atrioventricular block"}, {"id": "16453964_1_574", "context": "We describe a case of intraoperative gelatine-induced anaphylaxis whose diagnosis was delayed as the use of gelatine during surgical procedures was omitted for two times in patient's medical records.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] intraoperative gelatine [Effect] anaphylaxis"}, {"id": "2406680_3_575", "context": "The case of a 29-year-old man suffering from falciparum malaria disease who got a reversible hearing loss from quinine therapy is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] got [Subject] a 29-year-old man suffering from falciparum malaria disease [Treatment] quinine [Effect] reversible hearing loss"}, {"id": "7893301_3_576", "context": "The cases of two asthmatic patients who became hypokalemic after inhalation of normal doses of albuterol are presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] two asthmatic patients [Treatment] inhalation of normal doses of albutero [Effect] hypokalemic"}, {"id": "19537383_4_577", "context": "This article presents a case of an atypical localized cutaneous eruption with an unusual course and protracted resolution time associated with sorafenib therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] sorafenib therapy [Effect] an atypical localized cutaneous eruption with an unusual course and protracted resolution time"}, {"id": "16480245_1_578", "context": "METHOD: We describe two patients who presented with diabetic ketoacidosis after treatment with quetiapine and risperidone, respectively.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] two patients [Treatment] quetiapine and risperidone [Effect] diabetic ketoacidosis"}, {"id": "9855339_4_579", "context": "We suspect that nefazodone inhibits metabolism of tacrolimus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] inhibits [Treatment] nefazodone [Effect] metabolism of tacrolimus"}, {"id": "9184269_4_580", "context": "Our review of 194 RA patients and 38 PsA patients receiving MTX has identified four RA patients and one PsA patient with MTX-induced pneumonitis, giving a prevalence of 2.1% and 0.03%, respectively.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] 194 RA patients and 38 PsA patients receiving MTX has identified four RA patients and one PsA patient [Treatment] MTX [Effect] pneumonitis"}, {"id": "12862258_1_581", "context": "A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an Indian mid-borderline leprosy patient [Treatment] dapsone [Effect] agranulocytosis"}, {"id": "16498048_1_582", "context": "Autoimmune thyroid disease is a common side-effect of interferon-alpha (IFN-alpha) treatment of viral hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side-effect [Treatment] interferon-alpha (IFN-alpha) [Effect] Autoimmune thyroid disease"}, {"id": "15866658_4_583", "context": "The side effects of MMF, such as bone marrow toxicity, have been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] MMF [Effect] bone marrow toxicity"}, {"id": "15727358_1_584", "context": "He developed a late secondary infection in some sites treated with imiquimod.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] He [Treatment] imiquimod [Effect] late secondary infection"}, {"id": "19104709_3_585", "context": "We report the case of a 51-year-old man in whom IFN-alpha treatment was followed by recurrence of Graves' disease 10 years after thyroidectomy was performed and the patient was declared cured.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] followed [Subject] a 51-year-old man [Treatment] IFN-alpha treatment; 10 years after thyroidectomy [Effect] recurrence of Graves' disease"}, {"id": "9407188_2_586", "context": "We report 2 cases of maculopapular eruption and fever in patients infected with human immunodeficiency virus (HIV) on the 2nd day of first administration of ritonavir, a protease inhibitor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] infected [Subject] patients [Treatment] ritonavir [Effect] maculopapular eruption and fever"}, {"id": "18344734_2_587", "context": "We report the case of a woman who developed photo-onycholysis on multiple nails after uptake of olanzapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a woman [Treatment] uptake of olanzapine [Effect] photo-onycholysis on multiple nails"}, {"id": "6733633_2_588", "context": "Cimetidine is a rare cause of drug-induced fever.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Cimetidine [Effect] fever"}, {"id": "19745701_2_589", "context": "Reversible methotrexate-associated lymphoproliferative disorder resembling advanced gastric cancer in a patient with rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a patient with rheumatoid arthritis [Treatment] methotrexate [Effect] lymphoproliferative disorder"}, {"id": "11077455_5_590", "context": "The field defects and some electrophysiological abnormalities persist when vigabatrin therapy is withdrawn.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] persist [Treatment] vigabatrin therapy is withdrawn [Effect] field defects and some electrophysiological abnormalities persist"}, {"id": "9177620_1_591", "context": "A possible case of carbamazepine induced pancreatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] A possible case [Treatment] carbamazepine [Effect] pancreatitis"}, {"id": "24791374_4_592", "context": "Subsequent to the first dose of mirtazapine the patient experienced seizures, bradycardia and prolonged QRS as well as QTc intervals on EKG.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Subsequent [Subject] the patient [Treatment] mirtazapine [Effect] seizures, bradycardia and prolonged QRS as well as QTc intervals on EKG"}, {"id": "18665833_1_593", "context": "Stuttering priapism complicating warfarin therapy in a patient with protein C deficiency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient with protein C deficiency [Treatment] warfarin [Effect] Stuttering priapism"}, {"id": "12187348_6_594", "context": "She had been on a combined treatment of steroid and lobenzarit disodium for the first 3 years, and then continued with a combined treatment of steroid and bucillamine for the following years until she was found to have pulmonary tuberculosis, at which time the steroid was suspended 10 months before she visited the authors' clinic.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] steroid and lobenzarit disodium for the first 3 years, and then continued with a combined treatment of steroid and bucillamine for the following years [Effect] pulmonary tuberculosis"}, {"id": "24791374_2_595", "context": "We describe a rare case of severe drug-drug interaction between propafenone and mirtazapine leading to propafenone toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] leading [Subject] a rare case [Treatment] propafenone and mirtazapine [Effect] propafenone toxicity"}, {"id": "9512187_1_596", "context": "Because the combination of bleomycin and vinca alkaloids is commonly used for the treatment of AIDS-related Kaposi's sarcoma, clinicians should be aware of the risk of provoking acral necrosis in patients who develop Raynaud's phenomenon under chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] provoking [Treatment] bleomycin; vinca alkaloids [Effect] acral necrosis; Raynaud's phenomenon"}, {"id": "12875956_3_597", "context": "The psychotic behavior resolved completely soon after the discontinuation of levetiracetam.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Treatment] discontinuation of levetiracetam"}, {"id": "15034704_3_598", "context": "Male volunteers ( n=12) participated in a randomised, two-period, crossover trial evaluating the effect of multiple doses of 600 mg rifampicin once daily for 7 days on repaglinide metabolism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] on [Subject] Male volunteers ( n=12) [Treatment] multiple doses of 600 mg rifampicin once daily for 7 days [Effect] repaglinide metabolism"}, {"id": "17671884_9_599", "context": "This report suggests that anemia can occur due to MMF, in particular when it is given with prednisone, a side effect well documented in the transplantation literature when the triple combination of MMF, cyclosporine and prednisone is used.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] MMF; prednisone [Effect] anemia"}, {"id": "24163322_4_600", "context": "Warfarin was initiated for deep vein thrombosis prophylaxis due to the patient's inability to ambulate.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prophylaxis [Subject] patient's inability to ambulate [Treatment] Warfarin was initiated for deep vein thrombosis"}, {"id": "16432996_4_601", "context": "We report a case with chronic hepatitis C (CHC) who developed sarcoidosis after the treatment by interferon alpha and ribavirin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] treatment by interferon alpha and ribavirin [Effect] sarcoidosis"}, {"id": "15785053_2_602", "context": "The relation between tacrolimus treatment and staining was suggested by the appearance of pigmentation during topical tacrolimus treatment and its clinical disappearance when treatment was stopped.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] topical tacrolimus [Effect] appearance of pigmentation"}, {"id": "8239963_3_603", "context": "Though hypotension, dry mouth, and constipation are well-documented possible adverse effects, the possibility of clonidine-induced bradycardia is less well recognized and is rare.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] clonidine [Effect] bradycardia"}, {"id": "16540070_3_604", "context": "Several hypersensitivity reactions to cloxacillin have been reported, although IgE-mediated allergic reactions to the drug are rare and there is little information about possible tolerance to other semisynthetic penicillins or cephalosporins in patients with cloxacillin allergy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reactions to [Treatment] cloxacillin [Effect] hypersensitivity"}, {"id": "17547624_1_605", "context": "Brugada type electrocardiographic changes induced by concomitant use of lithium and propafenone in patient with Wolff-Parkinson-White syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patient with Wolff-Parkinson-White syndrome [Treatment] concomitant use of lithium and propafenone [Effect] Brugada type electrocardiographic changes"}, {"id": "17404582_2_606", "context": "Docetaxel-induced Meibomian duct inflammation and blockage leading to chalazion formation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Docetaxel [Effect] Meibomian duct inflammation and blockage leading to chalazion formation"}, {"id": "15628319_1_607", "context": "Allergic side effects of AZA are rare, and reported allergic skin eruptions from AZA are very limited in Japan.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] AZA [Effect] allergic skin eruptions"}, {"id": "11212595_1_608", "context": "Quetiapine and obsessive-compulsive symptoms (OCS): case report and review of atypical antipsychotic-induced OCS.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] antipsychotic [Effect] obsessive-compulsive symptoms (OCS); OCS"}, {"id": "17852449_1_609", "context": "Outcome of pregnancy in women treated with all-trans retinoic acid; a case report and review of literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] pregnancy in women [Treatment] all-trans retinoic acid"}, {"id": "19687711_6_610", "context": "The potential development of SJS/TEN, a severe life-threatening illness, emphasizes the need for judicious use of TMP-Sx and close monitoring and follow-up for patients who were given TMP-Sx for SSTIs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] patients [Treatment] TMP-Sx [Effect] SJS/TEN, a severe life-threatening illness"}, {"id": "665845_1_611", "context": "A case history of a 15-year-old boy who developed incapacitating tardive dyskinesia that resolved during treatment with deanol is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Subject] a 15-year-old boy [Treatment] deanol [Effect] incapacitating tardive dyskinesia"}, {"id": "12187348_2_612", "context": "Drug-induced mammary hyperplasias have been reported as rare complications of D-penicillamine and Neothetazone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Drug; D-penicillamine and Neothetazone [Effect] mammary hyperplasias"}, {"id": "10482872_2_613", "context": "The purpose of this report is to document a new case of in utero CP exposure with multiple congenital anomalies and to establish an apparent CP embryopathy phenotype.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exposure [Treatment] CP [Effect] multiple congenital anomalies; CP embryopathy"}, {"id": "18176653_2_614", "context": "AIM: The aim of this article is to present the clinical characteristics and management of an oral adverse effect stemming from the use of the antiretroviral medication Nevirapine (NVP).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] antiretroviral medication Nevirapine (NVP) [Effect] adverse effect"}, {"id": "16484748_1_615", "context": "A 27-year-old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim (TMP)-sulfamethoxazole (SMX) treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] A 27-year-old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia [Treatment] trimethoprim (TMP)-sulfamethoxazole (SMX) [Effect] fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia"}, {"id": "14674674_4_616", "context": "Treatment with infliximab is known to produce an increase of autoantibodies (antinuclear antibodies, anti-double-stranded DNA), but not clinical disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] produce [Treatment] Treatment with infliximab [Effect] increase of autoantibodies (antinuclear antibodies, anti-double-stranded DNA), but not clinical disease"}, {"id": "16882112_2_617", "context": "Serotonin syndrome, which occurs as a result of enhanced serotonin concentration in the central nervous system, is a well-known adverse effect of serotonin-active medications.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurs [Treatment] serotonin-active medications [Effect] Serotonin syndrome,"}, {"id": "11424102_5_618", "context": "Despite the risk of needle-track seeding, PEI remains useful in the treatment of HCC.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] remains [Treatment] PEI"}, {"id": "20412003_4_619", "context": "Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a pediatric patient [Treatment] Trimethoprim-sulfamethoxazole [Effect] hepatotoxicity"}, {"id": "10589077_3_620", "context": "Prolonged responses were achieved with low doses of HU (3-10 mg/kg/day) and higher doses were associated with mild reversible hematologic or hepatic toxicity and no further increases in Hb.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] HU (3-10 mg/kg/day) and higher doses [Effect] mild reversible hematologic or hepatic toxicity and no further increases in Hb [Adverse event] achieved [Treatment] low doses of HU [Effect] Prolonged responses"}, {"id": "8276031_1_621", "context": "Imidazoline intoxication in children.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] intoxication [Subject] children [Treatment] Imidazoline [Effect] Imidazoline intoxication"}, {"id": "19782276_10_622", "context": "Concomitant administration of cytarabine might have affected his liver function and there might have been interaction between the drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] affected [Treatment] cytarabine [Effect] liver function"}, {"id": "7351000_4_623", "context": "The probability of developing acute leukemia in this study was not significantly correlated to the total cumulative dosage of Treosulfan.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developing [Treatment] the total cumulative dosage of Treosulfan [Effect] acute leukemia"}, {"id": "1584367_1_624", "context": "Intraventricular vancomycin-induced cerebrospinal fluid eosinophilia: report of two patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] two patients. [Treatment] Intraventricular vancomycin [Effect] cerebrospinal fluid eosinophilia"}, {"id": "3438585_6_625", "context": "This case supports the view that in gold-induced pneumonitis a prolonged treatment with corticosteroids may be necessary, as lung function continued to improve.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] as [Treatment] a prolonged treatment with corticosteroids"}, {"id": "11443640_1_626", "context": "Massive plasmocytosis due to methimazole-induced bone marrow toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] methimazole [Effect] bone marrow toxicity; Massive plasmocytosis"}, {"id": "15331204_4_627", "context": "RESULTS: After 4- to 14-month period of therapy with the combination of indapamide (2.5 mg/day) and fosinopril (10 mg/day) in three patients and 6-month period of monotherapy with indapamide (2.5 mg/day) in one patient, glucose levels of all patients increased and achieve criteria of diabetes diagnoses.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] achieve [Subject] one patient [Treatment] 6-month period of monotherapy with indapamide (2.5 mg/day) [Effect] glucose levels of all patients increased and achieve criteria of diabetes diagnoses [Adverse event] achieve [Subject] three patients [Treatment] After 4- to 14-month period of therapy with the combination of indapamide (2.5 mg/day) and fosinopril (10 mg/day) [Effect] glucose levels of all patients increased and achieve criteria of diabetes diagnoses"}, {"id": "6453500_1_628", "context": "A reversible toxic liver damage was observed in a non-alcoholic woman treated with disulfiram.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] damage [Subject] a non-alcoholic woman [Treatment] disulfiram [Effect] reversible toxic liver damage"}, {"id": "10904571_1_629", "context": "A 60 year-old woman with chronic renal failure developed acute proximal muscle weakness after receiving a regular dosage of colchicine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 60 year-old woman with chronic renal failure [Treatment] regular dosage of colchicine [Effect] acute proximal muscle weakness"}, {"id": "9824032_2_630", "context": "The cause of these previously unreported side effects of niacin therapy is uncertain but may be related to prostaglandin-mediated vasodilatation, hyperalgesia of sensory nerve receptors, and potentiation of inflammation in the gingiva with referral of pain to the teeth.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] niacin [Effect] prostaglandin-mediated vasodilatation, hyperalgesia of sensory nerve receptors, and potentiation of inflammation in the gingiva with referral of pain to the teeth"}, {"id": "16404563_4_631", "context": "Nocardia is an important opportunistic infectious agent in immunocompromised hosts, i.e. in patients taking corticosteroids.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] infectious agent [Subject] immunocompromised hosts [Treatment] corticosteroids [Effect] Nocardia"}, {"id": "8835752_1_632", "context": "Hepatobiliary disorders associated with orally administered terbinafine have rarely been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] orally administered terbinafine [Effect] Hepatobiliary disorders"}, {"id": "3790438_2_633", "context": "We report a patient in whom the anti-depressant trazodone hydrochloride (Molipaxin, Roussel), a serotonin antagonist, provoked generalized pustular psoriasis (GPP).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] provoked [Subject] a patient [Treatment] trazodone hydrochloride (Molipaxin, Roussel) [Effect] generalized pustular psoriasis (GPP)"}, {"id": "11703329_1_634", "context": "Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] can [Treatment] Early recognition of hereditary motor and sensory neuropathy type 1"}, {"id": "19299370_3_635", "context": "Probable enoxaparin-induced hepatotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] enoxaparin [Effect] hepatotoxicity"}, {"id": "12581772_1_636", "context": "Interstitial pneumonitis associated with sirolimus: a dilemma for lung transplantation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] sirolimus [Effect] Interstitial pneumonitis"}, {"id": "19667003_15_637", "context": "He had also developed elevated serum ammonia levels while on valproic acid.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] He [Treatment] valproic acid [Effect] elevated serum ammonia levels"}, {"id": "16641839_4_638", "context": "Cutaneous rashes and eruptions can be caused by many medications, including carbamazepine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] carbamazepine [Effect] Cutaneous rashes and eruptions"}, {"id": "8140860_5_639", "context": "In this case, the increase in the INR value with associated bruising after the addition of amoxycillin suggests a drug interaction between acenocoumarol and amoxycillin, other possible causes having been eliminated.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] amoxycillin [Effect] the increase in the INR value with associated bruising"}, {"id": "19897274_4_640", "context": "Oncologists supervising future clinical trials for lung cancer should be alert to the fact that sorafenib can potentially induce serious interstitial lung disease, although this might depend on racial differences.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Treatment] sorafenib [Effect] serious interstitial lung disease"}, {"id": "19667003_3_641", "context": "SUMMARY: A 26-year-old man with bipolar disorder, seizures, and mild mental retardation secondary to a traumatic brain injury began treatment with carbamazepine for aggression and seizure control.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] A 26-year-old man with bipolar disorder, seizures, and mild mental retardation secondary to a traumatic brain injury [Treatment] carbamazepine"}, {"id": "18676387_3_642", "context": "Serotonin toxicity precipitated by fentanyl is unusual and has not previously been described in combination with SSRIs in the perioperative setting.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitated [Treatment] fentanyl [Effect] Serotonin toxicity"}, {"id": "16889287_1_643", "context": "It may cause a severe adverse drug reaction with multiorgan involvement known as dapsone hypersensitivity syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] dapsone [Effect] hypersensitivity syndrome; a severe adverse drug reaction"}, {"id": "15806568_3_644", "context": "Visual system side effects caused by parasympathetic dysfunction after botulinum toxin type B injections.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] botulinum toxin type B injections [Effect] Visual system side effects caused by parasympathetic dysfunction"}, {"id": "1124417_2_645", "context": "Renal failure associated with acetazolamide therapy for glaucoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] acetazolamide therapy [Effect] Renal failure"}, {"id": "12424571_1_646", "context": "Acute onset of nephrotic syndrome during interferon-alpha retreatment for chronic active hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] interferon-alpha retreatment [Effect] Acute onset of nephrotic syndrome"}, {"id": "12587815_1_647", "context": "A 16-year-old boy developed fever, generalized rigidity, leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and lithium.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] while [Subject] A 16-year-old boy [Treatment] olanzapine and lithium [Effect] fever, generalized rigidity, leukocytosis, and increased serum transaminase and creatine kinase levels"}, {"id": "17526968_4_648", "context": "The hyperpigmentation was diffuse scattered, flagellate like and linear streaking which was thought to be mainly related to the skin toxicity of bleomycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] bleomycin [Effect] hyperpigmentation was diffuse scattered, flagellate like and linear streaking"}, {"id": "11243427_5_649", "context": "Exacerbation of 5-FU dermatologic toxicities in patients with preexisting conditions suggests the importance of aggressive ocular prophylaxis, using frequent ocular lubrication and topical steroid preparations with concurrent medical management of pre-existing dermatologic conditions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicities [Treatment] 5-FU [Effect] dermatologic toxicities"}, {"id": "2295443_1_650", "context": "Bowel perforation associated with intraperitoneal chromic phosphate instillation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] intraperitoneal chromic phosphate instillation [Effect] Bowel perforation"}, {"id": "2224786_1_651", "context": "A 62-year-old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy-related hemolytic-uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of cisplatin, bleomycin, and methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 62-year-old woman who was being treated for squamous cell carcinoma of the head and neck [Treatment] the second cycle of neoadjuvant chemotherapy consisting of cisplatin, bleomycin, and methotrexate [Effect] a chemotherapy-related hemolytic-uremic syndrome"}, {"id": "10466445_7_652", "context": "These data confirm the therapeutic value of arsenic trioxide in relapsed/resistant APL.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] therapeutic value [Treatment] arsenic trioxide"}, {"id": "11373877_1_653", "context": "Avascular necrosis of the femoral head in patients with prostate cancer treated with cyproterone acetate and radiotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] patients with prostate cancer [Treatment] cyproterone acetate and radiotherapy [Effect] Avascular necrosis of the femoral head"}, {"id": "11243427_4_654", "context": "Ectropion secondary to bolus injection of 5-fluorouracil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] bolus injection of 5-fluorouracil [Effect] Ectropion"}, {"id": "2595431_1_655", "context": "Metoclopramide-induced parkinsonism is not rare, and appropriate dose reduction in patients with renal failure will help reduce the incidence of this morbidity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patients with renal failure [Treatment] Metoclopramide [Effect] parkinsonism"}, {"id": "19307676_1_656", "context": "Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] methotrexate neurotoxicity [Effect] Posterior reversible encephalopathy syndrome"}, {"id": "25407257_4_657", "context": "A 6-year-old boy (weight: 16 kg, at the start of treatment) began sodium valproate (valproate syrup 5%) treatment for epilepsy in February 2012.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] A 6-year-old boy (weight: 16 kg, at the start of treatment) [Treatment] sodium valproate (valproate syrup 5%)"}, {"id": "3465489_1_658", "context": "Pharmacokinetic determinants of 6-mercaptopurine myelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] children with acute lymphoblastic leukemia [Treatment] 6-mercaptopurine [Effect] myelotoxicity and therapeutic failure"}, {"id": "8816294_2_659", "context": "We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and hydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] identical twin brothers [Treatment] intrathecally administered methotrexate; intrathecally administered methotrexate and cranial irradiation [Effect] leukoencephalopathy and hydrocephalus"}, {"id": "15735923_8_660", "context": "Considering the increasing use of TMZ, which is regarded as a drug with moderate toxicity, careful follow-up with routine blood testing is vital.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] TMZ [Effect] moderate toxicity"}, {"id": "11093071_3_661", "context": "While for ribavirin antidepressant effects are not known, we suppose that antidepressants may prevent changes in serotonergic or noradrenergic neurotransmission caused by IFN-alpha.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prevent [Treatment] antidepressants [Adverse event] caused [Treatment] IFN-alpha [Effect] changes in serotonergic or noradrenergic neurotransmission"}, {"id": "17381671_2_662", "context": "To report a case of serotonin syndrome associated with interaction between fentanyl and citalopram, as evidenced by medication history, clinical features and reversal following discontinuation of fentanyl.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a case [Treatment] nteraction between fentanyl and citalopram [Effect] serotonin syndrome"}, {"id": "2586773_2_663", "context": "We report a case of ibuprofen-induced meningitis in an otherwise healthy individual.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an otherwise healthy individual [Treatment] ibuprofen [Effect] meningitis"}, {"id": "10482872_3_664", "context": "The reported cases of in utero exposure to cyclosposphamide shared the following manifestations with our patient: growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] shared [Subject] patient [Treatment] in utero exposure to cyclosposphamide [Effect] growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly"}, {"id": "2931445_1_665", "context": "L-Thyroxine-induced leukopenia in a patient with Hashimoto's disease: involvement of suppressor-cytotoxic T cells.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with Hashimoto's disease [Treatment] L-Thyroxine [Effect] leukopenia"}, {"id": "1295628_1_666", "context": "Carbamazepine-induced systemic lupus erythematosus-like disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Carbamazepine [Effect] systemic lupus erythematosus-like disease"}, {"id": "8038468_1_667", "context": "CONCLUSIONS: This case describes the clinically significant increase of INR in an elderly patient after adding a chemotherapy regimen of levamisole and 5-FU to a previous regimen of warfarin alone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] an elderly patient [Treatment] levamisole and 5-FU; warfarin [Effect] increase of INR"}, {"id": "7653281_8_668", "context": "These results suggest that the hepatoxicity of ethanol in alcoholic beverages is enhanced by interaction with its congeners and acetaldehyde; they also suggest that alcoholic beverages are not equivalent in their potential to cause liver damage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] enhanced [Treatment] alcoholic [Effect] hepatoxicity"}, {"id": "17671884_8_669", "context": "The dermatology literature heretofore has not noted that anemia is a side effect of patients taking MMF to treat pemphigus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] is [Subject] patients [Treatment] MMF [Effect] anemia"}, {"id": "3430507_4_670", "context": "The 9 other reported cases of D-penicillamine induced rapidly progressive glomerulonephritis have been reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] D-penicillamine [Effect] rapidly progressive glomerulonephritis"}, {"id": "15203443_2_671", "context": "We describe a heroin abuser in whom clinical and laboratory manifestations of acute hepatitis B and C appeared a few days after the insertion of a subcutaneous naltrexone implant.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a heroin abuser [Treatment] subcutaneous naltrexone implant [Effect] acute hepatitis B and C"}, {"id": "1504404_2_672", "context": "Ciprofloxacin-induced psychosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Ciprofloxacin [Effect] psychosis"}, {"id": "15694139_2_673", "context": "Thalidomide was withdrawn from world markets in 1961 following recognition of its teratogenic effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] Thalidomide [Effect] teratogenic effects"}, {"id": "24318743_1_674", "context": "Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] in [Treatment] Weekly AUC2 carboplatin; with or without oral phenoxodiol"}, {"id": "1688693_5_675", "context": "We suggest the use of esmolol for treatment of dysrhythmias secondary to caffeine toxicity; to the best of our knowledge, the use of esmolol has not been reported for this purpose.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] esmolol"}, {"id": "15806568_2_676", "context": "To date, there have been few reports of visual disturbances associated with BTX-B use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] BTX-B [Effect] visual disturbances"}, {"id": "19116715_1_677", "context": "Gemcitabine is a known risk factor for hemolytic uremic syndrome (HUS), which can often have a rapidly fatal clinical course despite intervention with steroids, plasmapheresis and hemodialysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Treatment] Gemcitabine [Effect] hemolytic uremic syndrome [Potential therapeutic event] intervention [Treatment] with steroids, plasmapheresis and hemodialysis"}, {"id": "16411025_4_678", "context": "Our objective is to present a retrospective analysis of the DWI findings in four patients who suffered subacute neurotoxicity after intrathecal MTX.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] four patients [Treatment] intrathecal MTX [Effect] subacute neurotoxicity"}, {"id": "17547624_2_679", "context": "We report a case of ST elevation in right precordial leads compatible with type 1 Brugada syndrome following administration of propafenone in a patient with Wolff-Parkinson-White syndrome who was receiving lithium at concentrations within therapeutic levels.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a patient with Wolff-Parkinson-White syndrome [Treatment] administration of propafenone; receiving lithium at concentrations within therapeutic levels [Effect] ST elevation in right precordial leads compatible with type 1 Brugada syndrome"}, {"id": "25957434_2_680", "context": "The spectrum of cutaneous eruptions associated with dihydropyridines is extensive, varying from exanthemas to severe adverse events.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] dihydropyridines [Effect] cutaneous eruptions; exanthemas"}, {"id": "3365032_2_681", "context": "Polymyositis after propylthiouracil treatment for hyperthyroidism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] propylthiouracil [Effect] Polymyositis"}, {"id": "8862924_2_682", "context": "Methamphetamine's extensive physiologic effects, inconsistent street purity, and multiple routes of administration offer many possibilities for injury to the cornea.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] offer [Treatment] Methamphetamine's"}, {"id": "2956288_4_683", "context": "Since ethambutol is actively excreted via the renal system, compromise of renal function such as due to renal tuberculosis may lead to serum concentration elevations of ethambutol sufficient to produce optic neuropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] lead [Treatment] ethambutol [Effect] serum concentration elevations of ethambutol sufficient to produce optic neuropathy"}, {"id": "788666_3_684", "context": "Renal failure appeared 8 to 17 days after beginning gentamicin therapy and was characterized by creatinine clearances 4 to 10 ml/min, urine to plasma creatinine ratios less than 20, urinary sodium concentrations 16 to 60 mEq/liter, proteinuria, and cylindruria.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] beginning [Treatment] gentamicin therapy [Effect] Renal failure; creatinine clearances 4 to 10 ml/min, urine to plasma creatinine ratios less than 20, urinary sodium concentrations 16 to 60 mEq/liter, proteinuria, and cylindruria"}, {"id": "8749646_2_685", "context": "Seizures associated with ofloxacin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] ofloxacin [Effect] Seizures"}, {"id": "11424102_1_686", "context": "Cutaneous seeding after ultrasound-guided percutaneous ethanol injection for treatment of hepatocellular carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] ultrasound-guided percutaneous ethanol injection [Effect] Cutaneous seeding"}, {"id": "19145124_3_687", "context": "Two patients who developed decreased visual acuity after several months of ethambutol treatment for Mycobacterium avium-intracellulare infection had bitemporal visual field defects that suggested optic chiasm damage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] Two patients; Mycobacterium avium-intracellulare infection [Treatment] ethambutol [Effect] decreased visual acuity; bitemporal visual field defects; optic chiasm damage"}, {"id": "9972383_1_688", "context": "CONCLUSIONS: Metoclopramide may cause reversible nonthrombocytopenic vascular-type palpable purpura.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Metoclopramide [Effect] reversible nonthrombocytopenic vascular-type palpable purpura"}, {"id": "18784429_2_689", "context": "CONCLUSIONS: Life-threatening adrenal suppression, requiring hydrocortisone supplementation and intensive therapy, was observed and successfully treated in a newborn, whose mother had received high-dose methylprednisolone in late pregnancy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] requiring [Subject] a newborn, whose mother had received high-dose methylprednisolone in late pregnancy [Treatment] hydrocortisone supplementation and intensive therapy [Effect] successfully treated"}, {"id": "17420198_2_690", "context": "A case of extrapyramidal symptoms (EPS) following administration of aripiprazole to a man with developmental disabilities who had never received antipsychotic medications and had no history of movement disorders is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a man with developmental disabilities who had never received antipsychotic medications and had no history of movement disorders is presented [Treatment] aripiprazole [Effect] extrapyramidal symptoms (EPS)"}, {"id": "2378415_1_691", "context": "Although high-dose methotrexate has been shown to be useful in the treatment of primary osteogenic sarcoma, the tumoricidal effects of therapy appear to have caused a fatal rise in intracranial pressure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] high-dose methotrexate [Effect] a fatal rise in intracranial pressure"}, {"id": "20298401_11_692", "context": "This case had radiation fibrosis, so we suggest that radiation fibrosis may be another contributor of the occurrence of ILD in patients taking erlotinib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Subject] patients [Treatment] taking erlotinib [Effect] occurrence of ILD"}, {"id": "16156485_1_693", "context": "Since recent studies have reported no negative interactions with concurrent use, we here report three cases (one case of a prolonged seizure, a serotonin syndrome and a focal seizure) of severe lithium-induced side effects while patients underwent ECT without complications and lithium serum levels were still subtherapeutic.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] lithium [Effect] a prolonged seizure [Adverse event] induced [Treatment] lithium [Effect] a serotonin syndrome [Adverse event] induced [Treatment] lithium [Effect] a focal seizure [Potential therapeutic event] underwent [Treatment] ECT [Effect] without complications and lithium serum levels were still subtherapeutic"}, {"id": "8363533_3_694", "context": "Lithium-associated transient thyrotoxicosis in 4 Chinese women with autoimmune thyroiditis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] 4 Chinese women with autoimmune thyroiditis [Treatment] Lithium [Effect] transient thyrotoxicosis"}, {"id": "2006943_2_695", "context": "A patient, while on intravenous ritodrine therapy for preterm labor, experienced an episode of acute chest pain.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] on [Subject] A patient [Treatment] intravenous ritodrine therapy [Effect] an episode of acute chest pain"}, {"id": "4095247_2_696", "context": "Subsequent in vivo/vitro studies clearly demonstrated that the neurological effects were due to a synergistic action of desferrioxamine and prochlorperazine, probably resulting in exceptional fluxes of intra/extra cellular iron/copper disturbing noradrenergic and serotonergic systems.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] desferrioxamine and prochlorperazine [Effect] neurological effects"}, {"id": "19725909_1_697", "context": "Favorable outcome of de novo hepatitis B infection after liver transplantation with lamivudine and adefovir therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] outcome [Treatment] after liver transplantation with lamivudine and adefovir therapy"}, {"id": "6498095_3_698", "context": "Pemphigus foliaceus was seen in a patient with pulmonary tuberculosis during rifampicin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] seen [Subject] a patient with pulmonary tuberculosis [Treatment] rifampicin [Effect] Pemphigus foliaceus"}, {"id": "11816261_2_699", "context": "CONCLUSIONS: Clinicians should be aware of a risk of serotonin syndrome with serious extrapyramidal reactions in patients receiving sertraline or venlafaxine when metoclopramide is coadministered even in a single, conventional dose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] patients [Treatment] sertraline or venlafaxine when metoclopramide is coadministered even in a single, conventional dose [Effect] serotonin syndrome with serious extrapyramidal reactions"}, {"id": "9260733_2_700", "context": "We report the case of a patient who developed polyserositis (pericardial effusion, pleural effusion, and pericarditis) after being started on clozapine, and whose symptoms remitted upon discontinuation of clozapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient [Treatment] started on clozapine [Effect] polyserositis (pericardial effusion, pleural effusion, and pericarditis)"}, {"id": "8053440_5_701", "context": "Three years later, treatment with ampicillin caused another episode of cholestatic hepatitis with cholestasis and duct paucity on rebiopsy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] ampicillin [Effect] cholestatic hepatitis with cholestasis and duct paucity on rebiopsy"}, {"id": "8071504_5_702", "context": "METHODS: A patient who developed dramatic, permanent vision loss after a 9-month course of treatment with ethambutol and isoniazid for pulmonary tuberculosis is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A patient [Treatment] 9-month course of treatment with ethambutol and isoniazid [Effect] permanent vision loss"}, {"id": "16239768_2_703", "context": "The authors report a case of urinary incontinence (UI) that occurred in a woman after administration of venlafaxine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] a woman [Treatment] venlafaxine [Effect] urinary incontinence (UI)"}, {"id": "8651254_3_704", "context": "The possibility can be raised that M-CSF accelerated the underlying renal disease in this case through enhancing macrophage accumulation into the glomerulus, leading to the development of nephrotic syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] accelerated [Treatment] M-CSF [Effect] underlying renal disease in this case through enhancing macrophage accumulation into the glomerulus, leading to the development of nephrotic syndrome"}, {"id": "14996269_2_705", "context": "We describe two ELBW infants affected by hyperkalaemia, treated with Kayexalate, who developed serious hypernatraemia, that has never been reported before in preterm infants.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two ELBW infants affected by hyperkalaemia [Treatment] Kayexalate [Effect] serious hypernatraemia"}, {"id": "8384030_2_706", "context": "DISCUSSION: Electrolyte disorders associated with foscarnet are reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] foscarnet [Effect] Electrolyte disorders"}, {"id": "9232614_3_707", "context": "We report two cases that developed acute myeloid leukaemia (AML) during tamoxifen therapy for breast cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two cases [Treatment] tamoxifen therapy for breast cancer [Effect] acute myeloid leukaemia (AML)"}, {"id": "15261876_1_708", "context": "Our patient was a 72-year-old man with advanced Parkinson's disease (PD) who received levodopa and anti-cholinergic drugs and whose head had become almost completely bald.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] become [Subject] a 72-year-old man with advanced Parkinson's disease (PD) [Treatment] levodopa and anti-cholinergic drugs [Effect] completely bald"}, {"id": "18633310_2_709", "context": "The patient experienced hallucinations, agitation, vomiting, tachycardia and seizures after ingestion of 1050 (48 mg/kg) of extended-release bupropion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Treatment] ingestion of 1050 (48 mg/kg) of extended-release bupropion [Effect] hallucinations, agitation, vomiting, tachycardia and seizures"}, {"id": "1440123_1_710", "context": "This case report describes a 38-year-old male in whom SIADH was strongly suspected secondary to Tegretol therapy to control a seizure disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suspected [Subject] 38-year-old male; a seizure disorder [Treatment] Tegretol [Effect] SIADH"}, {"id": "17199845_1_711", "context": "However, cyclosporine dependency is associated with the risk of nephrotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] cyclosporine dependency [Effect] nephrotoxicity"}, {"id": "3335488_1_712", "context": "The observations suggest that testicular swelling and pain are side effects of desipramine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effects [Treatment] desipramine [Effect] testicular swelling and pain"}, {"id": "11722307_3_713", "context": "METHOD: We describe three case-reports concerning haematological adverse effects of quetiapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse effects [Treatment] quetiapine [Effect] haematological adverse effects"}, {"id": "1575118_1_714", "context": "Typically, drug-induced neutropenia occurs in a patient receiving a semisynthetic penicillin for two weeks or more.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurs [Subject] a patient [Treatment] a semisynthetic penicillin for two weeks or more [Effect] drug-induced neutropenia"}, {"id": "2554727_5_715", "context": "Peripheral nerve dysfunction is a potentially serious complication of high-dose cytosine arabinoside.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] cytosine arabinoside [Effect] Peripheral nerve dysfunction"}, {"id": "17444802_1_716", "context": "Tumor-volume increase at beginning of primary treatment with topical interferon alpha 2-beta in a case of conjunctiva-cornea intraepithelial neoplasia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increase [Subject] a case of conjunctiva-cornea intraepithelial neoplasia [Treatment] primary treatment with topical interferon alpha 2-beta [Effect] Tumor-volume increase"}, {"id": "18504683_1_717", "context": "L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] children [Treatment] L-asparaginase [Effect] posterior reversible encephalopathy syndrome"}, {"id": "9184269_3_718", "context": "On the other hand, MTX-induced pneumonitis seems to be very rare in psoriatic arthritis (PsA).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] MTX [Effect] pneumonitis"}, {"id": "3899068_1_719", "context": "Ototoxicity as a result of cis-platinum administration is well documented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] cis-platinum administration [Effect] Ototoxicity"}, {"id": "9892272_1_720", "context": "Massive subfascial hematoma after alteplase therapy for acute myocardial infarction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] alteplase therapy [Effect] Massive subfascial hematoma"}, {"id": "11881322_7_721", "context": "We suggest that itraconazole should be added to the list of drugs that may be responsible for a drug-induced vanishing bile duct syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] responsible [Treatment] itraconazole [Effect] drug-induced vanishing bile duct syndrome"}, {"id": "14998226_2_722", "context": "A 67-year-old man receiving a stable maintenance dosage of warfarin experienced an increased international normalized ratio (INR) without bleeding when his atorvastatin therapy was switched to fluvastatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] A 67-year-old man [Treatment] warfarin [Effect] increased international normalized ratio (INR) [Potential therapeutic event] switched [Treatment] atorvastatin therapy was switched to fluvastatin"}, {"id": "1295628_4_723", "context": "The cases of CBZ-induced SLE reported in the literature were reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] CBZ [Effect] SLE"}, {"id": "19892516_1_724", "context": "Ciprofloxacin-induced hemorrhagic vasculitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Ciprofloxacin [Effect] hemorrhagic vasculitis"}, {"id": "8691927_4_725", "context": "INTERPRETATION: When high doses of fluticasone propionate are used, growth may be retarded and adrenal suppression may occur.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Treatment] high doses of fluticasone propionate [Effect] growth may be retarded and adrenal suppression"}, {"id": "10614572_2_726", "context": "To our knowledge, this is the first report of significant hypotension associated with intravenous valproate in the treatment of status epilepticus in the pediatric population.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] pediatric population [Treatment] intravenous valproate [Effect] hypotension"}, {"id": "8678015_3_727", "context": "While undergoing treatment with albendazole, he developed worsening diarrhea with abdominal pain and fever.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] he [Treatment] albendazole [Effect] worsening diarrhea with abdominal pain and fever"}, {"id": "17655517_1_728", "context": "Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Linezolid [Effect] peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome."}, {"id": "7538828_1_729", "context": "Bone marrow aplasia and severe skin rash after a single low dose of methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] a single low dose of methotrexate [Effect] Bone marrow aplasia and severe skin rash"}, {"id": "3124393_1_730", "context": "A woman 38-year-old, suffering for about ten years from multiple sclerosis and treated with repeated therapy cycles of intrathecal Depo-Medrol, developed a spastic paraparesis at the lower limbs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A woman 38-year-old, suffering for about ten years from multiple sclerosis [Treatment] repeated therapy cycles of intrathecal Depo-Medrol [Effect] a spastic paraparesis at the lower limbs"}, {"id": "8513656_10_731", "context": "The efficacy of single-dose disulfiram as an inhibitor of human P450 2E1 suggests that this modality for manipulating clinical P450 2E1 activity may provide a useful probe for delineating P450 2E1 participation in human drug biotransformation or for the treatment of poisoning by P450 2E1-activated toxins.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] by [Treatment] P450 2E1-activated toxins [Effect] poisoning"}, {"id": "3579660_2_732", "context": "To develop information on the relative rarity or frequency of neurologic worsening with the initiation of penicillamine therapy, we conducted a retrospective survey of 25 additional patients with Wilson's disease who met the criteria of presenting with neurologic disease and having been treated with penicillamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presenting [Subject] 25 additional patients with Wilson's disease [Treatment] penicillamine [Effect] neurologic disease"}, {"id": "10779995_3_733", "context": "The authors present a case of t-AML that developed in a child with metastatic neuroblastoma 18 months after he received oral etoposide, given for palliation purpose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a child with metastatic neuroblastoma [Treatment] oral etoposide [Effect] t-AML"}, {"id": "7781845_10_734", "context": "Mechanisms and triggering factors of hypoglycaemia induced by mefloquine and some other anti-malarial quinine analogues are discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] mefloquine and some other anti-malarial quinine analogues [Effect] hypoglycaemia"}, {"id": "11414270_15_735", "context": "Only nondepolarizing muscle relaxants should be used in patients who are at risk for mucositis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used [Subject] patients who are at risk for mucositis [Treatment] nondepolarizing muscle relaxants"}, {"id": "15685264_11_736", "context": "CONCLUSION: A possible pharmacokinetic interaction between Dantrolene and Oxybutynin should be borne in mind when considering Carbamazepine medication for a patient with a spinal cord lesion.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] medication [Subject] a patient [Treatment] Carbamazepine medication"}, {"id": "19307676_3_737", "context": "We describe a 15-year-old female patient diagnosed with acute lymphoblastic leukemia presenting with status epilepticus after receiving intrathecal methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 15-year-old female patient diagnosed with acute lymphoblastic leukemia [Treatment] receiving intrathecal methotrexate [Effect] presenting with status epilepticus"}, {"id": "3767790_1_738", "context": "Duodenal ulceration: a complication of tolazoline therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] tolazoline [Effect] Duodenal ulceration"}, {"id": "1747495_1_739", "context": "Hepatic damage after danazol treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] danazol [Effect] Hepatic damage"}, {"id": "10461415_2_740", "context": "Hepato-biliary abnormalities secondary to ceftriaxone use: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary to [Treatment] ceftriaxone use [Effect] Hepato-biliary abnormalities"}, {"id": "12243603_1_741", "context": "Rhabdomyolysis with concurrent atorvastatin and diltiazem.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] diltiazem; atorvastatin [Effect] Rhabdomyolysis"}, {"id": "7900744_1_742", "context": "Case report: mannitol nephrotoxicity syndrome: role of hemodialysis and postulate of mechanisms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] syndrome [Treatment] mannitol [Effect] nephrotoxicity"}, {"id": "8710040_1_743", "context": "Uveitis during treatment of disseminated Mycobacterium avium-intracellulare complex infection with the combination of rifabutin, clarithromycin and ethambutol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] combination of rifabutin, clarithromycin and ethambutol [Effect] Uveitis"}, {"id": "16527771_2_744", "context": "The visual loss in this patient seems to result from phenol neurotoxicity rather than mechanical compression of the intraorbital optic nerve.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Subject] patient [Treatment] phenol [Effect] visual loss; neurotoxicity"}, {"id": "16200540_1_745", "context": "Polysomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless legs syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] levodopa [Effect] augmentation of restless legs syndrome"}, {"id": "15752306_6_746", "context": "These cases highlight the occurrence of livedo reticularis as an uncommon side-effect of interferon alpha treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side-effect [Subject] These cases [Treatment] interferon alpha [Effect] livedo reticularis"}, {"id": "11399735_1_747", "context": "So far, few cases of pulmonary side effects caused by ticlopidine have been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] ticlopidine [Effect] pulmonary side effects"}, {"id": "21104646_1_748", "context": "Abnormal dexamethasone suppression tests in a rifampicin-treated patient with suspected Cushing's syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Abnormal [Subject] patient with suspected Cushing's syndrome [Treatment] rifampicin [Effect] Abnormal dexamethasone suppression tests"}, {"id": "16109609_2_749", "context": "Gemcitabine therapy has been associated with radiation recall reactions when used in the treatment of carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Gemcitabine [Effect] radiation recall reactions"}, {"id": "15266150_2_750", "context": "Increased lash length, thickness, and pigmentation are well-documented side effects of prostaglandin analog glaucoma drops.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] are [Treatment] prostaglandin analog glaucoma drops [Effect] Increased lash length, thickness, and pigmentation"}, {"id": "25957434_1_751", "context": "Bullous Eruption Associated With Dihydropyridines With Cross Reactivity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Associated [Treatment] Dihydropyridines [Effect] Bullous Eruption"}, {"id": "11020127_3_752", "context": "Ritonavir acted as a CYP3A4 inhibitor, diminishing carbamazepine metabolism and provoking an increase in serum levels and clinical toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] acted [Treatment] Ritonavir [Effect] CYP3A4 inhibitor, diminishing carbamazepine metabolism and provoking an increase in serum levels and clinical toxicity"}, {"id": "17083900_1_753", "context": "Acute generalized exanthematous pustulosis induced by nimesulide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] nimesulide [Effect] Acute generalized exanthematous pustulosis"}, {"id": "11225532_1_754", "context": "Quinine induced coagulopathy--a near fatal experience.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Quinine [Effect] coagulopathy--a near fatal experience"}, {"id": "71813_1_755", "context": "A 58-year-old man with rheumatoid arthritis developed lichen planus during treatment with gold.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 58-year-old man with rheumatoid arthritis [Treatment] treatment with gold [Effect] lichen planus during"}, {"id": "2347102_1_756", "context": "Atenolol-induced pseudolymphoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Atenolol [Effect] pseudolymphoma"}, {"id": "25407257_1_757", "context": "First case report of suspected onset of convulsive seizures due to co-administration of valproic acid and tebipenem.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] co-administration of valproic acid and tebipenem [Effect] convulsive seizures"}, {"id": "10755579_1_758", "context": "Fluoxetine-related death in a child with cytochrome P-450 2D6 genetic deficiency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] child with cytochrome P-450 2D6 genetic deficiency [Treatment] Fluoxetine [Effect] death"}, {"id": "448845_1_759", "context": "Aplastic anemia and agranulocytosis in patients using methazolamide for glaucoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] patients; glaucoma [Treatment] methazolamide [Effect] Aplastic anemia and agranulocytosis"}, {"id": "15735923_3_760", "context": "We report a 44-year-old woman with t-MDS (refractory anemia with excess blasts) following treatment of recurrent anaplastic astrocytoma with temozolomide (TMZ).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a 44-year-old woman [Treatment] treatment of recurrent anaplastic astrocytoma with temozolomide (TMZ) [Effect] t-MDS (refractory anemia with excess blasts)"}, {"id": "11332679_1_761", "context": "An infant who developed pancreatitis during meglumine antimoniate treatment for visceral leishmaniasis and who was successfully treated with a combination of allopurinol and ketoconazole is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] An infant [Treatment] a combination of allopurinol and ketoconazole [Effect] pancreatitis"}, {"id": "8345435_2_762", "context": "L-Carnitine supplementation has been recommended to prevent the fatal hepatotoxic effects associated with valproic acid.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] valproic acid [Effect] hepatotoxic effects [Potential therapeutic event] recommended [Treatment] L-Carnitine"}, {"id": "8641617_6_763", "context": "The purpose of this study was to examine the incidence and cause of Clostridium difficile colitis occurring after cisplatin-based combination chemotherapy in ovarian cancer patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] ovarian cancer patients [Treatment] cisplatin-based combination chemotherapy [Effect] Clostridium difficile colitis"}, {"id": "7854541_1_764", "context": "Cerebral demyelinating disease developed in a patient during adjuvant therapy with levamisole for malignant melanoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a patient [Treatment] adjuvant therapy with levamisole [Effect] Cerebral demyelinating disease"}, {"id": "3558331_1_765", "context": "Amoxapine-induced cognitive impairment in two patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] two patients [Treatment] Amoxapine [Effect] cognitive impairment"}, {"id": "21881031_5_766", "context": "Granisetron hydrochloride (3 mg on days 1, 8, and 15) and dexamethasone (13.2 mg on day 1 and 6.6 mg on days 2, 3, 8, and 15) were used prior to irinotecan administration in both patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used [Subject] both patients [Treatment] Granisetron hydrochloride (3 mg on days 1, 8, and 15) and dexamethasone (13.2 mg on day 1 and 6.6 mg on days 2, 3, 8, and 15); irinotecan"}, {"id": "6245286_3_767", "context": "Visceral herpesvirus infections in leukemic patients receiving cytarabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] leukemic patients [Treatment] cytarabine [Effect] Visceral herpesvirus infections"}, {"id": "8678015_2_768", "context": "Although a few case reports link metronidazole with the development of pseudomembranous colitis, albendazole has not been associated with the development of this condition.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] metronidazole [Effect] pseudomembranous colitis"}, {"id": "11414270_13_769", "context": "CONCLUSION: Oral mucositis is a frequent and potentially severe complication of cancer chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] cancer chemotherapy [Effect] Oral mucositis"}, {"id": "10431414_1_770", "context": "One case of priapism occurred during heparin therapy for a previous surgical operation to the knee is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] One case [Treatment] during heparin therapy [Effect] priapism"}, {"id": "12365708_5_771", "context": "While both amiodarone and digoxin can cause permanent visual changes, the ocular effects are often reversible.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] amiodarone and digoxin [Effect] permanent visual changes"}, {"id": "15543388_1_772", "context": "AIM: Report of a case of a woman patient who developed celiac disease after pegylated interferon alpha-2a and ribavirin use for chronic hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a woman patient [Treatment] pegylated interferon alpha-2a and ribavirin use for chronic hepatitis C [Effect] celiac disease"}, {"id": "11243427_2_773", "context": "Differential diagnoses included ocular rosacea with cicatrizing conjunctivitis and 5-FU-induced ectropion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] 5-FU [Effect] ectropion"}, {"id": "9660541_1_774", "context": "In rare cases mitomycin C (MMC) may induce cancer-associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Subject] In rare cases [Treatment] mitomycin C (MMC) [Effect] cancer-associated hemolytic uremic syndrome; hemolytic anemia, thrombocytopenia and progressive renal failure"}, {"id": "16968538_1_775", "context": "Hemolytic uremic syndrome following the infusion of oxaliplatin: case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] oxaliplatin [Effect] Hemolytic uremic syndrome"}, {"id": "12699871_4_776", "context": "Tacrolimus (FK506)-induced mutism after liver transplant.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Tacrolimus (FK506 [Effect] mutism"}, {"id": "17009081_4_777", "context": "Though proteinuria and nephrotic syndrome is a rare adverse effect of IFN-beta-1b therapy, physicians treating MS patients with this agent should pay careful attention to new clinical symptoms and laboratory findings.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse effect [Subject] MS patients [Treatment] IFN-beta-1b [Effect] proteinuria and nephrotic syndrome"}, {"id": "2894766_1_778", "context": "It is suggested that the patient had sulfasalazine-induced lupus, which manifested with serositis and pulmonary parenchymal involvement in the absence of joint symptoms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] sulfasalazine [Effect] lupus, which manifested with serositis and pulmonary parenchymal involvement in the absence of joint symptoms"}, {"id": "1310879_2_779", "context": "By means of the in vitro heparin-induced platelet activation (HIPA) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin (Sanofi Labaz, Munich, FRG), as well as the enoxaparine Clexane (Nattermann, Cologne, FRG), all induced platelet activation with the patient's serum.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] standard heparin and the LMW heparins Fragmin and Fraxiparin (Sanofi Labaz, Munich, FRG), as well as the enoxaparine Clexane (Nattermann, Cologne, FRG) [Effect] platelet activation"}, {"id": "19357764_2_780", "context": "DISCUSSION: This case shows that switching to zidovudine potentially can lead to a hyperlactatemia relapse.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] lead [Subject] This case [Treatment] zidovudine [Effect] hyperlactatemia relapse"}, {"id": "9232614_1_781", "context": "Acute leukaemia during tamoxifen therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] tamoxifen therapy [Effect] Acute leukaemia"}, {"id": "1310879_3_782", "context": "Heparin-associated thrombocytopenia: successful therapy with the heparinoid Org 10172 in a patient showing cross-reaction to LMW heparins.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a patient [Treatment] Heparin [Effect] thrombocytopenia"}, {"id": "3970339_1_783", "context": "A patient presented with a painful, oedematous, cyanosed hand having injected a solution of diamorphine and methylphenidate into his radial artery.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] A patient [Treatment] injected a solution of diamorphine and methylphenidate into his radial artery [Effect] painful, oedematous, cyanosed hand"}, {"id": "9509511_2_784", "context": "We conclude that vincristine and actinomycin D were the cause of this rare from of hepatotoxicity and that chemotherapy for the underlying malignant disease could be given safely after clinical recovery.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] vincristine and actinomycin D [Effect] hepatotoxicity"}, {"id": "6702890_2_785", "context": "Pure red cell aplasia associated with fenoprofen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] fenoprofen [Effect] Pure red cell aplasia"}, {"id": "16239768_1_786", "context": "A 56-year-old white woman with a diagnosis of reactive depression developed severe UI after a 30 days' treatment with venlafaxine 75 mg/day.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 56-year-old white woman with a diagnosis of reactive depression [Treatment] 30 days' treatment with venlafaxine 75 mg/day. [Effect] severe UI"}, {"id": "10891991_5_787", "context": "PATIENTS: Three patients developed a reproductive endocrine disorder during treatment with valproate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Three patients [Treatment] valproate [Effect] reproductive endocrine disorder"}, {"id": "10410183_2_788", "context": "OBJECTIVE: To report a case of marked elevation of serum creatine kinase (CK) associated with olanzapine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] olanzapine [Effect] marked elevation of serum creatine kinase"}, {"id": "8641617_5_789", "context": "Severe C. difficile colitis occurred in 2 patients (6.1%) after receiving cisplatin-based combination chemotherapy for ovarian malignancies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] 2 patients (6.1%) [Treatment] cisplatin-based combination chemotherapy [Effect] Severe C. difficile colitis"}, {"id": "3430507_6_790", "context": "A 56-year-old woman with scleroderma developed rapidly progressive glomerulonephritis with epithelial crescents associated with hemoptysis after 27 months of D-penicillamine therapy and a cumulative dose of 1,200 g.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 56-year-old woman with scleroderma [Treatment] 27 months of D-penicillamine therapy and a cumulative dose of 1,200 g [Effect] rapidly progressive glomerulonephritis with epithelial crescents associated with hemoptysis"}, {"id": "9831311_2_791", "context": "High-dose phosphate treatment leads to hypokalemia in hypophosphatemic osteomalacia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] leads [Treatment] High-dose phosphate [Effect] hypokalemia"}, {"id": "2212262_2_792", "context": "We report a patient who developed heparin associated thrombocytopenia during continuous arteriovenous haemofiltration and discuss its implications and alternative anticoagulant treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a patient [Treatment] heparin; continuous arteriovenous haemofiltration [Effect] heparin associated thrombocytopenia"}, {"id": "17133571_2_793", "context": "We describe a detailed case of fulminant hepatitis induced by nevirapine (Viramune) and treated by liver transplantation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] nevirapine [Effect] fulminant hepatitis"}, {"id": "7900744_5_794", "context": "The literature is also reviewed for ARF associated with mannitol infusion in patients who received dialysis and those who did not receive dialysis; and the possible mechanism(s) of mannitol nephrotoxicity are discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] patients [Treatment] mannitol infusion [Effect] ARF"}, {"id": "15190230_2_795", "context": "In this case report, we present clinical and laboratory findings of a case with chronic hepatitis B that developed acute dystonia soon after the first dose of pegylated interferon alpha.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a case with chronic hepatitis B [Treatment] the first dose of pegylated interferon alpha. [Effect] acute dystonia"}, {"id": "15266150_3_796", "context": "Trichiasis associated with prostaglandin analog use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] prostaglandin analog [Effect] Trichiasis"}, {"id": "2937155_2_797", "context": "The possible development of a drug-induced vasculitis or lupus-like syndrome should be added to the list of rare toxic effects of vancomycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] vancomycin [Effect] drug-induced vasculitis or lupus-like syndrome"}, {"id": "17381671_8_798", "context": "Healthcare professionals should be aware of the possible development of serotonin syndrome as a complication of initiation of fentanyl and other phenylpiperidine opioids in patients treated with SSRIs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] patients [Treatment] fentanyl and other phenylpiperidine opioids; treated with SSRIs [Effect] serotonin syndrome"}, {"id": "16196187_1_799", "context": "Acute myocardial ischemia following accidental intravenous administration of epinephrine in high concentration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] accidental intravenous administration of epinephrine in high concentration [Effect] Acute myocardial ischemia"}, {"id": "2299784_2_800", "context": "Bromide intoxication secondary to pyridostigmine bromide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] pyridostigmine bromide [Effect] Bromide intoxication"}, {"id": "11886466_3_801", "context": "We have recently encountered a patient with acquired haemophilia who developed a thrombotic left middle cerebral artery distribution stroke while being treated with pFVIII.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] patient with acquired haemophilia who developed a thrombotic left middle cerebral artery distribution stroke [Treatment] pFVIII [Effect] thrombotic left middle cerebral artery distribution stroke"}, {"id": "22735246_4_802", "context": "We present a case of serotonin syndrome, which was precipitated by this medicine in a patient who had been predisposed by long-term treatment with sertraline, a selective serotonin reuptake inhibitor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitated [Subject] a patient [Treatment] long-term treatment with sertraline [Effect] serotonin syndrome"}, {"id": "19789372_6_803", "context": "Of the 15 patients treated with tizanidine and mexiletine, 4 suffered tizanidine-induced adverse effects such as drowsiness and dry mouth in the retrospective survey.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] 15 patients; 4 [Treatment] tizanidine and mexiletine [Effect] drowsiness and dry mouth"}, {"id": "2006943_1_804", "context": "Type I second-degree AV block (Mobitz type I, Wenckebach AV block) during ritodrine therapy for preterm labor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] ritodrine [Effect] Type I second-degree AV block (Mobitz type I, Wenckebach AV block)"}, {"id": "20412003_1_805", "context": "After other potential causes of liver toxicity were excluded, TMP-SMX was determined to be the cause of his acute liver toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] determined [Treatment] TMP-SMX [Effect] acute liver toxicity"}, {"id": "6149250_3_806", "context": "One of the patients had a dexamethasone dependent brain metastatic condition.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] One of the patients [Treatment] dexamethasone [Effect] brain metastatic condition"}, {"id": "12365708_2_807", "context": "Biomicroscopy revealed amiodarone corneal deposits.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] revealed [Treatment] Biomicroscopy [Effect] amiodarone corneal deposits"}, {"id": "14601701_5_808", "context": "This case and a review of the literature show the severe and unpredictable nature of ethambutol toxicity and its potential for irreversible vision loss despite careful ophthalmologic monitoring.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] unpredictable [Treatment] ethambutol [Effect] irreversible vision loss"}, {"id": "15790469_4_809", "context": "Recently, some studies have also reported association between patients with juvenile rheumatoid arthritis (JRA) treated with Methotrexate (MTX) and malignant lymphoma developing.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Subject] patients with juvenile rheumatoid arthritis (JRA [Treatment] Methotrexate (MTX) [Effect] malignant lymphoma"}, {"id": "10679548_6_810", "context": "The two middle aged women presented with respiratory symptoms after prolonged treatment with nitrofurantoin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] The two middle aged women [Treatment] prolonged treatment with nitrofurantoin [Effect] respiratory symptoms"}, {"id": "20378385_1_811", "context": "OBJECTIVE: 1) To describe a patient with rheumatoid arthritis receiving adalimumab who developed fever, pancytopenia, splenomegaly, and extreme hyperferritinemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with rheumatoid arthritis [Treatment] adalimumab [Effect] fever, pancytopenia, splenomegaly, and extreme hyperferritinemia"}, {"id": "12523465_2_812", "context": "Visual hallucinations associated with zonisamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] zonisamide [Effect] Visual hallucinations"}, {"id": "8667442_1_813", "context": "Milk-alkali syndrome induced by 1,25(OH)2D in a patient with hypoparathyroidism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with hypoparathyroidism. [Treatment] 1,25(OH)2D [Effect] Milk-alkali syndrome"}, {"id": "10494874_1_814", "context": "We report the case of a female acromegalic patient in whom multiple hepatic adenomas appeared soon after danazol treatment for uterine fibromatosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] appeared [Subject] a female acromegalic patient [Treatment] danazol treatment [Effect] hepatic adenomas"}, {"id": "9347384_1_815", "context": "Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] psychiatric patients [Treatment] clarithromycin [Effect] Carbamazepine toxicity"}, {"id": "2116935_2_816", "context": "Thrombolytic therapy with tissue plasminogen activator (tPA) for acute myocardial infarction may result in major bleeding complications such as gastrointestinal or intracranial bleeding.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] tissue plasminogen activator [Effect] gastrointestinal or intracranial bleeding"}, {"id": "16968538_8_817", "context": "CONCLUSION: The hemolytic-uremic syndrome may be a rare complication of oxaliplatin-based chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] oxaliplatin-based chemotherapy [Effect] hemolytic-uremic syndrome"}, {"id": "10897389_1_818", "context": "However, recurrent staphylococcus aureus sepsis developed during CyA therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] CyA therapy [Effect] staphylococcus aureus sepsis"}, {"id": "8570441_1_819", "context": "Nabumetone-associated interstitial nephritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Nabumetone [Effect] interstitial nephritis"}, {"id": "18362995_1_820", "context": "A short review on imatinib-related hepatotoxicity is also presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] imatinib [Effect] hepatotoxicity"}, {"id": "17260498_1_821", "context": "Fatal interstitial pneumonitis associated with docetaxel administration in a patient with hormone-refractory prostate cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a patient with hormone-refractory prostate cancer [Treatment] docetaxel [Effect] Fatal interstitial pneumonitis"}, {"id": "17364199_2_822", "context": "BACKGROUND: Etanercept is a tumor necrosis factor (TNF) inhibitor that has been licensed in the United States for the treatment of adult and juvenile rheumatoid arthritis as well as psoriatic arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] licensed [Subject] adult and juvenile rheumatoid arthritis as well as psoriatic arthritis [Treatment] Etanercept; a tumor necrosis factor (TNF) inhibitor"}, {"id": "3379435_2_823", "context": "Reye-like syndrome following treatment with the pantothenic acid antagonist, calcium hopantenate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] calcium hopantenate [Effect] Reye-like syndrome"}, {"id": "834512_1_824", "context": "Sudden death in an infant from methemoglobinemia after administration of \"sweet spirits of nitre\".", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] an infant [Treatment] sweet spirits of nitre [Effect] Sudden death; methemoglobinemia"}, {"id": "8691927_2_825", "context": "FINDINGS: Six children with growth retardation noted after treatment with high-dose fluticasone propionate were found to have adrenal suppression.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] have [Subject] Six children with growth retardation [Treatment] high-dose fluticasone propionate [Effect] adrenal suppression"}, {"id": "16326413_3_826", "context": "Methotrexate-associated nephropathy is a rare complication in pediatric oncology, and a review of the literature suggests that exposure to nephrotoxic agents may be a significant but perhaps underrecognized risk factor for its development.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Methotrexate [Effect] nephropathy"}, {"id": "7428724_1_827", "context": "Four cases of oesophageal damage associated with ingestion of the urinary anti-spasmodic agent emepronium bromide are described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] Four cases [Treatment] ingestion of the urinary anti-spasmodic agent emepronium bromide [Effect] oesophageal damage"}, {"id": "10555917_1_828", "context": "A 66-year-old Japanese woman with severe scleroderma developed anemia and thrombocytopenia due to D-penicillamine (D-Pen) treatment, although the leukopenia was not markedly severe.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 66-year-old Japanese woman with severe scleroderma [Treatment] D-penicillamine (D-Pen) treatment [Effect] anemia and thrombocytopenia"}, {"id": "20456080_4_829", "context": "Corticosteroid injections are commonly used as effective treatments for a variety of pain disorders.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatments [Treatment] Corticosteroid injections"}, {"id": "15549981_1_830", "context": "We present two cases of anaphylaxis under anaesthesia where return of spontaneous circulation was refractory to epinephrine, but occurred following the administration of the alpha-agonist metaraminol.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] occurred [Treatment] epinephrine; administration of the alpha-agonist metaraminol [Effect] return of spontaneous circulation"}, {"id": "3310776_1_831", "context": "A 51-yr-old nonsmoking male patient without any history of previous allergies, asthma, hay fever, or urticaria developed attacks of asthma when captopril was added to the nadolol and dyazide treatment for his high blood pressure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 51-yr-old nonsmoking male patient without any history of previous allergies, asthma, hay fever, or urticaria [Treatment] captopril was added to the nadolol and dyazide [Effect] attacks of asthma"}, {"id": "9876809_5_832", "context": "After ticlopidine was discontinued, the patient was rechallenged with the same dose of phenytoin without symptoms of toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] After ticlopidine was discontinued; rechallenged with the same dose of phenytoin [Effect] toxicity"}, {"id": "19151423_1_833", "context": "Rhabdomyolysis due to an uncommon interaction of ciprofloxacin with simvastatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] interaction of ciprofloxacin with simvastatin [Effect] Rhabdomyolysis"}, {"id": "8672829_1_834", "context": "After receiving 3 doses of ifosfamide/mesna, she was found to be unresponsive.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] found [Subject] she [Treatment] ifosfamide/mesna [Effect] unresponsive"}, {"id": "2316232_2_835", "context": "Symptomatic hypoglycemia secondary to a glipizide-trimethoprim/sulfamethoxazole drug interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary to [Treatment] glipizide-trimethoprim/sulfamethoxazole drug interaction [Effect] Symptomatic hypoglycemia"}, {"id": "18421192_1_836", "context": "A 51-year-old man developed type 1 diabetes mellitus following 24 weeks of treatment with recombinant alpha-2b peginterferon plus ribavirin for chronic hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 51-year-old man [Treatment] 24 weeks of treatment with recombinant alpha-2b peginterferon plus ribavirin [Effect] type 1 diabetes mellitus"}, {"id": "8832451_1_837", "context": "A noninvasive method in the differential diagnosis of vecuronium-induced and magnesium-induced protracted neuromuscular block in a severely preeclamptic patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] severely preeclamptic patient [Treatment] vecuronium [Effect] protracted neuromuscular block [Adverse event] induced [Subject] severely preeclamptic patient [Treatment] magnesium [Effect] protracted neuromuscular block"}, {"id": "3725284_1_838", "context": "Paroxysmal supraventricular tachycardia during treatment with cisplatin and etoposide combination.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] cisplatin and etoposide combination [Effect] Paroxysmal supraventricular tachycardia"}, {"id": "424824_1_839", "context": "Conversely, diffuse interstitial pulmonary fibrosis should be considered in the differential diagnosis of patients receiving methotrexate who develop bilateral pulmonary infiltrates seen on chest roentgenograms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] patients [Treatment] methotrexate [Effect] diffuse interstitial pulmonary fibrosis; bilateral pulmonary infiltrates"}, {"id": "2316232_1_840", "context": "An 83-year-old man receiving glipizide 10 mg bid developed symptomatic hypoglycemia within three days of adding trimethoprim/sulfamethoxazole (TMP/SMX) to his regimen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] An 83-year-old man [Treatment] receiving glipizide 10 mg; three days of adding trimethoprim/sulfamethoxazole (TMP/SMX) [Effect] symptomatic hypoglycemia"}, {"id": "16268429_1_841", "context": "In this case senna was likely the cause of a subacute cholestatic hepatitis exemplifying again the potential role of herbal related liver injury.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] senna [Effect] a subacute cholestatic hepatitis; herbal related liver injury"}, {"id": "12598508_4_842", "context": "Early peritoneal dialysis has not previously been reported for lisinopril induced multiorgan failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] lisinopril [Effect] multiorgan failure"}, {"id": "12862258_3_843", "context": "Various case reports concerning dapsone-induced agranulocytosis are reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] dapsone [Effect] agranulocytosis"}, {"id": "18717612_3_844", "context": "We report the first case of a 54-year-old Turkish woman who presented with ceftriaxone-induced FDE.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 54-year-old Turkish woman [Treatment] ceftriaxone [Effect] FDE"}, {"id": "10487084_1_845", "context": "In all cases, seizures were controlled by withdrawal of phenytoin and reduction of drug levels.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] controlled [Treatment] withdrawal of phenytoin and reduction of drug levels [Effect] seizures"}, {"id": "15379082_3_846", "context": "This case describes fulminant hepatic failure in a patient taking disulfiram with no previous liver disease and report of being compliant with alcohol abstinence.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient [Treatment] disulfiram [Effect] fulminant hepatic failure"}, {"id": "15373932_2_847", "context": "Fungal infection is a significant comorbidity in patients with diabetes mellitus, and ketoconazole, an antifungal agent, causes a number of drug interactions with coadministered drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causes [Subject] patients with diabetes mellitus [Treatment] ketoconazole [Effect] a number of drug interactions with coadministered drugs"}, {"id": "15289139_1_848", "context": "Dorzolamide-induced choroidal detachment in a surgically untreated eye.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a surgically untreated eye [Treatment] Dorzolamide [Effect] choroidal detachment"}, {"id": "8438851_2_849", "context": "Idiosyncratic factors involving vasopressin receptor affinity and distribution, vasopressin-associated vasodilation in some vascular beds, and the effect of vasopressin on the renin-angiotensin system may further contribute to impaired tissue perfusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] contribute [Treatment] vasopressin [Effect] impaired tissue perfusion"}, {"id": "16765687_2_850", "context": "Rapid resolution of topiramate-induced angle-closure glaucoma with methylprednisolone and mannitol.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolution [Treatment] methylprednisolone and mannitol [Adverse event] induced [Treatment] topiramate [Effect] angle-closure glaucoma"}, {"id": "7098384_1_851", "context": "A 66-year-old mand suffering from severe coronary heart disease took digoxin with suicidal intent an was treated for the ensuing complete atrioventricular block with digoxin-specific antibody fragments.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] took [Subject] A 66-year-old mand suffering from severe coronary heart disease [Treatment] digoxin [Effect] complete atrioventricular block"}, {"id": "16116136_1_852", "context": "A patient with generalized MG was effectively managed with MM but developed CNS lymphoma after 3 years of treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] managed [Treatment] MM [Adverse event] developed [Subject] A patient with generalized MG [Treatment] MM [Effect] CNS lymphoma"}, {"id": "12114387_1_853", "context": "Epoprostenol may be associated rarely with severe erythroderma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Epoprostenol [Effect] severe erythroderma."}, {"id": "15533031_2_854", "context": "We report the case of a patient with increased cerebral cortical excitability following intoxication with flupirtine, a centrally acting analgesic and antispastic drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a patient [Treatment] flupirtine [Effect] increased cerebral cortical excitability"}, {"id": "6702890_3_855", "context": "This case represents the third example of erythroid aplasia associated with an anti-inflammatory agent and the first instance due to fenoprofen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] fenoprofen [Effect] erythroid aplasia"}, {"id": "11568758_1_856", "context": "Lichenoid drug eruption to salsalate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] eruption [Treatment] salsalate [Effect] Lichenoid drug eruption"}, {"id": "9211543_2_857", "context": "Two pediatric oncology patients with Ewing's sarcoma and one with mixed germ cell tumor were treated with drug regimens that included bleomycin or cyclophosphamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated with [Subject] Two pediatric oncology patients with Ewing's sarcoma and one with mixed germ cell tumor [Treatment] drug regimens that included bleomycin or cyclophosphamide"}, {"id": "8375752_1_858", "context": "Although retinoic acid is well tolerated by the majority of patients with this disease, a potentially fatal complication of this kind of treatment has been reported: \"the retinoic acid syndrome\".", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] retinoic acid [Effect] fatal complication"}, {"id": "2011096_2_859", "context": "Three of 38 children given high-dose cytosine arabinoside therapy developed a previously undescribed complication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 38 children [Treatment] high-dose cytosine arabinoside [Effect] complication"}, {"id": "20178709_1_860", "context": "A case of aseptic pleuropericarditis in a patient with chronic plaque psoriasis under methotrexate therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient with chronic plaque psoriasis [Treatment] methotrexate therapy [Effect] aseptic pleuropericarditis"}, {"id": "16207263_1_861", "context": "Linezolid-induced dyserythropoiesis: chloramphenicol toxicity revisited.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Linezolid [Effect] dyserythropoiesis"}, {"id": "11328247_1_862", "context": "CONCLUSION: The present findings suggest that fluvoxamine can cause increased libido in some patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] some patients [Treatment] fluvoxamine [Effect] increased libido"}, {"id": "2144305_1_863", "context": "A unique case of a transient, nonpigmenting fixed drug eruption caused by the radiopaque contrast medium iothalamate is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] iothalamate [Effect] a transient, nonpigmenting fixed drug eruption"}, {"id": "15785053_1_864", "context": "Mucosal pigmentation after oral lichen planus treatment with topical tacrolimus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment [Treatment] topical tacrolimus [Effect] Mucosal pigmentation"}, {"id": "10473079_2_865", "context": "We now report the first known cancer patient who developed life-threatening complications after treatment with topical 5-FU and was shown subsequently to have profound DPD deficiency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] cancer patient [Treatment] topical 5-FU [Effect] life-threatening complications; have profound DPD deficiency"}, {"id": "110153_2_866", "context": "When the acute manic state is characterized by marked psychotic symptoms and intense anxiety, it may be associated with increased vulnerability to the development of severe lithium neurotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] lithium [Effect] acute manic state is characterized by marked psychotic symptoms and intense anxiety"}, {"id": "7781845_11_867", "context": "Clinicians who manage cachectic patients, particularly those with protracted diarrhoea and/or receiving anti-malarial drugs including mefloquine, should be aware of the risk of severe hypoglycaemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Subject] cachectic patients; with protracted diarrhoea [Treatment] anti-malarial drugs including mefloquine [Effect] severe hypoglycaemia"}, {"id": "7696938_1_868", "context": "Arrhythmias and cardiac arrest have been reported during amphotericin B administration but no effective technique has been described to prevent them.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] amphotericin B administration [Effect] Arrhythmias and cardiac arrest"}, {"id": "15383642_15_869", "context": "Based upon the literature review, the hypotension in this patient was possibly due to the interaction between tizanidine and lisinopril.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] this patient [Treatment] the interaction between tizanidine and lisinopril [Effect] the hypotension"}, {"id": "16119501_1_870", "context": "Baclofen withdrawal: a cause of prolonged fever in the intensive care unit.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Baclofen withdrawal [Effect] prolonged fever"}, {"id": "17596682_1_871", "context": "Interstitial pneumonitis and alveolar hemorrhage complicating use of rituximab: case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicating [Treatment] rituximab [Effect] Interstitial pneumonitis and alveolar hemorrhage"}, {"id": "11022272_4_872", "context": "We introduce a case of a sixty years old woman with several previous episodes of rhinitis, conjunctivitis and perspiration immediately after the administration of salmon calcitonin with nasal spray or intramuscular administration (Calsynar).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a sixty years old woman [Treatment] salmon calcitonin with nasal spray or intramuscular administration (Calsynar) [Effect] several previous episodes of rhinitis, conjunctivitis and perspiration immediately"}, {"id": "15554737_1_873", "context": "In this article, we describe another case of subcutaneous changes following repeated glatiramer acetate injection, presented as localized panniculitis in the area around the injection sites, in a 46-year-old female patient who was treated with glatiramer acetate for 18 months.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a 46-year-old female patient [Treatment] repeated glatiramer acetate injection [Effect] subcutaneous changes; presented as localized panniculitis in the area around the injection sites [Potential therapeutic event] treated [Subject] a 46-year-old female patient [Treatment] glatiramer acetate for 18 months"}, {"id": "11033734_1_874", "context": "Eighty-two patients with various malignancies who received imipenem/cilastatin 143 times for neutropenic fever between March 1994 and October 1999 in Department of Pediatric Oncology, Gazi University, were identified.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] received [Subject] Eighty-two patients with various malignancies [Treatment] imipenem/cilastatin 143 times for neutropenic fever"}, {"id": "23624139_9_875", "context": "The present report first highlights the potentially life-threatening side effects associated with over-the-counter NSAIDs during DDAVP replacement therapy for central DI.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] NSAIDs [Effect] potentially life-threatening side effects"}, {"id": "16623611_1_876", "context": "Case report: lack of control of diabetes and weight gain in a patient on initiation and rechallenge of therapy with olanzapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] initiation and rechallenge [Subject] a patient [Treatment] olanzapine [Effect] diabetes; weight gain"}, {"id": "10030778_1_877", "context": "Intravenous azithromycin-induced ototoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] azithromycin [Effect] ototoxicity"}, {"id": "24318743_14_878", "context": "Orally delivered PXD showed no evidence of clinical activity, when combined with weekly AUC2-carboplatin in PROC.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] clinical activity [Treatment] Orally delivered PXD; weekly AUC2-carboplatin"}, {"id": "18079582_3_879", "context": "We report such a series of patients who had transient asymptomatic bradycardia after being treated with continuous infusion 5-FU.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a series of patients [Treatment] continuous infusion 5-FU [Effect] transient asymptomatic bradycardia"}, {"id": "18854289_1_880", "context": "Consolidation therapy with bortezomib/lenalidomide/ dexamethasone versus bortezomib/dexamethasone after a dexamethasone-based induction regimen in patients with multiple myeloma: a randomized phase III trial.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] in [Subject] patients with multiple myeloma [Treatment] Consolidation therapy with bortezomib/lenalidomide/ dexamethasone versus bortezomib/dexamethasone after a dexamethasone-based induction regimen"}, {"id": "24318743_3_881", "context": "Based on prior data suggesting that scheduling alterations of platinum would increase activity, the aim of the present study was to assess the potential therapeutic benefit of phenoxodiol (PXD), a novel biomodulator shown to have chemoresistance reversing potential, when combined with weekly AUC2-carboplatin in PROC patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] assess [Subject] PROC patients [Treatment] phenoxodiol (PXD), a novel biomodulator shown to have chemoresistance reversing potential, when combined with weekly AUC2-carboplatin [Effect] potential therapeutic benefit"}, {"id": "8832451_3_882", "context": "We also describe a new, noninvasive method to assess magnesium-induced neuromuscular block when curariform muscle relaxant was given simultaneously.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] curariform muscle relaxant was given simultaneously [Effect] neuromuscular block"}, {"id": "1378497_2_883", "context": "Our series of 3 patients supports a causal connection between bleomycin and scleroderma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] supports [Subject] 3 patients [Treatment] bleomycin [Effect] scleroderma"}, {"id": "16404563_6_884", "context": "In this paper, we report a patient with primary anti-phospholipid syndrome treated by corticosteroid, who developed disseminated nocardiosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] corticosteroid [Effect] disseminated nocardiosis"}, {"id": "9052919_1_885", "context": "Eye movement disorders in bone marrow transplant patients on cyclosporin and ganciclovir.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] on [Subject] bone marrow transplant patients [Treatment] cyclosporin and ganciclovir [Effect] Eye movement disorders"}, {"id": "4025011_1_886", "context": "Prolonged severe cholestasis induced by oxacillin derivatives.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] oxacillin derivatives [Effect] Prolonged severe cholestasis"}, {"id": "21881031_11_887", "context": "Cisplatin was the common drug in the cases presented and therefore could be related to the INR elevations.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] the cases [Treatment] Cisplatin [Effect] INR elevations"}, {"id": "17624096_1_888", "context": "5-Fluorouracil cardiotoxicity complicating treatment of stage IIB cervical cancer--case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicating [Treatment] 5-Fluorouracil [Effect] cardiotoxicity"}, {"id": "17241588_1_889", "context": "RESULTS: A clinical diagnosis of fixed drug eruption owing to use of the PDE5 inhibitor tadalafil (Cialis) was made.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] owing [Treatment] PDE5 inhibitor tadalafil (Cialis) [Effect] fixed drug eruption"}, {"id": "9719245_3_890", "context": "Pancytopenia associated with 5-aminosalicylic acid use in a patient with Crohn's disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a patient with Crohn's disease [Treatment] 5-aminosalicylic acid [Effect] Pancytopenia"}, {"id": "12111771_2_891", "context": "Fludarabine induced lung toxicity must be considered in all patients who develop unexplained lung disease while receiving fludarabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] all patients who develop unexplained lung disease [Treatment] fludarabine [Effect] Fludarabine induced lung toxicity"}, {"id": "8007037_1_892", "context": "Although other nitrites induce methemoglobinemia, exposure to methyl nitrite during phenylpropanolamine production appears to be a new cause of occupational methemoglobinemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] methyl nitrite [Effect] occupational methemoglobinemia"}, {"id": "15694139_5_893", "context": "We report four cases of sensorimotor axonal neuropathy in children aged 10-15 years, treated with thalidomide for myxopapillary ependymoma, Crohn's disease and recurrent giant aphthous ulceration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] four cases; children aged 10-15 years; myxopapillary ependymoma, Crohn's disease and recurrent giant aphthous ulceration [Treatment] thalidomide [Effect] sensorimotor axonal neuropathy"}, {"id": "20298401_9_894", "context": "The patient died of respiratory failure after 8 days of steroid infusion and erlotinib discontinuation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] The patient; The [Treatment] 8 days of steroid infusion and erlotinib discontinuation. [Effect] died of respiratory failure"}, {"id": "7962394_3_895", "context": "Hypo-oestrogenic and anabolic/androgenic side-effects of danazol are well known by the gynaecologist and some of them are present in > 50% of patients being treated for endometriosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side-effects [Treatment] danazol [Effect] Hypo-oestrogenic and anabolic/androgenic"}, {"id": "10656221_9_896", "context": "We believe that this is the first description of acute hepatitis caused by an idiosyncratic adverse reaction to gliclazide or to one of its metabolites.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] idiosyncratic adverse reaction [Treatment] gliclazide [Effect] acute hepatitis"}, {"id": "15482394_4_897", "context": "In view of our experience in the present case, it should be stressed that close monitoring of coagulation capacity is necessary in critically ill patients in order to avoid fatal haemorrhage after initiating warfarin therapy regardless of the dosage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] initiating warfarin therapy regardless of the dosage [Effect] haemorrhage"}, {"id": "17352036_4_898", "context": "We report a patient who developed acute pancreatitis during amiodarone therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a patient [Treatment] amiodarone [Effect] acute pancreatitis"}, {"id": "9602881_1_899", "context": "We report a 76-year-old man who developed an acute blistering eruption following high-dose penicillin treatment for pneumococcal septicaemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 76-year-old man [Treatment] high-dose penicillin treatment [Effect] acute blistering eruption"}, {"id": "14632592_5_900", "context": "OBJECTIVE: To report a case of colchicine-induced myopathy in a teenager with familial Mediterranean fever (FMF).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a teenager with familial Mediterranean fever (FMF) [Treatment] colchicine [Effect] myopathy"}, {"id": "11414270_14_901", "context": "We believe that mucositis was a contributing factor to this case of fatal hyperkalemia after administration of succinylcholine, with a mechanism similar to that reported with thermal injury.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] mucositis [Treatment] succinylcholine [Effect] fatal hyperkalemia"}, {"id": "10928688_1_902", "context": "Our experience supports hemodialysis for ESRF patients with atenolol toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Subject] ESRF patients with atenolol toxicity [Treatment] hemodialysis"}, {"id": "14679124_1_903", "context": "Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] administered [Subject] postmenopausal node-positive breast cancer patients [Treatment] Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently"}, {"id": "3628148_1_904", "context": "Rupture of a cerebral aneurysm associated with nifedipine treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] nifedipine [Effect] Rupture of a cerebral aneurysm"}, {"id": "15157248_1_905", "context": "An immediate hemolytic reaction induced by repeated administration of oxaliplatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] repeated administration of oxaliplatin [Effect] immediate hemolytic reaction"}, {"id": "15494638_8_906", "context": "Patient B developed perioral and upper extremity paresthesias during the fourth cycle of CAP alone (2500 mg/m2).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Patient B [Treatment] the fourth cycle of CAP alone (2500 mg/m2) [Effect] perioral and upper extremity paresthesias"}, {"id": "8749646_4_907", "context": "We describe four patients who had seizures while receiving ofloxacin; no other causes were evident.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] four patients [Treatment] ofloxacin [Effect] seizures"}, {"id": "14607011_2_908", "context": "The case history and toxicological findings of an infant fatality involving pseudoephedrine, brompheniramine, and dextromethorphan are presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] involving [Subject] an infant [Treatment] pseudoephedrine, brompheniramine, and dextromethorphan [Effect] infant fatality"}, {"id": "9701106_1_909", "context": "A drug interaction between zafirlukast and theophylline.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] between [Treatment] zafirlukast and theophylline [Effect] drug interaction"}, {"id": "16503727_1_910", "context": "Dipyrone, also known as metamizole, is an analgesic and antipyretic drug that was banned by the United States Food and Drug Administration because of its association with agranulocytosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] Dipyrone, also known as metamizole [Effect] agranulocytosis"}, {"id": "990658_1_911", "context": "A fatal case of pancytopenia due to levomepromazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] A fatal case [Treatment] levomepromazine [Effect] pancytopenia"}, {"id": "20130478_2_912", "context": "Reversible heart failure in a patient receiving etanercept for ankylosing spondylitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient [Treatment] etanercept [Effect] Reversible heart failure"}, {"id": "12503933_7_913", "context": "The most likely cause of liver failure in this patient was, therefore, clarithromycin, which undergoes hepatic metabolism and has been reported to cause fulminant hepatic failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] clarithromycin [Effect] liver failure"}, {"id": "15554737_2_914", "context": "Localized panniculitis and subsequent lipoatrophy with subcutaneous glatiramer acetate (Copaxone) injection for the treatment of multiple sclerosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] subcutaneous glatiramer acetate (Copaxone) injection [Effect] Localized panniculitis and subsequent lipoatrophy"}, {"id": "19224802_6_915", "context": "glycopyrrolate (5.0 microg/kg) not only resulting in resolution of bradycardia but also resulting in an exaggerated increase of arterial blood pressure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] glycopyrrolate (5.0 microg/kg) [Effect] resolution of bradycardia; an exaggerated increase of arterial blood pressure"}, {"id": "16511396_3_916", "context": "This case underscores problems in clinical management with sulfadiazine hypersensitivity, potential immunosuppression from corticosteroids and selection of medications for recurrences of toxoplasmic chorioretinitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] hypersensitivity [Treatment] sulfadiazine [Effect] hypersensitivity [Adverse event] from [Treatment] corticosteroids [Effect] immunosuppression"}, {"id": "10084639_2_917", "context": "CONCLUSION: The results suggest that olanzapine may be useful in treating patients with clozapine-induced granulocytopenia without the risk of recurrence of hematologic side effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treating [Subject] patients with clozapine-induced granulocytopenia [Treatment] olanzapine [Effect] without the risk of recurrence of hematologic side effects [Adverse event] induced [Treatment] clozapine [Effect] granulocytopenia"}, {"id": "10452772_1_918", "context": "CONCLUSION: Patients with insulin allergy may not have complete resolution of their symptoms after standard desensitization, particularly those patients with concomitant protamine allergy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolution [Subject] Patients with insulin allergy; concomitant protamine allergy [Treatment] standard desensitization"}, {"id": "2394154_4_919", "context": "To our knowledge, the syndrome of fever, pulmonary infiltrates, and pleural effusion following use of acyclovir has not been previously reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] acyclovir [Effect] fever, pulmonary infiltrates, and pleural effusion"}, {"id": "3485422_2_920", "context": "We are concerned that the macular lesion was a retinal toxic effect of gentamicin because of the recent description of similar lesions occurring after the inadvertent intraocular injection of massive doses of this drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] gentamicin [Effect] macular lesion"}, {"id": "16791713_1_921", "context": "Acute myocardial infarction during high-dose methylprednisolone therapy for Graves' ophthalmopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] high-dose methylprednisolone therapy [Effect] Acute myocardial infarction"}, {"id": "11881322_8_922", "context": "With itraconazole, hepatotoxic reactions have only very rarely been reported, and histologic data are lacking.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] itraconazole [Effect] hepatotoxic"}, {"id": "17675030_4_923", "context": "We describe in detail the first U.S. case report, of a 4(1/2)-year-old boy who experienced angioedema during treatment with oxcarbazepine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment [Subject] a 4(1/2)-year-old boy [Treatment] oxcarbazepine [Effect] angioedema"}, {"id": "21045170_11_924", "context": "Caution should be used when coadministering enfuvirtide and niacin to HIV-infected patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] used [Subject] HIV-infected patients [Treatment] coadministering enfuvirtide and niacin [Effect] Caution"}, {"id": "448845_3_925", "context": "Several case reports of aplastic anemia with use of acetazolamide, and two cases with use of methazolamide, have appeared in the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reports [Subject] Several case [Treatment] acetazolamide [Effect] aplastic anemia"}, {"id": "17381671_7_926", "context": "SSRIs and fentanyl are commonly co-administered, especially in the setting of chronic or malignant pain, as underlying depression may contribute to the pathogenesis of pain.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] in [Treatment] SSRIs and fentanyl are commonly co-administered"}, {"id": "1420650_2_927", "context": "In this report we present four patients treated with a combination of different psychotropic drugs, in whom asterixis was triggered either by adding carbamazepine (CBZ) to a treatment regimen, or by increasing its dosage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] triggered [Subject] four patients [Treatment] carbamazepine [Effect] asterixis"}, {"id": "458006_1_928", "context": "Squamous-cell carcinoma arising in a basal-cell epithelioma treated with 5-fluorouracil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Treatment] 5-fluorouracil [Effect] Squamous-cell carcinoma arising"}, {"id": "8313300_2_929", "context": "The case of a bipolar patient who developed thyrotoxicosis with severe exophthalmos while on lithium therapy is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] on [Subject] The case of a bipolar patient [Treatment] lithium [Effect] thyrotoxicosis with severe exophthalmos"}, {"id": "1267457_2_930", "context": "The patient received only the ophthalmic sulfonamide, and it was used for one day, but he developed Stevens-Johnson syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] The patient; he [Treatment] ophthalmic sulfonamide, and it was used for one day [Effect] Stevens-Johnson syndrome"}, {"id": "11545487_3_931", "context": "Papillary necrosis associated with the HIV protease inhibitor indinavir.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] indinavir [Effect] Papillary necrosis"}, {"id": "8360712_1_932", "context": "A case is reported of a 40 year old woman treated with intraventricular IL-2 for leptomeningeal disease who developed progressive cognitive dysfunction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 40 year old woman [Treatment] intraventricular IL-2 [Effect] progressive cognitive dysfunction"}, {"id": "15289139_3_933", "context": "We document the abrupt development of an extensive choroidal detachment after initiation of dorzolamide therapy in a surgically untreated eye with primary open-angle glaucoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] surgically untreated eye with primary open-angle glaucoma [Treatment] dorzolamide therapy [Effect] extensive choroidal detachment"}, {"id": "19226083_1_934", "context": "Serotonin toxicity as a consequence of linezolid use in revision hip arthroplasty.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] consequence [Treatment] linezolid use in revision hip arthroplasty; Serotonin [Effect] Serotonin toxicity"}, {"id": "11788010_2_935", "context": "Gallstones and bile sludge are common side effects of octreotide therapy but rarely become symptomatic or require treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effects of [Treatment] octreotide therapy [Effect] Gallstones and bile sludge"}, {"id": "14557583_3_936", "context": "The authors' results suggest that L-dopa may cause daytime somnolence in some patients with Parkinson's disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] some patients with Parkinson's disease [Treatment] L-dopa [Effect] daytime somnolence"}, {"id": "8597009_2_937", "context": "Seventy-four per cent of patients with epileptogenic disorders seen at the Emergency Unit at Groote Schuur Hospital were on phenytoin and 11.6% of these had blood levels in the toxic range.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] Seventy-four per cent of patients with epileptogenic disorders; 11.6% of these [Treatment] phenytoin [Effect] blood levels in the toxic range"}, {"id": "16284443_1_938", "context": "Based on the history and clinical features, a diagnosis of insulin-induced lipohypertrophy was made.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] insulin [Effect] lipohypertrophy"}, {"id": "16637972_2_939", "context": "An unusual presentation of spontaneous sub-conjunctival haematoma in a patient receiving warfarin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient [Treatment] warfarin [Effect] spontaneous sub-conjunctival haematoma"}, {"id": "19782276_4_940", "context": "He developed congestive heart failure 5 days after administration of cyclophosphamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] 5 days after administration of cyclophosphamide [Effect] congestive heart failure"}, {"id": "12503933_5_941", "context": "Fulminant liver failure associated with clarithromycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] clarithromycin [Effect] Fulminant liver failure"}, {"id": "2979256_3_942", "context": "Nifedipine may induce, or aggravate, pre-existing, gastro-oesophageal reflux.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce, or aggravate [Treatment] Nifedipine [Effect] gastro-oesophageal reflux"}, {"id": "2728526_1_943", "context": "Rifampin-associated thrombocytopenia secondary to poor compliance.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Rifampin [Effect] thrombocytopenia secondary to poor compliance"}, {"id": "8672829_2_944", "context": "CONCLUSIONS: There was a temporal relationship between the onset of nonconvulsive status epilepticus and initiation of ifosfamide infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] relationship [Treatment] initiation of ifosfamide infusion [Effect] onset of nonconvulsive status epilepticus"}, {"id": "16109609_1_945", "context": "Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Gemcitabine [Effect] pericardial effusion and tamponade"}, {"id": "7416268_3_946", "context": "Although useful in the management of chronic alcoholism, disulfiram is being increasingly associated with a wide spectrum of side effects and untoward medical sequelae, which now include catatonia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] disulfiram [Effect] a wide spectrum of side effects and untoward medical sequelae, which now include catatonia"}, {"id": "19567656_2_947", "context": "DISCUSSION: The Naranjo probability scale indicated a probable relationship between sertraline treatment and the onset of rhabdomyolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] relationship [Treatment] sertraline [Effect] rhabdomyolysis"}, {"id": "14677199_1_948", "context": "Severe Raynaud's phenomenon with yohimbine therapy for erectile dysfunction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] yohimbine [Effect] Raynaud's phenomenon"}, {"id": "10323129_1_949", "context": "Possible theophylline toxicity during anesthesia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] anesthesia [Effect] theophylline toxicity"}, {"id": "3124393_2_950", "context": "Calcification and ossification of the spinal arachnoid after intrathecal administration of Depo-Medrol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] intrathecal administration of Depo-Medrol [Effect] Calcification and ossification of the spinal arachnoid"}, {"id": "921427_2_951", "context": "Circulating anticoagulant in the procainamide-induced lupus syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] procainamide [Effect] lupus syndrome"}, {"id": "16405935_3_952", "context": "This report describes a case of bilateral ptosis induced by chloroquine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] chloroquine [Effect] bilateral ptosis"}, {"id": "12221670_5_953", "context": "When the data of the 57 patients are evaluated, a reversible direct cytotoxic effect of ticlopidine on the pluripotent/bipotent hematopoietic progenitor stem cell is proposed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] proposed [Subject] 57 patients [Treatment] ticlopidine [Effect] cytotoxic effect"}, {"id": "17526968_3_954", "context": "We report a child with yolk sac tumor who developed localized pigmentation after the first course of chemotherapy regimen that included cisplatin, etoposide and bleomycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a child with yolk sac tumor [Treatment] the first course of chemotherapy regimen that included cisplatin, etoposide and bleomycin [Effect] localized pigmentation"}, {"id": "16791713_2_955", "context": "Except hypothyroidism after radioiodine treatment (euthyroid under substitutional therapy), she suffered from no other diseases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] she [Treatment] radioiodine treatment (euthyroid under substitutional therapy) [Effect] hypothyroidism"}, {"id": "17034541_1_956", "context": "Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] rituximab [Effect] Late lethal hepatitis B virus reactivation"}, {"id": "15482394_3_957", "context": "Despite the low dosage of warfarin, international normalized ratio (INR) was markedly elevated from 1.15 to 11.28 for only 4 days, and bleeding symptoms concurrently developed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] low dosage of warfarin [Effect] international normalized ratio (INR) was markedly elevated; bleeding symptoms"}, {"id": "3815268_2_958", "context": "The possible role of interferon beta in the pathogenesis of sarcoidosis in this patient is discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] role [Subject] this patient [Treatment] interferon beta [Effect] sarcoidosis"}, {"id": "11144696_11_959", "context": "We hypothesize that a pharmacodynamic or pharmacokinetic drug interaction between venlafaxine and trimipramine involving the CYP2D6 isoenzyme may have played a role in inducing the seizures.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] inducing [Treatment] venlafaxine and trimipramine [Effect] seizures"}, {"id": "2116935_3_960", "context": "A case is described of severe splenic hemorrhage and rupture which developed 3 h after completion of tPA infusion for suspected acute myocardial infarction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] 3 h after completion of tPA infusion [Effect] severe splenic hemorrhage and rupture"}, {"id": "15383642_6_961", "context": "Three weeks later, the decerebrate rigidity and high BP remained, and tizanidine was initiated to see whether the decrease in muscle tone could facilitate hypertension control and motor recovery.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] initiated [Subject] decerebrate rigidity and high BP [Treatment] tizanidine [Effect] hypertension control and motor recovery"}, {"id": "1635565_2_962", "context": "CONCLUSIONS: The administration of prostaglandin E1 to neonates can cause gastric-outlet obstruction due to antral hyperplasia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] neonates [Treatment] prostaglandin E1 [Effect] gastric-outlet obstruction due to antral hyperplasia"}, {"id": "8013261_1_963", "context": "During and after IFN therapy we should consider the possibility of occurrence of IDDM as well as other autoimmune diseases and observe the clinical course carefully.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurrence [Treatment] IFN therapy [Effect] IDDM as well as other autoimmune diseases"}, {"id": "9754850_1_964", "context": "In two of these cases akathisia resolved after withdrawal of olanzapine and substitution by a classical or an atypical neuroleptic agent, respectively.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resolved [Subject] two of these cases [Treatment] withdrawal of olanzapine and substitution by a classical; neuroleptic agent [Effect] akathisia [Adverse event] resolved [Treatment] withdrawal of olanzapine and substitution by; an atypical neuroleptic agent [Effect] akathisia"}, {"id": "3310776_2_965", "context": "Captopril-related (and -induced?) asthma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] Captopril [Effect] asthma"}, {"id": "15671134_3_966", "context": "These findings suggest that clozapine-induced seizures can be successfully treated, that gradual dose titration can reduce the likelihood of further episodes of seizures and that concomitant use of a suitable mood stabilizer/anti-epileptic medication can improve the outcome of treatment-resistant schizophrenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] clozapine [Effect] seizures [Potential therapeutic event] treated [Treatment] gradual dose titration; concomitant use of a suitable mood stabilizer/anti-epileptic medication [Effect] the likelihood of further episodes of seizures; improve the outcome of treatment-resistant schizophrenia"}, {"id": "18094347_1_967", "context": "According to the Naranjo probability scale, the papular eruption was probably caused by methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] methotrexate [Effect] papular eruption"}, {"id": "3688031_3_968", "context": "The patient's defects may be due to methimazole teratogenicity or could represent a previously undescribed syndrome affecting ectodermal structures.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] methimazole [Effect] teratogenicity"}, {"id": "11881322_2_969", "context": "CONCLUSIONS: Itraconazole-induced liver injury presents with a cholestatic pattern of injury with damage to the interlobular bile ducts, possibly leading to ductopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Itraconazole [Effect] liver injury presents with a cholestatic pattern of injury with damage to the interlobular bile ducts, possibly leading to ductopenia"}, {"id": "12243603_8_970", "context": "Rhabdomyolysis resulting from the drug interaction between diltiazem and other HMG-CoA reductase inhibitors has been described in the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] diltiazem and other HMG-CoA reductase inhibitors [Effect] Rhabdomyolysis"}, {"id": "23552010_1_971", "context": "Acute angioedema response to topical 5-fluorouracil therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] response [Treatment] 5-fluorouracil [Effect] angioedema"}, {"id": "3569037_3_972", "context": "Hypersensitivity reactions due to chloramphenicol are rarely reported in the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] chloramphenicol [Effect] Hypersensitivity reactions"}, {"id": "18515982_3_973", "context": "Diagnosis of sclerosing glomerulonephritis occurred in this patient during anastrozole use, suggesting a newly defined side effect of anastrozole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] patient [Treatment] anastrozole [Effect] sclerosing glomerulonephritis"}, {"id": "582099_1_974", "context": "A patient with coccidioidal meningitis was treated with intrathecally administered amphotericin B, and an acute toxic delirium with EEG abnormalities developed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated with [Subject] A patient with coccidioidal meningitis [Treatment] intrathecally administered amphotericin B [Effect] an acute toxic delirium with EEG abnormalities"}, {"id": "18801826_5_975", "context": "This case raises important questions about non-ketotic, hyperosmolar diabetic coma with antipsychotics, the possible association between hyperglycaemia and hyperthermia, and the direction of causality in this, the recognition of either syndrome when they co-exist and management issues in such patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] antipsychotics [Effect] non-ketotic, hyperosmolar diabetic coma; hyperglycaemia and hyperthermia"}, {"id": "10203437_8_976", "context": "CONCLUSIONS: Reversible lupus-like syndrome appears to be a rare but significant side effect of 5-ASA compounds.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effect [Treatment] 5-ASA [Effect] Reversible lupus-like syndrome"}, {"id": "267281_1_977", "context": "A patient with chronic myeloid leukaemia treated with busulphan for 4-5 years, developed signs of busulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient with chronic myeloid leukaemia [Treatment] busulphan for 4-5 years [Effect] busulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice"}, {"id": "8828999_4_978", "context": "Several cases of lithium-induced Creutzfeldt-Jakob syndrome have been reported to date; all of them were elderly patients and a half had \"therapeutic\" lithium serum levels.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] elderly patients [Treatment] lithium; \"therapeutic\" lithium serum levels [Effect] Creutzfeldt-Jakob syndrome"}, {"id": "11206417_3_979", "context": "There is, however, currently no data on the effect of combined hyperglycaemia and hyperinsulinaemia on the renal and ocular blood flow seen in diabetic patients on insulin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] on [Subject] combined hyperglycaemia and hyperinsulinaemia; diabetic patients [Treatment] insulin therapy [Effect] renal and ocular blood flow"}, {"id": "8445549_2_980", "context": "Pemphigus vulgaris precipitated by glibenclamide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitated [Treatment] glibenclamide [Effect] Pemphigus vulgaris"}, {"id": "3804181_1_981", "context": "Methimazole-associated cholestatic liver injury: case report and brief literature review.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Methimazole [Effect] cholestatic liver injury"}, {"id": "2452936_2_982", "context": "The most likely cause of such hyponatremic episode is vinblastine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] is [Treatment] vinblastine [Effect] hyponatremic episode"}, {"id": "15770343_1_983", "context": "Anti-tuberculous drugs had been stopped on the 2nd day of therapy due to development of optic neuritis secondary to ethambutol administration at another hospital.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] ethambutol [Effect] optic neuritis secondary"}, {"id": "21751692_5_984", "context": "Based on this experience, we suggest that low-dose ketamine added to propofol may be associated with prevention of EA in children with a history of EA with propofol TIVA.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prevention [Subject] children with a history of EA with propofol TIVA [Treatment] low-dose ketamine added to propofol"}, {"id": "8903300_2_985", "context": "Tetany in a child with AIDS receiving intravenous tobramycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a child with AIDS [Treatment] intravenous tobramycin [Effect] Tetany"}, {"id": "15454180_3_986", "context": "Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] patient with a left ventricular assist device [Treatment] linezolid [Effect] Sideroblastic anemia"}, {"id": "17655376_2_987", "context": "Oral dapsone has been available for over 60 years and has been used to treat severe acne vulgaris; however, the oral formulation is known to cause dose-dependent haematological reactions and is currently indicated only for diseases such as dermatitis herpetiformis and Hansen's disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Oral dapsone [Effect] dose-dependent haematological reactions"}, {"id": "1580986_1_988", "context": "Enalapril-induced anemia in two kidney transplant recipients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] two kidney transplant recipients [Treatment] Enalapril [Effect] anemia"}, {"id": "10458196_5_989", "context": "PURPOSE: To report two cases in which topical brimonidine resulted in apparent central nervous system depression and unresponsiveness in an infant.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Subject] an infant [Treatment] topical brimonidine [Effect] apparent central nervous system depression and unresponsiveness"}, {"id": "16225183_2_990", "context": "BACKGROUND: Interferon beta has become standard therapy for reducing relapse frequency in relapsing/remitting Multiple Sclerosis (RRMS).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] standard therapy [Treatment] Interferon beta"}, {"id": "14566215_1_991", "context": "In this article lithium is not discussed, although there are a number of concerns about lithium's potential teratogenicity, and it has been implicated in Epstein's anomaly, a congenital heart defect among infants born to women taking lithium; as with other medications, however, the data have specific limitations.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] implicated [Treatment] lithium [Effect] Epstein's anomaly"}, {"id": "21751542_5_992", "context": "The risk of gastrointestinal bleeding during the treatment with antiagregants and anticoagulants, the risk of bradycardia in beta-blockade, possible interactions with other medications lowering the heart rate are discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] antiagregants and anticoagulants [Effect] gastrointestinal bleeding [Adverse event] in [Treatment] beta-blockade [Effect] bradycardia"}, {"id": "847572_1_993", "context": "Hepatotoxicity of paracetamol enhanced by ingestion of alcohol: report of two cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] enhanced [Subject] two cases. [Treatment] paracetamol; ingestion of alcohol [Effect] Hepatotoxicity"}, {"id": "10099659_7_994", "context": "Cancer patients who are receiving 5-FU treatment and are DPD deficient can develop severe side effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] Cancer patients; are DPD deficient [Treatment] receiving 5-FU [Effect] severe side effects"}, {"id": "876914_1_995", "context": "A patient is described who developed a poorly differentiated sarcoma after cyclophosphamide was used to treat his rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient; his rheumatoid arthritis [Treatment] cyclophosphamide [Effect] poorly differentiated sarcoma"}, {"id": "18344734_1_996", "context": "Photo-onycholysis caused by olanzapine and aripiprazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] olanzapine and aripiprazole [Effect] Photo-onycholysis"}, {"id": "7606071_7_997", "context": "We observed 5 reactions in 3 patients that appear to be related to a high dose-infusion time ratio, indicating that dose and rate of infusion may be important factors in precipitating anaphylactoid reactions with cisplatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitating [Subject] 3 patients [Treatment] high dose-infusion time ratio; cisplatin [Effect] anaphylactoid reactions"}, {"id": "10395123_1_998", "context": "CONCLUSION: Fixed drug eruption is associated with many drugs but this is the first such report with omeprazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] omeprazole [Effect] Fixed drug eruption"}, {"id": "6460590_1_999", "context": "One type of SMON is associated with acrodermatitis enteropathica which has a very high frequency of occurrence in association with administration of clioquinol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] clioquinol [Effect] SMON; acrodermatitis enteropathica"}, {"id": "8949576_3_1000", "context": "We report a case of amiodarone-induced thyrotoxicosis of protracted duration, unresponsive to conventional thionamide therapy, with therapy limited by severe adverse drug reactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] amiodarone [Effect] thyrotoxicosis"}, {"id": "19151423_3_1001", "context": "The addition of ciprofloxacin to chronic simvastatin therapy led to the development of rhabdomyolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] led [Treatment] ciprofloxacin; chronic simvastatin [Effect] rhabdomyolysis"}, {"id": "941054_1_1002", "context": "Nephropathy caused by methicillin therapy for staphylococcal septicemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] methicillin therapy for staphylococcal septicemia [Effect] Nephropathy"}, {"id": "2028358_1_1003", "context": "Four patients in whom pulmonary oedema developed during tocolysis with hexoprenaline are described and the aetiological factors and pathogenesis of this potentially lethal complication discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Four patients [Treatment] tocolysis with hexoprenaline [Effect] pulmonary oedema"}, {"id": "7379406_2_1004", "context": "A case of skeletal fluorosis induced by prolonged treatment with niflumic acid, a fast-acting non-steroid antiinflammatory agent, is reported in a 35-year-old woman suffering from rheumatoid arthritis and treated, in addition, with corticosteroids.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 35-year-old woman suffering from rheumatoid arthritis [Treatment] niflumic acid; in addition, with corticosteroids [Effect] skeletal fluorosis"}, {"id": "16637972_1_1005", "context": "A 65-year-old man on warfarin therapy with a sudden spontaneous onset of sub-conjunctival haematoma associated with bloody tears was assessed in the clinic following a referral from an optometrist.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] A 65-year-old man [Treatment] warfarin therapy [Effect] a sudden spontaneous onset of sub-conjunctival haematoma associated with bloody tears"}, {"id": "11749112_2_1006", "context": "This case report describes the development of asymptomatic visual field defects (VFDs) in a psychiatric patient with bipolar disorder receiving adjunctive tiagabine treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] patient [Treatment] tiagabine [Effect] asymptomatic visual field defects"}, {"id": "7436161_1_1007", "context": "Cardiorespiratory toxicity due to miconazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Treatment] miconazole [Effect] Cardiorespiratory toxicity"}, {"id": "9220046_5_1008", "context": "Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] clarithromycin; azithromycin; Lovastatin [Effect] rhabdomyolysis"}, {"id": "10490907_14_1009", "context": "For prevention of CYP2E1-mediated bioactivation, depending on protoxicant disposition, a second DSF dose might be necessary to completely prevent toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] to [Treatment] a second DSF dose"}, {"id": "3438585_3_1010", "context": "We describe a patient with rheumatoid arthritis treated with gold salts, who developed bilateral interstitial pulmonary abnormalities and showed a dramatic response on corticosteroid therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated with [Subject] a patient with rheumatoid arthritis [Treatment] gold salts [Effect] bilateral interstitial pulmonary abnormalities"}, {"id": "9184269_5_1011", "context": "Pneumonitis is emerging as one of the most unpredictable and potentially serious, adverse effects of treatment with MTX.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] MTX [Effect] Pneumonitis"}, {"id": "8771575_1_1012", "context": "A chronic reaction associated with long-term treatment with nitrofurantoin has also been reported and causes irreversible pulmonary fibrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causes [Treatment] long-term treatment with nitrofurantoin [Effect] irreversible pulmonary fibrosis"}, {"id": "19789166_2_1013", "context": "Nitrofurantoin-induced acute liver damage in pregnancy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] pregnancy [Treatment] Nitrofurantoin [Effect] acute liver damage"}, {"id": "12656748_1_1014", "context": "A 58-yr-old male patient with essential thrombocythaemia (ET) developed chronic myeloid leukaemia (CML) after continuous uneventful treatment with hydroxyurea for 18 yr.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 58-yr-old male patient with essential thrombocythaemia (ET) [Treatment] continuous uneventful treatment with hydroxyurea for 18 yr [Effect] chronic myeloid leukaemia (CML)"}, {"id": "7538828_2_1015", "context": "A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck developed severe skin rash and bone marrow aplasia 4 and 7 days, respectively, following a single dose of 40 mg/m2 methotrexate (MTX).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck [Treatment] a single dose of 40 mg/m2 methotrexate (MTX) [Effect] skin rash and bone marrow aplasia"}, {"id": "4004433_3_1016", "context": "We present four cases in which the use of heparin was associated with hyperkalemia and discuss the pathophysiology.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] four cases [Treatment] heparin [Effect] hyperkalemia"}, {"id": "16968538_6_1017", "context": "Three cycles of chemotherapy had been administered without complications when, at the beginning of the fourth cycle, the patient developed clinical and laboratory abnormalities consistent with the development of the hemolytic-uremic syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] the patient [Treatment] chemotherapy; at the beginning of the fourth cycle [Effect] hemolytic-uremic syndrome."}, {"id": "8862924_1_1018", "context": "Keratitis in methamphetamine abusers.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Treatment] methamphetamine abusers [Effect] Keratitis"}, {"id": "9399776_3_1019", "context": "A rechallenge, performed in both patients, confirmed the diagnosis of mesalamine-induced pancreatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] both patients [Treatment] mesalamine [Effect] pancreatitis"}, {"id": "8197046_1_1020", "context": "Central nervous system toxicity associated with meperidine use in hepatic disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] meperidine [Effect] Central nervous system toxicity"}, {"id": "12066972_2_1021", "context": "To our knowledge, this case is the first published report of levofloxacin-induced TEN.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] levofloxacin [Effect] TEN"}, {"id": "7282702_3_1022", "context": "On the second day of hospitalization, it was noted that the patient's dyspnea and sinus bradycardia could be related to a recent increase in his timolol dosage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] patient [Treatment] a recent increase in his timolol dosage [Effect] dyspnea and sinus bradycardia"}, {"id": "10870485_1_1023", "context": "Three months following splenectomy, multiple abscesses occurred in the muscles of both thighs while the patient was receiving the third course of the CHOP regimen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] while [Subject] the patient [Treatment] Three months following splenectomy; third course of the CHOP regimen [Effect] multiple abscesses occurred in the muscles of both thighs"}, {"id": "19423610_9_1024", "context": "Methylene blue is used in a variety of surgical settings as well as for treatment of various types of hypotensive shock and methemoglobinaemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Methylene blue"}, {"id": "9554064_1_1025", "context": "Methanol toxicity can cause severe central nervous system insult in which a characteristic pattern of bilateral putaminal injury is noted on brain imaging studies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Methanol toxicity [Effect] central nervous system insult"}, {"id": "11737689_5_1026", "context": "We believe that these skin eruptions belong to a spectrum of neutrophilic dermatoses that can be induced or aggravated by G-CSF therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] G-CSF [Effect] skin eruptions"}, {"id": "3892171_4_1027", "context": "Although adverse reactions to protamine are reported infrequently and are usually mild, we recently observed the first fatal case of type I anaphylaxis resulting from protamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] protamine [Effect] fatal case of type I anaphylaxis"}, {"id": "2595431_4_1028", "context": "We have reported six cases of metoclopramide-induced parkinsonism seen in consultation over a two-year period.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] six cases [Treatment] metoclopramide [Effect] parkinsonism"}, {"id": "14514135_1_1029", "context": "Neutrophilic eccrine hidradenitis mimicking cutaneous vasculitis in a lupus patient: a complication of cyclophosphamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Subject] a lupus patient [Treatment] cyclophosphamide [Effect] Neutrophilic eccrine hidradenitis"}, {"id": "10656221_1_1030", "context": "Gliclazide-induced acute hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Gliclazide [Effect] acute hepatitis"}, {"id": "8435665_1_1031", "context": "A 16-year-old white male with acute biphenotypic leukemia developed evidence of the eosinophilia myalgia syndrome associated with total parenteral nutritional support with solutions containing tryptophan, which were given during his initial induction chemotherapy and also after autologous marrow transplantation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 16-year-old white male with acute biphenotypic leukemia [Treatment] total parenteral nutritional support with solutions containing tryptophan, which were given during his initial induction chemotherapy and also after autologous marrow transplantation [Effect] eosinophilia myalgia syndrome"}, {"id": "16268429_2_1032", "context": "Subacute cholestatic hepatitis likely related to the use of senna for chronic constipation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related to [Treatment] use of senna [Effect] Subacute cholestatic hepatitis"}, {"id": "12460237_2_1033", "context": "Palmar-plantar erythrodysaesthesia (PPE) is an uncommon cutaneous complication of cytotoxic chemotherapy which generally presents as a painful erythema involving the palms and soles.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] cytotoxic chemotherapy [Effect] Palmar-plantar erythrodysaesthesia (PPE); an uncommon cutaneous complication; a painful erythema involving the palms and soles"}, {"id": "19363904_2_1034", "context": "We report a case of an 11-year-old boy who experienced an anaphylactic reaction after administration of bacitracin ointment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] an 11-year-old boy [Treatment] after administration of bacitracin ointment [Effect] an anaphylactic reaction"}, {"id": "15661067_2_1035", "context": "The patient was found to have no motile sperm with a normal sperm count, while taking a dose of 400 mg/day of carbamazepine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] found [Subject] The patient [Treatment] 400 mg/day of carbamazepine [Effect] no motile sperm with a normal sperm count"}, {"id": "990658_2_1036", "context": "A fatal pancytopenia occurred in a patient with an history of depression with hypomanic rebounds, admitted for a manic episode and treated with levomepromazine, diazepam and lithium carbonate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] a patient with an history of depression with hypomanic rebounds [Treatment] treated with levomepromazine, diazepam and lithium carbonate [Effect] A fatal pancytopenia"}, {"id": "15133245_2_1037", "context": "Oxatomide is an antiallergic drug used for the treatment of diseases mediated by type I allergy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used [Treatment] Oxatomide"}, {"id": "6453500_2_1038", "context": "Toxic hepatitis induced by disulfiram in a non-alcoholic.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a non-alcoholic [Treatment] disulfiram [Effect] Toxic hepatitis"}, {"id": "3143551_1_1039", "context": "Accordingly, camptocormia is a dose-dependent side effect of valproate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] effect [Treatment] valproate [Effect] camptocormia"}, {"id": "19390192_2_1040", "context": "The uncomplicated long-term use of adequately-dosed AZA and stable non-toxic metabolite levels could not acknowledge TPMT deficiency as a primary cause of the leukopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] long-term use of adequately-dosed AZA and stable non-toxic metabolite levels could not acknowledge TPMT deficiency [Effect] leukopenia"}, {"id": "17381671_9_1041", "context": "CASE SUMMARY: A 65-year-old patient chronically treated with the selective serotonin reuptake inhibitor (SSRI) citalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 65-year-old patient [Treatment] chronically treated with the selective serotonin reuptake inhibitor (SSRI) citalopram; following initiation of fentanyl [Effect] confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome"}, {"id": "3941210_2_1042", "context": "Such a case induced by hypothyroidism complicating long-term therapy with amiodarone in a 45 year old woman with pre-excitation is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicating [Subject] a 45 year old woman with pre-excitation [Treatment] long-term therapy with amiodarone [Effect] hypothyroidism"}, {"id": "2935070_4_1043", "context": "The diagnosis was based on the rapid onset of renal failure, presence of eosinophilia, skin rash, and characteristic renal biopsy finding, following the administration of ampicillin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] ampicillin [Effect] rapid onset of renal failure, presence of eosinophilia, skin rash, and characteristic renal biopsy"}, {"id": "16008658_1_1044", "context": "46-year-old woman developed painful ulcers over her lower abdomen in the form of reticulate erythema after injecting interferon beta-1b subcutaneously for multiple sclerosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 46-year-old woman [Treatment] injecting interferon beta-1b subcutaneously [Effect] painful ulcers over her lower abdomen in the form of reticulate erythema"}, {"id": "10203437_1_1045", "context": "Lupus-like syndrome caused by 5-aminosalicylic acid in patients with inflammatory bowel disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] patients with inflammatory bowel disease [Treatment] 5-aminosalicylic acid [Effect] Lupus-like syndrome"}, {"id": "566977_1_1046", "context": "Fatal acute tubular necrosis occurred in 1 patient in whom intravesical formalin was used to control massive persistent hemorrhage from radiation cystitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] 1 patient [Treatment] intravesical formalin [Effect] acute tubular necrosis"}, {"id": "9302445_3_1047", "context": "The hypercalcemia responded to discontinuation of rhGH and a single dose of intravenous pamidronate disodium and has not recurred in 8 months of follow-up.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] responded [Treatment] discontinuation of rhGH and a single dose of intravenous pamidronate disodium [Effect] has not recurred in 8 months of follow-up"}, {"id": "834512_2_1048", "context": "The administration of \"sweet spirits of nitre\" (4% ethyl nitrite CH3CH2ONO in 70% ethyl alcohol) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] followed [Subject] infant twins [Treatment] \"sweet spirits of nitre\" (4% ethyl nitrite CH3CH2ONO in 70% ethyl alcohol) [Effect] acute methemoglobinemia and severe anoxic metabolic acidosis [Potential therapeutic event] reversed [Subject] infant twins [Treatment] Methylene blue [Adverse event] died [Subject] one twin [Treatment] \"sweet spirits of nitre\" (4% ethyl nitrite CH3CH2ONO in 70% ethyl alcohol) [Effect] died from the consequences of hypoxemia"}, {"id": "12196666_1_1049", "context": "The authors describe three families in whom the occurrence of FVS in all the siblings strongly suggests hereditary susceptibility to valproic acid-induced adverse outcome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] susceptibility [Subject] three families; all the siblings [Treatment] valproic acid-induced [Effect] FVS"}, {"id": "17536204_6_1050", "context": "We hypothesize that capecitabine-induced headache is vascular in nature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] capecitabine [Effect] headache"}, {"id": "12792223_2_1051", "context": "A lupus-like syndrome associated with infliximab therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] infliximab [Effect] A lupus-like syndrome"}, {"id": "2669373_1_1052", "context": "A case report of a patient with probable cisplatin and bleomycin-induced TMA is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with probable cisplatin [Treatment] bleomycin [Effect] TMA"}, {"id": "11250985_3_1053", "context": "In some cases this seems to happen because spironolactone causes diarrhoea.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causes [Treatment] spironolactone [Effect] diarrhoea"}, {"id": "11737689_4_1054", "context": "Painful neutrophilic skin lesions were observed in two children receiving granulocyte colony-stimulating factor (G-CSF) for treatment of idiopathic neutropenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Subject] two children [Treatment] granulocyte colony-stimulating factor (G-CSF) [Effect] Painful neutrophilic skin lesions"}, {"id": "10458196_3_1055", "context": "Apparent central nervous system depression in infants after the use of topical brimonidine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] infants [Treatment] topical brimonidine [Effect] Apparent central nervous system depression"}, {"id": "16284443_4_1056", "context": "To our knowledge, this is the first report of insulin-induced lipohypertrophy with detailed histological examinations.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] insulin [Effect] lipohypertrophy"}, {"id": "19540093_4_1057", "context": "Tigecycline-induced acute pancreatitis: case report and literature review.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Tigecycline [Effect] acute pancreatitis"}, {"id": "11850606_3_1058", "context": "Polymyositis is a rare complication of interferon alpha treatment as a result of immune-modulating role of the drug itself.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication of [Treatment] interferon alpha treatment [Effect] Polymyositis"}, {"id": "4038510_3_1059", "context": "Sodium thiosulfate is a neutralizing agent for cisplatin that protects against renal damage.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] protects [Treatment] Sodium thiosulfate is a neutralizing agent for cisplatin [Effect] protects against renal damage"}, {"id": "19363904_1_1060", "context": "Anaphylactic reaction to bacitracin ointment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reaction [Treatment] bacitracin ointment [Effect] Anaphylactic"}, {"id": "7679525_1_1061", "context": "Severe bleomycin lung toxicity: reversal with high dose corticosteroids.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] bleomycin [Effect] Severe bleomycin lung toxicity"}, {"id": "11918514_1_1062", "context": "CONCLUSIONS: Although mirtazapine offers clinicians a combination of strong efficacy and good safety, we suggest bearing SS in mind when prescribing this drug, especially in frail, elderly patients with underlying chronic conditions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] bearing [Subject] frail, elderly patients with underlying chronic conditions [Treatment] mirtazapine [Effect] SS"}, {"id": "536461_1_1063", "context": "Five cases of clindamycin-associated pseudomembranous colitis in leukaemic patients are reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] leukaemic patients [Treatment] clindamycin [Effect] pseudomembranous colitis"}, {"id": "19707032_6_1064", "context": "Three days after receiving intravitreal injection of bevacizumab (1.25 mg in 0.1 ml), he developed acute vision loss and change of consciousness.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] he [Treatment] intravitreal injection of bevacizumab (1.25 mg in 0.1 ml), [Effect] acute vision loss and change of consciousness"}, {"id": "23868369_7_1065", "context": "The proposed cause of the nausea and anorexia was digoxin toxicity secondary to a drug-drug interaction with ciprofloxacin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] ciprofloxacin [Effect] nausea and anorexia was digoxin toxicity"}, {"id": "8222875_1_1066", "context": "Mitomycin C (MMC) is an alkylating agent that has been recently associated with the hemolytic-uremic syndrome (HUS).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Mitomycin C (MMC) [Effect] the hemolytic-uremic syndrome (HUS)"}, {"id": "10904571_3_1067", "context": "Muscle biopsy revealed variation in muscle fiber size and few vacuolated fibers which were features of colchicine-induced myopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] colchicine [Effect] variation in muscle fiber size and few vacuolated fibers; myopathy"}, {"id": "1467295_1_1068", "context": "We describe a patient who developed NEH on three separate occasions provoked by two different chemotherapeutic agents--cytarabine and mitoxantrone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] provoked [Subject] a patient [Treatment] cytarabine and mitoxantrone [Effect] NEH"}, {"id": "22791547_4_1069", "context": "Orofacial dyskinesia appeared 5 hours after methylphenidate administration, persisted for 10 hours, and had completely resolved within 2 days.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] appeared [Treatment] 5 hours after methylphenidate [Effect] Orofacial dyskinesia"}, {"id": "19789372_7_1070", "context": "Present results suggested that coadministration of mexiletine increased blood tizanidine concentrations and enhanced tizanidine pharmacodynamics in terms of reduction in blood pressure and adverse symptoms.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] enhanced [Treatment] coadministration of mexiletine increased blood tizanidine concentrations [Effect] tizanidine pharmacodynamics in terms of reduction in blood pressure and adverse symptoms"}, {"id": "7272895_3_1071", "context": "Bilateral acoustic (VIII) nerve palsy in this patient was most likely a manifestation of vincristine neurotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] most likely [Subject] this patient [Treatment] vincristine [Effect] Bilateral acoustic (VIII) nerve palsy; neurotoxicity"}, {"id": "633424_1_1072", "context": "Acute leukopenia associated with silver sulfadiazine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] silver sulfadiazine [Effect] Acute leukopenia"}, {"id": "12135176_3_1073", "context": "We describe two cases of PSVT that changed to non-sustained polymorphic ventricular tachycardia after administration of verapamil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] changed [Subject] two cases of PSVT [Treatment] administration of verapamil. [Effect] non-sustained polymorphic ventricular tachycardia"}, {"id": "8301877_4_1074", "context": "We described the occurrence of L-dopa-induced myoclonus and seizures in a case of parkinsonism with its SEPs findings.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] case of parkinsonism [Treatment] L-dopa [Effect] myoclonus and seizures"}, {"id": "12187348_8_1075", "context": "Retrospectively, bucillamine was believed to be the cause of the giant hypertrophy because of its structural similarity to D-penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause of [Treatment] bucillamine [Effect] giant hypertrophy"}, {"id": "11886466_5_1076", "context": "We speculate that platelet activation induced by pFVIII may have contributed to thrombosis and suggest that pFVIII be used with caution in elderly patients with pre-existing cardiovascular risk factors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] contributed [Treatment] pFVIII [Effect] thrombosis"}, {"id": "11181395_1_1077", "context": "Restoration of vancomycin susceptibility in Enterococcus faecalis by antiresistance determinant gene transfer.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] by [Treatment] antiresistance determinant gene transfer [Effect] Restoration of vancomycin susceptibility in Enterococcus faecalis"}, {"id": "9824032_1_1078", "context": "Dental and gingival pain as side effects of niacin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effects [Treatment] niacin [Effect] Dental and gingival pain"}, {"id": "12590235_5_1079", "context": "We describe a case of significant elevation of serum transaminases in a patient treated with 6-TG for a flare of Crohn's disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] elevation [Subject] a patient [Treatment] 6-TG [Effect] significant elevation of serum transaminases"}, {"id": "6236730_1_1080", "context": "A patient developed transient, acute myopia while on isotretinoin (Accutane) therapy for acne.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] acne; A patient [Treatment] isotretinoin (Accutane) [Effect] transient, acute myopia"}, {"id": "18094347_2_1081", "context": "CONCLUSIONS: The pathogenesis of methotrexate-induced papular eruption in collagen vascular diseases may suggest cutaneous small-vessel vasculitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] methotrexate [Effect] papular eruption"}, {"id": "1536494_1_1082", "context": "Aminophylline hypersensitivity apparently due to ethylenediamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] ethylenediamine [Effect] Aminophylline hypersensitivity"}, {"id": "3804181_3_1083", "context": "The main clinical features of this 58-year-old female patient were laboratory evidence of leucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg methimazole daily.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] demonstrated [Subject] this 58-year-old female [Treatment] antithyroid therapy with 20 mg methimazole daily [Effect] leucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis"}, {"id": "19892516_4_1084", "context": "In one patient the vasculitis resolved after termination of the ciprofloxacin therapy; in the other patient the ciprofloxacin-induced hemorrhagic vasculitis was superimposed on a severe forefoot infection, leading to progressive gangrene and a below-knee amputation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patient [Treatment] ciprofloxacin [Effect] hemorrhagic vasculitis was superimposed on a severe forefoot infection, leading to progressive gangrene and a below-knee amputation [Potential therapeutic event] resolved [Subject] one patient the vasculitis [Treatment] termination of the ciprofloxacin therapy"}, {"id": "9719245_1_1085", "context": "Excluding other causes, Pentasa-associated pancytopenia was considered.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Pentasa [Effect] pancytopenia"}, {"id": "15013892_3_1086", "context": "RESULTS: A patient developed a bilaterally symmetric bull's-eye maculopathy 45 years after taking quinacrine for 18 months as prophylaxis against malaria.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] 45 years after taking quinacrine for 18 months [Effect] A patient; bilaterally symmetric bull's-eye maculopathy"}, {"id": "23868369_1_1087", "context": "Possible digoxin toxicity associated with concomitant ciprofloxacin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] ciprofloxacin; digoxin [Effect] digoxin toxicity"}, {"id": "8313300_9_1088", "context": "The exophthalmos improved dramatically within 72 hours of the withdrawal of lithium.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] improved [Treatment] within 72 hours of the withdrawal of lithium"}, {"id": "8255797_3_1089", "context": "We report two cases of neutropenia following captopril use in cardiac patients with trisomy 21.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] two cases of; cardiac patients with trisomy 21 [Treatment] captopril use [Effect] neutropenia"}, {"id": "1433432_2_1090", "context": "We report a case of hyponatremia associated with a grand mal seizure in a 28 month-old child after intra-nasal desmopressin administration for high fluid intake with nocturnal enuresis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 28 month-old child [Treatment] intra-nasal desmopressin administration [Effect] hyponatremia associated with a grand mal seizure"}, {"id": "9719245_2_1091", "context": "He developed fever, nausea, diarrhea, and malaise and stopped taking on the third day after commencing Pentasa.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] He [Treatment] Pentasa [Effect] fever, nausea, diarrhea, and malaise"}, {"id": "15752306_1_1092", "context": "Livedo reticularis associated with interferon alpha therapy in two melanoma patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] two melanoma patients [Treatment] interferon alpha therapy [Effect] Livedo reticularis"}, {"id": "10656221_4_1093", "context": "A 60-year-old woman with diabetes mellitus (type 2) developed an acute icteric hepatitis-like illness 6 weeks after the initiation of gliclazide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 60-year-old woman with diabetes mellitus (type 2) [Treatment] 6 weeks after the initiation of gliclazide therapy [Effect] an acute icteric hepatitis-like illness"}, {"id": "1348483_3_1094", "context": "Thus cabergoline may cause similar pleuropulmonary abnormalities to bromocriptine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] bromocriptine; cabergoline [Effect] pleuropulmonary abnormalities"}, {"id": "7067510_1_1095", "context": "Although the existence of an acute pericarditis or an acute myocarditis as possible causes of the ST elevation cannot be fully ruled out, the sudden onset, prominent magnitude, and brief duration of the ST elevation are perhaps more indicative of an acute ischemic event, possibly related to a transient coronary vasoconstriction induced by the dopamine infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] dopamine [Effect] transient coronary vasoconstriction"}, {"id": "7594371_1_1096", "context": "Acute sensorineural hearing loss following intravenous ketoralac administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] intravenous ketoralac [Effect] Acute sensorineural hearing loss"}, {"id": "16484748_3_1097", "context": "Trimethoprim-sulfamethoxazole-induced hypersensitivity syndrome associated with reactivation of human herpesvirus-6.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Trimethoprim-sulfamethoxazole [Effect] hypersensitivity syndrome associated with reactivation of human herpesvirus-6"}, {"id": "1775411_1_1098", "context": "A patient is described who developed a rapid onset of pulmonary fibrosis following treatment with a new non-steroidal anti-inflammatory drug, nabumetone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient [Treatment] nabumetone [Effect] pulmonary fibrosis"}, {"id": "11675845_2_1099", "context": "To report a case of increased international normalized ratio (INR) in a geriatric patient receiving warfarin and ropinirole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] case [Subject] a geriatric patient [Treatment] warfarin and ropinirole [Effect] increased international normalized ratio (INR)"}, {"id": "8071504_8_1100", "context": "There is documentation of ocular toxicity with ethambutol when administered at dosages generally pronounced as being safe.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] ethambutol [Effect] ocular toxicity"}, {"id": "6329575_1_1101", "context": "k bipolar manic-depressive patient, developed while on lithium prophylaxis, akathisia at therapeutic serum lithium levels and subsequently bucco-linguo-masticatory dyskinesia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] k bipolar manic-depressive patient [Treatment] lithium; at therapeutic serum lithium levels [Effect] bucco-linguo-masticatory dyskinesia; akathisia"}, {"id": "11712064_2_1102", "context": "We describe a patient who had a systemic allergic contact dermatitis to 8-MOP develop during her second course of PUVA treatment for psoriasis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] a patient [Treatment] PUVA [Effect] systemic allergic contact dermatitis to 8-MOP"}, {"id": "3677571_8_1103", "context": "Seizures were treated with diazepam.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Treatment] diazepam"}, {"id": "10487084_2_1104", "context": "Paradoxical seizures in phenytoin toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] seizures [Treatment] phenytoin toxicity [Effect] Paradoxical seizures"}, {"id": "1477441_1_1105", "context": "CASE SUMMARY: Two children with attention deficit disorder treated with methylphenidate as a simple drug developed fixed drug eruption of the scrotum.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two children with attention deficit disorder [Treatment] methylphenidate as a simple drug [Effect] fixed drug eruption of the scrotum"}, {"id": "24477376_5_1106", "context": "While the patient was receiving both drugs, platelet aggregation studies revealed less platelet inhibition than would be expected in a patient not taking a concomitant inducer of ticagrelor metabolism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] revealed [Subject] a patient [Treatment] taking a concomitant inducer of ticagrelor metabolism. [Effect] less platelet inhibition than would be expected"}, {"id": "17667216_2_1107", "context": "Metformin-associated lactic acidosis precipitated by diarrhea.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Metformin [Effect] lactic acidosis"}, {"id": "9846036_6_1108", "context": "To date, only 1 death attributable to risperidone overdose has been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attributable [Subject] 1 [Treatment] risperidone overdose [Effect] death"}, {"id": "11712064_1_1109", "context": "Systemic allergic contact dermatitis to 8-methoxypsoralen (8-MOP).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] 8-methoxypsoralen (8-MOP) [Effect] Systemic allergic contact dermatitis"}, {"id": "3301251_1_1110", "context": "A case of a 21-year-old woman who had developed mild hepatotoxicity while receiving choline magnesium trisalicylate therapy is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] a 21-year-old woman [Treatment] choline magnesium trisalicylate [Effect] mild hepatotoxicity"}, {"id": "9407188_1_1111", "context": "Early ritonavir-induced maculopapular eruption.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ritonavir [Effect] maculopapular eruption"}, {"id": "14632592_4_1112", "context": "In our patient, an objective causality scale showed that therapeutic doses of colchicine for FMF were the definite cause of myopathy, even though his renal and hepatic function were normal.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] our patient; his renal and hepatic function were normal [Treatment] therapeutic doses of colchicine for FMF [Effect] myopathy"}, {"id": "20367573_3_1113", "context": "Thrombocytosis induced by enoxaparin has been reported as a rare adverse effect of this medication in adults.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] enoxaparin [Effect] Thrombocytosis"}, {"id": "3493797_1_1114", "context": "A woman with a 20-year history of acral pustular psoriasis of Hallopeau and recurrent pustular lesions of the forearms and lower legs, developed a B-cell lymphoma of the lip following 4 1/2 years of treatment with razoxane.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A woman with a 20-year history of acral pustular psoriasis of Hallopeau and recurrent pustular lesions of the forearms and lower legs [Treatment] 4 1/2 years of treatment with razoxane [Effect] a B-cell lymphoma of the lip"}, {"id": "9177620_3_1115", "context": "The evidence of high plasmatic levels of CBZ and the absence of other aetiologic factors lead the authors to conclude that the overdose of CBZ could have represented the precipitating of the episode of acute pancreatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitating [Treatment] overdose of CBZ [Effect] acute pancreatitis"}, {"id": "19904536_3_1116", "context": "In this report, we describe a fatal gemcitabine-induced pulmonary toxicity in a patient with gallbladder metastatic adenocarcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with gallbladder metastatic adenocarcinoma [Treatment] gemcitabine [Effect] pulmonary toxicity"}, {"id": "736591_2_1117", "context": "Progressive interstitial fibrosis with roentgenographic honeycombing developed in the case of a psoriatic patient who had been on a regimen of methotrexate for 18 years.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a psoriatic patient [Treatment] a regimen of methotrexate for 18 years [Effect] Progressive interstitial fibrosis with roentgenographic honeycombing"}, {"id": "9512187_2_1118", "context": "In this report, one patient who developed gangrene after bleomycin and vincristine/vinblastine chemotherapy for AIDS-related Kaposi's sarcoma and another HIV-infected patient who exhibited symptoms of severe Raynaud's phenomenon related to the same regimen are presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] one patient [Treatment] bleomycin and vincristine/vinblastine [Effect] gangrene"}, {"id": "8438851_4_1119", "context": "These multiple overlapping factors probably lead to rhabdomyolysis in a minority of patients receiving vasopressin infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] lead [Subject] patients [Treatment] vasopressin [Effect] rhabdomyolysis"}, {"id": "20412003_3_1120", "context": "Due to the increasing use of TMP-SMX in children, clinicians should be aware of this potentially life-threatening, immunemediated hypersensitivity reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reaction [Subject] children [Treatment] TMP-SMX [Effect] life-threatening, immunemediated hypersensitivity"}, {"id": "19789166_1_1121", "context": "Given that discontinuation of nitrofurantoin and introduction of methylprednisolon therapy significantly lowered liver enzyme levels, restoring most of them to normal, we concluded that this was probably the case of toxic liver damage caused by nitrofurantoin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] nitrofurantoin [Effect] toxic liver damage"}, {"id": "8597009_3_1122", "context": "Slow acetylators, who comprise roughly 50% of the South African population, are likely to develop clinical and biochemical features of phenytoin toxicity when this drug is given together with antituberculosis therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] Slow acetylators [Treatment] phenytoin; together with antituberculosis [Effect] clinical and biochemical features of phenytoin toxicity"}, {"id": "12235444_3_1123", "context": "Therefore there is the potential for significant concentration-related adverse effects when phenytoin is coadministered with other CYP2C9 substrates.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] potentia [Treatment] phenytoin; other CYP2C9 substrates [Effect] significant concentration-related adverse effects"}, {"id": "9554064_2_1124", "context": "Putaminal infarct in methanol intoxication: case report and role of brain imaging studies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] intoxication [Treatment] methanol [Effect] Putaminal infarct in methanol intoxication"}, {"id": "736591_3_1125", "context": "Progressive interstitial lung disease from prolonged methotrexate therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] prolonged methotrexate therapy [Effect] Progressive interstitial lung disease"}, {"id": "16044093_2_1126", "context": "The case reported here is of a child given a large dose of intravenous iron sucrose (16 mg/kg) over 3 hours, who subsequently developed features of systemic iron toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a child [Treatment] a large dose of intravenous iron sucrose [Effect] systemic iron toxicity"}, {"id": "11292139_1_1127", "context": "We report a patient with advanced colonic carcinoma who was treated with concomitant chemoirradiation with oxaliplatin and developed a peculiar dermnatitis in the irradiated field after being exposed to subsequent chemotherapy with oxaliplatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with advanced colonic carcinoma who was treated with concomitant chemoirradiation with oxaliplatin [Treatment] exposed to subsequent chemotherapy with oxaliplatin [Effect] a peculiar dermnatitis in the irradiated field"}, {"id": "1751354_2_1128", "context": "Recombinant human interferon-alpha has been used in the treatment of several cancers, but there have been several reports that it may exacerbate psoriasis or trigger off its onset.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] trigger [Treatment] Recombinant human interferon-alpha [Effect] exacerbate psoriasis"}, {"id": "17034541_3_1129", "context": "This is the first case of HBV reactivation occurring during the year following rituximab monotherapy in the absence of any other immunosuppressive factor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Treatment] the year following rituximab monotherapy in the absence of any other immunosuppressive factor [Effect] HBV reactivation"}, {"id": "6958210_2_1130", "context": "Systemic lupus erythematosus during penicillamine therapy for rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] penicillamine therapy [Effect] Systemic lupus erythematosus"}, {"id": "7538828_7_1131", "context": "In the absence of mucositis or diarrhea, severe dermatologic toxicity following a single low dose of the drug suggests an 'allergic' or acute hypersensitivity reaction to MTX in this patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] this patient [Treatment] a single low dose of the drug; MTX [Effect] dermatologic toxicity; an 'allergic' or acute hypersensitivity reaction"}, {"id": "3346128_2_1132", "context": "Erosion of psoriatic plaques after chronic methotrexate administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] methotrexate [Effect] Erosion of psoriatic plaques"}, {"id": "3982906_1_1133", "context": "Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] infants with supraventricular tachycardia [Treatment] verapamil therapy [Effect] Cardiac decompensation"}, {"id": "19183077_3_1134", "context": "We report two cases of tenofovir (TDF)-associated nephrotoxicity in perinatally HIV-infected adolescents.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] perinatally HIV-infected adolescents [Treatment] tenofovir (TDF) [Effect] nephrotoxicity"}, {"id": "12324937_6_1135", "context": "RESULTS: Including our own patient, a total of 26 cases of gemcitabine-associated HUS were identified.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] gemcitabine [Effect] HUS"}, {"id": "17260498_5_1136", "context": "Even though only a few cases of this adverse event have been reported in the literature, severe docetaxel-induced pulmonary toxicity needs to be considered in the differential diagnosis when such patients present with respiratory symptoms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] docetaxel [Effect] pulmonary toxicity; respiratory symptoms"}, {"id": "22791547_3_1137", "context": "In this article, the authors report a 7-year-old male patient who presented with orofacial and limb dyskinesia after his first dose of methylphenidate treatment for a diagnosis of attention-deficit/hyperactivity disorder; he was also receiving sodium valproate treatment for epilepsy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 7-year-old male patient [Treatment] first dose of methylphenidate [Effect] orofacial and limb dyskinesia [Potential therapeutic event] receiving [Subject] a 7-year-old male patient [Treatment] sodium valproate"}, {"id": "12221670_1_1138", "context": "The first case concerns a 70-year-old man who developed severe aplastic anemia 7 weeks after treatment with 500 mg of ticlopidine daily.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 70-year-old man [Treatment] 7 weeks after treatment with 500 mg of ticlopidine daily [Effect] severe aplastic anemia"}, {"id": "17931455_1_1139", "context": "CASE REPORT: A six-year-old boy with transfusion-dependent beta-thalassaemia developed a unilateral hearing loss shortly after commencing desferrioxamine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A six-year-old boy with transfusion-dependent beta-thalassaemia [Treatment] commencing desferrioxamine therapy [Effect] a unilateral hearing loss"}, {"id": "9796135_4_1140", "context": "Syncope in a 65-year-old woman after nitrate ingestion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 65-year-old woman [Treatment] nitrate ingestion [Effect] Syncope"}, {"id": "18691992_3_1141", "context": "Both the longitudinal melanonychia and the multiple skin cancers first appeared after approximately 6 months of hydroxyurea treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] appeared [Treatment] approximately 6 months of hydroxyurea treatment [Effect] longitudinal melanonychia and the multiple skin cancers"}, {"id": "7854541_2_1142", "context": "Multifocal inflammatory leukoencephalopathy associated with levamisole therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] levamisole therapy [Effect] Multifocal inflammatory leukoencephalopathy"}, {"id": "9247841_5_1143", "context": "The observation of cutaneous vasculitis during administration of propylthiouracil suggested that clinical awareness of this complication should be of considerable importance.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] propylthiouracil [Effect] cutaneous vasculitis"}, {"id": "16109609_3_1144", "context": "Physicians should be aware of the potential for developing a gemcitabine-induced radiation recall reaction resulting in hemodynamically significant pericardial effusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] gemcitabine [Effect] radiation recall reaction resulting in hemodynamically significant pericardial effusion"}, {"id": "18648015_3_1145", "context": "OBJECTIVE: To describe a case of cefazolin-induced leukopenia in a critically ill patient who developed this adverse reaction upon rechallenge with cefoxitin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a critically ill patient [Treatment] cefazolin [Effect] leukopenia"}, {"id": "6149250_4_1146", "context": "The second patient suffered from high blood pressure, which was controlled with beta-blocker drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] controlled [Subject] The second patient suffered from high blood pressure [Treatment] beta-blocker drugs"}, {"id": "11999915_3_1147", "context": "The female patient received clozapine in a daily dose of 400 mg, which induced agranulocytosis after 2 months.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] The female patient [Treatment] clozapine in a daily dose of 400 mg; after 2 months [Effect] agranulocytosis"}, {"id": "11399735_4_1148", "context": "We report a case of interstitial pulmonary disease that occurred together with lymphocytic colitis during treatment with ticlopidine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a case [Treatment] ticlopidine [Effect] interstitial pulmonary disease; lymphocytic colitis"}, {"id": "9579301_1_1149", "context": "Increased ocular pressure in two patients with narrow angle glaucoma treated with venlafaxine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] two patients with narrow angle glaucoma [Treatment] venlafaxine [Effect] Increased ocular pressure"}, {"id": "6484655_1_1150", "context": "Although they had complex medical problems, the high serum concentrations of ampicillin at the time of seizures without their recurrence after discontinuing the antibiotic suggest that the seizures were related to the ampicillin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] ampicillin therapy [Effect] seizures"}, {"id": "2250853_1_1151", "context": "Glaucoma secondary to epithelial downgrowth and 5-fluorouracil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] 5-fluorouracil [Effect] Glaucoma"}, {"id": "17319250_1_1152", "context": "Of particular interest in this patient is the fluctuation of the QT interval at a stable dose of methadone, suggesting that a single normal electrocardiogram (ECG) does not guarantee that the patient is not at risk of ventricular arrhythmias.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] at [Subject] this patient [Treatment] a stable dose of methadone [Effect] fluctuation of the QT interval"}, {"id": "20190474_4_1153", "context": "This is the first report of acute kidney injury due to zonisamide-induced DRESS/DIHS.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] zonisamide [Effect] acute kidney injury due to; DRESS/DIHS"}, {"id": "1393348_2_1154", "context": "Although both the spontaneous occurrence of SLE and the psychosis as a sign of CNS involvement of SLE cannot be excluded, SLE could be considered as an adverse effect of carbamazepine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] considered [Treatment] carbamazepine [Effect] SLE"}, {"id": "10803790_1_1155", "context": "BACKGROUND: Cyanamide, an aversive agent widely used in Japan, is known to induce various degrees of hepatic lesion with ground-glass inclusion bodies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Treatment] Cyanamide [Effect] various degrees of hepatic lesion with ground-glass inclusion bodies"}, {"id": "17675030_3_1156", "context": "Oxcarbazepine-associated angioedema manifested by swelling of the face, eyes, lips, or tongue or difficulty swallowing or breathing (or both) is a rare but potentially life-threatening reaction for which early recognition and management are vital.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Oxcarbazepine [Effect] angioedema manifested by swelling of the face, eyes, lips, or tongue or difficulty swallowing or breathing (or both)"}, {"id": "16432996_5_1157", "context": "The combination therapy of interferon alpha and ribavirin was given to a 50-year-old female with CHC who had not responded to a previous treatment by interferon alpha.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] given [Subject] a 50-year-old female with CHC who had not responded to a previous treatment by interferon alpha [Treatment] combination therapy of interferon alpha and ribavirin"}, {"id": "15494638_1_1158", "context": "Peripheral neuropathy associated with capecitabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] capecitabine. [Effect] Peripheral neuropathy"}, {"id": "16411025_1_1159", "context": "DESIGN: We reviewed the medical records of four patients, who were seen by us between July 2000 and February 2004 for sudden onset of a central neurological syndrome within days of intrathecal MTX.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] intrathecal [Subject] medical records of four patients [Treatment] MTX [Effect] a central neurological syndrome"}, {"id": "9497597_1_1160", "context": "Prothipendylhydrochloride-induced priapism: case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Prothipendylhydrochloride [Effect] priapism"}, {"id": "19897274_2_1161", "context": "Interstitial pneumonia probably associated with sorafenib treatment: An alert of an adverse event.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] sorafenib treatment: [Effect] Interstitial pneumonia"}, {"id": "19915794_1_1162", "context": "He had hypokalemia (K 2.3 mmol/L) induced by licorice and also had received disopyramide for arrhythmia, bicalutamide for prostate cancer, and silodosin for prostate hypertrophy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] licorice and also had received disopyramide for arrhythmia, bicalutamide for prostate cancer, and silodosin for prostate hypertrophy [Effect] hypokalemia (K 2.3 mmol/L)"}, {"id": "20412003_5_1163", "context": "Use of the Naranjo adverse drug reaction probability scale indicated a probable relationship (score of 5) between the patient's development of hepatotoxicity and the TMP-SMX therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] patient's [Treatment] TMP-SMX therapy [Effect] hepatotoxicity"}, {"id": "24429012_9_1164", "context": "Since its introduction in 2012, vismodegib has been implicated as a possible factor in seven reports of patient deaths.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] implicated [Subject] seven reports of patient [Treatment] vismodegib [Effect] deaths"}, {"id": "8461228_2_1165", "context": "Acceleration of ventricular response to atrial flutter after intravenous adenosine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] intravenous adenosine. [Effect] Acceleration of ventricular response"}, {"id": "15331204_1_1166", "context": "Possible induction of diabetes by treatment of hypertension with indapamide (with four case reports).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induction [Treatment] indapamide [Effect] diabetes"}, {"id": "4036917_1_1167", "context": "Physicians should be aware of the potential for the development of RS among children who are receiving long-term aspirin therapy for the treatment of systemic inflammatory illnesses.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] children [Treatment] long-term aspirin therapy [Effect] RS"}, {"id": "889156_7_1168", "context": "While a lower systemic steroid dosage may have been the provoking factor, we feel that an adverse reaction to oleic acid, a dispersing agent in the aerosol freon vehicle, is a strong possibility.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] oleic acid [Effect] adverse reaction"}, {"id": "16119501_2_1169", "context": "Baclofen withdrawal syndrome resulting from underdosing of oral baclofen should be considered as a potential source of prolonged fever in the intensive care unit.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] underdosing of oral baclofen [Effect] Baclofen withdrawal syndrome; prolonged fever in the intensive care unit"}, {"id": "7787496_2_1170", "context": "We present a case of sotalol-induced bradycardia reversed by glucagon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] sotalol [Effect] bradycardia"}, {"id": "8192712_2_1171", "context": "Hyperammonemia has been described as a complication of valproic acid therapy but may often be overlooked as a cause of lethargy in the postictal patient who presents to the emergency department.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] valproic acid therapy [Effect] Hyperammonemia"}, {"id": "19423610_7_1172", "context": "Methylene blue has been found to be a potent inhibitor of monoamine oxidase (MAO), and several cases of serotonin toxicity have been reported recently following its administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] several cases [Treatment] Methylene blue [Effect] serotonin toxicity"}, {"id": "8903300_1_1173", "context": "She had just finished a 3-week course of intravenous tobramycin for bronchiectasis and had an elevated serum tobramycin trough level 1 week before the onset of tetany.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Treatment] a 3-week course of intravenous tobramycin [Effect] elevated serum tobramycin trough level 1 week before the onset of tetany"}, {"id": "9796135_3_1174", "context": "In a postural challenge test after administration of isosorbide dinitrate (5 mg), blood pressure decreased from 120/67 to 65/35 mmHg, followed by syncope with a sudden decrease in pulse rate from 85 to 60 beats/min.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] administration of isosorbide dinitrate (5 mg) [Effect] blood pressure decreased; syncope; a sudden decrease in pulse rate"}, {"id": "19122478_7_1175", "context": "The condition improved slowly after stopping medication and systemic steroids.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] stopping [Treatment] steroids [Effect] condition improved"}, {"id": "19995690_2_1176", "context": "Acetaminophen is a widely used analgesic that can cause acute liver failure when consumed above a maximum daily dose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Acetaminophen [Effect] acute liver failure"}, {"id": "10203437_9_1177", "context": "Patients treated with 5-ASA compounds who experience acute inflammatory symptoms or clinical deterioration not related to their gastrointestinal disease should be screened to rule out a lupus-like reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experience [Subject] Patients; who experience acute inflammatory symptoms or clinical deterioration not related to their gastrointestinal disease [Treatment] 5-ASA compounds [Effect] lupus-like reaction"}, {"id": "10466445_1_1178", "context": "Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] a patient with ATRA-resistant relapse of acute promyelocytic leukemia [Treatment] arsenic trioxide"}, {"id": "19122478_1_1179", "context": "Drug rash with eosinophilia and systemic symptoms after chlorambucil treatment in chronic lymphocytic leukaemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] chlorambucil [Effect] Drug rash with eosinophilia and systemic symptoms"}, {"id": "1688693_3_1180", "context": "She manifested all the clinical symptoms and signs of caffeine toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] manifested [Subject] She [Treatment] caffeine [Effect] all the clinical symptoms and signs of caffeine toxicity."}, {"id": "2406680_1_1181", "context": "Quinine-induced hearing loss.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Quinine [Effect] hearing loss"}, {"id": "17458405_1_1182", "context": "Ezetimibe-induced acute pancreatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Ezetimibe [Effect] acute pancreatitis"}, {"id": "1569260_2_1183", "context": "We report a case of drug-induced pemphigus caused by an angiotensin-converting enzyme inhibitor, captopril.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] captopril [Effect] pemphigus"}, {"id": "10589077_5_1184", "context": "We conclude that low-dose HU therapy in patients with thalassemia intermedia may increase total Hb levels sufficiently to eliminate the need for transfusions.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] therapy [Subject] in patients with thalassemia intermedia [Treatment] low-dose HU therapy [Effect] increase total Hb levels"}, {"id": "1115340_6_1185", "context": "There is the risk of convulsions occurring in susceptible patients following the use of the new anaesthetic agents which are capable of inducing CNS excitability.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] susceptible patients [Treatment] the use of the new anaesthetic agents which are capable of inducing CNS excitability [Effect] convulsions"}, {"id": "984862_1_1186", "context": "A patient with psoriasis is described who had an abnormal response to the glucose tolerance test without other evidence of diabetes and then developed postprandial hyperglycemia and glycosuria during a period of topical administration of a corticosteroid cream, halcinonide cream 0.1%, under occlusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient with psoriasis is described who had an abnormal response to the glucose tolerance test without other evidence of diabetes [Treatment] a period of topical administration of a corticosteroid cream, halcinonide cream 0.1%, under occlusion [Effect] postprandial hyperglycemia and glycosuria"}, {"id": "8503421_1_1187", "context": "Although there is one case report of cholesterol crystal embolization following t-PA therapy with only extrarenal manifestations (N Engl J Med 321:1270, 1989), this is the first reported case of atheroembolic acute renal failure following t-PA therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] t-PA therapy [Effect] atheroembolic acute renal failure [Adverse event] following [Treatment] t-PA [Effect] cholesterol crystal embolization; with only extrarenal manifestations"}, {"id": "573779_3_1188", "context": "A young woman developed galactorrhea during treatment with a new dibenzoxazepine antidepressant, amoxapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A young woman [Treatment] during treatment with a new dibenzoxazepine antidepressant, amoxapine [Effect] galactorrhea"}, {"id": "7379406_7_1189", "context": "After ruling out a hydrotelluric source of fluorine, the patient's fluorosis was linked to chronic use of niflumic acid, following the publication in 1978 of the 2 previously reported cases affected by this drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] linked to [Subject] the patient's [Treatment] chronic use of niflumic acid [Effect] fluorosis"}, {"id": "20203465_2_1190", "context": "The hospital course of the acute renal failure is presented with a review of the literature on cases of acute renal failure after IVIG.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] IVIG [Effect] acute renal failure"}, {"id": "18504683_3_1191", "context": "We report 3 cases of children with acute lymphoblastic leukemia who developed seizures and altered sensorium after L-asparaginase therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] 3 cases of children with acute lymphoblastic leukemia [Treatment] L-asparaginase [Effect] seizures and altered sensorium"}, {"id": "8921647_2_1192", "context": "Caution with use of cimetidine in tolazoline induced upper gastrointestinal bleeding.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] tolazoline [Effect] upper gastrointestinal bleeding"}, {"id": "10749332_3_1193", "context": "Other thiazolidinediones currently in clinical trials may be able to provide the therapeutic benefits of troglitazone without significant hepatotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] provide [Treatment] thiazolidinediones"}, {"id": "15840734_2_1194", "context": "OBJECTIVE: To report a case of neuroleptic malignant syndrome (NMS) associated with fluphenazine in a schizophrenic patient and review the literature related to this condition.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] schizophrenic patient [Treatment] fluphenazine [Effect] a case of neuroleptic malignant syndrome (NMS)"}, {"id": "9876812_2_1195", "context": "CONCLUSIONS: Because of its structural similarity to the other vinca alkaloids, vinorelbine is believed to be responsible for SIADH in our patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] responsible [Treatment] vinorelbine [Effect] SIADH"}, {"id": "2940999_1_1196", "context": "Abnormal retinal function associated with isotretinoin therapy for acne.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] isotretinoin [Effect] Abnormal retinal function"}, {"id": "2299784_3_1197", "context": "To our knowledge , this is the first reported case of bromide intoxication due to pyridostigmine bromide administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] first reported case [Treatment] pyridostigmine bromide [Effect] bromide intoxication"}, {"id": "15920338_3_1198", "context": "In deciding if tamoxifen therapy is warranted, all potentially life-threatening adverse events associated with tamoxifen should be considered, including endometrial adenocarcinoma or uterine sarcoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] tamoxifen [Effect] potentially life-threatening adverse events; including endometrial adenocarcinoma or uterine sarcoma"}, {"id": "8891729_4_1199", "context": "We report the case of a patient with chronic lymphocytic leukemia (CLL) who developed fatal intravascular autoimmune hemolytic anemia (AIHA) after fludarabine treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient with chronic lymphocytic leukemia (CLL) [Treatment] fludarabine treatment [Effect] fatal intravascular autoimmune hemolytic anemia (AIHA)"}, {"id": "2299784_1_1200", "context": "A 59-year-old woman with myasthenia gravis who received a large dose of pyridostigmine bromide developed postoperative psychosis and was diagnosed as having bromide intoxication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 59-year-old woman with myasthenia gravis [Treatment] a large dose of pyridostigmine bromide [Effect] postoperative psychosis and was diagnosed as having bromide intoxication."}, {"id": "1743388_2_1201", "context": "This is a report of a renal transplant patient with Pneumocystis pneumonia who developed chemical cellulitis and ulceration following the extravasation of intravenous pentamidine into the soft tissues of the left hand and forearm.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a renal transplant patient with Pneumocystis pneumonia [Treatment] intravenous pentamidine into the soft tissues of the left hand and forearm [Effect] chemical cellulitis and ulceration"}, {"id": "9701106_2_1202", "context": "Attempts were made to stop and then restart the theophylline therapy at progressively lower doses; however, with each attempt, the patient's reaction to the drug became more toxic, with serum theophylline levels ranging between 99.9 and 149.9 micromol/L (18 and 27 microg/mL).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] became [Subject] patient [Treatment] theophylline therapy [Effect] reaction to the drug became more toxic"}, {"id": "16298824_4_1203", "context": "Dyspnea, hypoxemia, and pleuritic chest pain occurred within 24 hours of rituximab administration, and there was no other apparent explanation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] rituximab administration [Effect] Dyspnea, hypoxemia, and pleuritic chest pain"}, {"id": "11834188_3_1204", "context": "Dermatitis to captopril.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] to [Treatment] captopril"}, {"id": "3067748_2_1205", "context": "Histological examination of the dacryolith suggested its derivation from breakdown products of adrenaline.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] breakdown products of adrenaline [Effect] dacryolith"}, {"id": "515777_2_1206", "context": "Two patients developed diabetic coma when taking a combination of a thiazide diuretic and propranolol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two patients [Treatment] a combination of a thiazide diuretic and propranolol [Effect] diabetic coma"}, {"id": "24318743_2_1207", "context": "Platinum-resistant ovarian cancer (PROC) constitutes a therapeutic dilemma with limited efficacy from traditional cytotoxic agents.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] from [Treatment] traditional cytotoxic agents [Effect] limited efficacy"}, {"id": "1310879_1_1208", "context": "A patient suffering from heparin-associated thrombocytopenia (HAT), recurrent arteriothromboses, and acute renal failure after treatment with standard heparin is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A patient [Treatment] standard heparin [Effect] thrombocytopenia (HAT), recurrent arteriothromboses, and acute renal failure"}, {"id": "16116136_2_1209", "context": "Despite minimal short-term side effects and apparent efficacy, chronic treatment of MG with MM may be associated with increased risk of lymphoproliferative disorders.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] MG with MM [Effect] increased risk of lymphoproliferative"}, {"id": "2616440_2_1210", "context": "We report the case of a patient with multiple myeloma who developed acute life-threatening water intoxication following treatment with oral indomethacin and low dose intravenous cyclophosphamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with multiple myeloma [Treatment] oral indomethacin and low dose intravenous cyclophosphamide [Effect] acute life-threatening water intoxication"}, {"id": "19145124_1_1211", "context": "Multifocal electroretinographic abnormalities in ethambutol-induced visual loss.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ethambutol [Effect] visual loss"}, {"id": "17364199_7_1212", "context": "She was on etanercept and methotrexate for rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Subject] She [Treatment] etanercept and methotrexate"}, {"id": "1504404_1_1213", "context": "Central nervous system effects secondary to ciprofloxacin treatment are uncommon and usually consist only of minor dizziness or mild headache, although rare occurrences of seizures and hallucinations have been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] consist [Treatment] secondary to ciprofloxacin treatment [Effect] minor dizziness or mild headache, although rare occurrences of seizures and hallucinations"}, {"id": "14585456_1_1214", "context": "We present a case of a 20-year-old woman who ingested 900 mg of glyburide causing refractory hypoglycemia resistant to treatment with intravenous dextrose, glucagon, and diazoxide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] ingested [Subject] a 20-year-old woman [Treatment] 900 mg of glyburide [Effect] refractory hypoglycemia"}, {"id": "7619765_1_1215", "context": "Etoposide-related myocardial infarction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] Etoposide [Effect] myocardial infarction"}, {"id": "12460237_5_1216", "context": "Contrary to previous recommendations, our experience cautions against the further use of high-dose cytarabine in patients who develop PPE, and is a timely reminder of the potential toxicity of this agent, which is now increasingly being used as first-line treatment in the management of haematologic malignancies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] high-dose cytarabine [Effect] PPE"}, {"id": "18607107_4_1217", "context": "She had been on Copaxone 20 mg/day treatment for 2 years when she first exhibited gastrointestinal symptoms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exhibited [Subject] she [Treatment] Copaxone 20 mg/day treatment for 2 years [Effect] gastrointestinal symptoms"}, {"id": "15795553_3_1218", "context": "The authors present an elderly patient with mixed dementia who developed TD at multiple sites, (including respiratory dyskinesia [RD], limb dyskinesia, and orofacial dyskinesia) following abrupt withdrawal of risperidone therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] elderly patient with mixed dementia [Treatment] abrupt withdrawal of risperidone therapy [Effect] TD at multiple sites, (including respiratory dyskinesia [RD], limb dyskinesia, and orofacial dyskinesia)"}, {"id": "20118434_1_1219", "context": "Interferon-based treatments have the potential to decrease the burden of disease, but are complicated by side effects, including neuropsychiatric symptoms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicated [Treatment] Interferon [Effect] neuropsychiatric symptoms"}, {"id": "21416219_1_1220", "context": "Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] efficacy [Subject] patients with persistent elevated triglycerides [Treatment] adding fenofibric acid to moderate-dose statin therapy"}, {"id": "18421192_3_1221", "context": "Type 1 diabetes mellitus provoked by peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] provoked [Treatment] peginterferon alpha-2b plus ribavirin treatment [Effect] Type 1 diabetes mellitus"}, {"id": "17519584_1_1222", "context": "A 61-year-old man with early diffuse cutaneous scleroderma with myositis and progressive interstitial pneumonia developed generalized erythema with high fever 3 weeks after taking sulfamethoxazole/trimethoprim.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] A 61-year-old man with early diffuse cutaneous scleroderma with myositis and progressive interstitial pneumonia [Treatment] sulfamethoxazole/trimethoprim [Effect] generalized erythema with high fever"}, {"id": "18676387_1_1223", "context": "Serotonin toxicity caused by an interaction between fentanyl and paroxetine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] an interaction between fentanyl and paroxetine [Effect] Serotonin toxicity"}, {"id": "16637972_4_1224", "context": "The sub-conjunctival haematoma in a patient receiving warfarin can pose a significant management challenge.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Treatment] warfarin [Effect] sub-conjunctival haematoma"}, {"id": "8071504_1_1225", "context": "Toxic optic neuropathy associated with ethambutol: implications for current therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] ethambutol [Effect] Toxic optic neuropathy"}, {"id": "15316423_3_1226", "context": "The site of thrombosis and the chronological relationship with the IIR implicates a hypersensitivity to infliximab in the causation of the venous thrombosis in this case.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causation [Treatment] infliximab [Effect] venous thrombosis"}, {"id": "19875411_1_1227", "context": "One week after the initial-dose of adalimumab (160 mg), which was initiated due to an acute exacerbation of Crohn's disease, the patient developed a fulminant cardiomyopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] an acute exacerbation of Crohn's disease, the patient [Treatment] One week after the initial-dose of adalimumab (160 mg) [Effect] fulminant cardiomyopathy"}, {"id": "8071504_7_1228", "context": "RESULTS: Ethambutol, and to a lesser extent isoniazid, are both implicated in the development of visually related side effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] Ethambutol; isoniazid [Effect] visually related side effects"}, {"id": "24163322_2_1229", "context": "We report a case of an inadvertent increase in the international normalized ratio (INR) after the addition of bismuth subsalicylate for the treatment of diarrhea in an enterally fed patient receiving warfarin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] an enterally fed patient [Treatment] addition of bismuth subsalicylate; warfarin therapy [Effect] inadvertent increase in the international normalized ratio (INR)"}, {"id": "7995001_1_1230", "context": "Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Subject] patients [Treatment] triazolam [Effect] hazardous"}, {"id": "12776809_17_1231", "context": "LFT elevation is transient and the low risk of the SB-LOT therapy to increase LFT value can be limited when risk factors are considered.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] the low risk [Treatment] SB-LOT"}, {"id": "16012330_9_1232", "context": "Nineteen cases of unusual enhanced vincristine neurotoxicity related to itraconazole have been reported in children.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] Nineteen cases; children [Treatment] itraconazole [Effect] unusual enhanced vincristine neurotoxicity"}, {"id": "16718947_3_1233", "context": "Extended-release tolterodine 4 mg/day was then prescribed to manage overactive bladder.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prescribed [Treatment] Extended-release tolterodine 4 mg/day"}, {"id": "18067642_1_1234", "context": "Although it is difficult to be certain of the direct link of amiodarone on the basis of a single case, it is reasonable to presume that this histopathology is associated with amiodarone-induced hypothyroidism and that involution changes represent the hypofunctional status of this drug-induced disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a single case [Treatment] amiodarone [Effect] hypothyroidism"}, {"id": "7962394_4_1235", "context": "The present report describes the first case of acute pancreatitis associated with danazol treatment of endometriosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] the first case [Treatment] danazol treatment of endometriosis [Effect] acute pancreatitis"}, {"id": "2229534_1_1236", "context": "Awareness of this route of intoxication might be important in patients in whom neurologic or psychiatric symptoms develop while large amounts of lidocaine cream are being used.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Treatment] large amounts of lidocaine cream are being used [Effect] neurologic or psychiatric symptoms"}, {"id": "18648015_1_1237", "context": "Cephalosporin-induced leukopenia following rechallenge with cefoxitin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] cefoxitin; Cephalosporin [Effect] leukopenia"}, {"id": "17266059_2_1238", "context": "Thrombotic thrombocytopenic purpura induced by trimethoprim-sulfamethoxazole in a Jehovah's Witness.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a Jehovah's Witness [Treatment] trimethoprim-sulfamethoxazole [Effect] Thrombotic thrombocytopenic purpura"}, {"id": "17039658_2_1239", "context": "This eruption appears to be a distinct cutaneous toxicity of PLD.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] PLD [Effect] eruption; distinct cutaneous toxicity"}, {"id": "11999915_2_1240", "context": "Granulocytopenia and agranulocytosis are considered among the most dangerous adverse effects of clozapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] among [Treatment] clozapine [Effect] Granulocytopenia and agranulocytosis"}, {"id": "20298401_5_1241", "context": "RESULTS: We recently experienced a case of fatal erlotinib-induced ILD, diagnosed based on clinical and radiologic findings, which occurred in a patient with radiation fibrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with radiation fibrosis [Treatment] erlotinib [Effect] ILD"}, {"id": "15482394_5_1242", "context": "Unusual hypersensitivity to warfarin in a critically ill patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Subject] a critically ill patient [Treatment] warfarin [Effect] Unusual hypersensitivity"}, {"id": "7914463_1_1243", "context": "Flumazenil reversal of benzodiazepine-induced sedation for a patient with severe pre-ECT anxiety.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with severe pre-ECT anxiety [Treatment] benzodiazepine [Effect] sedation [Potential therapeutic event] reversal [Subject] a patient with severe pre-ECT anxiety [Treatment] Flumazenil"}, {"id": "11030530_3_1244", "context": "We report a case of seizure associated with L-asparaginase therapy but no evidence of hemorrhagic or thrombotic cerebrovascular events.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] L-asparaginase therapy [Effect] seizure"}, {"id": "15316423_2_1245", "context": "Here we describe a patient with Crohn's disease who developed a severe infliximab infusion reaction (IIR), complicated 1 day later by severe swelling of the forearm and hand ipsilateral to the site of infliximab infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with Crohn's disease [Treatment] infliximab infusion [Effect] severe infliximab infusion reaction (IIR), complicated 1 day later by severe swelling of the forearm and hand ipsilateral"}, {"id": "16167682_1_1246", "context": "She died within six weeks of developing congestive heart failure coupled with liver failure due to haemosiderosis despite regular use of desferrioxamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] despite [Treatment] regular use of desferrioxamine [Effect] died within six weeks of developing congestive heart failure coupled with liver failure"}, {"id": "14740795_1_1247", "context": "A 56-year-old Caucasian man who received concomitant chemotherapy and radiation for head and neck cancer developed fever concurrent with the administration of amifostine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 56-year-old Caucasian man [Treatment] concomitant chemotherapy and radiation for head and neck cancer; concurrent with the administration of amifostine [Effect] fever"}, {"id": "15806568_1_1248", "context": "In this study, we report on three individual patients who received BTX-B and who subsequently developed parasympathetic dysfunction of the visual system after injections of BTX-B at remote sites.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] three individual patients [Treatment] BTX-B; BTX-B [Effect] parasympathetic dysfunction of the visual system"}, {"id": "11026106_2_1249", "context": "Minocycline-induced autoimmune hepatitis is usually identical to sporadic autoimmune hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Minocycline [Effect] autoimmune hepatitis"}, {"id": "10891991_2_1250", "context": "BACKGROUND: Reproductive endocrine disorders characterized by menstrual disorders, polycystic ovaries, and hyperandrogenism seem to be common among women treated with sodium valproate for epilepsy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] women [Treatment] sodium valproate for epilepsy [Effect] Reproductive endocrine disorders characterized by menstrual disorders, polycystic ovaries, and hyperandrogenism"}, {"id": "2621382_3_1251", "context": "Two cases of lepromatous leprosy with erythema nodosum leprosum who were on high doses of clofazimine, showed discoloration of nail plate, subungual hyperkeratosis and onycholysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] showed [Subject] Two cases of lepromatous leprosy with erythema nodosum leprosum [Treatment] high doses of clofazimine [Effect] discoloration of nail plate, subungual hyperkeratosis and onycholysis"}, {"id": "14711147_1_1252", "context": "Doxycycline-induced photo-onycholysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Doxycycline [Effect] photo-onycholysis"}, {"id": "20203465_1_1253", "context": "Case report: acute renal failure after administering intravenous immunoglobulin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] administering intravenous immunoglobulin [Effect] acute renal failure"}, {"id": "15224368_1_1254", "context": "Sweet's syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] sargramostim (granulocyte-macrophage colony stimulating factor) treatment [Effect] Sweet's syndrome"}, {"id": "16416684_1_1255", "context": "This is a rare case of ARDS associated with lithium intoxication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] lithium [Effect] ARDS"}, {"id": "8520081_1_1256", "context": "Intravenous haloperidol is generally well tolerated, but multiform ventricular tachycardia has been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] Intravenous haloperidol [Effect] multiform ventricular tachycardia"}, {"id": "12243603_2_1257", "context": "To report a case of rhabdomyolysis and acute hepatitis associated with the coadministration of atorvastatin and diltiazem.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] coadministration of atorvastatin and diltiazem [Effect] rhabdomyolysis and acute hepatitis"}, {"id": "18094347_8_1258", "context": "Ten hours after the second methotrexate injection, the patient experienced a diffuse pruritic papular eruption located mainly on the limbs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] the patient [Treatment] Ten hours after the second methotrexate injection [Effect] diffuse pruritic papular eruption located mainly on the limbs"}, {"id": "19531695_10_1259", "context": "Flecainide and pharmacologically similar agents that interact with sodium channels may cause delirium in susceptible patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] susceptible patients [Treatment] Flecainide and pharmacologically similar agents that interact with sodium channels [Effect] delirium"}, {"id": "921427_1_1260", "context": "An elderly man with procainamide hydrochloride-induced lupus syndrome had a circulating anticoagulant against factor XI and a biologic false-positive (BFP) test result for syphilis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] An elderly man [Treatment] procainamide hydrochloride [Effect] lupus"}, {"id": "7151655_1_1261", "context": "In one patient, treatment with DCA was associated with a decrease in blood lactate levels from 11.2 mM before treatment to 0.8 mM 16 h later.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] one patient [Treatment] DCA [Effect] decrease in blood lactate levels"}, {"id": "7865488_3_1262", "context": "We report a case of noncardiogenic pulmonary edema developed after therapeutic trial of EO as sclerosing agent for esophageal varix.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] EO [Effect] noncardiogenic pulmonary edema"}, {"id": "15878975_3_1263", "context": "That review suggested that patients receiving anti-D IGIV be monitored for those and other potential complications of hemoglobinemia, particularly disseminated intravascular coagulation (DIC).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complications [Subject] patients [Treatment] receiving anti-D IGIV [Effect] hemoglobinemia, particularly disseminated intravascular coagulation (DIC)"}, {"id": "11144696_1_1264", "context": "Seizures associated with therapeutic doses of venlafaxine and trimipramine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] therapeutic doses of venlafaxine and trimipramine [Effect] Seizures"}, {"id": "14960440_1_1265", "context": "BACKGROUND: The risk/benefit ratio of warfarin therapy changes in the over 75s, when haemorrhagic side-effects become more common.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] become [Subject] over 75s [Treatment] warfarin therapy [Effect] haemorrhagic side-effects"}, {"id": "1445134_5_1266", "context": "Norethisterone in these 69 pregnancies accounted for 33.3% (5 of 15) cases of clitoral hypertrophy diagnosed in 100,756 consecutive births.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] accounted [Subject] 69 pregnancies [Treatment] Norethisterone [Effect] clitoral hypertrophy"}, {"id": "736591_1_1267", "context": "Interstitial fibrosis of the lung is a potential complication of methotrexate therapy for psoriasis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] methotrexate [Effect] Interstitial fibrosis of the lung"}, {"id": "22735246_5_1268", "context": "This is the first reported fatality due to this drug interaction and only the second case of serotonin syndrome reported with oxcarbazepine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] oxcarbazepine [Effect] serotonin syndrome"}, {"id": "15239684_1_1269", "context": "Purple glove syndrome, named for its distinctive purple discoloration and swelling of the hands in the distribution of a glove, is an uncommon complication of intravenous phenytoin administration through small dorsal veins of the hands.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] intravenous phenytoin administration through small dorsal veins of the hands [Effect] Purple glove syndrome; purple discoloration and swelling of the hands in the distribution of a glove"}, {"id": "11483161_1_1270", "context": "Possible linkage of amprenavir with intracranial bleeding in an HIV-infected hemophiliac.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] linkage [Subject] an HIV-infected hemophiliac [Treatment] amprenavir [Effect] intracranial bleeding"}, {"id": "8098286_2_1271", "context": "Inadvertent subsequent rechallenge with celiprolol led to recurrence of the pneumonitis, 10 weeks after drug readministration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] led to [Treatment] Inadvertent subsequent rechallenge with celiprolol; 10 weeks after drug readministration [Effect] recurrence of the pneumonitis"}, {"id": "19531695_5_1272", "context": "Flecainide had been started 2 weeks prior for atrial fibrillation.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Treatment] Flecainide"}, {"id": "18396749_4_1273", "context": "In the absence of evidence of a potential role for concomitant medication i.e. hydroxychloroquine sulfate to play a role in the clinical, biochemical and morphological picture, an interaction between the herbal preparation and tibolone was suspected as the likely cause of liver damage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suspected [Treatment] an interaction between the herbal preparation and tibolone [Effect] liver damage"}, {"id": "9128433_1_1274", "context": "Its overall toxicity is considerably less compared to standard induction chemotherapy; however, it is associated with a high incidence of a potentially fatal symptom complex referred to as \"retinoic acid syndrome.\" This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with APL [Treatment] a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis [Effect] symptom complex referred to as \"retinoic acid syndrome.\""}, {"id": "18609153_2_1275", "context": "During intravenous treatment with terlipressin for recurrent gastrointestinal (GI) bleeding, a 50-year-old male with no history of heart disease developed a newly prolonged QT interval and torsade de pointes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 50-year-old male with no history of heart disease [Treatment] During intravenous treatment with terlipressin for recurrent gastrointestinal (GI) bleeding [Effect] a newly prolonged QT interval and torsade de pointes"}, {"id": "1109248_9_1276", "context": "It is concluded that chloral hydrate and methaqualone may be administered safely without additional caution in prothrombin test monitoring during oral anticoagulant therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caution [Treatment] chloral hydrate and methaqualone; during oral anticoagulant therapy"}, {"id": "6692713_1_1277", "context": "Amiodarone hydrochloride, a new antiarrhythmic agent, has been associated with pulmonary toxicity characterized by cough, dyspnea and diffuse pulmonary infiltrates.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Amiodarone hydrochloride [Effect] pulmonary toxicity characterized by cough, dyspnea and diffuse pulmonary infiltrates"}, {"id": "9831311_1_1278", "context": "Although major hazards of treatment of hypophosphatemic osteomalacia with phosphate and calcitriol are secondary hyperparathyroidism and vitamin D intoxication, potassium loss also should be kept in mind.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] major hazards [Treatment] hypophosphatemic osteomalacia with phosphate and calcitriol [Effect] secondary hyperparathyroidism and vitamin D intoxication, potassium loss"}, {"id": "19579947_1_1279", "context": "He had priapism following the use of olanzapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] olanzapine [Effect] priapism"}, {"id": "20298401_10_1280", "context": "CONCLUSION: Our case shows a fatal side effect of erlotinib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] erlotinib [Effect] side effect"}, {"id": "2161782_1_1281", "context": "Data have been published regarding the possibility that tamoxifen may be responsible for the subsequent development of carcinoma of the corpus uteri in these patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] responsible [Subject] these patients [Treatment] tamoxifen [Effect] subsequent development of carcinoma of the corpus uteri"}, {"id": "16404563_3_1282", "context": "Corticosteroids may be useful for therapy of some features of this syndrome, such as thrombocytopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] be useful [Treatment] Corticosteroids"}, {"id": "15183980_1_1283", "context": "Eosinophilic cystitis after bladder instillation with dimethyl sulfoxide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] bladder instillation with dimethyl sulfoxide [Effect] Eosinophilic cystitis"}, {"id": "11881322_1_1284", "context": "Beginning ductopenia was present in two, suggesting that itraconazole might be responsible for the occurrence of prolonged drug-induced cholangiopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] responsible [Subject] two [Treatment] itraconazole [Effect] ductopenia"}, {"id": "576675_1_1285", "context": "A 15-kg weight gain developed in a patient during the third week of ibuprofen therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] ibuprofen [Effect] A 15-kg weight gain"}, {"id": "7019786_1_1286", "context": "Cefoxitin-associated renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Cefoxitin [Effect] renal failure"}, {"id": "9169264_4_1287", "context": "The rash seen in this patient, who was treated with cephalexin, may be similar to the rash seen with ampicillin treatment of patients with infectious mononucleosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] seen [Subject] patient [Treatment] cephalexin [Effect] rash [Adverse event] seen [Subject] patients [Treatment] ampicillin treatment [Effect] infectious mononucleosis"}, {"id": "15644988_2_1288", "context": "Two of our patients developed TD after 23 months and 34 months of ziprasidone monotherapy, respectively.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two of our patients [Treatment] ziprasidone [Effect] TD"}, {"id": "12932249_3_1289", "context": "We describe two dark-skinned patients who developed hyperpigmented skin and tongue lesions during combination therapy with IFN and ribavirin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] two dark-skinned patients [Treatment] combination therapy with IFN and ribavirin. [Effect] hyperpigmented skin and tongue lesions"}, {"id": "2643458_1_1290", "context": "Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] after [Treatment] substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation [Effect] Attenuation of asparaginase-induced hyperglycemia"}, {"id": "10749332_2_1291", "context": "It remains to be seen whether the hepatotoxicity associated with troglitazone is a drug-class effect or specific to troglitazone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] troglitazone [Effect] hepatotoxicity"}, {"id": "2935070_1_1292", "context": "Ampicillin-induced interstitial nephritis with generalised exfoliative dermatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Ampicillin [Effect] interstitial nephritis with generalised exfoliative dermatitis"}, {"id": "7900744_3_1293", "context": "High-dose intravenous mannitol infusion in various clinical settings may result in acute renal failure (ARF).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] High-dose intravenous mannitol infusion [Effect] acute renal failure"}, {"id": "6416845_1_1294", "context": "A 7-year-old boy developed a severe unilateral grand mal seizure at the age of 5 years (phenobarbitone therapy); 1.5 years later valproate (2-propylpentanoic acid, VPA) was added to the therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] therapy [Subject] A 7-year-old boy developed a severe unilateral grand mal seizure [Treatment] at the age of 5 years (phenobarbitone therapy); 1.5 years later valproate (2-propylpentanoic acid, VPA) was added to the therapy."}, {"id": "19474653_2_1295", "context": "We report the first case of rhabdomyolysis related to the administration of clarithromycin without concurrent use of other medications.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related to [Treatment] administration of clarithromycin without concurrent use of other medications [Effect] rhabdomyolysis"}, {"id": "3804181_2_1296", "context": "The authors report a further case of methimazole-associated liver damage and present a brief review of eleven previous cases found in the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a further case; eleven previous cases [Treatment] methimazole [Effect] liver damage"}, {"id": "2051906_1_1297", "context": "A 67-year-old patient, with primary polymyositis and without previous evidence of liver disease, developed clinical and biochemical features of severe cholestasis 3 months after initiation of azathioprine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 67-year-old patient, with primary polymyositis and without previous evidence of liver disease [Treatment] 3 months after initiation of azathioprine [Effect] cholestasis"}, {"id": "3569037_2_1298", "context": "Hypersensitivity reaction following chloramphenicol administration in a patient with typhoid fever.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a patient with typhoid fever [Treatment] chloramphenicol [Effect] Hypersensitivity reaction"}, {"id": "10357715_1_1299", "context": "Allergic and irritant contact dermatitis to calcipotriol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] calcipotriol [Effect] contact dermatitis"}, {"id": "3565435_1_1300", "context": "A 23-year-old woman with systemic lupus erythematosus had a severe hypersensitivity reaction to the drug ibuprofen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] A 23-year-old woman with systemic lupus erythematosus [Treatment] ibuprofen [Effect] hypersensitivity reaction"}, {"id": "2738729_1_1301", "context": "We present the first case of WES in an infant born to a mother taking haloperidol during her pregnancy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] case [Subject] an infant born to a mother [Treatment] haloperidol [Effect] WES"}, {"id": "17189581_7_1302", "context": "Despite treatment with levofloxacin, acyclovir, and voriconazole, the patient developed high fevers.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] patient [Treatment] levofloxacin, acyclovir, and voriconazole [Effect] high fevers"}, {"id": "6353252_2_1303", "context": "The 5 patients had severe renovascular disease which might thus represent a significant risk factor in the development of captopril-induced acute renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] The 5 patients had severe renovascular disease [Treatment] captopril [Effect] acute renal failure"}, {"id": "8691927_5_1304", "context": "METHODS: Growth retardation was observed in six severely asthmatic children after introduction of high-dose fluticasone propionate treatment (dry powder).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] six severely asthmatic children [Treatment] introduction of high-dose fluticasone propionate treatment (dry powder) [Effect] Growth retardation"}, {"id": "433855_1_1305", "context": "The toxic effects of methotrexate included elevated liver transaminases (3/4), nausea (2/4), abdominal pain (2/4), bone pain (2/4), mild neutropenia (1/4), and mild pruritus (1/4).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] methotrexate [Effect] toxic effects; elevated liver transaminases (3/4), nausea (2/4), abdominal pain (2/4), bone pain (2/4), mild neutropenia (1/4), and mild pruritus (1/4)"}, {"id": "20120657_1_1306", "context": "CONCLUSION: Zidovudine is well a known cause of anaemia and thus should be used with caution in the initiation of antiretroviral therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Zidovudine [Effect] anaemia"}, {"id": "18676387_4_1307", "context": "A 60-yr-old woman, established on paroxetine for depression, underwent excision of a chest wall myxofibrosarcoma and chest wall reconstruction.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] established [Subject] A 60-yr-old woman; depression [Treatment] paroxetine; underwent excision of a chest wall myxofibrosarcoma and chest wall reconstruction"}, {"id": "7397053_2_1308", "context": "Papilloedema and hepatic dysfunction apparently induced by perhexiline maleate (Pexid).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] perhexiline maleate (Pexid) [Effect] Papilloedema and hepatic dysfunction"}, {"id": "9103523_2_1309", "context": "The volatile anesthetic halothane undergoes substantial biotransformation generating metabolites that mediate hepatotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] mediate [Treatment] volatile anesthetic halothane [Effect] hepatotoxicity"}, {"id": "10803790_4_1310", "context": "Case 4: A 61-year-old male alcoholic who remained completely abstinent while taking cyanamide for 3 years showed slight elevation of serum transaminases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] 61-year-old male alcoholic who remained completely abstinent [Treatment] cyanamide for 3 years [Effect] elevation of serum transaminases"}, {"id": "1261772_3_1311", "context": "These observations indicate that submassive hepatic necrosis may result from treatment with propylthiouracil and are consistent with the notion that sensitization mechanisms may be responsible for the hepatic injury induced by this drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] propylthiouracil [Effect] submassive hepatic necrosis"}, {"id": "6197014_2_1312", "context": "Two children with rheumatic fever developed anicteric hepatitis while on high-dose aspirin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two children with rheumatic fever [Treatment] high-dose aspirin [Effect] anicteric hepatitis"}, {"id": "12095907_1_1313", "context": "The authors describe valproate-induced hyperammonemia and mental status changes in an 88-year-old man, the first known reported case in an elderly patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an 88-year-old man [Treatment] valproate [Effect] hyperammonemia and mental status changes"}, {"id": "9831311_5_1314", "context": "The mechanism of the decrease in plasma potassium induced by phosphate treatment was investigated in a 24-year-old hypertensive patient with hypophosphatemic osteomalacia, who was the youngest of four patients, belonging to a 23 number kindred of five generations.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 24-year-old hypertensive patient with hypophosphatemic osteomalacia, who was the youngest of four patients, belonging to a 23 number kindred of five generations [Treatment] phosphate treatment [Effect] decrease in plasma potassium"}, {"id": "1722991_6_1315", "context": "In the two cases, a combination of iloprost, a stable prostacyclin analogue (1 to 2 ng/kg/mn) with aspirin and dipyridamole was shown to inhibit ex vivo the heparin-induced platelet aggregation.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] inhibit ex vivo [Subject] two cases [Treatment] iloprost, a stable prostacyclin analogue (1 to 2 ng/kg/mn) with aspirin and dipyridamole [Adverse event] induced [Treatment] heparin [Effect] platelet aggregation"}, {"id": "3067748_1_1316", "context": "Adrenaline dacryolith: detection by ultrasound examination of the nasolacrimal duct.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Adrenaline dacryolith [Treatment] Adrenaline [Effect] dacryolith"}, {"id": "16012330_7_1317", "context": "Ten days after itraconazole was started, he developed paralytic ileus, neurogenic bladder, mild left ptosis, and absence of deep reflexes, with severe paralysis of the lower extremities and mild weakness of the upper extremities.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] itraconazole [Effect] paralytic ileus, neurogenic bladder, mild left ptosis, and absence of deep reflexes, with severe paralysis of the lower extremities and mild weakness of the upper extremities"}, {"id": "11328247_3_1318", "context": "OBJECTIVE: The aim of this paper is to describe a case of increased libido during fluvoxamine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a case [Treatment] fluvoxamine therapy. [Effect] increased libido"}, {"id": "11131346_3_1319", "context": "An 8-year-old child with familial Mediterranean fever exhibited signs of colchicine intoxication while receiving prophylactic doses of the drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exhibited [Subject] An 8-year-old child [Treatment] prophylactic doses of the drug [Effect] colchicine intoxication"}, {"id": "11675845_9_1320", "context": "Furthermore, the warfarin dose was again increased after discontinuation of ropinirole due to common gastrointestinal adverse effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] due to [Treatment] the warfarin dose was again increased after discontinuation of ropinirole"}, {"id": "25671244_1_1321", "context": "Serotonin syndrome following metaxalone overdose and therapeutic use of a selective serotonin reuptake inhibitor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] metaxalone overdose [Effect] Serotonin syndrome"}, {"id": "11700998_2_1322", "context": "The aim of this report is to describe the clinical and electroencephalographic findings seen in an elderly woman without previous history of seizures who developed a nonconvulsive generalized status epilepticus following acute withdrawal of lorazepam.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] an elderly woman [Treatment] acute withdrawal of lorazepam [Effect] nonconvulsive generalized status epilepticus"}, {"id": "9634122_4_1323", "context": "We describe a patient with androgen-independent prostate cancer in whom PSA continued to decrease for a period of 15 months after flutamide withdrawal.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient with androgen-independent prostate cancer [Treatment] flutamide withdrawal [Effect] PSA continued to decrease for a period of 15 months"}, {"id": "19203515_1_1324", "context": "Acute renal failure following intravenous immunoglobulin therapy in a HIV-infected patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a HIV-infected patient [Treatment] intravenous immunoglobulin therapy [Effect] Acute renal failure"}, {"id": "17189581_11_1325", "context": "After a total of four doses of linezolid, the patient reported further discomfort.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Subject] the patient [Treatment] a total of four doses of linezolid [Effect] further discomfort"}, {"id": "19018868_2_1326", "context": "Although moderate myelosuppression is not uncommonly seen in patients treated with lenalidomide, aplastic anemia has not previously been reported to be associated with this agent.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] lenalidomide [Effect] aplastic anemia"}, {"id": "18176653_11_1327", "context": "This paper contributed to the identification of possible reactions in the oral cavity due to antiretroviral medication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] antiretroviral medication [Effect] reactions in the oral cavity"}, {"id": "2076372_1_1328", "context": "Persistent light reactivity from systemic quinine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] systemic quinine [Effect] Persistent light reactivity"}, {"id": "15482394_2_1329", "context": "Based on the clinical status of the patient, it was suspected that several conditions contributed to the abnormal hypersensitivity to warfarin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Subject] the patient [Treatment] warfarin [Effect] abnormal hypersensitivity"}, {"id": "17852449_3_1330", "context": "Treatment of APL in pregnancy is controversial as the use of ATRA has been questioned due to the teratogenic effect of retinoids.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] retinoids [Effect] teratogenic effect"}, {"id": "2302898_1_1331", "context": "Diazepam use by pregnant women can be associated with a later presentation of withdrawal symptoms in the neonate than that induced by the use of other drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] neonate [Treatment] Diazepam [Effect] later presentation of withdrawal symptoms in the neonate"}, {"id": "17381671_3_1332", "context": "A 65-year-old patient chronically treated with the selective serotonin reuptake inhibitor (SSRI) citalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 65-year-old patient [Treatment] chronically treated with the selective serotonin reuptake inhibitor (SSRI) citalopram; following initiation of fentanyl [Effect] confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome"}, {"id": "21712512_11_1333", "context": "This case highlights rapid onset of adrenal insufficiency in a patient with CF-related liver disease treated briefly with a moderate CYP3A4 inhibitor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] onset [Subject] a patient with CF-related liver disease [Treatment] briefly with a moderate CYP3A4 inhibitor [Effect] rapid onset of adrenal insufficiency"}, {"id": "847572_2_1334", "context": "The biochemistry of paracetamol hepatotoxicity is outlined and the increased susceptibility of alcoholic patients to the hepatotoxic effects of paracetamol is remarked upon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] remarked [Subject] alcoholic patients [Treatment] paracetamol [Effect] hepatotoxic effects"}, {"id": "12951892_2_1335", "context": "The newborn manifested a four day course of lethargy with unexplained high lithium levels in the adult toxic range.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] manifested [Subject] newborn [Treatment] lithium [Effect] four day course of lethargy with unexplained high lithium levels"}, {"id": "8891729_3_1336", "context": "The occurrence of severe AIHA in CLL patients treated with fludarabine has been reported by several authors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] CLL patients [Treatment] fludarabine [Effect] severe AIHA"}, {"id": "19034138_4_1337", "context": "Corneal endothelial dysfunction associated with amantadine toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] amantadine [Effect] Corneal endothelial dysfunction"}, {"id": "1378497_4_1338", "context": "We describe the development of cutaneous scleroderma in 3 patients coincident with the use of bleomycin in low cumulative doses of less than 100 U.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] 3 patients [Treatment] the use of bleomycin in low cumulative doses of less than 100 U [Effect] cutaneous scleroderma"}, {"id": "10367184_3_1339", "context": "This case suggests that sarcoidosis and pravastatin, two entities not frequently associated with myotonia, may interact in a synergistic manner to produce severe clinical myotonia in humans.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] interact [Subject] humans. [Treatment] pravastatin [Effect] severe clinical myotonia"}, {"id": "7226916_2_1340", "context": "Disopyramide-induced heart block.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Disopyramide [Effect] heart block"}, {"id": "578255_2_1341", "context": "Telescoped digits of the hands and feet developed in a 69-year-old male with severe chronic tophaceous gout during allopurinol treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 69-year-old male with severe chronic tophaceous gout [Treatment] allopurinol treatment [Effect] Telescoped digits of the hands and feet"}, {"id": "8742573_2_1342", "context": "CONCLUSIONS: Jet-injection devices might constitute a helpful method to treat those patients affected by severe human insulin-induced lipoatrophy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treat [Subject] patients [Treatment] Jet-injection devices [Adverse event] induced [Treatment] insulin [Effect] lipoatrophy"}, {"id": "20412003_6_1343", "context": "We describe a relatively healthy, 9-year-old boy who developed a CA-MRSA skin and soft tissue infection and was treated with TMP-SMX.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] a relatively healthy, 9-year-old boy [Treatment] TMP-SMX"}, {"id": "10897389_2_1344", "context": "Recurrent septicemia with lethal outcome during and after cyclosporine therapy in severe ulcerative colitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] cyclosporine [Effect] Recurrent septicemia with lethal outcome"}, {"id": "14740795_2_1345", "context": "Amifostine-induced fever: case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Amifostine [Effect] fever"}, {"id": "16767537_3_1346", "context": "We report a patient who developed spontaneous splenic infarction after the use of sumatriptan for the treatment of migraine headache.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] sumatriptan [Effect] spontaneous splenic infarction"}, {"id": "12590235_2_1347", "context": "Hepatotoxicity associated with 6-thioguanine therapy for Crohn's disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] 6-thioguanine [Effect] Hepatotoxicity"}, {"id": "15694139_4_1348", "context": "Neuropathy is a significant side effect of thalidomide therapy, which may limit its clinical use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effect [Treatment] thalidomide [Effect] Neuropathy"}, {"id": "6414095_5_1349", "context": "A possible mechanism for focal neurological deficit in brain-damaged patients on phenytoin therapy is discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] mechanism [Subject] brain-damaged patients [Treatment] phenytoin therapy [Effect] focal neurological deficit"}, {"id": "11757641_1_1350", "context": "Pulmonary toxicity with mefloquine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] mefloquine [Effect] Pulmonary toxicity"}, {"id": "2327115_1_1351", "context": "Ciprofloxacin is one drug that has been reported to cause interstitial nephritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Ciprofloxacin [Effect] interstitial nephritis"}, {"id": "16945058_1_1352", "context": "Acute renal failure during lisinopril and losartan therapy for proteinuria.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] lisinopril and losartan [Effect] Acute renal failure"}, {"id": "9497597_2_1353", "context": "We present the first case of a patient with priapism after oral intake of the phenothiazine prothipendylhydrochloride.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient [Treatment] oral intake of the phenothiazine prothipendylhydrochloride [Effect] priapism"}, {"id": "12811715_3_1354", "context": "However, because diphenhydramine also exhibits type IA sodium channel blockade, cardiac toxicity is also possible.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] because [Treatment] diphenhydramine [Effect] also exhibits type IA sodium channel blockade, cardiac toxicity"}, {"id": "11399735_3_1355", "context": "Ticlopidine-induced interstitial pulmonary disease: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Ticlopidine [Effect] interstitial pulmonary disease"}, {"id": "19226083_16_1356", "context": "Linezolid is a popular choice of antibiotic, especially for the treatment of orthopedic-related MRSA infections.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Linezolid"}, {"id": "14711147_4_1357", "context": "We present a case of photo-onycholysis in a patient treated with doxycycline for acne vulgaris.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] a patient [Treatment] doxycycline [Effect] photo-onycholysis"}, {"id": "15097937_2_1358", "context": "Anticonvulsant hypersensitivity syndrome associated with Bellamine S, a therapy for menopausal symptoms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Bellamine S, a therapy for menopausal symptoms [Effect] Anticonvulsant hypersensitivity syndrome"}, {"id": "9161656_3_1359", "context": "CASE SUMMARY: A 66-year-old white woman with a 10-year history of hypertension and bronchial asthma was switched from immediate-release verapamil hydrocloride 40 mg tid to sustained-release verapamil 240 mg/d po for better hypertension control.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] control [Subject] A 66-year-old white woman with a 10-year history of hypertension and bronchial asthma [Treatment] switched from immediate-release verapamil hydrocloride 40 mg tid to sustained-release verapamil 240 mg/d po"}, {"id": "18294121_3_1360", "context": "Due to the severity of the rash, temozolomide was permanently discontinued.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Due [Treatment] temozolomide [Effect] rash"}, {"id": "7835785_1_1361", "context": "Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a postmenopausal breast cancer patient [Treatment] tamoxifen therapy [Effect] Ovarian endometrioid carcinoma and endometriosis"}, {"id": "18585545_2_1362", "context": "CONCLUSION: The new quinolone derivatives (levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin), also called gyrase inhibitors, are known for their potential to cause central nervous system-related adverse effects, including headache, dizziness and insomnia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] The new quinolone derivatives (levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin), also called gyrase inhibitors [Effect] central nervous system-related adverse effects, including headache, dizziness and insomnia"}, {"id": "18609153_1_1363", "context": "Terlipressin-induced ventricular arrhythmia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Terlipressin [Effect] ventricular arrhythmia"}, {"id": "17228132_4_1364", "context": "CASE REPORT: We report a case of acute severe hepatitis resulting from erlotinib monotherapy in a patient with locally advanced pancreatic cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Subject] a patient with locally advanced pancreatic cancer [Treatment] erlotinib monotherapy [Effect] acute severe hepatitis"}, {"id": "16914372_1_1365", "context": "We highlight two instances of systemic allergic reaction, and discuss the potential side effects of local aprotinin injections in the orthopaedic setting as well as the evidence base for its use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Subject] two instances [Treatment] aprotinin [Effect] systemic allergic reaction; potential side effects"}, {"id": "7962394_1_1366", "context": "Acute pancreatitis associated with danazol treatment for endometriosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] danazol treatment [Effect] Acute pancreatitis"}, {"id": "14526130_2_1367", "context": "CASE REPORT: We report the case of a 58 year old patient who, after 2 days of treatment with roxithromycin and betamethasone, manifested acute pancreatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] manifested [Subject] a 58 year old patient [Treatment] after 2 days of treatment with roxithromycin; betamethasone [Effect] acute pancreatitis"}, {"id": "576675_3_1368", "context": "It should be recognized that ibuprofen may be associated with salt and water retention in the same fashion as previously described with phenylbutazone and indomethacin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] ibuprofen [Effect] salt and water retention"}, {"id": "18459568_1_1369", "context": "Gastric tumor, endometrial carcinoma and cervical adenocarcinoma in situ were detected after treatment with tamoxifen for breast cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] detected [Treatment] tamoxifen [Effect] Gastric tumor, endometrial carcinoma and cervical adenocarcinoma in situ"}, {"id": "18665833_2_1370", "context": "This therapy was also complicated by Warfarin-induced skin necrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Warfarin [Effect] skin necrosis"}, {"id": "10048291_1_1371", "context": "Immobilization, while Paget's bone disease was present, and perhaps enhanced activation of dihydrotachysterol by rifampicin, could have led to increased calcium-release into the circulation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] led [Treatment] dihydrotachysterol [Effect] increased calcium-release"}, {"id": "8949576_2_1372", "context": "Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of protracted amiodarone-induced thyroiditis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] amiodarone [Effect] thyroiditis [Potential therapeutic event] ameliorate [Treatment] plasmapheresis, corticosteroids and thionamides"}, {"id": "15162903_1_1373", "context": "Although neurotoxicity is a frequent complication of methotrexate therapy, fatal acute neurotoxicity is extremely uncommon, especially in adults.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] methotrexate therapy [Effect] neurotoxicity"}, {"id": "566977_3_1374", "context": "Intravenous sodium bicarbonate appears to be indicated prophylactically in combating the associated metabolic acidosis due to absorbed formic acid.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] absorbed formic acid [Effect] metabolic acidosis [Potential therapeutic event] combating [Treatment] Intravenous sodium bicarbonate"}, {"id": "578255_1_1375", "context": "Allopurinol-associated hand and foot deformities in chronic tophaceous gout.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Allopurinol [Effect] hand and foot deformities"}, {"id": "11022272_3_1376", "context": "The intramuscular challenge test with 25 UI of Miacalcic was positive with an immediate anaphylactic reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reaction [Treatment] 25 UI of Miacalcic; immediate [Effect] anaphylactic reaction"}, {"id": "19226083_4_1377", "context": "There are several documented case reports of serotonin toxicity when used with selective serotonin reuptake inhibitors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reports [Subject] several documented case [Treatment] selective serotonin reuptake inhibitors [Effect] serotonin toxicity"}, {"id": "4082283_6_1378", "context": "A literature review revealed 83 other reported cases of rifampicin-induced renal insufficiency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] 83 other reported cases [Treatment] rifampicin [Effect] renal insufficiency"}, {"id": "8485005_1_1379", "context": "Complete regression of iatrogenic Kaposi's sarcoma due to corticosteroid treatment in a patient with tubercular pericarditis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] regression [Subject] a patient with tubercular pericarditis [Treatment] corticosteroid"}, {"id": "16757971_1_1380", "context": "DIAGNOSIS: Severe temozolomide-induced immunosuppression, exacerbated by corticosteroids, with profound T-cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] temozolomide; exacerbated by corticosteroids [Effect] immunosuppression; T-cell lymphocytopenia; Pneumocystis jiroveci pneumonia; brain abscess with Listeria monocytogenes; cutaneous Kaposi's sarcoma"}, {"id": "17163271_3_1381", "context": "The use of cyclosporin has been associated with the development of cholelithiasis in transplant recipients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] transplant recipients [Treatment] cyclosporin [Effect] cholelithiasis"}, {"id": "3200786_1_1382", "context": "Rifampicin-induced adrenal insufficiency in the acquired immunodeficiency syndrome: difficulties in diagnosis and treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Rifampicin [Effect] adrenal insufficiency"}, {"id": "19235747_2_1383", "context": "Bisphosphonate-related osteonecrosis of the skull base.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] Bisphosphonate [Effect] osteonecrosis of the skull base"}, {"id": "14641354_1_1384", "context": "Angioedema and dysphagia caused by contact allergy to inhaled budesonide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] inhaled [Treatment] budesonide [Effect] contact allergy; Angioedema and dysphagia"}, {"id": "12656748_2_1385", "context": "Emergence of Philadelphia positive chronic myeloid leukaemia during treatment with hydroxyurea for Philadelphia negative essential thrombocythaemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment [Treatment] hydroxyurea [Effect] Emergence of Philadelphia positive chronic myeloid leukaemia"}, {"id": "15592331_1_1386", "context": "Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] increases [Treatment] Ciprofloxacin [Effect] concentrations and hypotensive effect of tizanidine"}, {"id": "10426918_1_1387", "context": "2-CdA induces lymphocytopenia, which may explain the improvement in this patient's psoriasis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] induces [Subject] patient's psoriasis [Treatment] 2-CdA [Effect] lymphocytopenia"}, {"id": "7831179_2_1388", "context": "There is a dose-effect relationship between doxorubicin and the incidence of symptomatic cardiac failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] relationship [Treatment] doxorubicin [Effect] symptomatic cardiac failure"}, {"id": "19145124_2_1389", "context": "These are the first reported patients to show mfERG abnormalities that correspond to bitemporal visual field defects and add to the growing evidence that ethambutol damages the retina.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] evidence [Treatment] ethambutol [Effect] damages the retina"}, {"id": "19949685_3_1390", "context": "Two days after administration of Kalimate enema, he had profuse hematochezia, and a sigmoidoscopy showed diffuse colonic mucosal necrosis in the rectum and sigmoid colon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] he [Treatment] Two days after administration of Kalimate enema [Effect] profuse hematochezia; diffuse colonic mucosal necrosis in the rectum"}, {"id": "18191947_1_1391", "context": "Conventional and diffusion-weighted MRI findings of methotrexate related sub-acute neurotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] methotrexate [Effect] sub-acute neurotoxicity"}, {"id": "14760958_1_1392", "context": "Scleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on interferon beta-1a.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] on [Subject] a patient with multiple sclerosis and monoclonal gammopathy [Treatment] interferon beta-1a [Effect] Scleromyxedema"}, {"id": "9494448_8_1393", "context": "The literature search revealed 22 cases of hypersensitivity reaction to cyclosporine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Subject] 22 cases [Treatment] cyclosporine [Effect] hypersensitivity reaction"}, {"id": "9184269_6_1394", "context": "The presence of a lymphocyte alveolitis with a predominance of CD4+ T cells in 3 RA patients and CD8+ T cells with a concomitant increase in neutrophils in another case suggests that immunologically mediated reactions may be one damage mechanism in MTX-induced pneumonitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] 3 RA patients [Treatment] MTX [Effect] a lymphocyte alveolitis with a predominance of CD4+ T cells; pneumonitis; CD8+ T cells with a concomitant increase in neutrophils"}, {"id": "11972105_1_1395", "context": "The authors report two cases of delayed elimination of methotrexate in patients receiving ciprofloxacin, with severe toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Subject] patients receiving ciprofloxacin [Treatment] methotrexate [Effect] delayed elimination"}, {"id": "2329972_2_1396", "context": "Severe acute encephalopathy following inadvertent intrathecal doxorubicin administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] intrathecal doxorubicin administration [Effect] Severe acute encephalopathy"}, {"id": "11886466_2_1397", "context": "Porcine factor VIII (pFVIII), which is used to control bleeding in patients with congenital or acquired haemophilia who have high-titre neutralizing antibodies to human FVIII, is not known to increase the risk of arterial or venous thrombosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increase [Subject] patients with congenital or acquired haemophilia who have high-titre neutralizing antibodies to human FVIII [Treatment] Porcine factor VIII (pFVIII) [Effect] risk of arterial or venous thrombosis."}, {"id": "4031907_1_1398", "context": "In all the patients, pellagra symptoms appeared during isoniazid therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] appeared [Subject] all the patients [Treatment] isoniazid therapy [Effect] pellagra symptoms"}, {"id": "19904536_1_1399", "context": "Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] gemcitabine [Effect] pulmonary toxicity"}, {"id": "18801826_1_1400", "context": "Olanzapine-induced hyperglycaemic coma and neuroleptic malignant syndrome: case report and review of literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Olanzapine [Effect] hyperglycaemic coma and neuroleptic malignant syndrome"}, {"id": "15494638_20_1401", "context": "Neurologic symptoms resolved after stopping CAP for 4 weeks in Patient A, with no recurrence after reinitiating CAP alone at 2000 mg/m2.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] after [Treatment] stopping CAP for 4 weeks [Effect] Neurologic symptoms resolved"}, {"id": "17381671_11_1402", "context": "OBJECTIVE: To report a case of serotonin syndrome associated with interaction between fentanyl and citalopram, as evidenced by medication history, clinical features and reversal following discontinuation of fentanyl.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] interaction [Subject] a case [Treatment] fentanyl and citalopram [Effect] serotonin syndrome"}, {"id": "17968817_2_1403", "context": "We report (to our knowledge, for the first time in a child) the emergence of psychosis in a 12-year old white girl with an increased efavirenz concentration and heterozygous gene polymorphism of the CYP2B6-G516T.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] emergence [Subject] a 12-year old white girl; heterozygous gene polymorphism of the CYP2B6-G516T [Treatment] increased efavirenz concentration [Effect] psychosis"}, {"id": "12114387_2_1404", "context": "Severe erythroderma as a complication of continuous epoprostenol therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] continuous epoprostenol [Effect] Severe erythroderma"}, {"id": "18717612_2_1405", "context": "FDE from cephalosporins has been rarely reported, and to the best of our knowledge there is no published report of ceftriaxone-induced FDE in the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] cephalosporins [Effect] FDE [Adverse event] induced [Treatment] ceftriaxone [Effect] FDE"}, {"id": "12503933_3_1406", "context": "CASE SUMMARY: A 58-year-old white woman developed fulminant liver failure while being treated with the macrolide antibiotic clarithromycin for pneumonia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 58-year-old white woman [Treatment] macrolide antibiotic clarithromycin for pneumonia [Effect] fulminant liver failure"}, {"id": "10410183_10_1407", "context": "CONCLUSIONS: Marked elevation of serum CK may be a possible complication of olanzapine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] olanzapine therapy [Effect] Marked elevation of serum CK"}, {"id": "12163813_2_1408", "context": "OBJECTIVE: To describe a case of severe skin necrosis resulting from peripheral intravenous administration of low-dose vasopressin in a patient with catecholamine-resistant septic shock.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Subject] a patient with catecholamine-resistant septic shock [Treatment] peripheral intravenous administration of low-dose vasopressin [Effect] skin necrosis"}, {"id": "8445549_1_1409", "context": "Although the essential cause of PV is unclear, its onset has occasionally been associated with drug therapy, in particular penicillamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] penicillamine [Effect] PV"}, {"id": "8031432_1_1410", "context": "Recurrent hypotension immediately after seizures in nortriptyline overdose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Treatment] nortriptyline overdose [Effect] Recurrent hypotension immediately after seizures"}, {"id": "12460237_4_1411", "context": "We report a patient with recurrent, increasingly severe episodes of PPE, ultimately complicated by a severe bullous eruption, following successive cycles of high-dose cytarabine for the treatment of acute lymphoblastic leukaemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a patient [Treatment] cycles of high-dose cytarabine for the treatment of acute lymphoblastic leukaemia [Effect] recurrent, increasingly severe episodes of PPE, ultimately complicated by a severe bullous eruption"}, {"id": "6408978_1_1412", "context": "Intravenous diazepam exacerbated the seizures.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exacerbated [Treatment] Intravenous diazepam [Effect] seizures"}, {"id": "12494253_1_1413", "context": "After nine previous uncomplicated cycles she developed severe anaphylaxis to cisplatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] she [Treatment] cisplatin [Effect] severe anaphylaxis"}, {"id": "7937287_1_1414", "context": "Cefuroxime-induced acute renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Cefuroxime [Effect] acute renal failure"}, {"id": "11026106_3_1415", "context": "We describe the clinical and liver biopsy morphologic features for 4 patients with minocycline-induced autoimmune hepatitis (group 1).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] 4 patients [Treatment] minocycline [Effect] autoimmune hepatitis"}, {"id": "16371793_1_1416", "context": "Intravitreal triamcinolone acetonide for persisting cystoid macular edema after penetrating keratoplasty.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Treatment] ntravitreal triamcinolone acetonide [Adverse event] after [Treatment] penetrating keratoplasty [Effect] persisting cystoid macular edema"}, {"id": "24661191_4_1417", "context": "We report a case of a 29-year-old liver transplant patient who suffered liver injury most likely induced by drug interaction between capecitabine and warfarin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 29-year-old liver transplant patient [Treatment] drug interaction between capecitabine and warfarin [Effect] liver injury"}, {"id": "11243427_3_1418", "context": "DISCUSSION: Patients with 5-FU-induced ectropion experience tender, red, scaled lids, making contact lens wear difficult.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] Patients with 5-FU-induced ectropion [Treatment] 5-FU [Effect] ectropion; tender, red, scaled lids"}, {"id": "15197722_3_1419", "context": "Restless legs syndrome may thus be an adverse effect of IFN alpha treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse effect [Treatment] IFN alpha treatment. [Effect] Restless legs syndrome"}, {"id": "11093071_2_1420", "context": "Treatment of chronic hepatitis C with interferon alpha (IFN-alpha) is relatively contraindicated in patients with psychiatric disorders because of possible severe psychiatric side effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] contraindicated [Subject] patients with psychiatric disorders [Treatment] interferon alpha (IFN-alpha) [Effect] possible severe psychiatric side effects"}, {"id": "9494448_6_1421", "context": "METHODS: We report a patient who had an anaphylactic reaction during the intravenous infusion of cyclosporine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a patient [Treatment] intravenous infusion of cyclosporine [Effect] anaphylactic reaction"}, {"id": "18721173_2_1422", "context": "Gabapentin toxicity in renal failure: the importance of dose adjustment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] Gabapentin [Effect] renal failure"}, {"id": "16854757_1_1423", "context": "We describe a case of a man treated with an EGFR-inhibitor (erlotinib) for a cell lung cancer who developed skin manifestations localized in an uncommon area and with an atypical evolution.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a man [Treatment] EGFR-inhibitor (erlotinib) [Effect] skin manifestations localized in an uncommon area and with an atypical evolution"}, {"id": "15671134_4_1424", "context": "We describe a case of clozapine-induced seizures in a patient with treatment-resistant schizophrenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with treatment-resistant schizophrenia [Treatment] clozapine [Effect] seizures"}, {"id": "847572_3_1425", "context": "Two fatal cases of poisoning by paracetamol are described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] by [Subject] Two fatal cases [Treatment] paracetamol [Effect] poisoning"}, {"id": "3470173_4_1426", "context": "The neurotoxicity seen with HDARAC is dose-related and has occurred in up to 60 percent of treated patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] 60 percent of treated patients [Treatment] HDARAC [Effect] neurotoxicity"}, {"id": "11545487_5_1427", "context": "The HIV protease inhibitor indinavir may cause nephrolithiasis and interstitial nephritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] HIV protease inhibitor indinavir [Effect] nephrolithiasis and interstitial nephritis"}, {"id": "9022114_1_1428", "context": "BACKGROUND: Colchicine has a known adverse effect on wound healing through its inhibitory effect on tubulin-dependent cell functions and through collagenase activation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse effect [Treatment] Colchicine [Effect] wound healing"}, {"id": "1792646_1_1429", "context": "Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] methotrexate [Effect] Pneumocystis carinii pneumonia"}, {"id": "14690166_5_1430", "context": "2-CdA typically causes a long-lasting state of immunodeficiency and the profound influence of this drug on the immune system has raised questions concerning the emergence of secondary neoplasms after its use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causes [Treatment] 2-CdA [Effect] a long-lasting state of immunodeficiency; emergence of secondary neoplasms after its use"}, {"id": "14700673_1_1431", "context": "CONCLUSIONS: Topiramate may be associated with ciliochoroidal effusion with forward displacement of the lens-iris diaphragm and anterior chamber shallowing, resulting in acute myopia and angle-closure glaucoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] Topiramate [Effect] acute myopia and angle-closure glaucoma"}, {"id": "19745701_1_1432", "context": "Increased awareness is needed on the possible occurrence of LPD resembling gastric cancer in rheumatoid arthritis patients treated with MTX.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurrence [Subject] rheumatoid arthritis patients [Treatment] MTX [Effect] LPD"}, {"id": "3195622_2_1433", "context": "A dapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] patients [Treatment] dapsone [Effect] hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis"}, {"id": "16371793_11_1434", "context": "CONCLUSIONS: Intravitreal injection of triamcinolone acetonide may be an additional tool in the treatment of therapy-resistant cystoid macular edema after penetrating keratoplasty.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Intravitreal injection of triamcinolone acetonide"}, {"id": "17458405_2_1435", "context": "Since its FDA approval in 2002, there are no known citations of ezetimibe-induced pancreatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ezetimibe [Effect] pancreatitis"}, {"id": "7272895_2_1436", "context": "Acute acoustic nerve palsy associated with vincristine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] vincristine therapy [Effect] Acute acoustic nerve palsy"}, {"id": "17852449_6_1437", "context": "Review of all reported cases of the use of ATRA in pregnancy revealed no serious adverse outcomes or congenital anomalies although only very few cases had exposure in the first trimester.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] revealed [Subject] in pregnancy [Treatment] ATRA [Effect] adverse outcomes or congenital anomalies"}, {"id": "19857154_5_1438", "context": "The first patient was a 57-year-old man with HIV and bipolar disease who developed rapid and severe weight gain when quetiapine was added to a stable atazanavir-ritonavir-based antiretroviral regimen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 57-year-old man with HIV and bipolar disease [Treatment] quetiapine was added to a stable atazanavir-ritonavir-based antiretroviral regimen [Effect] rapid and severe weight gain"}, {"id": "17009081_1_1439", "context": "A 43-year-old woman with multiple sclerosis (MS) had nephrotic syndrome 21 months after starting treatment with interferon (IFN)-beta-1b (subcutaneous administration).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] A 43-year-old woman with multiple sclerosis (MS) [Treatment] 21 months after starting treatment with interferon (IFN)-beta-1b (subcutaneous administration) [Effect] nephrotic syndrome"}, {"id": "17444802_4_1440", "context": "RESULTS: An 81-year-old man with a history of neoplasies of the colon and prostate and anticoagulant treatment was referred for treatment of an ocular surface neoplasia on his left eye.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] referred [Subject] An 81-year-old man with a history of neoplasies of the colon and prostate [Treatment] anticoagulant [Effect] an ocular surface neoplasia on his left eye"}, {"id": "16421117_1_1441", "context": "CONCLUSION: The present findings suggest that: (i) amantadine probably exerts its anti-dyskinetic effect by acting on the \"indirect\" pathway; (ii) the pathophysiological mechanisms of subthalamotomy induced dyskinesias may differ from those involved in L-dopa induced dyskinesias; (iii) dyskinesias induced by STN surgery resolve spontaneously as compensatory mechanisms develop.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] exerts [Treatment] amantadine [Effect] anti-dyskinetic effect"}, {"id": "15097937_3_1442", "context": "We report a case of a previously healthy, postmenopausal woman who developed anticonvulsant hypersensitivity syndrome while taking Bellamine S (belladonna alkaloids; ergotamine; phenobarbital) for hot flashes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a previously healthy, postmenopausal woman [Treatment] Bellamine S (belladonna alkaloids; ergotamine; phenobarbital) [Effect] anticonvulsant hypersensitivity syndrome"}, {"id": "2332596_3_1443", "context": "Skin rash began after 2 weeks of treatment, and signs of hepatocellular failure developed 3 weeks after phenobarbital had been started.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] phenobarbital [Effect] Skin rash; hepatocellular failure"}, {"id": "10461415_1_1444", "context": "Ceftriaxone was approved in 1997 for the treatment of otitis media despite previous studies that documented an association of ceftriaxone with elevated hepato-biliary enzymes and transient biliary stasis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association of [Treatment] ceftriaxone [Effect] elevated hepato-biliary enzymes and transient biliary stasis"}, {"id": "11487721_2_1445", "context": "A rare case of advanced ovarian carcinoma who developed difficulty walking 25 days after treatment with weekly paclitaxel.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A rare case of advanced ovarian carcinoma [Treatment] 25 days after treatment with weekly paclitaxel [Effect] difficulty walking"}, {"id": "7919557_5_1446", "context": "We report a case of cough following the administration of quinapril, with complete resolution after changing to the alternative ACE inhibitor fosinopril in a patient with essential hypertension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] patient with essential hypertension [Treatment] the administration of quinapril [Effect] cough"}, {"id": "7321956_1_1447", "context": "Liver disease induced by perhexiline maleate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced by [Treatment] perhexiline maleate [Effect] Liver disease"}, {"id": "7606071_6_1448", "context": "OBJECTIVE: To report the occurrence of anaphylactoid reactions to intraperitoneal cisplatin in 3 patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Subject] 3 patients. [Treatment] intraperitoneal cisplatin [Effect] anaphylactoid reactions"}, {"id": "2329972_1_1449", "context": "In a female with acute lymphoblastic leukemia, inadvertent doxorubicin administration intrathecally caused severe, life-threatening, acute encephalopathy with high-pressure hydrocephalus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] female with acute lymphoblastic leukemia [Treatment] inadvertent doxorubicin administration intrathecally [Effect] severe, life-threatening, acute encephalopathy with high-pressure hydrocephalus"}, {"id": "12932249_2_1450", "context": "These skin lesions may be induced or worsened during antiviral therapy with interferon-alpha (IFN).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] antiviral therapy with interferon-alpha (IFN) [Effect] skin lesions"}, {"id": "11144696_12_1451", "context": "Clinicians should be aware of the proepileptogenic effect of venlafaxine and trimipramine at therapeutic doses and that this combination may eventually increase the risk of seizures.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] eventually [Treatment] venlafaxine and trimipramine at therapeutic doses [Effect] increase the risk of seizures"}, {"id": "16298824_6_1452", "context": "We report the case of a 43-year-old man with ITP refractory to steroids and intravenous immunoglobulin who developed acute respiratory distress syndrome (ARDS) after a single infusion of rituximab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] the case of a 43-year-old man with ITP refractory to steroids and intravenous immunoglobulin [Treatment] single infusion of rituximab [Effect] acute respiratory distress syndrome (ARDS)"}, {"id": "16573370_6_1453", "context": "She had been prescribed two mood stabilizers and suffered from anticholinergic adverse effects and the movement disorder tardive dyskinesia (TD).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suffered from [Treatment] prescribed two mood stabilizers [Effect] anticholinergic adverse effects and the movement disorder tardive dyskinesia (TD)"}, {"id": "19357764_1_1454", "context": "CASE REPORT: We describe here a case of a 60 year old female that experienced a relapse of symptomatic hyperlactatemia after being switched from stavudine to zidovudine and how the case was managed at the Infectious Diseases Institute, Kampala, Uganda.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a case of a 60 year old female [Treatment] switched from stavudine to zidovudine [Effect] relapse of symptomatic hyperlactatemia"}, {"id": "2743258_1_1455", "context": "This report describes two patients who developed acute myelocytic leukemia only after exposure to cyclophosphamide, methotrexate, and 5-fluorouracil adjuvant therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two patients [Treatment] exposure to cyclophosphamide, methotrexate, and 5-fluorouracil adjuvant therapy [Effect] acute myelocytic leukemia"}, {"id": "1694575_1_1456", "context": "Reversible corneal keratinization following trabeculectomy and treatment with 5-fluorouracil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] 5-fluorouracil [Effect] Reversible corneal keratinization"}, {"id": "8742573_1_1457", "context": "CASE: We report a case of a woman with severe human insulin-induced lipoatrophy who has been treated exclusively with recombinant DNA human insulin since the onset of IDDM.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] woman [Treatment] recombinant DNA human insulin [Effect] severe human insulin-induced lipoatrophy"}, {"id": "16923659_6_1458", "context": "METHOD: Case analysis of a poly-drug overdose (venlafaxine, topiramate, divalproex sodium, risperidone, and carbamazepine) presenting with mixed SS/NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS/NMS in critical care settings.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presenting [Treatment] a poly-drug overdose (venlafaxine, topiramate, divalproex sodium, risperidone, and carbamazepine) [Effect] mixed SS/NMS features"}, {"id": "17526968_2_1459", "context": "Hyperpigmentation is one of the cutaneous side effects of chemotherapautic agents, but it is usually accepted as a cosmetic problem.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] chemotherapautic agents [Effect] Hyperpigmentation"}, {"id": "17352036_2_1460", "context": "Pancreatitis is a very rare adverse effect associated with the use of amiodarone, and only four cases of amiodarone-induced pancreatitis have been reported in literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] four cases [Treatment] amiodarone [Effect] pancreatitis"}, {"id": "3773837_1_1461", "context": "The latter form (Macrodantin) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form--liver damage, acute and chronic pulmonary reactions, peripheral neuropathy, blood dyscrasias and allergic reactions--and does so just as rapidly and floridly; one such case is reported here.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse effects [Subject] one such case [Treatment] Macrodantin [Effect] less gastrointestinal intolerance; liver damage, acute and chronic pulmonary reactions, peripheral neuropathy, blood dyscrasias and allergic reactions"}, {"id": "18176653_4_1462", "context": "CASE REPORT: A 29-year-old black man, HIV-infected since 1996, began highly active antiretroviral therapy (HAART) with zidovudine, lamivudine, and indinavir.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] began [Subject] A 29-year-old black man, HIV-infected since 1996 [Treatment] highly active antiretroviral therapy (HAART) with zidovudine, lamivudine, and indinavir"}, {"id": "20118434_3_1463", "context": "METHOD: The authors followed a patient with chronic HCV who received interferon and ribavirin and who developed hallucinations ultimately requiring psychiatric hospitalization.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with chronic HCV [Treatment] interferon and ribavirin [Effect] hallucinations"}, {"id": "19733945_3_1464", "context": "This case of linezolid-associated acute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in a patient treated with linezolid raises concerns about the presumed renal safety of this drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] linezolid [Effect] acute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms (DRESS) syndrome"}, {"id": "15359206_1_1465", "context": "Easily reversible hypoxemia and hypotension induced by nimodipine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] nimodipine [Effect] hypoxemia and hypotension"}, {"id": "17352036_1_1466", "context": "Adverse effects of amiodarone including pulmonary toxicity, hepatotoxicity, aggravation of arrhythmia, and thyroid diseases are well understood.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] including [Treatment] amiodarone [Effect] pulmonary toxicity, hepatotoxicity, aggravation of arrhythmia, and thyroid diseases"}, {"id": "3977377_1_1467", "context": "Chronic photosensitivity associated with hydrochlorothiazide ingestion occurred in four patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] four patients [Treatment] hydrochlorothiazide ingestion [Effect] Chronic photosensitivity"}, {"id": "4054170_2_1468", "context": "Chlorambucil central nervous toxicity: a significant side effect of chlorambucil therapy in childhood nephrotic syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effect [Treatment] Chlorambucil [Effect] central nervous toxicity"}, {"id": "25671244_3_1469", "context": "The mechanism of action of this centrally acting muscle relaxant is unknown; however, the observation of serotonin syndrome in patients with metaxalone overdose suggests a role in the serotonergic pathway.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] patients [Treatment] centrally acting muscle relaxant; metaxalone overdose [Effect] serotonin syndrome"}, {"id": "12598508_2_1470", "context": "In general, angiotensin converting enzyme (ACE) inhibitors should be discontinued in pregnancy, as they can induce an ACE fetopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Subject] pregnancy [Treatment] angiotensin converting enzyme (ACE) inhibitors [Effect] ACE fetopathy"}, {"id": "1993143_1_1471", "context": "Of 371 patients treated with 8MOP, three (0.8%) developed an acute dermatitis in the PUVA-treated areas.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Of 371 patients; three (0.8%) [Treatment] treated with 8MOP [Effect] acute dermatitis"}, {"id": "1174301_1_1472", "context": "There is a putative role of liothyronine administration in precipitating or activating hyperthyroidism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitating or activating [Treatment] liothyronine [Effect] hyperthyroidism"}, {"id": "16436462_1_1473", "context": "Neutropenic colitis during standard dose combination chemotherapy with nedaplatin and irinotecan for testicular cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] standard dose combination chemotherapy with nedaplatin and irinotecan for testicular cancer [Effect] Neutropenic colitis"}, {"id": "17383767_2_1474", "context": "Brain metastases are a frequent finding in patients with advanced non-small cell lung cancer and concomitant administration of antiepileptic and chemotherapeutic drugs or epidermal growth factor receptor (EGFR) inhibitor is necessary in many cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] necessary [Subject] patients with advanced non-small cell lung cancer [Treatment] concomitant administration of antiepileptic and chemotherapeutic drugs or epidermal growth factor receptor (EGFR) inhibitor"}, {"id": "18343993_2_1475", "context": "A female patient with HER2 positive, metastatic breast cancer presented with pulmonary infiltrates, and a plural effusion dyspnoea after several months of trastuzumab treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] A female patient with HER2 positive, metastatic breast cancer [Treatment] trastuzumab [Effect] pulmonary infiltrates, and a plural effusion dyspnoea"}, {"id": "12944250_3_1476", "context": "Thrombocytosis under ciprofloxacin and tazobactam/piperacillin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] under [Treatment] ciprofloxacin and tazobactam/piperacillin [Effect] Thrombocytosis"}, {"id": "7781845_2_1477", "context": "Quinine and its isomer quinidine are well-known causes of iatrogenic hypoglycaemia, due to excessive insulin secretion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causes [Treatment] Quinine and its isomer quinidine [Effect] iatrogenic hypoglycaemia, due to excessive insulin secretion"}, {"id": "14690166_6_1478", "context": "Therefore, it is reasonable to conclude that: 1) 2-CdA can induce durable complete remission in MCD patients but unfortunately it cannot cure the disease; 2) the possibility that 2-CdA may accelerate the transformation of MCD to NHL cannot be ruled out.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] induce [Treatment] 2-CdA [Effect] durable complete remission [Adverse event] accelerate [Treatment] 2-CdA [Effect] the transformation of MCD to NHL"}, {"id": "8192712_3_1479", "context": "Hyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] a postictal patient [Treatment] valproic acid [Effect] Hyperammonemia"}, {"id": "11215836_2_1480", "context": "OBJECTIVE: To report on the possible development of serotonin syndrome in a patient receiving clomipramine after clozapine was withdrawn from the treatment regimen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] patient [Treatment] clomipramine [Effect] serotonin syndrome"}, {"id": "7295427_1_1481", "context": "Fatal ventricular fibrillation after treatment with digoxin in a 27-year-old man with mitral leaflet prolapse syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 27-year-old man with mitral leaflet prolapse syndrome [Treatment] digoxin [Effect] Fatal ventricular fibrillation"}, {"id": "8641617_4_1482", "context": "Clostridium difficile colitis associated with cisplatin-based chemotherapy in ovarian cancer patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] ovarian cancer patients. [Treatment] cisplatin-based chemotherapy [Effect] Clostridium difficile colitis"}, {"id": "8828999_2_1483", "context": "Lithium-induced Creutzfeldt-Jakob syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Lithium [Effect] Creutzfeldt-Jakob syndrome"}, {"id": "12944250_1_1484", "context": "It is concluded that simultaneous administration of ciprofloxacin and tazobactam/piperacillin may cause marked thrombocytosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] simultaneous administration of ciprofloxacin and tazobactam/piperacillin [Effect] marked thrombocytosis"}, {"id": "12121061_6_1485", "context": "Alone or in combination with corticosteroids, cyclosporine is an effective drug of choice for the resistant patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] is [Subject] resistant patients [Treatment] Alone or in combination with corticosteroids, cyclosporine"}, {"id": "15013892_1_1486", "context": "Bull's-eye maculopathy associated with quinacrine therapy for malaria.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] quinacrine [Effect] Bull's-eye maculopathy"}, {"id": "11545487_4_1487", "context": "Physicians should be aware that indinavir nephrolithiasis may cause papillary necrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] indinavir nephrolithiasis [Effect] papillary necrosis"}, {"id": "2394154_2_1488", "context": "Following the institution of intravenous therapy with acyclovir, the patient developed fever, hemoptysis, and a pleural friction rub.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] the patient [Treatment] acyclovir [Effect] fever, hemoptysis, and a pleural friction rub"}, {"id": "16637972_3_1489", "context": "Due to discomfort, diplopia and lagophthalmos, the haematoma necessitated suspension of warfarin therapy and a surgical evacuation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Due to [Treatment] warfarin therapy and a surgical evacuation [Effect] discomfort, diplopia and lagophthalmos, the haematoma"}, {"id": "9476721_1_1490", "context": "Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] penicillamine [Effect] Acute dystonia with thalamic and brainstem lesions"}, {"id": "12862258_2_1491", "context": "Fatal agranulocytosis in an Indian male receiving 100mg of dapsone daily, hospitalized for mid-borderline leprosy in type I reaction with triple nerve paralysis is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] mid-borderline leprosy in type I reaction with triple nerve paralysis [Treatment] 100mg of dapsone daily [Effect] Fatal agranulocytosis"}, {"id": "17285101_2_1492", "context": "The authors presented a case of pulmonary hypertension during lithium therapy, while she has been on lithium for 6 years.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] she [Treatment] lithium therapy [Effect] pulmonary hypertension"}, {"id": "16968538_2_1493", "context": "BACKGROUND: Oxaliplatin is a platinum derivative, which is used in the treatment of colorectal cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Oxaliplatin is a platinum derivative"}, {"id": "17406804_2_1494", "context": "After having received gemcitabine on day 1 of the second course, the patient developed dry cough, subfebrile temperatures and dyspnea within 48 h.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] the patient [Treatment] received gemcitabine on day 1 of the second course [Effect] dry cough, subfebrile temperatures and dyspnea within 48 h"}, {"id": "15454180_2_1495", "context": "As linezolid has been shown to have hematologic side effects, blood count monitoring is recommended in patients receiving this drug for long-term therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] have [Treatment] linezolid [Effect] hematologic side effects"}, {"id": "189279_3_1496", "context": "The role of Adriamycin in the production of cardiotoxicity is reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] production [Treatment] Adriamycin [Effect] cardiotoxicity"}, {"id": "7663030_5_1497", "context": "He began taking propafenone only 6 days prior to admission because of uncontrolled atrial fibrillation and symptoms of fatigue.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] taking [Treatment] propafenone"}, {"id": "12013364_1_1498", "context": "A 53-year-old man developed NMS without rigidity while taking olanzapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 53-year-old man [Treatment] olanzapine [Effect] NMS without rigidity"}, {"id": "10650865_2_1499", "context": "We report on a 14-year-old boy with severe haemophilia A who developed a portal vein thrombosis during continuous infusion of F VIII.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 14-year-old boy with severe haemophilia A [Treatment] continuous infusion of F VIII [Effect] a portal vein thrombosis"}, {"id": "961329_2_1500", "context": "Suxamethonium apnoea terminated with commercial serumcholinesterase.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] terminated [Treatment] commercial serumcholinesterase [Effect] Suxamethonium apnoea"}, {"id": "9788533_1_1501", "context": "Fatal multiple drug intoxication following acute sertraline use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] acute sertraline use [Effect] multiple drug intoxication"}, {"id": "15611427_1_1502", "context": "OBSERVATIONS: We observed aggravation and spreading of a psoriatic plaque when treated topically with the toll-like receptor (TLR) 7 agonist imiquimod.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Treatment] the toll-like receptor (TLR) 7 agonist imiquimod [Effect] aggravation and spreading of a psoriatic plaque"}, {"id": "9302445_2_1503", "context": "Hypercalcemia in an AIDS patient treated with growth hormone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] an AIDS patient [Treatment] growth hormone [Effect] Hypercalcemia"}, {"id": "17383767_1_1504", "context": "Significant drug interaction: phenytoin toxicity due to erlotinib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] erlotinib [Effect] phenytoin toxicity"}, {"id": "10599932_2_1505", "context": "A pharmacokinetic interaction between the selective serotonin reuptake inhibitor citalopram and a tricyclic antidepressant, clomipramine, was noted in a patient treated for major depression and obsessive-compulsive disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] interaction [Subject] a patient treated for major depression and obsessive-compulsive disorder [Treatment] the selective serotonin reuptake inhibitor citalopram and a tricyclic antidepressant, clomipramine [Effect] A pharmacokinetic interaction"}, {"id": "3301251_4_1506", "context": "They continued to rise for five more days before salicylate hepatotoxicity was suspected.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suspected [Treatment] salicylate [Effect] hepatotoxicity"}, {"id": "8832451_2_1507", "context": "The occurrence of neuromuscular blockade and the resulting potentiation of muscle relaxants during magnesium sulfate (MgSO4) administration is well known.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] magnesium sulfate [Effect] neuromuscular blockade; potentiation of muscle relaxants"}, {"id": "12680486_1_1508", "context": "Based on these findings, the patient was diagnosed with diabetes insipidus secondary to lithium therapy and was treated successfully with amiloride.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] diagnosed [Treatment] lithium [Effect] diabetes insipidus [Potential therapeutic event] treated [Treatment] amiloride [Effect] successfully"}, {"id": "11034877_1_1509", "context": "Gabapentin-induced mood changes with hypomanic features in adults.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] adults [Treatment] Gabapentin [Effect] mood changes with hypomanic features"}, {"id": "1954704_1_1510", "context": "Drug induced polymyositis secondary to leuprolide acetate (Lupron) therapy for prostate carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary to [Treatment] leuprolide acetate (Lupron) therapy [Effect] Drug induced polymyositis"}, {"id": "18465737_1_1511", "context": "Incomplete posterior hyaloid detachment after intravitreal pegaptanib injection in diabetic macular edema.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] ntravitreal pegaptanib injection in diabetic macular edema [Effect] Incomplete posterior hyaloid detachment"}, {"id": "7321956_2_1512", "context": "This paper reports a case of fatal perhexiline maleate liver injury.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] a case of [Treatment] perhexiline maleate [Effect] liver injury"}, {"id": "21448111_5_1513", "context": "During the second hospitalization it is possible that antipsychotic treatment combined with an antidepressant caused akathisia or there were symptoms of agitated depression and akathisia present at the same time, which is very difficult to determine in everyday clinical practice.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] antipsychotic treatment combined with an antidepressant [Effect] akathisia"}, {"id": "7724306_5_1514", "context": "OBJECTIVES: To describe the presentation and treatment of acute isoniazid (INH) neurotoxicity appearing at an inner-city municipal hospital.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] neurotoxicity [Treatment] isoniazid (INH) [Effect] isoniazid (INH) neurotoxicity"}, {"id": "9846036_4_1515", "context": "Clozapine, an atypical antipsychotic, can be toxic at doses 4 times a moderate dose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] be [Treatment] doses 4 times a moderate dose; Clozapine [Effect] toxic"}, {"id": "18344455_3_1516", "context": "This article presents a 3(1/2)-year-old child on valproic acid, lamotrigine, and phenytoin who developed simultaneous hepatotoxicity and bone marrow toxicity during a parainfluenza virus type 3 infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 3(1/2)-year-old child [Treatment] valproic acid, lamotrigine, and phenytoin [Effect] simultaneous hepatotoxicity and bone marrow toxicity"}, {"id": "2051906_3_1517", "context": "Reversible cholestasis with bile duct injury following azathioprine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] azathioprine [Effect] Reversible cholestasis with bile duct injury"}, {"id": "20185472_1_1518", "context": "The authors report five cases of tremor related to itraconazole therapy, which occurred within 1-12 months of initiating treatment and resolved gradually following itraconazole withdrawal.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] itraconazole therapy, [Effect] tremor"}, {"id": "9337441_2_1519", "context": "OBJECTIVE: To report a case of phenolphthalein-induced toxic epidermal necrolysis (TEN) in a patient maintained on several other medications more commonly known to be associated with TEN.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case of; a patient [Treatment] phenolphthalein; maintained on several other medications more commonly known to be associated with TEN [Effect] toxic epidermal necrolysis (TEN)"}, {"id": "1295628_3_1520", "context": "Clinical symptoms and leukopenia normalized after discontinuation of CBZ and administration of prednisolone at 40 mg.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] normalized [Treatment] discontinuation of CBZ and administration of prednisolone at 40 mg [Effect] Clinical symptoms and leukopenia normalized"}, {"id": "6766717_1_1521", "context": "A patient with alcoholic cerebellar degeneration had periodic alternating nystagmus during a period of phenytoin intoxication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] A patient with alcoholic cerebellar degeneration [Treatment] phenytoin [Effect] periodic alternating nystagmus"}, {"id": "15316423_1_1522", "context": "Extensive forearm deep venous thrombosis following a severe infliximab infusion reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] infliximab [Effect] Extensive forearm deep venous thrombosis; nfusion reaction"}, {"id": "527355_2_1523", "context": "Severe acidosis from acetazolamide in a diabetic patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Subject] a diabetic patient [Treatment] acetazolamide [Effect] Severe acidosis"}, {"id": "18607107_1_1524", "context": "CONCLUSIONS: Clinicians should be aware that Crohn's disease is a potential novel adverse drug effect of Copaxone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] effect [Treatment] Copaxone [Effect] Crohn's disease"}, {"id": "16062101_2_1525", "context": "ADR induced by drug treatment can be a side effect of treatment with antipsychotic drugs and other drugs; however, there have been no reports of lamivudine-induced ADR in the English literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] lamivudine [Effect] ADR"}, {"id": "17324248_2_1526", "context": "CONCLUSIONS: The piloerection observed after the replacement of fluvoxamine with milnacipran in this patient appears to have been due to an increase in the alpha(1)-adrenoceptor occupancy by endogenous norepinephrine induced by milnacipran.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] milnacipran [Effect] an increase in the alpha(1)-adrenoceptor occupancy by endogenous norepinephrine [Adverse event] observed [Subject] this patient [Treatment] milnacipran [Effect] piloerection"}, {"id": "17122225_1_1527", "context": "Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] interaction of cyclobenzaprine with other serotoninergic drugs [Effect] Serotonin syndrome"}, {"id": "19897274_1_1528", "context": "However, a recent post-marketing survey in Japan revealed that interstitial pneumonia occurred in 4 among approximately 2 000 Japanese patients treated with sorafenib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] 4 among approximately 2 000 Japanese patients [Treatment] sorafenib [Effect] interstitial pneumonia"}, {"id": "20338114_2_1529", "context": "The other patient developed transient intraoperative hypertension immediately after inadvertent submucosal injection of concentrated epinephrine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] The other patient [Treatment] inadvertent submucosal injection of concentrated epinephrine [Effect] transient intraoperative hypertension immediately"}, {"id": "1722991_9_1530", "context": "This experience supports the hypothesis that heparin can be readministered early to patients with heparin-associated thrombocytopenia and thrombosis, provided antiplatelet therapy is given.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] readministered [Treatment] heparin; antiplatelet therapy is given [Adverse event] associated [Treatment] heparin [Effect] thrombocytopenia and thrombosis"}, {"id": "3997294_1_1531", "context": "Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] amiodarone therapy [Effect] Pneumonitis with pleural and pericardial effusion and neuropathy"}, {"id": "15852680_2_1532", "context": "We report a case of interstitial pneumonitis induced by bicalutamide and/or leuprorelin acetate given as therapy for prostate cancer, in which the pneumonitis was successfully managed by steroid treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] bicalutamide and/or leuprorelin acetate given as therapy for prostate cancer [Effect] interstitial pneumonitis"}, {"id": "10410183_9_1533", "context": "For those patients with a history of NMS, or even of isolated serum CK elevation during antipsychotic therapy, follow-up should be stricter.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] patients with a history of NMS [Treatment] antipsychotic therapy [Effect] isolated serum CK elevation"}, {"id": "8292513_2_1534", "context": "Children with acute lymphoblastic leukemia (ALL), treated with L-asparaginase are at risk for cerebral thrombosis or hemorrhage because of coagulation protein deficiencies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Subject] Children with acute lymphoblastic leukemia (ALL) [Treatment] L-asparaginase [Effect] cerebral thrombosis or hemorrhage; coagulation protein deficiencies"}, {"id": "8530331_6_1535", "context": "Two of the five patients who worsened motorically also developed encephalopathy during risperidone treatment; the encephalopathy resolved when the patients were switched to clozapine treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two of the five patients who worsened motorically [Treatment] risperidone treatment [Effect] encephalopathy [Potential therapeutic event] resolved [Subject] Two of the five patients who worsened motorically [Treatment] switched to clozapine treatment"}, {"id": "25157214_2_1536", "context": "The effectiveness of sugammadex in reversing rocuronium-induced neuromuscular blockade (NMB) in the presence of drugs that may potentiate NMB remains to be fully established.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] rocuronium [Effect] neuromuscular blockade (NMB) [Potential therapeutic event] reversing [Treatment] sugammadex; in the presence of drugs that may potentiate NMB"}, {"id": "2781955_1_1537", "context": "Dexamethasone treatment of amiodarone-induced thyrotoxicosis (AIT) with or without persistent administration of the drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] amiodarone [Effect] thyrotoxicosis (AIT)"}, {"id": "7973922_1_1538", "context": "Acyclovir neurotoxicity: clinical experience and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experience [Treatment] Acyclovir [Effect] neurotoxicity"}, {"id": "24163322_1_1539", "context": "Inadvertent exaggerated anticoagulation following use of bismuth subsalicylate in an enterally fed patient receiving warfarin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] an enterally fed patient [Treatment] bismuth subsalicylate; warfarin therapy [Effect] Inadvertent exaggerated anticoagulation"}, {"id": "9230324_1_1540", "context": "We report the specifics of 12 cases of severe hypertension after the intraoperative use of topical phenylephrine, submucosal epinephrine, or both.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] 12 cases [Treatment] intraoperative use of topical phenylephrine, submucosal epinephrine, or both [Effect] hypertension"}, {"id": "8384030_5_1541", "context": "The patient experienced muscle twitches, tremulousness, and anxiety on day 17 of foscarnet therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] patient [Treatment] foscarnet therapy [Effect] muscle twitches, tremulousness, and anxiet"}, {"id": "7282702_1_1542", "context": "A case of timolol-associated heart failure in a 73-year old white man is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a 73-year old white man [Treatment] timolol [Effect] heart failure"}, {"id": "25407257_6_1543", "context": "In December, he was prescribed 160 mg/day tebipenem pivoxil by an otolaryngologist for inflammation of the tympanic membrane.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Subject] he [Treatment] 160 mg/day tebipenem pivoxil"}, {"id": "19669617_1_1544", "context": "A 65-year-old female patient presented with jaundice followed 2 days later by severe dyspnea and tachypnea which worsened when patient was lying flat, 1 week after the fourth dose of adalimumab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] A 65-year-old female patient [Treatment] 1 week after the fourth dose of adalimumab [Effect] jaundice followed 2 days later by severe dyspnea and tachypnea which worsened when patient was lying flat"}, {"id": "4082283_2_1545", "context": "Renal failure is a rare complication associated with the use of rifampicin for the treatment of tuberculosis, usually occurring well into the course of therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] rifampicin [Effect] Renal failure"}, {"id": "21887897_1_1546", "context": "An autopsy case of multiple psychotropic drug poisoning.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] poisoning [Subject] An autopsy case [Treatment] multiple psychotropic drug [Effect] poisoning"}, {"id": "2212262_1_1547", "context": "Severe heparin associated thrombocytopenia is a rare complication of heparin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] heparin [Effect] thrombocytopenia"}, {"id": "10546851_5_1548", "context": "Six patients at steady state in treatment with indinavir participated in the study.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] Six patients [Treatment] indinavir"}, {"id": "19034138_6_1549", "context": "RESULTS: A 52-year-old woman with Parkinson disease who had taken amantadine for 6 years had bilateral corneal edema for 2 months at baseline.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] A 52-year-old woman with Parkinson disease [Treatment] taken amantadine for 6 years [Effect] bilateral corneal edema for 2 months at baseline"}, {"id": "12114387_3_1550", "context": "We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with epoprostenol, presented with rapidly progressive erythema, scaling, nausea and vomiting, and fever.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] a patient with pulmonary hypertension and undifferentiated connective tissue disease [Treatment] 2 months of treatment with epoprostenol [Effect] rapidly progressive erythema, scaling, nausea and vomiting, and fever"}, {"id": "12587815_3_1551", "context": "Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] adolescent [Treatment] olanzapine-lithium combination therapy [Effect] Neuroleptic malignant syndrome"}, {"id": "3878320_1_1552", "context": "A lethal complication of peripheral vein vasopressin infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] peripheral vein vasopressin infusion [Effect] complication"}, {"id": "16641839_3_1553", "context": "Cutaneous eruptions occur in 3% of individuals administered carbamazepine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Treatment] carbamazepine [Effect] Cutaneous eruptions"}, {"id": "23868369_2_1554", "context": "A 27 year old female with a complex history of congenital heart disease, cardiac surgery, heart failure, and arrhythmias was admitted for a Pseudomonas aeruginosa sternal wound infection and treated with intravenous antibiotics.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] A 27 year old female with a complex history of congenital heart disease, cardiac surgery, heart failure, and arrhythmias [Treatment] intravenous antibiotics"}, {"id": "8244201_2_1555", "context": "Hyperkalaemia with renal tubular dysfunction by oral therapy of sulfamethoxazole-trimethoprim (co-trimoxazole) is described in 2 elderly Japanese patients with lymphoid malignancy, who developed Pneumocystis carinii pneumonia and improved.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] described [Subject] 2 elderly Japanese patients with lymphoid malignancy [Treatment] oral therapy of sulfamethoxazole-trimethoprim (co-trimoxazole) [Effect] Hyperkalaemia with renal tubular dysfunction"}, {"id": "18067642_4_1556", "context": "This is the first report on the histopathological findings of thyroid tissue from a patient with amiodarone-induced hypothyroidism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] amiodarone [Effect] hypothyroidism"}, {"id": "8771575_2_1557", "context": "Acute pulmonary reactions to nitrofurantoin are an uncommon side effect of therapy and can cause minor or life-threatening pulmonary dysfunction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] are [Treatment] nitrofurantoin [Effect] Acute pulmonary reactions; can cause minor or life-threatening pulmonary dysfunction"}, {"id": "2554727_2_1558", "context": "High-dose cytosine arabinoside may benefit patients with refractory acute leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] benefit [Subject] patients with refractory acute leukemia [Treatment] High-dose cytosine arabinoside"}, {"id": "2452936_1_1559", "context": "Life-threatening hyponatremia caused by vinblastine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] vinblastine [Effect] hyponatremia"}, {"id": "17556909_3_1560", "context": "We report a myeloma patient who developed severe paralytic ileus during bortezomib therapy, which presented in the context of progressive constipation without other known causes and which regressed promptly with medical management after drug cessation, suggesting a direct causal relationship.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a myeloma patient [Treatment] bortezomib therapy [Effect] paralytic ileus; presented in the context of progressive constipation without other known causes and which regressed promptly with medical management after drug cessation"}, {"id": "12776809_4_1561", "context": "Here, we report on the drug safety of coumarin with special respect to liver reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] respect [Treatment] coumarin [Effect] liver reaction"}, {"id": "7865488_2_1562", "context": "However, EO-induced noncardiogenic pulmonary edema has not been reported in human.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] human [Treatment] EO [Effect] noncardiogenic pulmonary edema"}, {"id": "12944250_2_1563", "context": "Since the thrombocyte count started to increase immediately after initiation and dropped immediately after discontinuation of ciprofloxacin and tazobactam/piperacillin and all other drugs were discontinued already before or were started after the nadir of the thrombocyte count, these two antibiotics were regarded causative.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Since [Treatment] discontinuation of ciprofloxacin and tazobactam/piperacillin [Effect] the thrombocyte count started to increase immediately after initiation and dropped immediately"}, {"id": "8586895_1_1564", "context": "However, in 1993, a clinical study involving 400 patients on the Thai-Burmese border revealed cardiac effects of antimalarial treatment with halofantrine, including one sudden death after the treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] effects [Subject] 400 patients on the Thai-Burmese border [Treatment] halofantrine [Effect] cardiac effects; sudden death"}, {"id": "10723699_1_1565", "context": "Tetracycline-induced benign intracranial hypertension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Tetracycline [Effect] benign intracranial hypertension"}, {"id": "12889716_2_1566", "context": "Only one case of a generalized maculopapular rash with enoxaparin has been reported in Europe.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] one case [Treatment] enoxaparin [Effect] generalized maculopapular rash"}, {"id": "15331204_7_1567", "context": "After 3- to 13-month period of therapy without indapamide, glucose levels of all patients decreased and diabetes disappeared.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] After [Treatment] 3- to 13-month period of therapy without indapamide [Effect] glucose levels of all patients decreased and diabetes disappeared"}, {"id": "10679548_4_1568", "context": "The favourable outcome in these two patients contrasts with the fatal outcome of the two other reported cases of nitrofurantoin induced BOOP.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] two patients [Treatment] nitrofurantoin [Effect] BOOP"}, {"id": "12163813_3_1569", "context": "Skin necrosis after extravasation of low-dose vasopressin administered for septic shock.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] extravasation [Treatment] vasopressin [Effect] Skin necrosis"}, {"id": "24477376_4_1570", "context": "The patient was previously on phenytoin and was initiated on ticagrelor for antiplatelet therapy following stent placement.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Subject] The patient [Treatment] previously on phenytoin; initiated on ticagrelor; following stent placement"}, {"id": "8239963_1_1571", "context": "Clonidine-induced bradycardia in patients with spinal cord injury.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patients with spinal cord injury [Treatment] Clonidine [Effect] bradycardia"}, {"id": "11122162_1_1572", "context": "MI related to the use of activated and non-activated PCCs predominantly affects young patients who often have no preceding history of, or risk factors for, MI and tends to be associated with large cumulative doses of concentrate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] young patients who often have no preceding history of, or risk factors for, MI [Treatment] activated and non-activated PCCs; large cumulative doses of concentrate [Effect] MI"}, {"id": "6093724_3_1573", "context": "To our knowledge, we describe the first reported case of isolated paresthesia and peripheral neuropathy, without systemic involvement, secondary to sulindac administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] sulindac administration [Effect] isolated paresthesia and peripheral neuropathy"}, {"id": "9876809_2_1574", "context": "To report a probable case of ticlopidine-induced phenytoin toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a probable case [Treatment] phenytoin; ticlopidine [Effect] phenytoin toxicity"}, {"id": "3558331_2_1575", "context": "Two patients are described in whom subtle cognitive impairments are associated with therapeutic doses of amoxapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] Two patients [Treatment] therapeutic doses of amoxapine [Effect] subtle cognitive impairments"}, {"id": "16012330_2_1576", "context": "Itraconazole is particularly attractive in fungal prophylaxis for cancer patients due to its broad spectrum, including Candida and Aspergillus.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prophylaxis [Subject] cancer patients [Treatment] Itraconazole"}, {"id": "16062101_4_1577", "context": "The authors think that although lamivudine is widely used and well tolerated, it can cause ADRs, which are reversible after drug withdrawal.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] lamivudine [Effect] ADRs"}, {"id": "1751354_1_1578", "context": "Psoriasis induced by interferon-alpha.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] interferon-alpha [Effect] Psoriasis"}, {"id": "12915840_2_1579", "context": "We report the first case of IHA associated with cefuroxime administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] the first case [Treatment] cefuroxime [Effect] IHA"}, {"id": "7577414_3_1580", "context": "We report a 16-year-old male who developed nephrotic syndrome related to membranous glomerulopathy with clinical and serological evidence of systemic lupus erythematosus after treatment with griseofulvin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 16-year-old male [Treatment] treatment with griseofulvin [Effect] nephrotic syndrome related to membranous glomerulopathy with clinical and serological evidence of systemic lupus erythematosus"}, {"id": "10803790_5_1581", "context": "CONCLUSION: In some abstainers who take cyanamide for several years, thin septum-like liver fibrosis progresses along with the emergence of ground-glass hepatocytes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] In [Subject] some abstainers [Treatment] take cyanamide for several years [Effect] thin septum-like liver fibrosis progresses along with the emergence of ground-glass hepatocytes"}, {"id": "1814986_1_1582", "context": "Metabolic acidosis induced by acetazolamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] acetazolamide [Effect] Metabolic acidosis"}, {"id": "15359206_2_1583", "context": "In this paper we report a case of nimodipine overdosage resulting in prolonged hypotension and hypoxemia, which was successfully treated with calcium gluconate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] nimodipine overdosage [Effect] prolonged hypotension and hypoxemia [Potential therapeutic event] treated [Treatment] calcium gluconate"}, {"id": "21512888_4_1584", "context": "Valproic acid also displaces warfarin from the protein binding sites resulting in significant INR changes but this type of drug interaction is less well known.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] Valproic acid also displaces warfarin from the protein binding sites [Effect] significant INR changes"}, {"id": "15190230_3_1585", "context": "Therapy with IFN-alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, akathisia, seizure, and depressive disorders.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] Therapy with IFN-alpha [Effect] neuropsychiatric symptoms, such as Parkinsonism, akathisia, seizure, and depressive disorders"}, {"id": "18805724_1_1586", "context": "DISCUSSION: The main adverse effects of leflunomide consist of diarrhea, nausea, liver enzyme elevation, hypertension, alopecia, and allergic skin reactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] effects [Treatment] leflunomide [Effect] diarrhea, nausea, liver enzyme elevation, hypertension, alopecia, and allergic skin reactions"}, {"id": "1445134_3_1587", "context": "In a single practice during the 21 years 1971-1991, the incidence of gestational diabetes in pregnancies in which norethisterone was prescribed was 32.4% (22 of 69) in comparison with 7.1% in pregnancies in which the women did not take norethisterone (137 of 1,684) (p < 0.001).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] incidence [Subject] pregnancies [Treatment] norethisterone [Effect] gestational diabetes"}, {"id": "1765991_2_1588", "context": "The development of systemic lupus erythematosus (SLE) after 38 months of therapy with recombinant human interferon gamma (rIFN-gamma) was observed in a patient with rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] a patient with rheumatoid arthritis. [Treatment] after 38 months; recombinant human interferon gamma [Effect] systemic lupus erythematosus"}, {"id": "7668127_3_1589", "context": "To the best of our knowledge no comparable case and no discussion of possible complications of aspirin prophylaxis in patients with brain tumours have been published.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complications [Subject] patients with brain tumours [Treatment] aspirin prophylaxis"}, {"id": "16225183_6_1590", "context": "CASE REPORT: We present a case of a 28-yr-old male who developed a severe case of nephrotic syndrome while being treated for relapsing/remitting Multiple Sclerosis (RRMS) with weekly injections of interferon beta 1a.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 28-yr-old male; relapsing/remitting Multiple Sclerosis (RRMS) [Treatment] weekly injections of interferon beta 1a [Effect] nephrotic syndrome"}, {"id": "2369419_3_1591", "context": "This is the third report of reversible hepatic decompensation associated with prolonged MTX therapy in patients with rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] patients with rheumatoid arthritis [Treatment] MTX [Effect] reversible hepatic decompensation"}, {"id": "17228132_6_1592", "context": "CONCLUSIONS: Acute severe hepatitis though rare is occasionally observed with EGFR inhibitors gefitinib or erlotinib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Treatment] EGFR inhibitors gefitinib or erlotinib [Effect] Acute severe hepatitis"}, {"id": "24791374_6_1593", "context": "Propafenone is an established class IC antiarrhythmic drug commonly used in the treatment of atrial fibrillation.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Propafenone"}, {"id": "9972383_3_1594", "context": "Reversible nonthrombocytopenic palpable purpura associated with metoclopramide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] metoclopramide [Effect] Reversible nonthrombocytopenic palpable purpura"}, {"id": "2894766_2_1595", "context": "Physicians who use sulfasalazine to treat patients with inflammatory bowel disease should be aware of the signs of sulfasalazine-induced lupus syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] sulfasalazine; sulfasalazine [Effect] lupus syndrome"}, {"id": "6414095_1_1596", "context": "Transient hemiparesis caused by phenytoin toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] phenytoin toxicity [Effect] Transient hemiparesis"}, {"id": "2406680_2_1597", "context": "Sensorineural hearing loss due to quinine therapy for malaria has frequently been mentioned in the literature but has not been a subject of research during the last decades.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] quinine [Effect] Sensorineural hearing loss"}, {"id": "16527771_3_1598", "context": "We report a 78-year-old man who had acute unilateral total visual loss after retrogasserian phenol injection for the treatment of trigeminal neuralgia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 78-year-old man [Treatment] retrogasserian phenol injection [Effect] acute unilateral total visual loss"}, {"id": "18983414_1_1599", "context": "Four months after receiving an orthotopic liver transplant, a 51-year-old man was admitted for progressive liver failure and severe hepatocellular necrosis thought to be due to tacrolimus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Subject] Four months after receiving an orthotopic liver transplant, a 51-year-old man [Treatment] tacrolimus [Effect] progressive liver failure and severe hepatocellular necrosis"}, {"id": "10452772_4_1600", "context": "Patients receiving neutral protamine Hagedorn (NPH) insulin are at increased risk for the development of protamine hypersensitivity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] Patients [Treatment] neutral protamine Hagedorn (NPH) insulin [Effect] protamine hypersensitivity"}, {"id": "8053440_3_1601", "context": "The second patient, who developed cholestasis after receiving trimethoprim-sulfamethoxazole, had marked duct paucity in the liver biopsy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] The second patient [Treatment] trimethoprim-sulfamethoxazole [Effect] cholestasis; duct paucity"}, {"id": "9191742_2_1602", "context": "We describe a patient who became hypothyroid while taking ferrous sulfate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] became [Subject] a patient [Treatment] ferrous sulfate [Effect] hypothyroid"}, {"id": "16540070_2_1603", "context": "Allergy to cloxacillin with normal tolerance to amoxicillin and cefuroxime.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] cloxacillin [Effect] Allergy"}, {"id": "1642627_2_1604", "context": "Triazolam-induced nocturnal bingeing with amnesia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Triazolam [Effect] nocturnal bingeing with amnesia"}, {"id": "12221670_3_1605", "context": "Ticlopidine-induced aplastic anemia (TIAA) is considered very uncommon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Ticlopidine [Effect] aplastic anemia (TIAA)"}, {"id": "14998226_9_1606", "context": "One case report describes an interaction between simvastatin and the anticoagulant acenocoumarol, which resulted in an elevated INR.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Subject] One case [Treatment] simvastatin and the anticoagulant acenocoumarol [Effect] elevated INR"}, {"id": "16884425_1_1607", "context": "A 35-year-old woman presented with neurotoxicity correlated to an i.v. regimen of 5-fluorouracil as episodes of acute confusional state and abnormalities of symmetrically restricted diffusion in the periventricular white matter and corpus callosum.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] correlated [Subject] A 35-year-old woman [Treatment] an i.v. regimen of 5-fluorouracil [Effect] neurotoxicity; acute confusional state and abnormalities of symmetrically restricted diffusion in the periventricular white matter and corpus callosum"}, {"id": "3947272_2_1608", "context": "Ampicillin may aggravate clinical and experimental myasthenia gravis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] aggravate [Treatment] Ampicillin [Effect] myasthenia gravis"}, {"id": "8586895_2_1609", "context": "In the present paper, we discuss the first Japanese vivax malaria patient whose QT interval was prolonged after treatment with halofantrine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] Japanese vivax malaria patient [Treatment] halofantrine [Effect] QT interval was prolonged"}, {"id": "1772299_2_1610", "context": "The Center for Disease Control has received numerous reports of an eosinophilia-myalgia syndrome related to products containing L-tryptophan.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] products containing L-tryptophan [Effect] eosinophilia-myalgia syndrome"}, {"id": "6998294_2_1611", "context": "Disopyramide (Norpace)-induced hypoglycemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Disopyramide (Norpace) [Effect] hypoglycemia"}, {"id": "3195622_1_1612", "context": "A case report of the hypersensitivity syndrome occurring in a patient being treated with dapsone for a brown recluse spider bite is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] a patient [Treatment] dapsone [Effect] hypersensitivity syndrome"}, {"id": "17324248_1_1613", "context": "AIMS: To present a case of piloerection after replacing fluvoxamine maleate with milnacipran hydrochloride, and to analyse this effect based on receptor occupancy theory.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] fluvoxamine maleate [Effect] piloerection"}, {"id": "18171260_4_1614", "context": "Serotonin syndrome after concomitant linezolid and meperidine therapy has not been described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] linezolid and meperidine [Effect] Serotonin syndrome"}, {"id": "23868369_4_1615", "context": "She presented to clinic with nausea and anorexia within a few days of addition of ciprofloxacin to her current regimen of medications, which included digoxin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] She [Treatment] addition of ciprofloxacin to her current regimen of medications, which included digoxin [Effect] nausea and anorexia"}, {"id": "15379082_1_1616", "context": "Disulfiram-induced fulminant hepatic failure in an active duty soldier.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an active duty soldier [Treatment] Disulfiram [Effect] fulminant hepatic failure"}, {"id": "8530331_2_1617", "context": "BACKGROUND: We report six cases of psychosis in patients with akinetic-rigid syndromes who were treated with risperidone.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] six cases; patients with akinetic-rigid syndromes [Treatment] risperidone"}, {"id": "19949685_2_1618", "context": "Colonic necrosis is known as a rare complication following the administration of Kayexalate (sodium polystryrene sulfonate) in sorbitol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] Kayexalate (sodium polystryrene sulfonate) in sorbitol [Effect] Colonic necrosis"}, {"id": "12494253_3_1619", "context": "Anaphylaxis to cisplatin is an infrequent life-threatening complication which may occur even in patients who have received prior treatment with cisplatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Subject] patients [Treatment] cisplatin [Effect] Anaphylaxis"}, {"id": "17324248_3_1620", "context": "Piloerection induced by replacing fluvoxamine with milnacipran.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] replacing fluvoxamine with milnacipran [Effect] Piloerection"}, {"id": "14601701_2_1621", "context": "Ethambutol is an antimicrobial agent used frequently to treat tuberculosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treat [Treatment] Ethambutol"}, {"id": "15878975_4_1622", "context": "The purpose of this review is to increase awareness among physicians and other health care professionals that DIC may be a rare but potentially severe complication of anti-D IGIV treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] anti-D IGIV [Effect] DIC"}, {"id": "8363533_2_1623", "context": "Four Chinese female patients who suffered from manic-depressive disorder and underlying autoimmune thyroiditis developed transient episodes of thyrotoxicosis during maintenance lithium therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] Four Chinese female patients who suffered from manic-depressive disorder and underlying autoimmune thyroiditis [Treatment] maintenance lithium therapy [Effect] transient episodes of thyrotoxicosis"}, {"id": "17522786_2_1624", "context": "Neurointensive care management of raised intracranial pressure caused by severe valproic acid intoxication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] valproic acid [Effect] raised intracranial pressure"}, {"id": "15790469_1_1625", "context": "Primary ovarian large B-cell lymphoma in patient with juvenile rheumatoid arthritis treated with low dose Methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] patient with juvenile rheumatoid arthritis [Treatment] low dose Methotrexate [Effect] Primary ovarian large B-cell lymphoma"}, {"id": "1420650_1_1626", "context": "Asterixis induced by carbamazepine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] carbamazepine [Effect] Asterixis"}, {"id": "2320800_6_1627", "context": "Ifosfamide is a known nephrotoxic drug with demonstrated tubulopathies.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] Ifosfamide [Effect] tubulopathies"}, {"id": "7865488_1_1628", "context": "A case of noncardiogenic pulmonary edema by ethanolamine oleate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] by [Subject] A case [Treatment] ethanolamine oleate [Effect] noncardiogenic pulmonary edema"}, {"id": "11737689_1_1629", "context": "A boy with chronic neutropenia and recurrent inflammatory skin lesions developed multiple erythematous nodules following administration of G-CSF.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A boy with chronic neutropenia and recurrent inflammatory skin lesions [Treatment] G-CSF [Effect] multiple erythematous nodules"}, {"id": "1261772_2_1630", "context": "Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] propylthiouracil [Effect] Fulminant hepatitis; lymphocyte sensitization"}, {"id": "9754850_5_1631", "context": "We report on three patients with acute schizophrenia, who developed severe akathisia during treatment with olanzapine (20-25 mg/d).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] three patients with acute schizophrenia [Treatment] olanzapine (20-25 mg/d) [Effect] akathisia"}, {"id": "11206417_2_1632", "context": "AIMS/HYPOTHESIS: There is evidence that insulin and glucose cause renal and ocular vasodilation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] insulin and glucose [Effect] renal and ocular vasodilation"}, {"id": "17536204_1_1633", "context": "A cause-effect relationship to capecitabine was suggested due to resolution of headache with capecitabine withdrawal and reappearance with capecitabine rechallenge.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] relationship to [Treatment] capecitabine [Effect] headache"}, {"id": "7900744_6_1634", "context": "This is a report of a case of anuric ARF after high-dose mannitol infusion for treatment of narrow-angle glaucoma that readily responded to acute hemodialysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a case [Treatment] high-dose mannitol infusion [Effect] anuric ARF"}, {"id": "23673446_6_1635", "context": "She was treated with sorafenib at 400 mg daily.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] She [Treatment] sorafenib at 400 mg daily"}, {"id": "18421192_2_1636", "context": "The clinical course suggested that recombinant alpha-2b peginterferon plus ribavirin provoked type 1 diabetes mellitus, therefore, in patients who are candidates for interferon therapy the presence of pancreatic autoantibodies and the fasting plasma glucose level should be investigated before and during treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] provoked [Treatment] recombinant alpha-2b peginterferon plus ribavirin [Effect] type 1 diabetes mellitus"}, {"id": "19474653_1_1637", "context": "Rhabdomyolysis following clarithromycin monotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] clarithromycin monotherapy [Effect] Rhabdomyolysis"}, {"id": "11788010_4_1638", "context": "In addition to its known effect on gallbladder stasis, octreotide alters bile acid composition and may thus hasten intrahepatic sludge and stone formation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] effect on [Treatment] octreotide [Effect] gallbladder stasis; alters bile acid composition and may thus hasten intrahepatic sludge and stone formation"}, {"id": "16326413_1_1639", "context": "A 17-year-old boy with acute lymphoblastic leukemia developed acute renal failure within 48 h of an intravenous high-dose methotrexate (5 g/m2) infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 17-year-old boy with acute lymphoblastic leukemia [Treatment] intravenous high-dose methotrexate (5 g/m2) infusion [Effect] acute renal failure"}, {"id": "2116935_1_1640", "context": "Splenic hemorrhage: a complication of tissue plasminogen activator treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication of [Treatment] tissue plasminogen activator treatment [Effect] Splenic hemorrhage"}, {"id": "18648015_2_1641", "context": "CONCLUSIONS: Cefazolin was a probable cause of this patient's leukopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] patient [Treatment] Cefazolin [Effect] leukopenia"}, {"id": "15533031_1_1642", "context": "Paradoxical cerebral cortical hyperexcitability following flupirtine overdose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] flupirtine overdose [Effect] Paradoxical cerebral cortical hyperexcitability"}, {"id": "6245286_1_1643", "context": "Autopsy evidence of herpesvirus infection was found in visceral organs of four leukemic patients who had received large doses of cytarabine (cytosine arabinoside; Ara-C) shortly before their death.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] found [Subject] four leukemic patients [Treatment] large doses of cytarabine [Effect] herpesvirus infection"}, {"id": "4004433_1_1644", "context": "Heparin-induced hyperkalemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Heparin [Effect] hyperkalemia"}, {"id": "6608139_1_1645", "context": "Although myelosuppression is mild, immunosuppression and superinfection are potential hazards of treatment with DCF.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] hazards [Treatment] DCF [Effect] myelosuppression; immunosuppression and superinfection"}, {"id": "2076372_2_1646", "context": "The photosensitivity is still present 3 years after the withdrawal of quinine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] withdrawal of quinine [Effect] photosensitivity is still present 3 years"}, {"id": "8396491_1_1647", "context": "Interference with the cortisol axis by the microtubule antagonist, CPH82.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] by [Treatment] CPH82 [Effect] Interference with the cortisol axis"}, {"id": "9892272_2_1648", "context": "Physicians should be aware of the possible association between the use of alteplase and the development of subfascial hemorrhage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] alteplase [Effect] subfascial hemorrhage"}, {"id": "3763264_5_1649", "context": "The clinical findings and laboratory studies suggested an autoimmune cell-mediated hypersensitivity reaction triggered by phenobarbital.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] triggered [Treatment] phenobarbital [Effect] an autoimmune cell-mediated hypersensitivity reaction"}, {"id": "9642842_1_1650", "context": "Anaphylactic reaction to oral prednisone: a case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Subject] a case [Treatment] oral prednisone [Effect] Anaphylactic reaction"}, {"id": "9634122_2_1651", "context": "Prolonged prostate-specific antigen response in flutamide withdrawal syndrome despite disease progression.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Treatment] flutamide [Effect] Prolonged prostate-specific antigen response"}, {"id": "7436161_4_1652", "context": "None of them had a history of cardiac disease, and with the possible exception of one case of cardiac arrest, where the patient received doxorubicin, no predisposing factors could be found.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] received [Subject] the patient [Treatment] doxorubicin [Effect] cardiac arrest"}, {"id": "8013261_4_1653", "context": "We report a case of IDDM which occurred during interferon therapy for chronic hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] a case [Treatment] interferon therapy [Effect] IDDM"}, {"id": "11174414_4_1654", "context": "Though physicians treating large populations of patients with HIV are well aware of this complication, only one other report of nevirapine-associated SJS has been documented in the dermatology literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] patients with HIV [Treatment] nevirapine [Effect] SJS"}, {"id": "16119501_4_1655", "context": "We report a case of baclofen withdrawal syndrome resulting from oral baclofen underdosing.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] oral baclofen underdosing [Effect] baclofen withdrawal syndrome"}, {"id": "9403220_1_1656", "context": "A 35-year-old nephrotic man developed acute renal failure with serum creatinine to 1543 micromol/l after a month of therapy with enalapril.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 35-year-old nephrotic man [Treatment] a month of therapy with enalapril [Effect] acute renal failure with serum creatinine to 1543 micromol/l"}, {"id": "7663030_14_1657", "context": "Comparable adverse effects, such as disorientation and temporary amnesia, have been reported in patients in the analogous agent, propranolol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] been reported [Subject] patients [Treatment] propranolol [Effect] disorientation and temporary amnesia"}, {"id": "18821094_2_1658", "context": "This is an image and brief case report of a 13-year-old boy who presented with severe rash and systemic symptoms after starting oxcarbazepine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 13-year-old boy [Treatment] oxcarbazepine [Effect] severe rash and systemic symptoms"}, {"id": "489527_1_1659", "context": "Renal damage associated with long term use of lithium carbonate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] lithium carbonate [Effect] Renal damage"}, {"id": "20456080_1_1660", "context": "Triamcinolone acetonide induced secondary adrenal insufficiency related to impaired CYP3A4 metabolism by coadministration of nefazodone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Triamcinolone acetonide; coadministration of nefazodone [Effect] secondary adrenal insufficiency"}, {"id": "16044093_1_1661", "context": "Hepatocellular damage following therapeutic intravenous iron sucrose infusion in a child.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a child [Treatment] intravenous iron sucrose infusion [Effect] Hepatocellular damage"}, {"id": "14641354_2_1662", "context": "We report a 43-year-old woman who developed sore throat, swelling of the lips and oral cavity and dysphagia, 2 weeks after the use of budesonide spray (Budefat) for treatment of bronchial asthma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 43-year-old woman [Treatment] 2 weeks after the use of budesonide spray (Budefat) [Effect] sore throat, swelling of the lips and oral cavity and dysphagia"}, {"id": "7496198_9_1663", "context": "Among the risk factors studied, two appear to increase the risk of ARE: the prescription of thiabendazole to treat strongyloidiasis during the melarsoprol cure and the bad general clinical conditions of patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] appear to [Treatment] prescription of thiabendazole; during the melarsoprol cure [Effect] increase the risk of ARE"}, {"id": "3997294_2_1664", "context": "Review of this and previously reported cases indicates the need for early diagnosis of amiodarone pneumonitis, immediate withdrawal of amiodarone, and prompt but continued steroid therapy to ensure full recovery.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] amiodarone [Effect] pneumonitis [Potential therapeutic event] recovery [Treatment] immediate withdrawal of amiodarone, and prompt but continued steroid therapy"}, {"id": "12503933_2_1665", "context": "A second possibility is an interaction between clarithromycin and isradipine, potentially increasing the hepatic toxicity of isradipine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increasing [Treatment] interaction between clarithromycin and isradipine [Effect] hepatic toxicity"}, {"id": "1584367_3_1666", "context": "We report two cases of cerebrospinal fluid eosinophilia (CSFE) secondary to the intraventricular administration of vancomycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Subject] two cases [Treatment] intraventricular administration of vancomycin [Effect] cerebrospinal fluid eosinophilia (CSFE)"}, {"id": "19857154_4_1667", "context": "We describe two patients who experienced serious quetiapine adverse effects potentially mediated through an interaction with ritonavir-boosted atazanavir.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] two patients [Treatment] ritonavir-boosted atazanavir [Effect] serious quetiapine adverse effects"}, {"id": "11020127_4_1668", "context": "The patient was diagnosed with carbamazepine toxicity related to the introduction of ritonavir.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] patient [Treatment] ritonavir [Effect] carbamazepine toxicity"}, {"id": "17987285_12_1669", "context": "Caution should be exercised, especially in patients who are given voriconazole or fluconazole during long-lasting fentanyl treatment, because insidiously elevated fentanyl concentration may lead to respiratory depression.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] lead [Subject] patients [Treatment] fentanyl [Effect] respiratory depression"}, {"id": "15878975_5_1670", "context": "This review presents the first case series of DIC associated with acute hemoglobinemia or hemoglobinuria following anti-D IGIV administration for ITP.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] anti-D IGIV administration [Effect] DIC associated with acute hemoglobinemia or hemoglobinuria"}, {"id": "15795553_1_1671", "context": "Risperidone is a frequently used member of a new class of atypical antipsychotics-the serotonin-dopamine antagonists (SDAs)-due to its comparatively high efficacy and low D2/5HT2 binding ratio, which results in a low incidence of extrapyramidal side effects including tardive dyskinesia (TD).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] results [Treatment] Risperidone [Effect] tardive dyskinesia"}, {"id": "10458196_1_1672", "context": "A 5-month-old infant became lethargic and poorly responsive after receiving 1 drop of brimonidine in each eye.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] became [Subject] A 5-month-old infant [Treatment] receiving 1 drop of brimonidine in each eye [Effect] lethargic and poorly responsive"}, {"id": "489527_2_1673", "context": "The authors report 2 cases of renal damage associated with lithium carbonate treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] 2 cases [Treatment] lithium carbonate treatment [Effect] renal damage"}, {"id": "9545161_4_1674", "context": "It was hypothesized that valproic acid may interfere with glucuronidation of lamotrigine, leading to increased serum lamotrigine levels, or perhaps alter the drug's metabolism, resulting in accumulation of a toxic intermediate metabolite.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] leading [Treatment] valproic acid may interfere with glucuronidation of lamotrigine [Effect] increased serum lamotrigine levels, or perhaps alter the drug's metabolism, resulting in accumulation of a toxic intermediate metabolite"}, {"id": "10650865_1_1675", "context": "Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding--successful thrombolysis under heparin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a patient with severe haemophilia A and F V G1691A mutation [Treatment] continuous infusion of F VIII [Effect] Portal vein thrombosis [Potential therapeutic event] therapy [Treatment] heparin [Effect] successful thrombolysis"}, {"id": "6093724_1_1676", "context": "A healthy, 30-year-old man, exposed to sulindac on two separate occasions, had an incapacitating isolated idential sensory neuropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exposed [Subject] A healthy, 30-year-old man [Treatment] sulindac [Effect] incapacitating isolated idential sensory neuropathy"}, {"id": "7439122_1_1677", "context": "Clofibrate-induced myopathy in patients with diabetes insipidus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patients with diabetes insipidus [Treatment] Clofibrate [Effect] myopathy"}, {"id": "17473493_2_1678", "context": "This is the first histologically confirmed case of NASH that was aggravated by raloxifene.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] aggravated [Subject] the first histologically confirmed case [Treatment] raloxifene [Effect] NASH"}, {"id": "9545161_5_1679", "context": "To date, eight cases of TEN and one of SJS related to lamotrigine administration have been reported in the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] lamotrigine [Effect] TEN; SJS"}, {"id": "11207969_1_1680", "context": "ARA-C is frequently associated with dermatologic toxicity, but this is only the second case of toxic epidermal necrolysis described in connection with this drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] ARA-C [Effect] dermatologic toxicity"}, {"id": "515777_1_1681", "context": "Hyperglycemia and diabetic coma: possible relationship to diuretic-propranolol therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] propranolol [Effect] Hyperglycemia and diabetic coma"}, {"id": "15977922_1_1682", "context": "Potential mechanisms involved in the occurrence of ischemic colitis in patients receiving tegaserod are also discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurrence [Subject] patients [Treatment] tegaserod [Effect] ischemic colitis"}, {"id": "9494448_2_1683", "context": "Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Subject] case [Treatment] intravenous cyclosporine [Effect] Anaphylaxis"}, {"id": "14960440_2_1684", "context": "CASE REPORT: A woman of 80 years, on long-term warfarin therapy presented with an acute dissecting thoracic aortic aneurysm; on investigation the only precipitating factor found was an international normalised ratio of 4.8.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] A woman of 80 years [Treatment] on long-term warfarin [Effect] acute dissecting thoracic aortic aneurysm"}, {"id": "10808214_1_1685", "context": "A patient with an allergy to a macrolide antibiotic was given tacrolimus and developed a sudden cutaneous reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient with an allergy to a macrolide antibiotic [Treatment] given tacrolimus [Effect] sudden cutaneous reaction"}, {"id": "9240497_2_1686", "context": "This case suggests the importance of careful observation for extramedullary relapse in patients who are treated with ATRA.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] patients [Treatment] ATRA [Effect] extramedullary relapse"}, {"id": "16863495_1_1687", "context": "Olanzapine-associated neuroleptic malignant syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Olanzapine [Effect] neuroleptic malignant syndrome"}, {"id": "16062101_1_1688", "context": "Acute dystonia induced by lamivudine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] lamivudine [Effect] Acute dystonia"}, {"id": "12792223_4_1689", "context": "We report in detail an unusual adverse reaction to infliximab therapy, a drug-induced lupus-like clinical syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] infliximab [Effect] lupus-like clinical syndrome"}, {"id": "11722307_4_1690", "context": "RESULTS: Quetiapine was associated with leucopenia in two patients and clinically apparent agranulocytosis in one patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] two patients [Treatment] Quetiapine [Effect] leucopenia [Adverse event] associated [Subject] one patient [Treatment] Quetiapine [Effect] clinically apparent agranulocytosis"}, {"id": "11180704_1_1691", "context": "Oral intake and acarbose were withheld and the ileus spontaneously resolved after 2 days.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] Oral intake and acarbose [Effect] the ileus spontaneously resolved"}, {"id": "8260059_2_1692", "context": "No explanation for this delay was found, other than the possibility that magnesium sulfate treatment impeded lactogenesis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] impeded [Treatment] magnesium sulfate [Effect] lactogenesis"}, {"id": "9205466_1_1693", "context": "Although its side effects are few, tamoxifen increases the incidence of proliferative lesions of the endometrium, which theoretically should be preventable with progestational agents.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increases [Treatment] tamoxifen [Effect] incidence of proliferative lesions of the endometrium"}, {"id": "3379435_3_1694", "context": "Three senile patients developed fatal acute encephalopathy while receiving calcium hopantenate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Three senile patients [Treatment] calcium hopantenate [Effect] encephalopathy"}, {"id": "18515982_4_1695", "context": "Renal injury due to anastrozole has not been published in the English literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] anastrozole [Effect] Renal injury"}, {"id": "17420198_10_1696", "context": "Facial, tongue, and arm movements were first reported approximately five weeks after the initiation of aripiprazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] initiation of aripiprazole [Effect] Facial, tongue, and arm movements"}, {"id": "15197722_2_1697", "context": "Restless legs syndrome due to interferon-alpha.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] interferon-alpha [Effect] Restless legs syndrome"}, {"id": "10885900_1_1698", "context": "HUS has been reported after several anticancer chemotherapies and most often after mitomycin C-based chemotherapy regimens.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] several anticancer chemotherapies and most often after mitomycin C-based chemotherapy regimens [Effect] HUS"}, {"id": "19687711_3_1699", "context": "Although the association between SJS/TEN and the sulfonamide class of antibiotics is well established, the increasing prevalence of CA-MRSA has left practitioners with limited regimens to effectively treat skin and soft tissue infections (SSTIs) in the outpatient setting.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Subject] CA-MRSA [Treatment] sulfonamide class of antibiotics [Effect] SJS/TEN"}, {"id": "7351000_2_1700", "context": "Acute non-lymphocytic leukemia occurred in eight women following long-term treatment with Treosulfan (= dihydroxybusulfan) for ovarian carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] eight women [Treatment] Treosulfan (= dihydroxybusulfan) [Effect] Acute non-lymphocytic leukemia"}, {"id": "9796135_2_1701", "context": "Elderly patients for whom nitrate has been prescribed should be warned of the occurrence of hypotension, leading to unconsciousness.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurrence [Subject] Elderly patients [Treatment] nitrate [Effect] hypotension; unconsciousness"}, {"id": "2937155_1_1702", "context": "A patient receiving vancomycin for a serious staphylococcal infection had a lupus-like syndrome characterized by a malar rash, pain and erythema of the cartilage of both ears, and tender erythematous and hemorrhagic lesions of the finger tips.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Treatment] vancomycin [Effect] a lupus-like syndrome characterized by a malar rash, pain and erythema of the cartilage of both ears, and tender erythematous and hemorrhagic lesions of the finger tips"}, {"id": "7436161_2_1703", "context": "Seven patients with hematologic malignancies who were treated with miconazole for either suspected or proven fungal infections developed eight episodes of major adverse cardiorespiratory and anaphylactic reactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Seven patients with hematologic malignancies [Treatment] miconazole [Effect] eight episodes of major adverse cardiorespiratory and anaphylactic reactions"}, {"id": "12802933_3_1704", "context": "We report the first case, to our knowledge, of rituximab-related autoimmune hemolytic anemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] rituximab [Effect] autoimmune hemolytic anemia"}, {"id": "7606071_1_1705", "context": "Anaphylactoid reactions with intraperitoneal cisplatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] intraperitoneal cisplatin [Effect] Anaphylactoid reactions"}, {"id": "20185472_2_1706", "context": "Tremor: a newly described adverse event with long-term itraconazole therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] long-term itraconazole therapy [Effect] Tremor"}, {"id": "15735923_1_1707", "context": "Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] temozolomide [Effect] myelodysplastic syndrome"}, {"id": "9366852_3_1708", "context": "It occasionally accompanies the heparin-associated thrombocytopenia and thrombosis syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] heparin [Effect] thrombocytopenia and thrombosis syndrome"}, {"id": "16035204_1_1709", "context": "We report an unusual case of massive fluoxetine ingestion resulting in neurological and cardiovascular toxicity resulting in death.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting in [Subject] an unusual case [Treatment] massive fluoxetine ingestion [Effect] neurological and cardiovascular toxicity resulting in death"}, {"id": "9161656_14_1710", "context": "Although dyspnea associated with verapamil administration has been reported, this is the first report of an elderly asymptomatic asthmatic patient with hypertension who developed an acute asthma attack following sustained-release verapamil administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] an elderly asymptomatic asthmatic patient with hypertension [Treatment] sustained-release verapamil administration [Effect] an acute asthma attack"}, {"id": "11483161_2_1711", "context": "The bleeding resolved on discontinuation of APV.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Treatment] discontinuation of APV"}, {"id": "16249064_1_1712", "context": "We describe a case of infection with Mycobacterium abscessus in a 67-year-old woman receiving infliximab as a component of her therapy for RA.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] a 67-year-old woman; RA [Treatment] infliximab as a component of her therapy [Effect] infection with Mycobacterium abscessus"}, {"id": "2327115_2_1713", "context": "Renal toxicities have been reported in less than one percent of the patients receiving ciprofloxacin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Subject] less than one percent of the patients [Treatment] ciprofloxacin therapy. [Effect] Renal toxicities"}, {"id": "10513720_1_1714", "context": "Taxane-induced glaucoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Taxane [Effect] glaucoma"}, {"id": "14735388_1_1715", "context": "Ciprofloxacin-induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] nduced [Subject] a patient with systemic lupus erythematosus. [Treatment] Ciprofloxacin [Effect] toxic epidermal necrolysis"}, {"id": "15383642_1_1716", "context": "Hypotension due to interaction between lisinopril and tizanidine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Treatment] interaction between lisinopril and tizanidine [Effect] Hypotension"}, {"id": "7538828_8_1717", "context": "Development of an extensive skin rash following a single dose of MTX may be an early warning sign for life-threatening bone marrow aplasia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] MTX [Effect] extensive skin rash"}, {"id": "6159523_1_1718", "context": "Anaphylactoid reaction to 50% solution of dextrose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] 50% solution of dextrose [Effect] Anaphylactoid reaction"}, {"id": "7893301_2_1719", "context": "Hypokalemia after normal doses of neubulized albuterol (salbutamol).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] normal doses of neubulized albuterol (salbutamol) [Effect] Hypokalemia"}, {"id": "9770151_1_1720", "context": "Although praziquantel administration may have been effective in killing the parasite in both patients, we are concerned about the production of marked inflammation as a result of treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] production [Subject] parasite in both patients [Treatment] praziquantel [Effect] marked inflammation"}, {"id": "16503727_3_1721", "context": "We describe a patient who developed granulocytopenia and fever after taking dipyrone and discuss the available literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] taking dipyrone [Effect] granulocytopenia and fever"}, {"id": "20126479_3_1722", "context": "Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] before [Treatment] hydroxychloroquine [Effect] symptomatic vision loss"}, {"id": "11961411_1_1723", "context": "A 64-year-old man presented with proteinuria during postoperative interferon (IFN)-beta therapy against malignant melanoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] A 64-year-old man [Treatment] postoperative interferon (IFN)-beta therapy [Effect] proteinuria"}, {"id": "17509184_2_1724", "context": "Ethambutol toxicity manifesting as acute onset psychosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] Ethambutol [Effect] acute onset psychosis"}, {"id": "8503421_2_1725", "context": "Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasminogen activator.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] therapy with recombinant tissue-type plasminogen activator [Effect] Cholesterol crystal embolization-associated renal failure"}, {"id": "15289139_2_1726", "context": "METHODS: A 76-year-old woman with primary open-angle glaucoma and no history of ocular surgery developed a choroidal detachment 12 hours after initiation of therapy with dorzolamide eye drops.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 76-year-old woman with primary open-angle glaucoma and no history of ocular surgery [Treatment] 12 hours after initiation of therapy with dorzolamide eye drops [Effect] choroidal detachment"}, {"id": "717931_1_1727", "context": "Life-threatening hyperkalemia induced by arginine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] arginine [Effect] hyperkalemia"}, {"id": "11881322_6_1728", "context": "We report on three patients who developed acute liver damage during therapy with itraconazole, and in whom liver biopsy specimens were obtained.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] three patients [Treatment] itraconazole [Effect] acute liver damage"}, {"id": "15126179_2_1729", "context": "METHODS: A 68-year-old man developed intense conjunctival hyperemia and cystoid macula edema after switching from latanoprost to bimatoprost 9 months after cataract surgery in an eye at low-risk for this cystoid macular edema.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 68-year-old man [Treatment] bimatoprost [Effect] intense conjunctival hyperemia and cystoid macula edema"}, {"id": "12699871_3_1730", "context": "Tacrolimus (FK506), an immunosuppressant, has been associated with mutism in adults after liver transplant.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Subject] adults after liver transplant [Treatment] Tacrolimus (FK506), an immunosuppressant [Effect] mutism"}, {"id": "19904536_13_1731", "context": "Gemcitabine-induced pulmonary toxicity is usually a dramatic condition.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Gemcitabine [Effect] pulmonary toxicity"}, {"id": "6987607_1_1732", "context": "However, the amount of prednisone required to maintain normotension resulted in Cushingoid features and has been discontinued.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted in [Treatment] prednisone; to maintain normotension [Effect] Cushingoid features"}, {"id": "8140860_2_1733", "context": "We present the case of a woman undergoing treatment with acenocoumarol for deep vein thrombosis, who maintained an international normalized ratio (INR) of between 2.5 and 4 for 2 months.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] a woman [Treatment] acenocoumarol"}, {"id": "18408649_1_1734", "context": "Development of tics in a thirteen-year-old male following atomoxetine use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a thirteen-year-old male [Treatment] atomoxetine [Effect] Development of tics"}, {"id": "7919557_3_1735", "context": "OBJECTIVE: To report a case of chronic, nonproductive cough secondary to the angiotensin-converting enzyme (ACE) inhibitor quinapril, with complete resolution after switching to another ACE inhibitor, fosinopril.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolution [Treatment] switching to another ACE inhibitor, fosinopril [Effect] chronic, nonproductive cough secondary to the angiotensin-converting enzyme (ACE) inhibitor quinapril"}, {"id": "17163271_1_1736", "context": "Cholelithiasis and thrombosis of the central retinal vein in a renal transplant recipient treated with cyclosporin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a renal transplant recipient [Treatment] cyclosporin [Effect] Cholelithiasis and thrombosis of the central retinal vein"}, {"id": "11788010_6_1737", "context": "We report a case of hepatolithiasis (intrahepatic stone) complicated by gram-negative sepsis in a 37 year old male with acromegaly being treated with octreotide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a 37 year old male with acromegaly [Treatment] octreotide [Effect] hepatolithiasis (intrahepatic stone) complicated by gram-negative sepsis"}, {"id": "1288290_1_1738", "context": "Proliferation of abnormal bone marrow histiocytes, an undesired effect of granulocyte macrophage-colony-stimulating factor therapy in a patient with Hurler's syndrome undergoing bone marrow transplantation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] undesired effect [Subject] a patient with Hurler's syndrome [Treatment] granulocyte macrophage-colony-stimulating factor [Effect] Proliferation of abnormal bone marrow histiocytes"}, {"id": "18431096_2_1739", "context": "We report 4 patients, 2 on methylphenidate and 2 on dextroamphetamine who presented with acral cyanosis, livedo reticularis, or Raynaud phenomenon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] 2 [Treatment] dextroamphetamine [Effect] acral cyanosis, livedo reticularis, or Raynaud phenomenon [Adverse event] presented [Subject] 4 patients, 2 on [Treatment] methylphenidate [Effect] acral cyanosis, livedo reticularis, or Raynaud phenomenon"}, {"id": "10575189_1_1740", "context": "Described here are 2 patients who developed thrombotic microangiopathy of the kidneys after receiving high cumulative doses of the new anticancer drug gemcitabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] 2 patients [Treatment] gemcitabine [Effect] thrombotic microangiopathy of the kidneys"}, {"id": "15840734_11_1741", "context": "CONCLUSIONS: An objective causality assessment revealed that fluphenazine was the probable cause of NMS in this patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] patient [Treatment] fluphenazine [Effect] NMS"}, {"id": "9754850_2_1742", "context": "Like other atypical neuroleptics olanzapine is considered to show a reduced prevalence of extrapyramidal side effects when compared to classical neuroleptic drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] show [Treatment] olanzapine [Effect] reduced prevalence of extrapyramidal side effects"}, {"id": "8192712_1_1743", "context": "Based on our experience and on previously published data, serum ammonia levels appear to be indicated in all ED patients on valproic acid therapy who present with altered mental status.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] present [Subject] all ED patients [Treatment] valproic acid therapy [Effect] altered mental status"}, {"id": "12581772_3_1744", "context": "Rapamycin/sirolimus (SR), trade named Rapammune (Wyeth-Ayerst, Sydney, Australia), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Rapamycin/sirolimus (SR), trade named Rapammune (Wyeth-Ayerst, Sydney, Australia) [Effect] myelosuppression, hypertension, hyperlipidemia, and infection"}, {"id": "12889716_1_1745", "context": "Enoxaparin-induced generalized exanthem.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Enoxaparin [Effect] generalized exanthem"}, {"id": "7776854_1_1746", "context": "Our cases constitute the most severe cases of benzarone hepatotoxicity reported so far, and comprise the first cases of (sub)fulminant hepatitis and cirrhosis related to benzarone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] benzarone [Effect] hepatotoxicity; (sub)fulminant hepatitis and cirrhosis"}, {"id": "24163322_8_1747", "context": "Within 3 days after starting bismuth subsalicylate therapy, the patient's INR increased from 2.56 to 3.54 and minor bleeding was noted from the patient's tracheostomy site.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] noted [Subject] the patient [Treatment] Within 3 days after starting bismuth subsalicylate therapy [Effect] INR increased from 2.56 to 3.54 and minor bleeding was noted from the patient's tracheostomy site"}, {"id": "19667003_4_1748", "context": "After three weeks of carbamazepine therapy, the patient arrived at the emergency department (ED) with severe agitation and aggressive behavior.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] After [Subject] patient [Treatment] After three weeks of carbamazepine therapy [Effect] severe agitation and aggressive behavior"}, {"id": "1504404_4_1749", "context": "OBJECTIVE: To report a case of ciprofloxacin-induced psychosis and to discuss occurrence rates, risk factors, possible etiologies, preventive measures, and treatment courses for this adverse reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ciprofloxacin [Effect] psychosis"}, {"id": "12126225_3_1750", "context": "A 77-year-old man developed ankle, hand, and facial swelling 2 weeks after starting rosiglitazone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 77-year-old man [Treatment] 2 weeks after starting rosiglitazone [Effect] ankle, hand, and facial swelling"}, {"id": "3659584_5_1751", "context": "Although rare, massive pulmonary embolus must be considered to be a major risk of thrombolytic therapy for deep venous thrombosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Treatment] thrombolytic [Effect] massive pulmonary embolus"}, {"id": "7781845_5_1752", "context": "We report a case of hypoglycaemia after mefloquine therapy (1,500 mg over two days) for severe gastrointestinal cryptosporidiasis in a cachectic AIDS patient with protracted diarrhoea.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a cachectic AIDS patient with protracted diarrhoea [Treatment] mefloquine therapy (1,500 mg over two days) [Effect] hypoglycaemia"}, {"id": "9876812_3_1753", "context": "OBJECTIVE: To describe onset of syndrome of inappropriate antidiuretic hormone (SIADH) associated with vinorelbine therapy for advanced breast cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] vinorelbine [Effect] syndrome of inappropriate antidiuretic hormone (SIADH)"}, {"id": "11160777_9_1754", "context": "The thiazolidinediones (rosiglitazone and pioglitazone), a new class of oral antidiabetic agents, are \"insulin sensitizers\" and exert direct effects on the mechanisms of insulin resistance.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] exert [Treatment] thiazolidinediones"}, {"id": "15611427_4_1755", "context": "The exacerbation of psoriasis was accompanied by a massive induction of lesional type I interferon activity, detected by MxA expression after imiquimod therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] detected [Treatment] imiquimod [Effect] exacerbation of psoriasis; a massive induction of lesional type I interferon activity"}, {"id": "2857534_3_1756", "context": "Two patients treated with alprazolam had histories suggestive of a bipolar disorder and developed lithium-responsive manic episodes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two patients [Treatment] alprazolam [Effect] lithium-responsive manic episodes"}, {"id": "8292513_1_1757", "context": "Cerebrovascular complications of L-asparaginase therapy in children with leukemia: aphasia and other neuropsychological deficits.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complications [Subject] children with leukemia [Treatment] L-asparaginase [Effect] Cerebrovascular complications; aphasia and other neuropsychological deficits"}, {"id": "15752306_2_1758", "context": "We report two patients who developed intense livedo reticularis clearly related to the administration of interferon alpha 2b as an adjuvant therapy for melanoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] two patients [Treatment] interferon alpha 2b as an adjuvant therapy for melanoma [Effect] intense livedo reticularis"}, {"id": "6833205_1_1759", "context": "A case of SIADH associated with desipramine treatment in an elderly depressed woman is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] an elderly depressed woman [Treatment] desipramine treatment [Effect] SIADH"}, {"id": "7379406_1_1760", "context": "Niflumic acid-induced skeletal fluorosis: iatrogenic disease or therapeutic perspective for osteoporosis?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Niflumic acid [Effect] skeletal fluorosis"}, {"id": "6149250_5_1761", "context": "Both patients developed severe complications when treated with aminoglutethimide as a cancer hormonal therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Both patients [Treatment] aminoglutethimide [Effect] severe complications"}, {"id": "10458196_2_1762", "context": "An 11-day-old infant became lethargic and apneic after a single drop of brimonidine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] became [Subject] An 11-day-old infant [Treatment] a single drop of brimonidine [Effect] lethargic and apneic"}, {"id": "6159523_3_1763", "context": "Investigations suggested that the dextrose, rather than any additives, was responsible for the reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] responsible [Treatment] dextrose [Effect] the reaction"}, {"id": "10660641_8_1764", "context": "Since renal insufficiency was induced by AMPH and the other antifungal drugs were ineffective, daily administration of 200 mg of ITCZ was initiated, and the inflammatory signs and symptoms gradually subsided.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] initiated [Treatment] daily administration of 200 mg of ITCZ [Effect] the inflammatory signs and symptoms gradually subsided. [Adverse event] induced [Treatment] AMPH [Effect] renal insufficiency"}, {"id": "7696938_2_1765", "context": "Correction of serum electrolyte imbalance prevents cardiac arrhythmia during amphotericin B administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] amphotericin B administration [Effect] cardiac arrhythmia"}, {"id": "1356045_1_1766", "context": "Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] methylprednisolone; vecuronium [Effect] Acute myopathy with selective degeneration of myosin filaments"}, {"id": "1124417_1_1767", "context": "Presented is a case of acute renal failure induced by acetazolamide therapy for glaucoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] acetazolamide therapy for glaucoma [Effect] acute renal failure"}, {"id": "10803790_6_1768", "context": "Cyanamide-induced liver dysfunction after abstinence in alcoholics: a long-term follow-up study on four cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] abstinence in alcoholics [Treatment] Cyanamide [Effect] liver dysfunction"}, {"id": "16680561_10_1769", "context": "Fewer subjects reported adverse events following treatment with desipramine alone than when receiving desipramine with cinacalcet (33 versus 86%), the most frequent of which (nausea and headache) have been reported for patients treated with either desipramine or cinacalcet.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Subject] patients [Treatment] desipramine or cinacalcet [Effect] nausea and headache"}, {"id": "412488_2_1770", "context": "Three patients developed proteinuria following gold therapy for rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] Three patients [Treatment] gold [Effect] proteinuria"}, {"id": "9892272_3_1771", "context": "The authors report a case of a patient who received alteplase for acute myocardial infarction and developed spontaneous subfascial hematoma without any evidence of direct trauma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a case of a patient [Treatment] alteplase [Effect] spontaneous subfascial hematoma without any evidence of direct trauma"}, {"id": "12121061_1_1772", "context": "Ticlopidine-induced marrow aplasia treated with cyclosporine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Ticlopidine [Effect] marrow aplasia"}, {"id": "6947095_1_1773", "context": "Dural sinus thrombosis developed in two children with acute lymphoblastic leukemia during induction treatment with vincristine sulfate, prednisone, and asparaginase.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two children with acute lymphoblastic leukemia [Treatment] induction treatment with vincristine sulfate, prednisone, and asparaginase [Effect] Dural sinus thrombosis"}, {"id": "8926752_1_1774", "context": "Zolpidem (Ambien), a relatively new nonbenzodiazepine sedative-hypnotic, was involved in the death of a 39-year-old obese male who was being treated for depression and insomnia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] involved [Subject] a 39-year-old obese male [Treatment] Zolpidem (Ambien) [Effect] death"}, {"id": "9494448_1_1775", "context": "A MEDLINE search identified all the reported cases of hypersensitivity reactions to cyclosporine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reactions [Treatment] cyclosporine [Effect] hypersensitivity reactions"}, {"id": "16029707_2_1776", "context": "METHODS: A 79-year-old woman being treated with imiquimod 5 days per week for a nodular basal cell developed a verrucous plaque over the treatment area after 7 weeks of therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 79-year-old woman [Treatment] imiquimod 5 days per week; after 7 weeks [Effect] verrucous plaque"}, {"id": "22735246_2_1777", "context": "Oxcarbazepine, a metabolite of carbamazepine, is used as an antiepileptic, analgesic for neuropathic pain and in the treatment of affective disorders.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used [Treatment] Oxcarbazepine [Effect] antiepileptic, analgesic"}, {"id": "15543388_3_1778", "context": "PATIENT AND METHOD: A 34-year-old woman with chronic hepatitis C, genotype 3, receiving pegylated interferon alpha-2a and ribavirin for 6 months, developed progressive malaise and anemia 6 months after the end of treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 34-year-old woman with chronic hepatitis C, genotype 3 [Treatment] pegylated interferon alpha-2a and ribavirin for 6 months [Effect] progressive malaise and anemia"}, {"id": "19224802_5_1779", "context": "We report on three cases wherein treatment of dexmedetomidine-induced bradycardia with i.v.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] treatment of dexmedetomidine [Effect] bradycardia with i.v"}, {"id": "1688693_4_1780", "context": "Esmolol, an ultrashort-acting beta 1-selective antagonist, controlled her multiple dysrhythmias and symptoms of sympathetic nervous system hyperstimulation.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] controlled [Subject] her [Treatment] Esmolol, an ultrashort-acting beta 1-selective antagonist"}, {"id": "25671244_4_1781", "context": "(Case 1) A 29-year-old woman with overdose of metaxalone presented to the emergency department with altered mental status, seizure-like activity, hyperthermia, rigidity in the lower extremities, myoclonus, and hyperreflexia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] A 29-year-old woman [Treatment] metaxalone [Effect] altered mental status, seizure-like activity, hyperthermia, rigidity in the lower extremities, myoclonus, and hyperreflexia"}, {"id": "25515435_1_1782", "context": "Warfarin and boceprevir interaction causing subtherapeutic international normalized ratio: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causing [Treatment] Warfarin; boceprevir [Effect] subtherapeutic international normalized ratio"}, {"id": "3569037_1_1783", "context": "A brief review of reported cases of chloramphenicol hypersensitivity in the English-language literature, as well as possible alternative explanations in this case, are provided.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] chloramphenicol [Effect] hypersensitivity"}, {"id": "6692713_2_1784", "context": "Possible recurrence of amiodarone pulmonary toxicity following corticosteroid therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] corticosteroid [Effect] amiodarone pulmonary toxicity"}, {"id": "10466445_3_1785", "context": "In the present study, arsenic trioxide was given intravenously for 42 days to a 56-year-old female patient suffering from chemotherapy/ATRA-resistant APL, with 43% APL blasts in the bone marrow and elevated D-dimers.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] given [Subject] 56-year-old female patient [Treatment] arsenic trioxide"}, {"id": "1765991_4_1786", "context": "We assume that rIFN-gamma induced the de novo development of SLE in our patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] our patient [Treatment] rIFN-gamma [Effect] the de novo development of SLE"}, {"id": "6519218_2_1787", "context": "Interstitial pneumopathy and low-dosage amiodarone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] and [Treatment] low-dosage amiodarone [Effect] Interstitial pneumopathy"}, {"id": "19995222_2_1788", "context": "CONCLUSIONS: These results suggest that clozapine may cause TD; however, the prevalence is low and the severity is relatively mild, with no or mild self-reported discomfort.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] clozapine [Effect] TD"}, {"id": "17228132_8_1789", "context": "Hepatotoxicity resolved once erlotinib was discontinued and serum transaminases returned to baseline normal values.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] discontinued [Treatment] erlotinib [Effect] Hepatotoxicity"}, {"id": "9161656_15_1790", "context": "CONCLUSIONS: Sustained-release verapamil is thought to be the cause of the asthma attack in this patient because she was not taking any other preparations; the symptoms started with the administration of sustained-release verapamil and were relieved after its discontinuation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Sustained-release verapamil [Effect] asthma attack"}, {"id": "150825_1_1791", "context": "A patient developed cholestatic hepatitis while being treated with nitrofurantoin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] nitrofurantoin [Effect] cholestatic hepatitis"}, {"id": "19826099_2_1792", "context": "Severe apnea in an infant exposed to lamotrigine in breast milk.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] an infant [Treatment] lamotrigine [Effect] apnea"}, {"id": "2894766_3_1793", "context": "Pneumonitis, bilateral pleural effusions, echocardiographic evidence of cardiac tamponade, and positive autoantibodies developed in a 43-year-old man, who was receiving long-term sulfasalazine therapy for chronic ulcerative colitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 43-year-old man [Treatment] long-term sulfasalazine [Effect] Pneumonitis, bilateral pleural effusions, echocardiographic evidence of cardiac tamponade, and positive autoantibodies"}, {"id": "3166573_1_1794", "context": "Bone formation induced in an infant by systemic prostaglandin-E2 administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] induced [Subject] an infant [Treatment] systemic prostaglandin-E2 administration [Effect] Bone formation"}, {"id": "8244201_1_1795", "context": "A high dose of cotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N-acetyl glucosaminase after several days of the drug administration in these patients; one patient became unconscious.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] these patients [Treatment] A high dose of cotrimoxazole; after several days of the drug administration [Effect] hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N-acetyl glucosaminase [Adverse event] became [Subject] one patient [Treatment] A high dose of cotrimoxazole; after several days of the drug administration [Effect] unconscious"}, {"id": "16641839_2_1796", "context": "Angioedema, a rare side effect of carbamazepine, involves vascular leakage in dermis and subcutis mediated by immunoglobulin E and/or bradykinins.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] carbamazepine [Effect] Angioedema; involves vascular leakage in dermis and subcutis mediated by immunoglobulin E and/or bradykinins"}, {"id": "18343993_1_1797", "context": "A diagnosis of trastuzumab-induced pneumonitis was made.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] trastuzumab [Effect] pneumonitis"}, {"id": "10885900_3_1798", "context": "We present a case of HUS in an advanced ovarian cancer patient treated with carboplatin and gemcitabine, and described its favorable outcome after chemotherapy interruption and supportive care with a 1 year follow-up.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Treatment] carboplatin and gemcitabine [Effect] HUS [Potential therapeutic event] after [Subject] an advanced ovarian cancer patient [Treatment] chemotherapy interruption and supportive care with a 1 year follow-up [Effect] favorable outcome"}, {"id": "17034541_2_1799", "context": "Several such HBV reactivations were reported after combined rituximab and multiagent chemotherapy for B-cell lymphomas.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] combined rituximab and multiagent chemotherapy [Effect] Several such HBV reactivations"}, {"id": "8435665_3_1800", "context": "Thus, the eosinophilia myalgia syndrome can be associated with parenteral tryptophan administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] parenteral tryptophan [Effect] eosinophilia myalgia syndrome"}, {"id": "3790438_1_1801", "context": "Generalized pustular psoriasis precipitated by trazodone in the treatment of depression.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitated [Treatment] trazodone [Effect] Generalized pustular psoriasis"}, {"id": "15224368_3_1802", "context": "We report a case of Sweet's syndrome in association with sargramostim treatment following chemotherapy for acute myelogenous leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] sargramostim treatment following chemotherapy [Effect] Sweet's syndrome"}, {"id": "10772434_2_1803", "context": "This regimen could prove useful for other patients who develop hypersensitivity reactions to carboplatin and allow therapy to continue.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] patients [Treatment] carboplatin [Effect] hypersensitivity reactions"}, {"id": "12150593_2_1804", "context": "We present a neonate with a seizure disorder who acutely developed pupillary mydriasis secondary to lidocaine overdose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a neonate with a seizure disorde [Treatment] lidocaine overdose [Effect] pupillary mydriasis"}, {"id": "18691992_2_1805", "context": "Based on the Naranjo algorithm, the adverse reaction observed was probably related to the hydroxyurea treatment (score = 6); however, the hydroxyurea chemotherapy could not be discontinued because of the myeloproliferative disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] hydroxyurea chemotherapy [Effect] myeloproliferative disorder"}, {"id": "7673653_2_1806", "context": "Extrapyramidal side effects induced by some selective serotonin reuptake inhibitors (SSRIs), i.e. fluoxetine and sertraline, have been previously reported in patients with depression and obsessive-compulsive disorder (OCD).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced by [Subject] patients with depression and obsessive-compulsive disorder (OCD) [Treatment] some selective serotonin reuptake inhibitors (SSRIs), i.e. fluoxetine and sertraline [Effect] Extrapyramidal side effects"}, {"id": "9291634_6_1807", "context": "Ten-17 days after receiving chemotherapy, five patients (4 males and 1 female) with acute lymphoblastic leukemia developed incapacitating myalgias in neck, thighs and arms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] five patients (4 males and 1 female) with acute lymphoblastic leukemia [Treatment] Ten-17 days after receiving chemotherapy [Effect] incapacitating myalgias in neck, thighs and arms"}, {"id": "21597286_2_1808", "context": "We report a case of a potential drug-drug interaction in a woman treated by a first injection of high-dose methotrexate for a T-lymphoblastic lymphoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] a woman [Treatment] a first injection of high-dose methotrexate"}, {"id": "16791713_4_1809", "context": "We conclude that myocardial infarction may develop in patients treated with high-dose glucocorticoids for Graves' ophthalmopathy, and increased blood pressure may herald this complication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] patients [Treatment] high-dose glucocorticoids [Effect] myocardial infarction; increased blood pressure"}, {"id": "19798640_1_1810", "context": "A 40-year-old man with relapsing-remitting multiple sclerosis (MS) developed primary central nervous system lymphoma (PCNSL) after having received 21 doses of natalizumab monotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 40-year-old man with relapsing-remitting multiple sclerosis (MS) [Treatment] 21 doses of natalizumab monotherapy [Effect] primary central nervous system lymphoma (PCNSL)"}, {"id": "11816261_4_1811", "context": "Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] selective serotonin reuptake-inhibitors-metoclopramide interaction [Effect] Serotonin syndrome"}, {"id": "7937287_10_1812", "context": "This is the first reported case of suspected DIAN due to cefuroxime.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Subject] first reported case [Treatment] cefuroxime [Effect] DIAN"}, {"id": "7995508_2_1813", "context": "We report a cae of paranoid psychosis following use of a decongestant containing PPA and summarize the case report literature of psychiatric adverse effects to PPA in which doses were known and stated to be within recommended guidelines.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a cae [Treatment] decongestant containing PPA [Effect] paranoid psychosis"}, {"id": "17133571_1_1814", "context": "Liver transplantation for fulminant hepatitis related to nevirapine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] nevirapine therapy [Effect] Liver transplantation for fulminant hepatitis"}, {"id": "11414270_2_1815", "context": "OBJECTIVE: To report a case of fatal hyperkalemia owing to succinylcholine administration in a patient with mucositis secondary to chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] owing [Subject] a patient with mucositis secondary to chemotherapy [Treatment] succinylcholine administration [Effect] hyperkalemia [Adverse event] secondary [Subject] a patient [Treatment] chemotherapy [Effect] mucositis"}, {"id": "8835752_3_1816", "context": "We describe a case of prolonged terbinafine-induced cholestatic liver disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] prolonged terbinafine [Effect] cholestatic liver disease"}, {"id": "10707759_3_1817", "context": "We describe a case of interstitial hypoxaemiant pneumonitis probably related to flecainide in a patient with the LEOPARD syndrome, a rare congenital disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] a patient with the LEOPARD syndrome [Treatment] flecainide [Effect] interstitial hypoxaemiant pneumonitis"}, {"id": "7718983_4_1818", "context": "This case showed sequential manifestation from transient thyrotoxicosis to the appearance of TSH-receptor autoantibodies, and then the occurrence of Graves' hyperthyroidism during IFN therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurrence [Subject] This case [Treatment] IFN therapy [Effect] Graves' hyperthyroidism"}, {"id": "3405528_2_1819", "context": "Halothane hepatitis and prompt resolution with methionine therapy: case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolution [Subject] case [Treatment] methionine"}, {"id": "11706664_2_1820", "context": "This report describes an unexpected drug-induced hepatitis in a previously healthy young woman exposed to 2 doses of amodiaquine and artesunate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exposed [Subject] a previously healthy young woman [Treatment] 2 doses of amodiaquine and artesunate [Effect] hepatitis"}, {"id": "3680913_1_1821", "context": "It was restarted 6 weeks later, and 10 weeks after that, the patient presented with fulminant hepatic failure, which resolved rapidly after cessation of nicotinic acid therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] the patient [Treatment] 10 weeks after; nicotinic acid [Effect] fulminant hepatic failure"}, {"id": "9366852_4_1822", "context": "We describe a patient with the antiphospholipid syndrome who had skin necrosis develop from low-molecular weight heparin therapy at sites distant from injection sites.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] a patient with the antiphospholipid syndrome [Treatment] low-molecular weight heparin therapy at sites distant from injection sites [Effect] skin necrosis"}, {"id": "18022748_11_1823", "context": "While CYP form induction by Pyrethrins, Phenobarbital and related compounds can be associated with liver and thyroid gland tumour formation in rodents, epidemiological data for Phenobarbital suggests that such effects do not occur in humans.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induction [Treatment] Pyrethrins, Phenobarbital and related compounds [Effect] liver and thyroid gland tumour formation in rodents"}, {"id": "7416268_1_1824", "context": "Disulfiram encephalopathy as a cause of the catatonia syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Disulfiram [Effect] catatonia syndrome; encephalopathy"}, {"id": "7653281_2_1825", "context": "Little has been studied of the adverse effects of the exposure of the liver to the interaction of ethanol with its congeners and acetaldehyde, coexisting in the contents of alcoholic beverages.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] interaction [Treatment] ethanol with its congeners and acetaldehyde [Effect] adverse effects of the exposure of the liver"}, {"id": "22735246_1_1826", "context": "Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitated [Subject] a patient [Treatment] oxcarbazepine [Effect] serotonin syndrome"}, {"id": "11568758_2_1827", "context": "This eruption emerged after 1 month of therapy with salsalate, persisted for as long as salsalate was administered, and cleared within 3 weeks of discontinuing the medication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] emerged [Treatment] after 1 month of therapy with salsalate [Effect] eruption"}, {"id": "8969033_1_1828", "context": "A case report is presented concerning the administration of ketanserin in the treatment of pulmonary vasoconstriction and right ventricular failure following the infusion of protamine in a patient undergoing coronary artery bypass surgery and mitral valve replacement.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a patient [Treatment] infusion of protamine; undergoing coronary artery bypass surgery and mitral valve replacement [Effect] pulmonary vasoconstriction and right ventricular failure"}, {"id": "10803790_7_1829", "context": "When cyanamide-treated alcoholics relapse into drinking, more severe inflammation develops in the liver.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develops [Subject] cyanamide-treated alcoholics [Treatment] cyanamide [Effect] inflammation"}, {"id": "9256906_2_1830", "context": "Acute renal failure should be recognized as a potential complication of suramin treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] suramin treatment [Effect] Acute renal failure"}, {"id": "8936932_2_1831", "context": "After induction of general anesthesia and administration of a standard dose of intravenous esmolol hydrochloride, her cardiac rhythm progressed to asystole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] After [Subject] her [Treatment] induction of general anesthesia and administration of a standard dose of intravenous esmolol hydrochloride [Effect] asystole"}, {"id": "2875665_1_1832", "context": "Exacerbation of schizophrenia associated with amantadine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] amantadine [Effect] Exacerbation of schizophrenia"}, {"id": "10431414_2_1833", "context": "Priapism as a complication of heparin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] heparin [Effect] Priapism"}, {"id": "1977935_1_1834", "context": "Torsades de pointes occurring in association with terfenadine use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] terfenadine [Effect] Torsades de pointes"}, {"id": "10452772_5_1835", "context": "Protamine allergy as a complication of insulin hypersensitivity: A case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] insulin [Effect] hypersensitivity; Protamine allergy"}, {"id": "10524732_2_1836", "context": "We report a case of recurrent torsades de pointes following treatment with pentavalent antimonial drugs and amiodarone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment with [Treatment] pentavalent antimonial drugs and amiodarone [Effect] recurrent torsades de pointes"}, {"id": "2038845_1_1837", "context": "This case presentation is of a patient who had the clinical appearance of epiglottitis, but actually had an oro-pharyngeal dystonic reaction to prochlorperazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] a patient [Treatment] prochlorperazine [Effect] clinical appearance of epiglottitis; actually had an oro-pharyngeal dystonic reaction"}, {"id": "19537383_1_1838", "context": "Localized dyskeratotic plaque with milia associated with sorafenib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] sorafenib [Effect] Localized dyskeratotic plaque with milia"}, {"id": "7416268_2_1839", "context": "The authors describe a case of the catatonia syndrome associated with disulfiram therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] disulfiram therapy [Effect] catatonia syndrome"}, {"id": "23624139_2_1840", "context": "Most of the clinical data on the safety profile of desmopressin (DDAVP), which is an effective treatment for both polyuric conditions and bleeding disorders, originate from studies on the tailoring of drug treatment, whereas few reports exist describing severe side effects secondary to drug-drug interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] both polyuric conditions and bleeding disorders [Treatment] desmopressin (DDAVP)"}, {"id": "7663030_12_1841", "context": "Propafenone's distribution, clearance, and structural similarity to propranolol contribute to its central nervous system effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] contribute [Treatment] Propafenone [Effect] central nervous system effects"}, {"id": "19423610_1_1842", "context": "Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] co-administration of methylene blue and serotonin reuptake inhibitors [Effect] serotonin toxicity; post-operative delirium"}, {"id": "19782276_9_1843", "context": "Cyclophosphamide-induced cardiotoxicity occurred, even though the patient had both shown normal cardiac function before high-dose chemotherapy and had received a lower dose of cyclophosphamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] the patient had both shown normal cardiac function [Treatment] Cyclophosphamide; high-dose chemotherapy and had received a lower dose of cyclophosphamide [Effect] cardiotoxicity"}, {"id": "18707772_1_1844", "context": "A 64 year old woman with previous history of coronary stenting five days before was admitted in our institution for intracranial bleeding while receiving aspirin and clopidogrel.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] A 64 year old woman with previous history of coronary stenting [Treatment] five days before; aspirin and clopidogrel [Effect] intracranial bleeding"}, {"id": "12324937_5_1845", "context": "METHODS: A case is presented of a 45-year-old woman on prolonged gemcitabine treatment for ovarian cancer who developed HUS and recovered after drug discontinuation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 45-year-old woman [Treatment] prolonged gemcitabine treatment [Effect] HUS"}, {"id": "889156_4_1846", "context": "A more serious development of adrenal insufficiency may occur upon the improper replacement of systemic steroids.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] replacement [Treatment] systemic steroids [Effect] development of adrenal insufficiency"}, {"id": "1495728_2_1847", "context": "We describe a case of pneumonitis following local administration of methotrexate for nonsurgical termination of an ectopic pregnancy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a case [Treatment] local administration of methotrexate [Effect] pneumonitis"}, {"id": "14690166_2_1848", "context": "There is currently no consensus on the best treatment for unresectable hyaline-vascular variant or for multicentric Castleman's disease (MCD), because none of the reported regimens have consistently produced complete response or durable remission in the majority of patients In the present study, we report on the use of 2-CdA (2-chloro-deoxyadenosine) in three patients, two of them with MCD and one with unresectable hyaline-vascular type disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] use [Subject] one [Potential therapeutic event] use [Subject] two [Treatment] 2-CdA (2-chloro-deoxyadenosine); 2-CdA (2-chloro-deoxyadenosine)"}, {"id": "19667003_1_1849", "context": "Carbamazepine-induced hyperammonemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Carbamazepine [Effect] hyperammonemia"}, {"id": "10803790_3_1850", "context": "Case 3: A 29-year-old female alcoholic complained of general fatigue and a slight fever after 1.5 years of abstinence with cyanamide treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complained [Subject] A 29-year-old female alcoholic [Treatment] after 1.5 years of abstinence with cyanamide [Effect] general fatigue and a slight fever"}, {"id": "10667036_1_1851", "context": "Caution is, therefore, needed to prevent undesired accumulation of TCA that may lead to protracted Cushing's syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] lead to [Treatment] TCA [Effect] protracted Cushing's syndrome"}, {"id": "7408538_2_1852", "context": "Unusual pigmentary changes associated with 5-fluorouracil therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] 5-fluorouracil [Effect] Unusual pigmentary changes"}, {"id": "9876812_4_1853", "context": "Syndrome of inappropriate antidiuretic hormone associated with vinorelbine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] vinorelbine [Effect] Syndrome of inappropriate antidiuretic hormone"}, {"id": "18453852_14_1854", "context": "The study showed a high incidence of adverse events when a higher than standard dose of the new lopinavir/ritonavir tablets was combined with rifampicin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] when [Treatment] higher than standard dose of the new lopinavir/ritonavir tablets was combined with rifampicin [Effect] adverse events"}, {"id": "19499966_3_1855", "context": "Onset of male gynaecomastia in a patient treated with sunitinib for metastatic renal cell carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Onset [Subject] male; a patient [Treatment] sunitinib for metastatic renal cell carcinoma [Effect] gynaecomastia"}, {"id": "7973922_3_1856", "context": "Systemic disease, most commonly renal dysfunction, preceded all 30 reported cases of acyclovir neurotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] preceded [Subject] 30 reported cases [Treatment] acyclovir [Effect] Systemic disease, most commonly renal dysfunction; neurotoxicity"}, {"id": "4082283_1_1857", "context": "Rifampicin-induced renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Rifampicin [Effect] renal failure"}, {"id": "15920338_1_1858", "context": "A case of high-grade endometrial stromal sarcoma, confined into an intrauterine polypoid growth, in a woman with a history of breast cancer who was treated with adjuvant tamoxifen.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] A case of high-grade endometrial stromal sarcoma, confined into an intrauterine polypoid growth, in a woman with a history of breast cancer [Treatment] adjuvant tamoxifen"}, {"id": "8880251_1_1859", "context": "After therapy for diabetic coma with insulin (containing the preservative cresol) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a high fever and respiratory and metabolic acidosis and lost consciousness.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] After [Subject] the patient [Treatment] therapy for diabetic coma with insulin (containing the preservative cresol) and electrolyte solutions [Effect] increasing myalgia, developed a high fever and respiratory and metabolic acidosis and lost consciousness"}, {"id": "19018868_1_1860", "context": "A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Subject] A case [Treatment] lenalidomide for multiple myeloma [Effect] severe aplastic anemia"}, {"id": "21712512_5_1861", "context": "Seven weeks after the initiation of inhaled fluticasone, she developed vaginal candidiasis and was prescribed fluconazole 100 mg/day, a CYP3A4 inhibitor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] Seven weeks after the initiation of inhaled fluticasone [Effect] vaginal candidiasis [Potential therapeutic event] prescribed [Treatment] fluconazole 100 mg/day, a CYP3A4 inhibitor"}, {"id": "7393795_4_1862", "context": "The introduction of para-aminosalicylic acid (PAS) led to hypoglycaemic coma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] led to [Treatment] The introduction of para-aminosalicylic acid (PAS) [Effect] hypoglycaemic coma"}, {"id": "19434733_2_1863", "context": "The risk of developing sAML is estimated to be between 1% and 5%, 2-20 years after exposure to etoposide but may also be related to cumulative drug doses, treatment schedules, host factors and co-administration of other antineoplastic agents.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] 2-20 years after exposure to etoposide [Effect] sAML"}, {"id": "3688031_1_1864", "context": "An infant girl with choanal atresia, athelia, minor anomalies, and mild to moderate mental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with methimazole and propranolol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] a woman [Treatment] methimazole and propranolo [Effect] An infant girl with choanal atresia, athelia, minor anomalies, and mild to moderate mental retardation"}, {"id": "2956288_1_1865", "context": "Ethambutol is frequently used in the treatment of tuberculosis, and, although optic neuropathies have been reported with the use of ethambutol, this adverse side effect has been considered to be rare and generally reversible with discontinuation of the medication.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used [Treatment] Ethambutol"}, {"id": "10923593_1_1866", "context": "Skin manifestations of a case of phenylbutazone-induced serum sickness-like reactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] phenylbutazone [Effect] serum sickness-like reactions"}, {"id": "18607107_2_1867", "context": "Development of Crohn's disease in a patient with multiple sclerosis treated with copaxone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Development [Subject] a patient with multiple sclerosis [Treatment] copaxone [Effect] Crohn's disease"}, {"id": "19281746_1_1868", "context": "Aliskiren-associated acute renal failure with hyperkalemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Aliskiren [Effect] acute renal failure"}, {"id": "7752014_3_1869", "context": "Fever caused by the use of furosemide was proved; the fever resolved after discontinuation of this medication and recurred after its reintroduction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] furosemide [Effect] Fever"}, {"id": "8034807_1_1870", "context": "The use of methotrexate (MTX) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which MTX appeared to potentiate opportunistic infections and accelerate HIV disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] accelerate [Treatment] MTX [Effect] HIV disease"}, {"id": "17655376_1_1871", "context": "Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] dapsone gel, 5%"}, {"id": "19183077_2_1872", "context": "To our knowledge, these cases represent the first reports of TDF-associated irreversible renal failure and rickets in pediatric patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] pediatric patients [Treatment] TDF [Effect] irreversible renal failure and rickets"}, {"id": "7781845_4_1873", "context": "In particular, this adverse effect has never been described with mefloquine (Lariam).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] described [Treatment] mefloquine (Lariam) [Effect] adverse effect"}, {"id": "8949576_1_1874", "context": "A potential role for renal and hepatic impairment in the observed protracted course of amiodarone-induced thyrotoxicosis is suggested.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] amiodarone [Effect] thyrotoxicosis"}, {"id": "18691992_7_1875", "context": "The patient completed a 10-month follow-up, maintaining a complete resolution of the treated skin lesions; however, the development of a painful hand ulcer, possibly associated with the hydroxyurea, and new skin cancers were observed at the last follow-up visit.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] The patient [Treatment] hydroxyurea [Effect] a painful hand ulcer; new skin cancers"}, {"id": "17420198_1_1876", "context": "Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] mediated [Subject] an adult with developmental disabilities [Treatment] aripiprazole [Effect] extrapyramidal symptoms"}, {"id": "12823045_1_1877", "context": "We describe a patient with extranodal non-Hodgkin lymphoma who developed systemic candidiasis after treatment with a cyclophosphamide-based chemotherapy regimen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment [Subject] a patient with extranodal non-Hodgkin lymphoma [Treatment] a cyclophosphamide-based chemotherapy regimen. [Effect] systemic candidiasis"}, {"id": "2663536_2_1878", "context": "We describe the first case of de novo asthma following treatment with the angiotensin converting enzyme (ACE) inhibitor captopril.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment with [Treatment] the angiotensin converting enzyme (ACE) inhibitor captopril [Effect] de novo asthma"}, {"id": "8120934_1_1879", "context": "A 53-year-old male, without any prior history of psychosis, developed schizophrenia 4 days after starting low-dose bromocriptine therapy for a macroprolactinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 53-year-old male, without any prior history of psychosis; macroprolactinoma [Treatment] 4 days after starting low-dose bromocriptine therapy [Effect] schizophrenia"}, {"id": "20298401_7_1880", "context": "Six days after taking erlotinib, a chest radiograph showed rapid progression of reticular infiltration in both lung fields.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] Six days; erlotinib [Effect] rapid progression of reticular infiltration in both lung fields"}, {"id": "11144696_6_1881", "context": "Because of suspected drug-induced seizures, both antidepressants were stopped.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] stopped [Treatment] antidepressants [Effect] seizures"}, {"id": "17381671_4_1882", "context": "Based on the Naranjo probability scale, serotonin syndrome was a probable adverse reaction associated with co-administration of citalopram and fentanyl.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] co-administration of citalopram and fentanyl [Effect] serotonin syndrome"}, {"id": "18034202_1_1883", "context": "We report a case of a patient with rheumatoid arthritis treated with low-dose methotrexate (15 mg/week) who developed infection with both M. tuberculosis and M. chelonae after the revision of a prosthetic hip.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] patient with rheumatoid arthritis [Treatment] low-dose methotrexate (15 mg/week) [Effect] nfection with both M. tuberculosis and M. chelonae"}, {"id": "10575189_2_1884", "context": "Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] undergoing [Subject] two patients [Treatment] gemcitabine chemotherapy [Effect] Thrombotic microangiopathy with renal failure"}, {"id": "8771575_3_1885", "context": "Despite the known pulmonary side effects of nitrofurantoin, there is no report of this toxicity occurring in pregnant patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] nitrofurantoin [Effect] pulmonary side effects"}, {"id": "19995222_3_1886", "context": "However, several case reports have suggested that clozapine could also cause TD.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] clozapine [Effect] TD"}, {"id": "2862137_1_1887", "context": "A case is presented in which a 68-year-old man became delirious after being withdrawn from a low dosage of alprazolam.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] 68-year-old man [Treatment] withdrawn from a low dosage of alprazolam [Effect] delirious"}, {"id": "19499966_2_1888", "context": "However, re-initiation of sunitinib treatment was followed by bilateral breast enlargement again.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] followed [Treatment] sunitinib [Effect] bilateral breast enlargement"}, {"id": "18691992_1_1889", "context": "BACKGROUND: Hydroxyurea is a cytostatic agent used to treat myeloproliferative disorders and long-term treatment is associated with mucocutaneous adverse events and nail hyperpigmentation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Hydroxyurea is a cytostatic agen [Effect] mucocutaneous adverse events and nail hyperpigmentation"}, {"id": "6353252_1_1890", "context": "Captopril-induced acute reversible renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Captopril [Effect] acute reversible renal failure"}, {"id": "16498048_3_1891", "context": "Hence, hyperthyroidism induced by IFN-alpha could correspond to the first phase of silent thyroiditis, to Graves' disease or to the succession of both.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] IFN-alpha [Effect] hyperthyroidism"}, {"id": "12107858_1_1892", "context": "The epivodes of NMS occured under treatment with clozapine, risperidone, and amisulpride.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occured [Treatment] clozapine, risperidone, and amisulpride [Effect] NMS"}, {"id": "10466445_8_1893", "context": "During the first days of arsenic trioxide treatment a rapid decrease in the D-dimers was seen (normal values reached until day 7), together with a slight decrease in peripheral blood leukocytes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] During [Treatment] the first days of arsenic trioxide treatment [Effect] a rapid decrease in the D-dimers was seen (normal values reached until day 7), together with a slight decrease in peripheral blood leukocytes"}, {"id": "19104709_2_1894", "context": "In contrast to chronic or subacute thyroiditis, Graves' disease rarely complicates IFN-alpha therapy for chronic viral C hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Subject] Graves' disease [Treatment] IFN-alpha"}, {"id": "17551408_1_1895", "context": "We postulate that gastritis caused by dexamethasone, mucositis caused by doxorubicin, and the unique anatomic nature of a Meckel diverticulum may have contributed to this extremely unlikely and previously unreported event.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] dexamethasone [Effect] gastritis [Adverse event] caused [Treatment] doxorubicin [Effect] mucositis"}, {"id": "9013348_3_1896", "context": "Mesalamine may cause hypersensitivity pneumonitis in patients with Crohn's disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] patients with Crohn's disease [Treatment] Mesalamine [Effect] hypersensitivity pneumonitis"}, {"id": "7814182_2_1897", "context": "We present a case in which dipyridamole induced high-grade atrioventricular (AV) block that responded promptly to intravenous aminophylline but not to atropine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] dipyridamole [Effect] high-grade atrioventricular (AV) block [Potential therapeutic event] responded [Treatment] intravenous aminophylline but not to atropine"}, {"id": "2442958_3_1898", "context": "This paper reports an autopsy case of a 78-year-old male with multiple nodules in the liver developed after long-termed administration of phosphate diethylstilbestrol (PDES) for prostatic cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] an autopsy case of a 78-year-old male; prostatic cancer [Treatment] phosphate diethylstilbestrol (PDES) [Effect] multiple nodules in the liver"}, {"id": "7933665_1_1899", "context": "Fracture of the femoral neck occurred in one patient during PSL therapy, although the relationship between the fracture and PSL therapy was uncertain.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] one patient [Treatment] PSL therapy [Effect] Fracture of the femoral neck"}, {"id": "2796025_2_1900", "context": "This panic anxiety was not relieved by taking etizolam and flunitrazepam again, but subsided rapidly by the re-administration of mianserin 30 mg/day, and because of that the depressive symptom also disappeared.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] subsided [Treatment] etizolam and flunitrazepam; mianserin 30 mg/day [Effect] because of that the depressive symptom also disappeared"}, {"id": "3101617_2_1901", "context": "When co-trimoxazole was stopped the red cell aplasia resolved.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] stopped [Treatment] co-trimoxazole [Effect] red cell aplasia resolved"}, {"id": "10546851_1_1902", "context": "Interaction of sildenafil and indinavir when co-administered to HIV-positive patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] co-administered [Subject] HIV-positive patients [Treatment] Interaction of sildenafil and indinavir"}, {"id": "4095247_1_1903", "context": "Cerebral and ocular toxicity induced by desferrioxamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] desferrioxamine [Effect] Cerebral and ocular toxicity"}, {"id": "7397053_1_1904", "context": "A patient developed papilloedema and hepatic dysfunction while being treated with perhexiline maleate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] while [Subject] A patient [Treatment] perhexiline maleate [Effect] papilloedema and hepatic dysfunction"}, {"id": "11868077_2_1905", "context": "We describe a case of subcutaneous metastasis along the needle track after percutaneous ethanol injection (PEI) for treatment of hepatocellular carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a case [Treatment] percutaneous ethanol injection (PEI) [Effect] subcutaneous metastasis"}, {"id": "17420198_5_1906", "context": "He developed episodic movements possibly consistent with EPS secondary to aripiprazole usage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] secondary to aripiprazole usage [Effect] episodic movements possibly consistent with EPS"}, {"id": "15133245_3_1907", "context": "Recently, it has been reported that terfenadine and astemizole, which have antiallergic actions similar to those of oxatomide, show side effects on the cardiovascular system, such as QT prolongation, ventricular arrhythmia and cardiac arrest.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] show [Treatment] terfenadine and astemizole [Effect] side effects on the cardiovascular system, such as QT prolongation, ventricular arrhythmia and cardiac arrest"}, {"id": "9476721_3_1908", "context": "We reported 3 patients who developed acute generalized dystonia and akinetic rigid syndrome following an initial therapy with d-penicillamine 125-500 mg daily.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] 3 patients [Treatment] d-penicillamine 125-500 mg daily [Effect] acute generalized dystonia and akinetic rigid syndrome"}, {"id": "19579947_2_1909", "context": "Priapism associated with olanzapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] olanzapine [Effect] Priapism"}, {"id": "9883483_2_1910", "context": "Thus, an immunological mechanism might be involved in the mechanism of pirmenol-induced QT prolongation and T wave inversion on the electrocardiogram.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] pirmenol [Effect] QT prolongation and T wave inversion"}, {"id": "16997047_1_1911", "context": "Five months after initiating mirtazapine therapy, she developed symptomatic hyponatremia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] she [Treatment] Five months after initiating mirtazapine [Effect] symptomatic hyponatremia"}, {"id": "3797173_1_1912", "context": "Intravenous verapamil therapy in babies may cause apnea, hypotension, and bradycardia; continued episodes of atrial flutter in a child may cause sudden death; quinidine may be related to the death; children with \"familial seizure disorders\" may in fact have the long QT interval syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] babies [Treatment] Intravenous verapamil [Effect] apnea, hypotension, and bradycardia [Adverse event] related [Treatment] quinidine [Effect] death"}, {"id": "12796597_4_1913", "context": "The renal biopsy showed focal segmental glomerulosclerosis, which has only been previously reported in two cases of CML treated with IFNalpha.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Subject] two cases [Treatment] IFNalpha [Effect] The renal biopsy showed focal segmental glomerulosclerosis"}, {"id": "6093724_2_1914", "context": "Sulindac (Clinoril), a nonsteroidal anti-inflammatory agent, has few reported neurologic toxic effects, all of which have been associated with systemic disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] Sulindac (Clinoril) [Effect] neurologic toxic effects"}, {"id": "19857154_7_1915", "context": "The second patient was a 32-year-old woman with HIV, anxiety disorder, and a history of intravenous drug abuse who developed increased sedation and mental confusion when an atazanavir-ritonavir-based antiretroviral regimen was added to her stable antianxiety drug regimen, which included quetiapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 32-year-old woman with HIV, anxiety disorder, and a history of intravenous drug abuse [Treatment] atazanavir-ritonavir-based antiretroviral regimen was added to her stable antianxiety drug regimen, which included quetiapine [Effect] increased sedation and mental confusion"}, {"id": "6860059_1_1916", "context": "Fulminant hepatitis associated with disulfiram.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] disulfiram [Effect] Fulminant hepatitis"}, {"id": "3397227_1_1917", "context": "Anhedonic ejaculation with desipramine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] desipramine [Effect] Anhedonic ejaculation"}, {"id": "9674820_1_1918", "context": "Serotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] four patient [Treatment] phenelzine to venlafaxine [Effect] Serotonin syndrome"}, {"id": "16960880_2_1919", "context": "Lower extremity arterial thrombosis following sonographically guided thrombin injection of a femoral pseudoaneurysm.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] thrombin injection of a femoral pseudoaneurysm [Effect] Lower extremity arterial thrombosis"}, {"id": "8313300_6_1920", "context": "A severe form of exophthalmos resulting from lithium therapy has not been described in the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] lithium [Effect] exophthalmos"}, {"id": "8604715_2_1921", "context": "No cases of renal acidosis, and only one case of nephrogenic diabetes insipidus, has been previously reported as a complication of foscarnet treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] foscarnet treatment [Effect] nephrogenic diabetes insipidus"}, {"id": "7919557_2_1922", "context": "Cough induced by quinapril with resolution after changing to fosinopril.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolution [Treatment] fosinopril [Effect] Cough"}, {"id": "20298401_2_1923", "context": "INTRODUCTION: Although gefitinib used for the treatment of non-small-cell lung cancer is a well-known cause of interstitial lung disease (ILD), few case reports on erlotinib-induced ILD have been issued.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] gefitinib [Effect] interstitial lung disease (ILD) [Adverse event] induced [Treatment] erlotinib [Effect] ILD"}, {"id": "17383767_4_1924", "context": "We report a case in which a potential drug interaction resulted in elevated phenytoin levels after initiation of erlotinib therapy in a patient who was receiving phenytoin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted in [Subject] a patient [Treatment] a potential drug interaction; initiation of erlotinib therapy; receiving phenytoin [Effect] elevated phenytoin levels"}, {"id": "18515982_1_1925", "context": "Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a patient with breast cancer. [Treatment] Anastrozole [Effect] sclerosing glomerulonephritis"}, {"id": "12324937_1_1926", "context": "BACKGROUND: Gemcitabine has mild renal toxicity, but cases of gemcitabine-associated hemolytic-uremic syndrome (HUS) have been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] cases [Treatment] gemcitabine [Effect] hemolytic-uremic syndrome (HUS); renal toxicity"}, {"id": "12460237_1_1927", "context": "Recurrent palmar-plantar erythrodysaesthesia following high-dose cytarabine treatment for acute lymphoblastic leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] high-dose cytarabine [Effect] palmar-plantar erythrodysaesthesia"}, {"id": "12163813_1_1928", "context": "CONCLUSIONS: Peripheral administration of low-dose vasopressin for septic shock should be discouraged because of the risk of ischemic skin complications.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Treatment] Peripheral administration of low-dose vasopressin [Effect] ischemic skin complications"}, {"id": "21448111_3_1929", "context": "Many types of medicaments can cause akathisia as an adverse event of their use and they include: antipsychotics, antidepressants, antiemetics, antihistamines, and psychoactive substances.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse event [Treatment] antipsychotics, antidepressants, antiemetics, antihistamines, and psychoactive substances [Effect] akathisia"}, {"id": "17039658_3_1930", "context": "We report the case of a 60-year-old woman who developed erythema and erosions in the axilla and groin while on PLD for breast cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 60-year-old woman; breast cancer [Treatment] PLD [Effect] erythema; erosions in the axilla and groin"}, {"id": "18171260_2_1931", "context": "Serotonin syndrome has been reported with administration of linezolid and serotonin reuptake inhibitors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported with [Treatment] administration of linezolid and serotonin reuptake inhibitors [Effect] Serotonin syndrome"}, {"id": "6159523_6_1932", "context": "We suggest that the treatment of hypoglycaemia with 50% solution of dextrose is associated with a significant risk factor in those diabetic individuals who are either allergic or are receiving beta-adrenoreceptor blocking drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] diabetic individuals who are either allergic or are receiving beta-adrenoreceptor blocking drugs [Treatment] 50% solution of dextrose [Effect] a significant risk factor"}, {"id": "1509179_1_1933", "context": "A case of phenobarbital exacerbation of a preexisting maladaptive behavior partially suppressed by chlorpromazine and misinterpreted as chlorpromazine efficacy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exacerbation [Subject] preexisting maladaptive behavior [Treatment] phenobarbital; partially suppressed by chlorpromazine [Effect] exacerbation of a preexisting maladaptive behavior"}, {"id": "14632592_1_1934", "context": "Colchicine-induced myopathy in a teenager with familial Mediterranean fever.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a teenager with familial Mediterranean fever [Treatment] Colchicine [Effect] myopathy"}, {"id": "18585545_4_1935", "context": "Levofloxacin-induced delirium with psychotic features.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Levofloxacin [Effect] delirium with psychotic features"}, {"id": "8007037_2_1936", "context": "Methemoglobinemia: an occupational hazard of phenylpropanolamine production.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] production [Treatment] phenylpropanolamine [Effect] Methemoglobinemia"}, {"id": "16498048_2_1937", "context": "Destructive thyrotoxicosis appeared 4-6 months after starting IFN-alpha, followed by Graves' hyperthyroidism within 8 to 11 months.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] IFN-alpha [Effect] Destructive thyrotoxicosis; Graves' hyperthyroidism"}, {"id": "9220046_1_1938", "context": "CASE SUMMARIES: In each case, the patients were treated over 5 years with lovastatin and developed rhabdomyolysis that coincided with the completion of a prescribed regimen of a newer macrolide antibiotic.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] patients [Treatment] 5 years with lovastatin; a newer macrolide antibiotic [Effect] rhabdomyolysis"}, {"id": "11886466_1_1939", "context": "Thrombotic stroke associated with the use of porcine factor VIII in a patient with acquired haemophilia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] patient with acquired haemophilia [Treatment] porcine factor VIII [Effect] Thrombotic stroke"}, {"id": "16371793_2_1940", "context": "PURPOSE: The intravitreal application of triamcinolone acetonide as treatment of long-standing, therapy-resistant cystoid macular edema after penetrating keratoplasty is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] The intravitreal application of triamcinolone acetonide"}, {"id": "23868369_8_1941", "context": "Patients receiving ciprofloxacin and digoxin should be monitored closely for the risk of digoxin toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] the risk [Subject] Patients [Treatment] ciprofloxacin and digoxin [Effect] digoxin toxicity"}, {"id": "11443640_2_1942", "context": "To our knowledge this is the first report of pancytopenia due to MMI, where the usual hypoplasia found is replaced by massive plasmocytosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] MMI [Effect] pancytopenia"}, {"id": "4082283_3_1943", "context": "The following is a report of 2 cases of rifampicin-induced renal insufficiency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] rifampicin [Effect] renal insufficiency"}, {"id": "8435665_2_1944", "context": "Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attributed [Subject] marrow transplant patient [Treatment] total parenteral nutrition with a solution containing tryptophan [Effect] Fatal eosinophilia myalgia syndrome"}, {"id": "14601701_4_1945", "context": "We describe a 43-year-old man who developed signs and symptoms of bilateral optic neuropathy during treatment with ethambutol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 43-year-old man [Treatment] ethambutol [Effect] bilateral optic neuropathy"}, {"id": "8445549_3_1946", "context": "The patient described in this paper was a 78-year-old diabetic man who developed oral lesions of PV following institution of glibenclamide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] The patient described in this paper was a 78-year-old diabetic man [Treatment] institution of glibenclamide [Effect] oral lesions of PV"}, {"id": "16146480_2_1947", "context": "Since elevated cortisol levels in Cushing's disease poses a threat for pancreatitis, there is a possibility that patients with Cushing's disease might be more prone to acute pancreatitis following propofol administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] patients with Cushing's disease [Treatment] propofol [Effect] acute pancreatitis"}, {"id": "9433539_3_1948", "context": "Ticlopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease and is rarely associated with severe bone marrow suppression, typically aplastic anemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Ticlopidine is an oral antiplatelet agent [Effect] severe bone marrow suppression, typically aplastic anemia"}, {"id": "21715267_2_1949", "context": "Moxifloxacin and lomefloxacin are fluoroquinolone antibiotics used in treating urinary and respiratory tract infections.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treating [Treatment] Moxifloxacin and lomefloxacin; fluoroquinolone antibiotics"}, {"id": "9337441_14_1950", "context": "To our knowledge, this case report represents only the third description of laxative-induced TEN.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] laxative [Effect] TEN"}, {"id": "21417793_2_1951", "context": "Prompted by the advent of potentially life-threatening neuromuscular symptoms following initiation of linezolid therapy in two patients receiving treatment with a serotonin reuptake inhibitor antidepressant, an evaluation was conducted to determine the incidence and characteristics of symptomatic serotonin toxicity among hospitalized patients receiving combined treatment with these medications.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] two patients [Treatment] linezolid; with a serotonin reuptake inhibitor antidepressant [Effect] life-threatening neuromuscular symptoms"}, {"id": "15543388_2_1952", "context": "Celiac disease onset after pegylated interferon and ribavirin treatment of chronic hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] onset [Treatment] pegylated interferon and ribavirin treatment of chronic hepatitis C [Effect] Celiac disease"}, {"id": "8244201_3_1953", "context": "Hyperkalaemia with renal tubular dysfunction by sulfamethoxazole-trimethoprim for Pneumocystis carinii pneumonia in patients with lymphoid malignancy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] by [Subject] patients with lymphoid malignancy [Treatment] sulfamethoxazole-trimethoprim for Pneumocystis carinii pneumonia [Effect] Hyperkalaemia with renal tubular dysfunction"}, {"id": "19540093_2_1954", "context": "Following 7 days of tigecycline she developed severe abdominal pain and elevated pancreatic enzymes suggesting acute pancreatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] she [Treatment] 7 days of tigecycline [Effect] abdominal pain and elevated pancreatic enzymes"}, {"id": "11850606_4_1955", "context": "To treat hepatitis B, interferon alpha was administered until the proximal muscle weakness developed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] interferon alpha [Effect] proximal muscle weakness"}, {"id": "16882112_4_1956", "context": "We report a case of the serotonin syndrome during treatment with lithium and venlafaxine, an antidepressant with a dual selective re-uptake inhibition mechanism, and review the literature for similar cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a case [Treatment] lithium and venlafaxine [Effect] serotonin syndrome"}, {"id": "19531695_13_1957", "context": "Supratherapeutic flecainide plasma concentrations may cause delirium.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Supratherapeutic flecainide plasma concentrations [Effect] delirium"}, {"id": "19499966_1_1958", "context": "At the end of his fifth cycle of sunitinib therapy, the patient complained of the development of abnormally large mammary glands associated with pain and peri-areolar erythema.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] the patient [Treatment] fifth cycle of sunitinib therapy [Effect] abnormally large mammary glands associated with pain and peri-areolar erythema"}, {"id": "18644535_2_1959", "context": "This is a case report of possible association of methylphenidate and enuresis in an 11-year-old boy with attention deficit hyperactivity disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Subject] an 11-year-old boy with attention deficit hyperactivity disorder [Treatment] methylphenidate [Effect] enuresis"}, {"id": "19331262_4_1960", "context": "This report describes a case of neuroleptic malignant syndrome due to risperidone in a child with Joubert syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Subject] a child with Joubert syndrome [Treatment] risperidone [Effect] neuroleptic malignant syndrome"}, {"id": "21045170_3_1961", "context": "A 47-year-old HIV-infected man with dilated cardiomyopathy and prolonged QT syndrome with an automatic implantable cardiovascular defibrillator device was prescribed subcutaneous enfuvirtide 90 mg twice daily as part of his antiretroviral regimen and oral extended-release niacin 500 mg/day for a high-density lipoprotein level of 8 mg/dL. After 1 week of concomitant therapy, the patient began experiencing extreme redness, edema, and swelling at the injection site that corresponded with the flushing sensation due to niacin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experiencing [Subject] A 47-year-old HIV-infected man with dilated cardiomyopathy and prolonged QT syndrome with an automatic implantable cardiovascular defibrillator device [Treatment] subcutaneous enfuvirtide 90 mg twice daily as part of his antiretroviral regimen and oral extended-release niacin 500 mg/day for a high-density lipoprotein level of 8 mg/dL [Effect] extreme redness, edema, and swelling at the injection site that corresponded with the flushing sensation due to niacin"}, {"id": "7724306_1_1962", "context": "Acute INH neurotoxicity was not suspected on the first admission; however, when readmitted 4 weeks later with another seizure, the diagnosis of acute INH neurotoxicity was made.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] diagnosis [Treatment] INH [Effect] seizure; acute INH neurotoxicity"}, {"id": "12066972_1_1963", "context": "Levofloxacin-induced toxic epidermal necrolysis in an elderly patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an elderly patient. [Treatment] Levofloxacin [Effect] toxic epidermal necrolysis"}, {"id": "18079582_1_1964", "context": "The incidence of 5-fluorouracil (5-FU)-related cardiotoxicity seems to be dosage and schedule dependent.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] 5-fluorouracil; dosage; schedule [Effect] cardiotoxicity"}, {"id": "19915794_3_1965", "context": "Torsades de Pointes induced by a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs during hypokalemia due to licorice.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs [Effect] Torsades de Pointes"}, {"id": "10981493_1_1966", "context": "Ataxia caused by propafenone has been reported to the pharmaceutical companies and drug monitoring agencies, but has not been well described or emphasized in the medical literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] propafenone [Effect] Ataxia"}, {"id": "7582710_2_1967", "context": "The first patient developed mild nitritoid symptoms and pain in a band-like distribution, corresponding to T10-T12 dermatomes, shortly after gold sodium thiomalate (GSTM) injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] The first patient [Treatment] gold sodium thiomalate (GSTM) injection [Effect] mild nitritoid symptoms and pain in a band-like distribution"}, {"id": "9433539_1_1968", "context": "A case is reported of an elderly woman who developed febrile agranulocytosis several weeks after commencing ticlopidine but who had a favorable outcome after cessation of that drug and treatment with filgastrim.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] an elderly woman [Treatment] several weeks after commencing ticlopidine [Effect] febrile agranulocytosis [Potential therapeutic event] after [Subject] an elderly woman [Treatment] cessation of that drug and treatment with filgastrim [Effect] a favorable outcome"}, {"id": "9824032_3_1969", "context": "Two 65-year-old white men with coronary heart disease, given niacin therapy for dyslipidemia for 5 months, developed intense dental and gingival pain that was associated with increases in dose and that was relieved with discontinuance of niacin treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two 65-year-old white men with coronary heart disease [Treatment] niacin therapy for dyslipidemia for 5 months; increases in dose [Effect] intense dental and gingival pain"}, {"id": "3335488_2_1970", "context": "Two patients are described who developed testicular swelling and pain during treatment with desipramine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] Two patients [Treatment] desipramine [Effect] testicular swelling and pain"}, {"id": "6635723_1_1971", "context": "Metabolic balance studies and rechallenge with hydrochlorothiazide were undertaken to investigate the mechanism of the thiazide-induced hyponatremia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] thiazide [Effect] hyponatremia"}, {"id": "3926849_2_1972", "context": "Paradoxical pulmonary vasoconstriction induced by nitroglycerin in idiopathic pulmonary hypertension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] nitroglycerin [Effect] Paradoxical pulmonary vasoconstriction"}, {"id": "12523465_1_1973", "context": "Although visual hallucinations have not been reported as an adverse effect of this agent, we describe three patients who experienced complex visual hallucinations and altered mental status after zonisamide treatment was begun or its dosage increased.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] zonisamide [Effect] complex visual hallucinations and altered mental status"}, {"id": "17675030_2_1974", "context": "Clinical profile of oxcarbazepine-related angioneurotic edema: case report and review.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] case [Treatment] oxcarbazepine [Effect] angioneurotic edema"}, {"id": "11788010_1_1975", "context": "Extra caution should be taken in using octreotide or its long-acting analog in patients otherwise predisposed to intrahepatic bile stasis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] predisposed [Subject] patients [Treatment] octreotide or its long-acting analog [Effect] intrahepatic bile stasis"}, {"id": "8253700_1_1976", "context": "BACKGROUND: Fluoxetine, a highly specific serotonin reuptake inhibitor, has been reported to cause sexual dysfunction in a minority of patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] minority of patients [Treatment] Fluoxetine [Effect] sexual dysfunction"}, {"id": "18362995_4_1977", "context": "We report a 45-year-old Chinese man with CML and chronic hepatitis B virus infection, on imatinib treatment, presenting with herpetic rash and acute liver failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presenting [Subject] a 45-year-old Chinese man with CML and chronic hepatitis B virus infection [Treatment] on imatinib treatment [Effect] herpetic rash and acute liver failure"}, {"id": "3947272_4_1978", "context": "One patient had severe temporary weakness after an ampicillin sodium challenge.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] One patient [Treatment] an ampicillin sodium challenge [Effect] temporary weakness"}, {"id": "11142491_1_1979", "context": "Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] a chronic lymphocytic leukemia patient [Treatment] fludarabine and autologous peripheral blood stem-cell transplantation [Effect] Acute myeloid leukemia and lung cancer"}, {"id": "16960880_1_1980", "context": "Despite a very low complication rate, several severe arterial thrombotic events have been reported following thrombin injection of pseudoaneurysms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] thrombin injection [Effect] arterial thrombotic"}, {"id": "8396491_2_1981", "context": "The results clearly demonstrate that CPH82 was associated with suppression of the endogeneous production of ACTH and cortisol with a concomitant paradoxical picture of clinical hypercortisolism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] CPH82 [Effect] suppression of the endogeneous production of ACTH and cortisol with a concomitant paradoxical picture of clinical hypercortisolism"}, {"id": "17060191_2_1982", "context": "Exposure of the fetus to indomethacin by administration of the drug to the mother may cause many side effects, including premature closure of the ductus arteriosus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] side effects [Subject] fetus [Treatment] indomethacin [Effect] premature closure of the ductus arteriosus"}, {"id": "19745701_3_1983", "context": "She was diagnosed with Epstein-Barr virus-associated polymorphic lymphoproliferative disorder (LPD) due to immunodeficiency caused by MTX administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] She [Treatment] immunodeficiency caused by MTX administration [Effect] Epstein-Barr virus-associated polymorphic lymphoproliferative disorder (LPD)"}, {"id": "17285101_1_1984", "context": "Pulmonary hypertension during lithium therapy: clinical case study.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] lithium therapy [Effect] Pulmonary hypertension"}, {"id": "18682542_1_1985", "context": "CONCLUSIONS: Clinicians should be aware of this adverse reaction when facing similar complex neurologic symptoms in patients who are receiving the antibiotic treatment described here, especially vancomycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse reaction [Subject] patients [Treatment] vancomycin [Effect] neurologic symptoms"}, {"id": "19034138_3_1986", "context": "Corneal edema recurred when the administration of amantadine was resumed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] when [Treatment] the administration of amantadine was resumed [Effect] Corneal edema"}, {"id": "24661191_5_1987", "context": "Vitamin K1 caused skin rash possibly because of the distribution and metabolism characteristic of the drug in this patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] Vitamin K1 [Effect] skin rash"}, {"id": "15311565_1_1988", "context": "Initial treatment with heparin was substituted with thrombolysis, which resulted in clinical improvement and dissolution of right heart thrombus but was followed by fatal intracerebral haemorrhage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Treatment] thrombolysis [Effect] fatal intracerebral haemorrhage"}, {"id": "14601701_3_1989", "context": "The most commonly recognized toxic effect of ethambutol is optic neuropathy, which generally is considered uncommon and reversible in medical literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] effect [Treatment] ethambutol [Effect] optic neuropathy"}, {"id": "189279_1_1990", "context": "A case of congestive heart failure in a child with Wilms' tumor treated Adriamycin is presented and discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a child with Wilms' tumor [Treatment] Adriamycin [Effect] congestive heart failure"}, {"id": "9494448_3_1991", "context": "BACKGROUND: Hypersensitivity reactions to cyclosporine are rare.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] cyclosporine [Effect] Hypersensitivity reactions"}, {"id": "16484748_2_1992", "context": "This is the first case of TMP-SMX-induced hypersensitivity syndrome associated with the reactivation of a latent viral infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] first case [Treatment] TMP-SMX [Effect] hypersensitivity syndrome; reactivation of a latent viral infection"}, {"id": "24318743_15_1993", "context": "In addition, single-agent weekly AUC2-carboplatin appeared to be inactive by response criteria in a homogenously defined population of PROC.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] inactive [Subject] a homogenously defined population of PROC [Treatment] single-agent weekly AUC2-carboplatin"}, {"id": "18533420_1_1994", "context": "CONCLUSIONS: Intrathecal baclofen can impair sexual function and ejaculation in some patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] impair [Subject] some patients [Treatment] Intrathecal baclofen [Effect] impair sexual function and ejaculation"}, {"id": "15671134_1_1995", "context": "A case of clozapine-induced tonic-clonic seizures managed with valproate: implications for clinical care.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] A case [Treatment] clozapine [Effect] tonic-clonic seizures [Potential therapeutic event] managed [Subject] A case [Treatment] valproate"}, {"id": "10923593_2_1996", "context": "Serum sickness consists of a systemic reaction resulting from the formation of soluble circulating immunocomplexes after the introduction of a foreign substance into the body We studied a 38-year-old woman diagnosed with anxiety, depression and right sacroileitis who was treated with phenylbutazone, ranitidine, clomipramine and levomepromazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] a 38-year-old woman diagnosed with anxiety, depression and right sacroileitis [Treatment] phenylbutazone, ranitidine, clomipramine and levomepromazin"}, {"id": "8276031_5_1997", "context": "The symptomatology of 18 other paediatric cases of naphthylimidazoline exposure reported to the Belgian National Poison Centre, is also discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] symptomatology [Subject] 18 other paediatric cases [Treatment] naphthylimidazoline [Effect] naphthylimidazoline exposure"}, {"id": "85289_1_1998", "context": "Anterior spinal artery syndrome--a complication of cervical intrathecal phenol injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] cervical intrathecal phenol injection [Effect] Anterior spinal artery syndrome"}, {"id": "3677571_16_1999", "context": "Phenytoin was discontinued after admission; however, phenytoin 1 g i.v. was given for a tonic-clonic seizure two days after admission, after which swelling of the face and legs and pruritus developed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] phenytoin 1 g i.v. [Effect] swelling of the face and legs and pruritus"}, {"id": "11961411_3_2000", "context": "To our knowledge this is the first report that demonstrates histological abnormalities of the glomerulus associated with postoperative IFN-beta therapy for the malignant melanoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] postoperative IFN-beta therapy [Effect] histological abnormalities of the glomerulus"}, {"id": "11020127_1_2001", "context": "Protease inhibitor-induced carbamazepine toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Protease inhibitor [Effect] carbamazepine toxicity"}, {"id": "11452688_1_2002", "context": "This report details a case of bilateral avascular necrosis of the femoral heads in a patient receiving 'standard' doses of dexamethasone as part of the antiemetic regimen used in cisplatin-based combination chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] a patient [Treatment] 'standard' doses of dexamethasone [Effect] bilateral avascular necrosis of the femoral heads"}, {"id": "7679525_3_2003", "context": "He recovered successfully after treatment with very high doses of corticosteroids and azathioprine.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] recovered [Subject] He [Treatment] very high doses of corticosteroids and azathioprine"}, {"id": "717931_2_2004", "context": "Marked hyperkalemia was observed during and immediately after an infusion of arginine monohydrochloride in two patients with severe hepatic disease and moderate renal insufficiency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Subject] two patients with severe hepatic disease and moderate renal insufficiency [Treatment] during and immediately after an infusion of arginine monohydrochloride [Effect] Marked hyperkalemia"}, {"id": "937377_1_2005", "context": "Finally, reserpine toxicity, in particular central nervous system (CNS) disturbances, was reported more frequently in patients also receiving barbiturates, suggesting additive CNS effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] reserpine; also receiving barbiturates, [Effect] reserpine toxicity, in particular central nervous system (CNS) disturbances; additive CNS effects"}, {"id": "14740795_3_2006", "context": "Patients receiving amifostine who develop only fever should be evaluated for an adverse drug reaction, as well as for sepsis and fevers of neutropenia, and it may be necessary to discontinue the drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Treatment] amifostine [Effect] fever; sepsis and fevers of neutropenia"}, {"id": "9215418_1_2007", "context": "Clinical signs of hypermagnesemia are an uncommon complication following oral administration of magnesium sulfate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] oral administration of magnesium sulfate [Effect] hypermagnesemia"}, {"id": "7408538_1_2008", "context": "Markedly increased pigmementation of skin immediately overlying veins used for multiple 5-fluorouracil infusions was noted.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] noted [Treatment] multiple 5-fluorouracil infusions [Effect] Markedly increased pigmementation of skin immediately overlying veins"}, {"id": "2140997_3_2009", "context": "Severe hepatitis caused by cyproterone acetate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] cyproterone acetate [Effect] Severe hepatitis"}, {"id": "14693027_2_2010", "context": "Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] three patients [Treatment] phenytoin and cranial radiation therapy [Effect] Erythema multiforme"}, {"id": "12967198_2_2011", "context": "Chloroquine has been used for many decades in the prophylaxis and treatment of malaria.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] of [Treatment] Chloroquine [Effect] prophylaxis and treatment"}, {"id": "11414270_7_2012", "context": "Before ICU admission, the patient had suffered from painful mucositis causing severe dysphagia and bleeding, which was thought to be the result of chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Subject] the patient had suffered from painful mucositis [Treatment] chemotherapy [Effect] severe dysphagia and bleeding"}, {"id": "3200786_3_2013", "context": "We report the case of a patient with the acquired immunodeficiency syndrome treated with rifampicin who had a 'normal' screening test for adrenal insufficiency, yet had clinical evidence of adrenal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] a patient with the acquired immunodeficiency syndrome [Treatment] rifampicin [Effect] adrenal failure"}, {"id": "9052919_3_2014", "context": "We postulate that cyclosporin, possibly together with ganciclovir, can produce transient brain stem or neuromuscular dysfunction with eye movement abnormality in occasional patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] produce [Subject] occasional patients [Treatment] cyclosporin; together with ganciclovir [Effect] transient brain stem or neuromuscular dysfunction with eye movement abnormality"}, {"id": "313865_1_2015", "context": "Three patients, in whom tumour overkill by cytotoxic treatment, including high dose methotrexate with folinic acid rescue, resulted in the 'phosphate shower syndrome' (hyper-uricaemia, hyperkalaemia and hyperphosphataemia with hypocalcaemia and tetany, with metabolic acidosis and acute renal impairment) are described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Subject] Three patients [Treatment] cytotoxic treatment, including high dose methotrexate with folinic acid rescue [Effect] 'phosphate shower syndrome' (hyper-uricaemia, hyperkalaemia and hyperphosphataemia with hypocalcaemia and tetany, with metabolic acidosis and acute renal impairment)"}, {"id": "24846936_3_2016", "context": "Methylene blue-associated serotonin toxicity has been described before but usually as mild toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Methylene blue [Effect] serotonin toxicity"}, {"id": "12221670_2_2017", "context": "The second was an 82-year-old man receiving ticlopidine for 2 years when, during a febrile episode, he was found neutropenic with marrow aplasia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] found [Subject] 82-year-old man [Treatment] receiving ticlopidine for 2 years [Effect] neutropenic with marrow aplasia."}, {"id": "19357764_3_2018", "context": "INTRODUCTION: In resource limited settings patients on antiretroviral treatment who develop stavudine induced hyperlactatemia are often switched to zidovudine on the basis of published studies that demonstrate that this agent can be a safe alternative.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patients on antiretroviral treatment [Treatment] stavudine [Effect] hyperlactatemia [Potential therapeutic event] switched [Subject] patients on antiretroviral treatment [Treatment] zidovudine"}, {"id": "18633310_3_2019", "context": "We report a case of pediatric bupropion ingestion resulting in multiple seizures.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Subject] pediatric [Treatment] bupropion ingestion [Effect] multiple seizures"}, {"id": "18676387_8_2020", "context": "The co-administration of SSRIs and fentanyl may precipitate serotonin toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitate [Treatment] co-administration of SSRIs and fentanyl [Effect] serotonin toxicity"}, {"id": "19707032_5_2021", "context": "Three days after intravitreal injection of bevacizumab, acute ocular ischemic syndrome occurred.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] Three days after intravitreal injection of bevacizumab [Effect] acute ocular ischemic syndrome"}, {"id": "18453852_10_2022", "context": "After addition of lopinavir/ritonavir, eight volunteers suffered from both nausea and vomiting, one from nausea only, and one from vomiting only.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] After [Subject] eight volunteers [Treatment] lopinavir/ritonavir [Effect] nausea and vomiting [Adverse event] After [Subject] one [Treatment] lopinavir/ritonavir [Effect] vomiting [Adverse event] After [Subject] one [Treatment] lopinavir/ritonavir [Effect] nausea"}, {"id": "10357715_2_2023", "context": "Calcipotriol (Daivonex R; Leo Pharmaceuticals, Zurich, Switzerland) may cause irritation of the skin, whereas allergic reactions are less common.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Calcipotriol [Effect] irritation of the skin"}, {"id": "2309833_1_2024", "context": "After discontinuation of danazol the diabetes completely resolved.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Treatment] discontinuation of danazo"}, {"id": "15977922_3_2025", "context": "We describe the development of ischemic colitis in a woman who was treated with tegaserod and review the relationship among ischemic colitis, tegaserod use, and irritable bowel syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] woman [Treatment] tegaserod [Effect] ischemic colitis"}, {"id": "11834188_4_2026", "context": "We presented the case of a patient who developed a cutaneous reaction induced by captopril with positive patch test.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient [Treatment] captopril [Effect] cutaneous reaction"}, {"id": "11033734_4_2027", "context": "Three of these patients had convulsions attributed to imipenem/cilastatin; 3.6% of the patients had seizure, or 2% of imipenem/cilastatin administrations was followed by a seizure attack.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attributed [Subject] Three of these patients [Treatment] imipenem/cilastatin [Effect] convulsions [Adverse event] followed [Subject] 2% [Treatment] imipenem/cilastatin [Effect] seizure"}, {"id": "16225183_10_2028", "context": "This latest (third) report suggests that the safety profile should be reexamined and at least raises the question of potential renal toxicity of interferons in MS.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] raises [Treatment] interferons [Effect] potential renal toxicity"}, {"id": "3101617_1_2029", "context": "Co-trimoxazole red cell aplasia in leukaemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Treatment] Co-trimoxazole [Effect] red cell aplasia"}, {"id": "12639299_1_2030", "context": "Interferon-alpha (IFN-alpha) may precipitate or exacerbate the occurrence of MPGN.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurrence [Treatment] Interferon-alpha (IFN-alpha) [Effect] MPGN"}, {"id": "11207969_3_2031", "context": "Toxic epidermal necrolysis after the use of high-dose cytosine arabinoside.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] high-dose cytosine arabinoside [Effect] Toxic epidermal necrolysis"}, {"id": "10981493_4_2032", "context": "We describe 3 elderly patients with moderate to severe ataxia that occurred while they were taking propafenone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] 3 elderly patients [Treatment] taking propafenone [Effect] moderate to severe ataxia"}, {"id": "1445134_1_2033", "context": "Gestational diabetes was no less severe (degree of hyperglycaemia, need for insulin therapy) when associated with norethisterone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] norethisterone [Effect] Gestational diabetes"}, {"id": "1445134_2_2034", "context": "However, follow-up revealed that gestational diabetes when associated with norethisterone had a lesser risk of emerging diabetes mellitus and impaired glucose tolerance.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] emerging [Treatment] norethisterone [Effect] diabetes mellitus and impaired glucose tolerance"}, {"id": "3470173_1_2035", "context": "Because the cerebellar toxicity may be worsened by continuation of therapy after initial onset of symptoms, prompt termination of HDARAC is recommended.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] HDARAC [Effect] cerebellar toxicity"}, {"id": "2746565_3_2036", "context": "We describe a case of ulcerative proctitis after ibuprofen treatment in a girl with juvenile systemic lupus erythematosus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a girl with juvenile systemic lupus erythematosus [Treatment] ibuprofen treatment [Effect] ulcerative proctitis"}, {"id": "9337441_18_2037", "context": "Clinicians should include phenolphthalein in their list of possible causes of drug-induced TEN.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] phenolphthalein [Effect] TEN"}, {"id": "424824_4_2038", "context": "Methotrexate-induced diffuse interstitial pulmonary fibrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Methotrexate [Effect] diffuse interstitial pulmonary fibrosis"}, {"id": "16008658_2_2039", "context": "Abdominal wall ulceration and mucinosis secondary to recombinant human interferon-beta-1b.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] recombinant human interferon-beta-1b [Effect] Abdominal wall ulceration and mucinosis"}, {"id": "15661067_1_2040", "context": "Asthenozoospermia: possible association with long-term exposure to an anti-epileptic drug of carbamazepine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] long-term exposure to an anti-epileptic drug of carbamazepine [Effect] Asthenozoospermia"}, {"id": "15611427_2_2041", "context": "Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] triggered [Treatment] imiquimod [Effect] Psoriasis"}, {"id": "6414095_3_2042", "context": "A 52-year-old Black woman on phenytoin therapy for post-traumatic epilepsy developed transient hemiparesis contralateral to the injury.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 52-year-old Black woman [Treatment] phenytoin [Effect] transient hemiparesis contralateral to the injury"}, {"id": "18648015_4_2043", "context": "Use of the Naranjo probability scale determined the association between cephalosporin use and leukopenia to be probable.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] use [Treatment] cephalosporin [Effect] leukopenia"}, {"id": "6142995_2_2044", "context": "Sister chromatid exchanges (SCEs), a sensitive measure of chromosome damage, were counted in peripheral-blood lymphocytes from 10 patients with Behcet's syndrome receiving chlorambucil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] 10 patients with Behcet's syndrome [Treatment] chlorambucil [Effect] chromosome damage"}, {"id": "876914_2_2045", "context": "Sarcoma complicating therapy with cyclophosphamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complicating [Treatment] cyclophosphamide [Effect] Sarcoma"}, {"id": "9260733_1_2046", "context": "Clozapine induced polyserositis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Clozapine [Effect] polyserositis"}, {"id": "20298401_1_2047", "context": "Fatal interstitial lung disease after erlotinib administration in a patient with radiation fibrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient with radiation fibrosis [Treatment] erlotinib [Effect] interstitial lung disease"}, {"id": "8586895_4_2048", "context": "The pharmaceutical company producing Halfan has reported 8 cardiac arrests, leading to 6 deaths, when a higher dose than recommended was used, there was recent or concomitant treatment with mefloquine, there was pre-existing prolongation of the QT interval or the patient had a thiamine deficiency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] Halfan; when a higher dose than recommended was used [Effect] 8 cardiac arrests; 6 deaths"}, {"id": "1477441_2_2049", "context": "CONCLUSIONS: Fixed drug rash induced by methylphenidate is a possible but rare phenomenon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] methylphenidate [Effect] Fixed drug rash"}, {"id": "11399735_2_2050", "context": "Special care should be taken when pulmonary symptoms appear in association with ticlopidine treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] appear [Treatment] ticlopidine treatment [Effect] pulmonary symptoms"}, {"id": "11722307_2_2051", "context": "CONCLUSION: Although a definite association has not been proven, clinicians should be aware of the possibility of agranulocytosis while using quetiapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] using [Treatment] quetiapine [Effect] agranulocytosis"}, {"id": "19203515_2_2052", "context": "Acute renal failure is a rare complication following the administration of intravenous immunoglobulin (IVIG).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] intravenous immunoglobulin (IVIG) [Effect] Acute renal failure"}, {"id": "1751354_3_2053", "context": "We report four patients, three of whom first developed psoriasis and one who had an aggravation of the condition during treatment with interferon-alpha.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] one [Treatment] interferon-alpha [Effect] had an aggravation of the condition [Adverse event] developed [Subject] three [Treatment] interferon-alpha [Effect] psoriasis"}, {"id": "1661260_1_2054", "context": "Reactivation of cytomegalovirus probably followed the treatment of Wegener's granulomatosis with corticosteroids and azathioprine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] followed [Treatment] corticosteroids and azathioprine [Effect] Reactivation of cytomegalovirus"}, {"id": "8771575_5_2055", "context": "We present a case of respiratory failure occurring in a woman at 16 weeks' gestation who was being treated with nitrofurantoin for a urinary tract infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] a woman at 16 weeks' gestation [Treatment] being treated with nitrofurantoin for a urinary tract infection [Effect] respiratory failure"}, {"id": "10963515_2_2056", "context": "We describe a case of EGE manifested as an allergy to gemfibrozil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] manifested [Subject] a case of EGE [Treatment] gemfibrozil [Effect] allergy"}, {"id": "7724306_7_2057", "context": "RESULTS: At our institution, no children appeared with acute INH neurotoxicity in the period 1985 through 1990, whereas seven patients were treated from 1991 through 1993.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] appeared with [Subject] children [Treatment] INH [Effect] neurotoxicity"}, {"id": "7249424_3_2058", "context": "Two patients on long-term lithium therapy developed the nephrotic syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two patients [Treatment] long-term lithium therapy [Effect] nephrotic syndrome"}, {"id": "12875956_1_2059", "context": "Acute psychosis associated with levetiracetam.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] levetiracetam [Effect] Acute psychosis"}, {"id": "19365885_2_2060", "context": "Hypoglycemia induced by long-acting somatostatin analogues in a patient with nonfunctional neuroendocrine tumor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with nonfunctional neuroendocrine tumor [Treatment] long-acting somatostatin analogues [Effect] Hypoglycemia"}, {"id": "15157248_2_2061", "context": "CASE REPORT: We report a patient who developed a DAT-positive hemolytic episode after a red cell (RBC) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient [Treatment] a red cell (RBC) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin [Effect] developed a DAT-positive hemolytic episode"}, {"id": "8313300_8_2062", "context": "Regression of thyrotoxic ophthalmopathy following lithium withdrawal.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] Regression [Treatment] lithium withdrawal"}, {"id": "14700673_2_2063", "context": "Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] topiramate [Effect] acute-onset myopia and angle closure glaucoma"}, {"id": "17610180_1_2064", "context": "The clinical symptoms of gastric mucosa foveolar hyperplasia due to long-term PGE1 therapy simulate hypertrophic pyloric stenosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] long-term PGE1 therapy [Effect] gastric mucosa foveolar hyperplasia; simulate hypertrophic pyloric stenosis"}, {"id": "7831179_1_2065", "context": "Aggressive management of doxorubicin-induced cardiomyopathy associated with 'low' doses of doxorubicin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] doxorubicin; 'low' doses [Effect] cardiomyopathy"}, {"id": "8157823_1_2066", "context": "Generalized argyria after habitual use of AgNO3.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] habitual use of AgNO3 [Effect] Generalized argyria"}, {"id": "12187348_3_2067", "context": "The authors report the first case of bucillamine-induced giant mammary hyperplasia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] bucillamine [Effect] giant mammary hyperplasia"}, {"id": "10589077_1_2068", "context": "Hydroxyurea (HU) and sodium phenylbutyrate (SPB) have been shown to increase fetal hemoglobin (Hb F) levels in patients with thalassemia intermedia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increase [Subject] patients with thalassemia intermedia [Treatment] Hydroxyurea (HU) and sodium phenylbutyrate (SPB) [Effect] hemoglobin (Hb F) levels"}, {"id": "1954704_2_2069", "context": "We report a case of biopsy proven myositis whose symptoms began within 10 days of receiving leuprolide acetate therapy for prostate cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] symptoms began [Subject] a case [Treatment] within 10 days of receiving leuprolide acetate therapy [Effect] myositis"}, {"id": "16239768_3_2070", "context": "Venlafaxine-induced urinary incontinence resolved after switching to sertraline.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Venlafaxine [Effect] urinary incontinence [Potential therapeutic event] resolved [Treatment] sertraline"}, {"id": "17122225_4_2071", "context": "We report two cases of severe serotonin syndrome induced by the administration of cyclobenzaprine in postoperative patients already receiving another proserotoninergic drug (phenelzine in one case and duloxetine in the other).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] postoperative patients [Treatment] cyclobenzaprine; duloxetine [Effect] serotonin syndrome [Adverse event] induced [Subject] postoperative patients [Treatment] cyclobenzaprine; phenelzine [Effect] serotonin syndrome"}, {"id": "11816261_3_2072", "context": "OBJECTIVE: To report 2 cases of serotonin syndrome with serious extrapyramidal movement disorders occurring when metoclopramide was coadministered with sertraline or venlafaxine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] 2 cases [Treatment] metoclopramide was coadministered with sertraline or venlafaxine [Effect] serotonin syndrome with serious extrapyramidal movement disorders"}, {"id": "11703329_4_2073", "context": "We report a 31-year-old women with recurrent Hodgkin's lymphoma and unrecognized HMSN-1 who developed severe motor neuropathy 3 weeks after the first cycle of treatment including 2 mg of vincristine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 31-year-old women with recurrent Hodgkin's lymphoma and unrecognized HMSN-1 [Treatment] 3 weeks after the first cycle of treatment including 2 mg of vincristine [Effect] severe motor neuropathy"}, {"id": "8891729_5_2074", "context": "When the patient was treated again with fludarabine nine months later, the DAT became positive with anti-IgG and anti-C3d antiglobulins after the second course of treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] the patient [Treatment] fludarabine; second course of treatment [Effect] the DAT became positive with anti-IgG and anti-C3d antiglobulins"}, {"id": "10566542_2_2075", "context": "This case report describes a patient who was previously prescribed alendronate (Fosamax) and presented with postoperative hypophosphatemia and hypocalcemic tetany after bowel preparation with Fleet Phospho-Soda.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] patient [Treatment] alendronate (Fosamax); after bowel preparation with Fleet Phospho-Soda [Effect] postoperative hypophosphatemia and hypocalcemic tetany"}, {"id": "8496127_1_2076", "context": "Acute dystonic reaction with low-dose pimozide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] low-dose pimozide [Effect] Acute dystonic reaction"}, {"id": "18408649_2_2077", "context": "There are, however, case studies describing patients experiencing recurrences of tics following treatment with atomoxetine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] treatment with atomoxetine [Effect] recurrences of tics"}, {"id": "3680913_2_2078", "context": "Nicotinic acid-induced fulminant hepatic failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Nicotinic acid [Effect] fulminant hepatic failure"}, {"id": "8969033_2_2079", "context": "Ketanserin in the treatment of protamine-induced pulmonary hypertension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] protamine [Effect] pulmonary hypertension."}, {"id": "11122162_3_2080", "context": "We have safely used recombinant factor VIIa to treat bleeding in the immediate and long-term period following PCC-related MI.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treat [Subject] PCC-related MI [Treatment] recombinant factor VIIa [Adverse event] related [Treatment] PCC [Effect] MI"}, {"id": "16882112_1_2081", "context": "Lithium and venlafaxine interaction: a case of serotonin syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] case [Treatment] Lithium and venlafaxine interaction [Effect] serotonin syndrome"}, {"id": "25407257_3_2082", "context": "The seizures were suspected to be caused by a reduced concentration of VPA in the blood.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] reduced concentration of VPA in the blood [Effect] seizures"}, {"id": "3430507_1_2083", "context": "D-penicillamine induced crescentic glomerulonephritis: report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] D-penicillamine [Effect] crescentic glomerulonephritis"}, {"id": "19423610_4_2084", "context": "We offered several tentative explanations for this event, including an adverse interaction between paroxetine and other agent(s) used in the course of the anaesthesia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] between [Treatment] paroxetine and other agent(s) [Effect] adverse interaction"}, {"id": "19331262_3_2085", "context": "Neuroleptic malignant syndrome is an uncommon and potentially fatal idiosynchratic reaction of antipsychotic drugs, in which the clinical scenario encompass muscular rigidity, hyperthermia, autonomic dysfunction, altered consciousness, high creatinine phosphokinase levels, and leukocytosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reaction [Treatment] antipsychotic drugs [Effect] Neuroleptic malignant syndrome; muscular rigidity, hyperthermia, autonomic dysfunction, altered consciousness, high creatinine phosphokinase levels, and leukocytosis"}, {"id": "11545487_2_2086", "context": "Indinavir-associated nephrolithiasis and chronic interstitial nephritis were the only possible causes identified in this patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Indinavir [Effect] nephrolithiasis and chronic interstitial nephritis"}, {"id": "19904536_2_2087", "context": "Gemcitabine is a chemotherapy agent that may cause unpredictable side effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Gemcitabine [Effect] unpredictable side effects"}, {"id": "8678015_1_2088", "context": "Albendazole-induced pseudomembranous colitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Albendazole [Effect] pseudomembranous colitis"}, {"id": "17364199_1_2089", "context": "Tuberculous uveitis after treatment with etanercept.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] etanercept [Effect] Tuberculous uveitis"}, {"id": "3301251_3_2090", "context": "Salicylate-induced hepatotoxicity is reviewed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Salicylate [Effect] hepatotoxicity"}, {"id": "19531695_2_2091", "context": "To describe a case of flecainide-induced delirium associated with a pharmacokinetic drug interaction with paroxetine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] flecainide; interaction with paroxetine [Effect] delirium"}, {"id": "8098286_3_2092", "context": "We report on a patient who developed hypersensitivity pneumonitis during treatment with the beta-blocker, celiprolol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] celiprolol [Effect] hypersensitivity pneumonitis"}, {"id": "19224802_3_2093", "context": "dexmedetomidine is used to provide sedation for pediatric patients undergoing nonpainful radiological imaging studies.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used to [Subject] pediatric patients undergoing nonpainful radiological imaging studies [Treatment] dexmedetomidine [Effect] provide sedation"}, {"id": "16882112_5_2094", "context": "A 71-year-old woman developed serotonin syndrome while receiving treatment with moderate doses of lithium and venlafaxine for refractory depression.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 71-year-old woman [Treatment] moderate doses of lithium and venlafaxine [Effect] serotonin syndrome"}, {"id": "8013261_2_2095", "context": "Four years after the beginning of IFN therapy, he acutely developed moderate hyperglycemia and severe ketonuria with positive islet cell antibody, and then 28 units/day of insulin injection was started.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] he [Treatment] Four years after the beginning of IFN therapy [Effect] acutely developed moderate hyperglycemia and severe ketonuria with positive islet cell antibody"}, {"id": "15644988_1_2096", "context": "Tardive dyskinesia in 2 patients treated with ziprasidone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] 2 patients [Treatment] ziprasidone [Effect] Tardive dyskinesia"}, {"id": "15866658_3_2097", "context": "The mean time from starting MMF to the development of neutropenia was 4 months.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] MMF [Effect] neutropenia"}, {"id": "9037299_1_2098", "context": "Fulminant hepatic failure associated with bicalutamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] bicalutamide [Effect] Fulminant hepatic failure"}, {"id": "17366681_1_2099", "context": "A complex pattern of melanonychia and onycholysis after treatment with pemetrexed for lung cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment [Treatment] pemetrexed for lung cancer [Effect] melanonychia and onycholysis"}, {"id": "14996269_1_2100", "context": "Hypernatraemia induced by sodium polystyrene sulphonate (Kayexalate) in two extremely low birth weight newborns.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced by [Subject] two extremely low birth weight newborns [Treatment] sodium polystyrene sulphonate (Kayexalate) [Effect] Hypernatraemia"}, {"id": "17060191_3_2101", "context": "Hypoxia is a predisposing factor for premature ductal closure and often occurs after maternal indomethacin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] maternal indomethacin therapy [Effect] premature ductal closure"}, {"id": "640344_2_2102", "context": "Severe histological osteomalacia developed in a woman with Crohn's disease 2 years after ileal resection and the start of cholestyramine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a woman with Crohn's disease [Treatment] 2 years after ileal resection and the start of cholestyramine [Effect] histological osteomalacia"}, {"id": "16923659_2_2103", "context": "Serotonin syndrome (SS) and neuroleptic malignant syndrome (NMS) are medical emergencies associated with psychotropic administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] psychotropic administration [Effect] Serotonin syndrome (SS) and neuroleptic malignant syndrome (NMS)"}, {"id": "15628319_3_2104", "context": "Drug eruption caused by azathioprine: value of using the drug-induced lymphocytes stimulation test for diagnosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] azathioprine [Effect] Drug eruption"}, {"id": "11435808_1_2105", "context": "Continuous EEG monitoring is helpful in managing seizures that occur as a complication of CBZ OD, after the course of recovery or worsening, and in providing assistance with prognosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Treatment] a complication of CBZ OD [Effect] seizures"}, {"id": "7379406_8_2106", "context": "The fluorine contained in niflumic acid induced a marked densification of trabecular bone in all 3 cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] all 3 cases [Treatment] fluorine; niflumic acid [Effect] marked densification of trabecular bone"}, {"id": "19017039_1_2107", "context": "A 17-year-old boy with refractory psoriatic arthritis and alpha-1 antitrypsin deficiency who developed a syringotropic hypersensitivity reaction after 9 months of therapy with infliximab and leflunomide is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 17-year-old boy with refractory psoriatic arthritis and alpha-1 antitrypsin deficiency [Treatment] 9 months of therapy with infliximab and leflunomide [Effect] syringotropic hypersensitivity reaction"}, {"id": "17448102_1_2108", "context": "Managing cardiovascular collapse in severe flecainide overdose without recourse to extracorporeal therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Treatment] severe flecainide overdose [Effect] cardiovascular collapse"}, {"id": "9788533_2_2109", "context": "A 53-year-old Caucasian male victim of suicide was suspected of overdose with sertraline and alprazolam after death-scene investigation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] 53-year-old Caucasian male victim of suicide [Treatment] overdose; sertraline and alprazolam"}, {"id": "12792223_3_2110", "context": "Infliximab therapy may cause a lupus-like syndrome that is reversible upon discontinuing this agent.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Infliximab therapy [Effect] lupus-like syndrome"}, {"id": "16511396_1_2111", "context": "A 7-year-old with congenital toxoplasmosis who took pyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 7-year-old with congenital toxoplasmosis [Treatment] pyrimethamine and sulfadiazine for reactivated chorioretinitis [Effect] fever, severe cutaneous involvement, swelling, abdominal pain and transaminitis"}, {"id": "24801976_1_2112", "context": "Pain management discussion forum: serious interaction among frequently used drugs for chronic pain.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] among [Treatment] frequently used drugs [Effect] serious interaction"}, {"id": "15383642_13_2113", "context": "This kind of reaction is seldom mentioned as occurring during co-administration with tizanidine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Treatment] co-administration with tizanidine [Effect] This kind of reaction"}, {"id": "91848_1_2114", "context": "A retrospective epidemiological study of deaths from hepatic angiosarcoma (HAS) in the U.S. showed that during 1964--74 there were 168 such cases, of which 37 (22%) were associated with previously known causes (vinyl chloride, 'Thorotrast', and inorganic arsenic) and 4 (3.1%) of the remaining 131 cases with the use of androgenic-anabolic steroids.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] 37 (22%) [Treatment] vinyl chloride, 'Thorotrast', and inorganic arsenic [Effect] hepatic angiosarcoma [Adverse event] with [Subject] 4 (3.1%) [Treatment] androgenic-anabolic steroids [Effect] hepatic angiosarcoma"}, {"id": "9831311_4_2115", "context": "Progressive hypokalemia developed during phosphate treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] phosphate [Effect] Progressive hypokalemia"}, {"id": "6702890_1_2116", "context": "A 69-year-old man developed pure red cell aplasia after taking fenoprofen for ten months.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 69-year-old man [Treatment] taking fenoprofen for ten months [Effect] pure red cell aplasia"}, {"id": "20130478_1_2117", "context": "Introduction of etanercept was also clinically effective but followed by development of severe heart failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] etanercept [Effect] severe heart failure."}, {"id": "11961411_2_2118", "context": "Minimal change nephrotic syndrome developing during postoperative interferon-beta therapy for malignant melanoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developing [Treatment] postoperative interferon-beta therapy for malignant melanoma [Effect] Minimal change nephrotic syndrome"}, {"id": "11816261_6_2119", "context": "She was admitted following a fall and, after being given metoclopramide, developed movement disorder and a period of unresponsiveness.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] She was admitted following a fall [Treatment] metoclopramide [Effect] movement disorder and a period of unresponsiveness"}, {"id": "12605322_1_2120", "context": "We observed transient panhypogammaglobulinaemia in a patient with neuropsychiatric SLE after treatment with prednisolone and cyclophosphamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment [Subject] a patient with neuropsychiatric SLE [Treatment] prednisolone and cyclophosphamide [Effect] transient panhypogammaglobulinaemia"}, {"id": "4031907_2_2121", "context": "Isoniazid inhibits the conversion of tryptophan to niacin and may induce pellagra, particularly in poorly nourished patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Subject] poorly nourished patients [Treatment] Isoniazid [Effect] pellagra"}, {"id": "9022114_5_2122", "context": "The authors suggest that in patients with corneal ulcers refractory to conventional treatment who are receiving colchicine, cessation of colchicine therapy should be considered.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] receiving [Subject] patients with corneal ulcers [Treatment] colchicine"}, {"id": "6498095_1_2123", "context": "After the patient discontinued rifampicin, the skin lesions cleared completely within 5 weeks without any systemic medication.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] After [Treatment] patient discontinued rifampicin [Effect] skin lesions cleared completely within 5 weeks"}, {"id": "15644988_3_2124", "context": "Ziprasidone is an atypical antipsychotic drug that is believed to have a low propensity for inducing extrapyramidal symptoms, including tardive dyskinesia (TD).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] inducing [Treatment] Ziprasidone [Effect] extrapyramidal symptoms, including tardive dyskinesia (TD)"}, {"id": "19003750_2_2125", "context": "Acute ischaemia of the leg following accidental intra-arterial injection of dissolved flunitrazepam tablets.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] intra-arterial injection of dissolved flunitrazepam tablets [Effect] Acute ischaemia of the leg"}, {"id": "25157214_11_2126", "context": "These findings suggest that prophylactic antibiotic use is unlikely to have a major impact on the recovery time from rocuronium-induced NMB with sugammadex reversal.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] use [Treatment] prophylactic antibiotic [Effect] unlikely to have a major impact on the recovery time [Adverse event] induced [Treatment] rocuronium [Effect] NMB with sugammadex reversa"}, {"id": "10530201_9_2127", "context": "Emphasis is given to the differentiation of diphenylhydantoin induced gingival hyperplasia from the angiomatous enlargement of the gingiva before any treatment is planned.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] diphenylhydantoin [Effect] gingival hyperplasia; the angiomatous enlargement of the gingiva"}, {"id": "11077455_2_2128", "context": "Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attributed [Subject] patients [Treatment] vigabatrin [Effect] visual field constriction"}, {"id": "7655130_1_2129", "context": "CASE SUMMARIES: Two patients with stable hypothyroidism experienced symptoms of hypothyroidism with increased serum thyroid-stimulating hormone (TSH) concentrations after switching from 1 levothyroxine product to another.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] Two patients with stable hypothyroidism [Treatment] switching from 1 levothyroxine product to another [Effect] hypothyroidism with increased serum thyroid-stimulating hormone"}, {"id": "15482394_1_2130", "context": "An objective causality assessment indicated a probable relationship between clotting abnormality and warfarin administration, although the degree of elevation of the INR was unusual in the light of the daily warfarin dose and duration of its exposure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] relationship [Treatment] warfarin [Effect] clotting abnormality"}, {"id": "12802933_2_2131", "context": "The pathophysiological mechanisms remain unknown, although the drug could act through massive cytokines liberation after destruction of CD20 positive cells by rituximab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] act [Treatment] rituximab [Effect] massive cytokines liberation; destruction of CD20 positive cells"}, {"id": "19499966_5_2132", "context": "The more common grade 3 or 4 adverse effects of sunitinib include hypertension, fatigue, hand-foot syndrome, elevated lipase and lymphopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse effects [Treatment] sunitinib [Effect] hypertension, fatigue, hand-foot syndrome, elevated lipase and lymphopenia"}, {"id": "18446030_2_2133", "context": "We report a 45-year-old psoriasis patient who developed eruptive mollusca contagiosa during an antipsoriatic treatment with efalizumab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 45-year-old psoriasis patient [Treatment] antipsoriatic treatment with efalizumab [Effect] eruptive mollusca contagiosa"}, {"id": "9366852_2_2134", "context": "Skin necrosis is a rare complication of subcutaneous heparin therapy that usually occurs at injection sites.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] subcutaneous heparin therapy [Effect] Skin necrosis"}, {"id": "12141409_1_2135", "context": "Epsilon-aminocaproic acid and renal complications: case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complications [Treatment] Epsilon-aminocaproic acid [Effect] renal complications"}, {"id": "2746565_1_2136", "context": "Ibuprofen rarely causes lower gastrointestinal adverse reactions but has been implicated in systemic and local side effects in patients with lupus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] implicated in [Treatment] Ibuprofen [Effect] systemic and local side effects in patients with lupus"}, {"id": "7606071_2_2137", "context": "CASE SUMMARIES: While conducting a protocol evaluating the efficacy of intraperitoneal cisplatin and hyperthermia in the treatment of recurrent ovarian cancer, 3 patients were noted to exhibit anaphylactoid reactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exhibit [Subject] 3 patients [Treatment] intraperitoneal cisplatin and hyperthermia [Effect] anaphylactoid reactions"}, {"id": "10774758_1_2138", "context": "Perinatal vasoconstrictive renal insufficiency associated with maternal nimesulide use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] maternal nimesulide use [Effect] Perinatal vasoconstrictive renal insufficiency"}, {"id": "11020127_2_2139", "context": "Protease inhibitors (ritonavir and saquinavir) were added to the treatment and the patient developed progressive ataxia related to carbamazepine toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] the patient [Treatment] Protease inhibitors (ritonavir and saquinavir) were added to the treatment; carbamazepine [Effect] progressive ataxia related to carbamazepine toxicity"}, {"id": "10755579_2_2140", "context": "The medical examiner's report indicated death caused by fluoxetine toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] fluoxetine toxicity [Effect] death"}, {"id": "17448102_4_2141", "context": "Hypertonic sodium bicarbonate is recognized as effective therapy for hypotension and arrhythmias.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] effective [Treatment] Hypertonic sodium bicarbonate"}, {"id": "19531695_14_2142", "context": "Because toxicity may occur when flecainide is prescribed with paroxetine and other potent CYP2D6 inhibitors, flecainide plasma concentrations should be monitored closely with commencement of CYP2D6 inhibitors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Treatment] flecainide is prescribed with paroxetine and other potent CYP2D6 inhibitors [Effect] toxicity"}, {"id": "788666_2_2143", "context": "Gentamicin-associated acute renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Gentamicin [Effect] acute renal failure"}, {"id": "1359782_3_2144", "context": "Sulfasalazine-induced lung disorder is an extremely rare entity which must be considered in all ulcerative colitis patients while on sulfasalazine therapy, despite the absence of pulmonary symptomatology.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Sulfasalazine [Effect] lung disorder"}, {"id": "2327115_3_2145", "context": "Suspected ciprofloxacin-induced interstitial nephritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ciprofloxacin [Effect] interstitial nephritis"}, {"id": "15977922_2_2146", "context": "Tegaserod-associated ischemic colitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Tegaserod [Effect] ischemic colitis"}, {"id": "15162903_2_2147", "context": "Clinicians should be aware of the signs and symptoms of neurotoxicity during treatment, as well as predisposing factors that put patients receiving methotrexate at risk for neurotoxic effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Subject] patients [Treatment] methotrexate [Effect] neurotoxic effects"}, {"id": "19122478_5_2148", "context": "We report the first case of chlorambucil-induced DRESS syndrome in a 70-year-old man recently diagnosed with chronic lymphocytic leukaemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 70-year-old man [Treatment] chlorambucil [Effect] DRESS syndrome"}, {"id": "19775485_1_2149", "context": "Are nasal decongestants safer than rhinitis? A case of oxymetazoline-induced syncope.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] oxymetazoline [Effect] syncope"}, {"id": "10410183_1_2150", "context": "Marked elevation of serum creatine kinase associated with olanzapine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] olanzapine therapy [Effect] Marked elevation of serum creatine kinase"}, {"id": "19034138_1_2151", "context": "After cessation of amantadine, the edema resolved, and the endothelial cell densities were <or=600/mm.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] After [Treatment] cessation of amantadine [Effect] the edema resolved, and the endothelial cell densities were <or=600/mm"}, {"id": "10410183_6_2152", "context": "DISCUSSION: Olanzapine, like other atypical antipsychotic drugs, may cause muscle injury with concomitant elevations of serum CK of muscle origin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Olanzapine; atypical antipsychotic drugs [Effect] muscle injury with concomitant elevations of serum CK of muscle origin"}, {"id": "24755135_3_2153", "context": "Study 202 was an open-label, add-on study in patients with partial or generalized epilepsy treated with valproic acid (VPA), carbamazepine (CBZ), phenytoin (PHT), or topiramate (TPM) as monotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] patients with partial or generalized epilepsy [Treatment] valproic acid (VPA), carbamazepine (CBZ), phenytoin (PHT), or topiramate (TPM) as monotherapy"}, {"id": "24477376_7_2154", "context": "Dual antiplatelet therapy with aspirin and a P2Y12 receptor antagonist following placement of coronary stents is critical to prevent stent thrombosis and subsequent myocardial infarction.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prevent [Treatment] aspirin and a P2Y12 receptor antagonist following placement of coronary stents"}, {"id": "6536282_3_2155", "context": "Organometals also compromise the limbic system and result in deficits in learning and memory.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] Organometals [Effect] compromise the limbic system; deficits in learning and memory"}, {"id": "6233326_1_2156", "context": "Optic neuropathy associated with penicillamine therapy in a patient with rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a patient with rheumatoid arthritis [Treatment] penicillamine [Effect] Optic neuropathy"}, {"id": "7835785_3_2157", "context": "We present the first case of ovarian endometrioid carcinoma and endometriosis in a postmenopausal patient who was treated with tamoxifen for breast cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated with [Subject] postmenopausal patient; breast cancer. [Treatment] tamoxifen [Effect] ovarian endometrioid carcinoma and endometriosis"}, {"id": "6311654_5_2158", "context": "There was a good correlation between the total dose of ACTH and the percentage decrease of brain parenchyma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] correlation [Treatment] total dose of ACTH [Effect] percentage decrease of brain parenchyma"}, {"id": "19423610_3_2159", "context": "We noted that the delirium resembled serotonin toxicity and that the patient had been taking paroxetine until 2 days before surgery.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Treatment] paroxetine until 2 days before surgery [Effect] delirium resembled serotonin toxicity"}, {"id": "19798640_2_2160", "context": "Primary central nervous system lymphoma in a patient treated with natalizumab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] a patient [Treatment] natalizumab [Effect] Primary central nervous system lymphoma"}, {"id": "21751692_3_2161", "context": "We retrospectively reviewed the records of 7 pediatric oncology patients who received low-dose ketamine in conjunction with propofol for total intravenous anesthesia (TIVA) repeatedly for radiation therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] received [Subject] 7 pediatric oncology patients [Treatment] low-dose ketamine in conjunction with propofol for total intravenous anesthesia (TIVA) repeatedly for radiation therapy"}, {"id": "20666169_9_2162", "context": "We presume the cause for multiple organ failure could be the result of drug-drug interaction, atorvastatin and verapamil, as verapamil is known to increase the serum concentration of atorvastatin significantly.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] interaction, atorvastatin and verapamil [Effect] multiple organ failure"}, {"id": "20190474_2_2163", "context": "Hypersensitivity to zonisamide was confirmed by the skin patch test.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] zonisamide [Effect] Hypersensitivity"}, {"id": "3612639_2_2164", "context": "Pulmonary edema occurred 24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous terbutaline therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] 24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous terbutaline therapy [Effect] Pulmonary edema"}, {"id": "6236730_3_2165", "context": "Transient acute myopia resulting from isotretinoin (accutane) therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] isotretinoin (accutane) therapy [Effect] Transient acute myopia"}, {"id": "6860059_2_2166", "context": "We report a case of fatal fulminant hepatitis caused by the use of disulfiram in a man with previously normal hepatocellular function.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] a man [Treatment] disulfiram [Effect] fatal fulminant hepatitis"}, {"id": "9220046_6_2167", "context": "OBJECTIVE: To describe two cases of rhabdomyolysis in patients taking lovastatin that were precipitated by the use of the newer macrolide antibiotics clarithromycin and azithromycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] two cases; patients [Treatment] lovastatin that were precipitated by the use of the newer macrolide antibiotics clarithromycin and azithromycin [Effect] rhabdomyolysis"}, {"id": "11737689_3_2168", "context": "Neutrophilic dermatoses in two children with idiopathic neutropenia: association with granulocyte colony-stimulating factor (G-CSF) therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Subject] two children with idiopathic neutropenia [Treatment] granulocyte colony-stimulating factor (G-CSF) therapy [Effect] Neutrophilic dermatoses"}, {"id": "21762153_9_2169", "context": "The zinc/o-cymen-5-ol system has direct antimicrobial effects and inhibits oral disease-related processes.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] inhibits [Treatment] zinc/o-cymen-5-ol system [Effect] antimicrobial effects; inhibits oral disease-related processes"}, {"id": "1388041_2_2170", "context": "Paroxetine is a selective serotonin reuptake inhibitor possessing anti-depressant activity.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] possessing [Treatment] Paroxetine"}, {"id": "11850606_1_2171", "context": "A case of polymyositis with dilated cardiomyopathy associated with interferon alpha treatment for hepatitis B.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] A case [Treatment] interferon alpha [Effect] polymyositis with dilated cardiomyopathy"}, {"id": "18315788_1_2172", "context": "Phenytoin toxicity: an easily missed cause of cerebellar syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Phenytoin [Effect] cerebellar syndrome"}, {"id": "11332679_2_2173", "context": "Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] an infant who developed pancreatitis caused by meglumine antimoniate [Treatment] visceral leishmaniasis with allopurinol plus ketoconazole [Adverse event] caused [Treatment] meglumine antimoniate [Effect] pancreatitis"}, {"id": "19935411_1_2174", "context": "Hepatotoxicity after high-dose methylprednisolone for demyelinating disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] high-dose methylprednisolone [Effect] Hepatotoxicity"}, {"id": "12796597_3_2175", "context": "Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Interferon-alpha [Effect] focal segmental glomerulosclerosis in chronic myelogenous leukemia"}, {"id": "6837655_1_2176", "context": "Prior reports have emphasized the tubular and interstitial lesions associated with intermittent or discontinuous rifampin therapy for tuberculosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] intermittent or discontinuous rifampin therapy [Effect] tubular and interstitial lesions"}, {"id": "2378415_3_2177", "context": "Transtentorial herniation caused by an intracranial mass lesion following high-dose methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] high-dose methotrexate [Effect] an intracranial mass lesion; Transtentorial herniation"}, {"id": "961329_1_2178", "context": "A case of prolonged suxamethonium apnoea successfully terminated by the infusion of a commercial preparation of serumcholinesterase is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] terminated [Treatment] the infusion of a commercial preparation of serumcholinesterase [Effect] prolonged suxamethonium apnoea"}, {"id": "16718947_2_2179", "context": "53-year-old woman with a history of deep vein thrombosis and pulmonary embolism was receiving warfarin to prevent thromboembolic complications; her international normalized ratio (INR) had been stable for 1 month.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prevent [Subject] 53-year-old woman with a history of deep vein thrombosis and pulmonary embolism [Treatment] warfarin"}, {"id": "9161656_2_2180", "context": "OBJECTIVE: To describe a patient with asymptomatic bronchial asthma and hypertension who developed an acute asthma attack after receiving sustained-release verapamil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient with asymptomatic bronchial asthma and hypertension [Treatment] sustained-release verapamil [Effect] acute asthma attack"}, {"id": "7776854_2_2181", "context": "Severe hepatotoxicity related to benzarone: a report of three cases with two fatalities.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] three cases [Treatment] benzarone [Effect] hepatotoxicity"}, {"id": "9883483_3_2182", "context": "We report on a 56-year-old female who exhibited drug refractory paroxysmal atrial fibrillation, in which marked prolongation of the QT interval and T wave inversion on electrocardiogram was demonstrated reproducibly shortly after the administration of oral pirmenol therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 56-year-old female [Treatment] pirmenol [Effect] drug refractory paroxysmal atrial fibrillation, in which marked prolongation of the QT interval and T wave inversion"}, {"id": "16284443_2_2183", "context": "Insulin-induced lipohypertrophy: report of a case with histopathology.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Insulin [Effect] lipohypertrophy"}, {"id": "15331204_2_2184", "context": "OBJECTIVE: To study therapy with indapamide impairing carbohydrate metabolism in essential hypertension patients and achieve earlier prevention, diagnoses and treatment of diabetes induced by indapamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] therapy [Subject] essential hypertension patients [Treatment] indapamide [Adverse event] induced [Treatment] indapamide [Effect] diabetes"}, {"id": "14677199_2_2185", "context": "We describe a patient with CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasia) who paradoxically experienced worsening of Raynaud's phenomenon when using yohimbine for ED.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] a patient with CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasia) [Treatment] yohimbine [Effect] worsening of Raynaud's phenomenon"}, {"id": "16326413_2_2186", "context": "High-dose methotrexate-associated acute renal failure may be an avoidable complication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] High-dose methotrexate [Effect] acute renal failure"}, {"id": "12796597_1_2187", "context": "Chronic myelogenous leukemia (CML), hepatitis C, and interferon alpha (IFNalpha) have all been associated with renal dysfunction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] interferon alpha (IFNalpha) [Effect] renal dysfunction"}, {"id": "17277758_2_2188", "context": "CONCLUSIONS: Infectious endophthalmitis is a potential complication of intravitreal bevacizumab injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] intravitreal bevacizumab injection [Effect] Infectious endophthalmitis"}, {"id": "19844714_1_2189", "context": "RESULTS: One case of recurrent primary peritoneal carcinoma previously treated with a carboplatin-based regimen, developed a platinum hypersensitivity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] a carboplatin-based regimen [Effect] a platinum hypersensitivity"}, {"id": "9220046_7_2190", "context": "To our knowledge, these cases are the first published reports of lovastatin-induced rhabdomyolysis associated with azithromycin and clarithromycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] lovastatin; associated with azithromycin and clarithromycin [Effect] rhabdomyolysis"}, {"id": "20038831_3_2191", "context": "Prick tests and intradermal tests with a series of dilutions of carboplatin and cisplatin were performed on three patients who had exhibited medium and severe hypersensitivity reactions to carboplatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exhibited [Subject] three patients [Treatment] carboplatin [Effect] medium and severe hypersensitivity reactions"}, {"id": "15454180_1_2192", "context": "A case of sideroblastic anemia is presented in a patient with a left ventricular assist device drive-line infection who was receiving linezolid, an antibiotic used for serious infections with gram-positive organisms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] a patient with a left ventricular assist device drive-line infection [Treatment] receiving linezolid [Effect] sideroblastic anemia"}, {"id": "8651254_1_2193", "context": "Development of nephrotic syndrome in a patient with acute myeloblastic leukemia after treatment with macrophage-colony-stimulating factor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient with acute myeloblastic leukemia [Treatment] macrophage-colony-stimulating factor [Effect] nephrotic syndrome"}, {"id": "7724306_4_2194", "context": "In patients with a known access to INH, seizures should be considered to be caused by INH toxicity unless proved otherwise.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] INH [Effect] seizures"}, {"id": "12889716_3_2195", "context": "To our knowledge, this is the first case reported in the English literature of a generalized exanthem due to subcutaneous injection of enoxaparin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] the first case [Treatment] subcutaneous injection of enoxaparin [Effect] generalized exanthem"}, {"id": "9634122_3_2196", "context": "This case illustrates the potential decoupling of PSA response from disease status in flutamide withdrawal.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] illustrates [Treatment] flutamide withdrawa [Effect] potential decoupling of PSA response"}, {"id": "2369419_4_2197", "context": "Upon discontinuation of MTX, her ascites resolved, and her arthritis became more active.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Subject] her [Treatment] discontinuation of MTX [Adverse event] active [Subject] her [Treatment] discontinuation of MTX [Effect] arthritis became more active"}, {"id": "19949685_1_2198", "context": "Colonic mucosal necrosis following administration of calcium polystryrene sulfonate (Kalimate) in a uremic patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] administration [Subject] uremic patient [Treatment] calcium polystryrene sulfonate (Kalimate) [Effect] Colonic mucosal necrosis"}, {"id": "6933231_1_2199", "context": "Intracranial hemorrhage and focal seizures secondary to use of L-asparaginase during induction therapy of acute lymphocytic leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary to [Treatment] L-asparaginase [Effect] Intracranial hemorrhage and focal seizures"}, {"id": "21887897_2_2200", "context": "A fatal poisoning case involving etizolam, phenobarbital, promethazine and chlorpromazine is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] involving [Subject] A fatal poisoning case [Treatment] etizolam, phenobarbital, promethazine and chlorpromazine [Effect] A fatal poisoning"}, {"id": "19116715_3_2201", "context": "Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patient with metastatic pancreatic adenocarcinoma [Treatment] gemcitabine [Effect] hemolytic uremic syndrome"}, {"id": "19390192_1_2202", "context": "Leukopenia due to parvovirus B19 in a Crohn's disease patient using azathioprine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] parvovirus B19 in a Crohn's disease patient [Treatment] azathioprine [Effect] Leukopenia"}, {"id": "1477441_3_2203", "context": "Fixed drug eruption of the scrotum due to methylphenidate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] methylphenidate [Effect] Fixed drug eruption of the scrotum"}, {"id": "3470173_2_2204", "context": "Cytarabine-induced cerebellar syndrome: case report and literature review.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Cytarabine [Effect] cerebellar syndrome"}, {"id": "10513720_2_2205", "context": "We report a case of glaucoma induced by doxetaxel therapy for metastatic breast cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] doxetaxel therapy for metastatic breast cancer [Effect] glaucoma"}, {"id": "8301877_3_2206", "context": "Myoclonus was induced and enhanced by L-dopa, developing into generalized seizures.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced and enhanced [Treatment] L-dopa [Effect] developing into generalized seizures; Myoclonus"}, {"id": "15494638_4_2207", "context": "During analysis of 28 patients receiving CAP with concomitant radiation (XRT) for pancreatic cancer (resected or locally advanced), two patients developed signs and symptoms consistent with peripheral neuropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two patients [Treatment] CAP with concomitant radiation (XRT) [Effect] peripheral neuropathy"}, {"id": "25515435_8_2208", "context": "A liver biopsy in 2012 revealed marked fibrosis, leading the patient to start hepatitis C treatment with peginterferon alfa-2a, ribavirin and boceprevir.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] fibrosis, leading the patient [Treatment] peginterferon alfa-2a, ribavirin and boceprevir"}, {"id": "15494638_19_2209", "context": "Knowledge regarding potential adverse effects of CAP is paramount and dose modification is indicated with development of neurotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse effects [Treatment] CAP [Effect] neurotoxicity"}, {"id": "11111942_2_2210", "context": "We present a case of significant over-anticoagulation temporally associated with a bout of protracted diarrhea in a patient on warfarin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] over-anticoagulation [Treatment] warfarin [Effect] protracted diarrhea"}, {"id": "11160777_1_2211", "context": "New oral therapies for type 2 diabetes mellitus:", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Treatment] oral therapies"}, {"id": "10679548_3_2212", "context": "The case histories are presented of two patients who developed lung disease associated with the use of nitrofurantoin with histological features of bronchiolitis obliterans organising pneumonia (BOOP), a rare but recognised form of drug induced injury.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two patients [Treatment] the use of nitrofurantoin [Effect] lung disease; with histological features of bronchiolitis obliterans organising pneumonia (BOOP)"}, {"id": "7226916_1_2213", "context": "A 57-year-old woman with right bundle branch block +LPH and ventricular premature contractions developed complete heart block (CHB) following administration of disopyramide phosphate (Norpace).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 57-year-old woman with right bundle branch block +LPH and ventricular premature contractions [Treatment] disopyramide phosphate (Norpace) [Effect] complete heart block (CHB)"}, {"id": "14700673_3_2214", "context": "METHODS: In an institutional practice setting, two women, aged 25 and 45, developed acute myopia after starting topiramate for epilepsy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two women, aged 25 and 45 [Treatment] topiramate [Effect] acute myopia"}, {"id": "16411025_2_2215", "context": "Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] methotrexate [Effect] subacute; neurotoxicity"}, {"id": "16298824_3_2216", "context": "ARDS is rarely associated with rituximab infusion for lympho-proliferative disorders, but it should be considered by those administering rituximab, especially when a patient develops severe pulmonary symptoms soon after infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient [Treatment] infusion; rituximab [Effect] ARDS; severe pulmonary symptoms"}, {"id": "7351000_3_2217", "context": "Seven of the eight cases of acute leukemia occurred in a series of 553 patients treated with Treosulfan for ovarian cancer in the period from 1970 to 1977 and followed closely for a total of 1159 patient-years up to February 1978.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] Seven of the eight cases [Treatment] Treosulfan [Effect] acute leukemia"}, {"id": "6833205_2_2218", "context": "Desipramine-associated SIADH in an elderly woman: case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] an elderly woman [Treatment] Desipramine [Effect] SIADH"}, {"id": "16146480_1_2219", "context": "Can propofol precipitate pancreatitis in patients with Cushing's syndrome?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitate [Subject] patients with Cushing's syndrome? [Treatment] propofol [Effect] pancreatitis"}, {"id": "23552010_3_2220", "context": "This case presents the possibility of anaphylaxis to topical 5-FU treatments and/or the interaction with angiotensin converting enzyme inhibitors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] 5-FU; angiotensin converting enzyme inhibitors [Effect] anaphylaxis"}, {"id": "15331204_8_2221", "context": "After stopping indapamide, glucose tolerance impairing may be reversed.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] stopping [Treatment] indapamide, glucose tolerance impairing"}, {"id": "11424102_3_2222", "context": "We describe a case of needle-track cutaneous seeding of hepatocellular carcinoma (HCC) after sonographically guided percutaneous ethanol injection (PEI).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] sonographically guided percutaneous ethanol injection [Effect] needle-track cutaneous seeding of hepatocellular carcinoma"}, {"id": "8083821_3_2223", "context": "Zidovudine use in pregnancy: a report on 104 cases and the occurrence of birth defects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurrence [Treatment] Zidovudine [Effect] birth defects"}, {"id": "2369419_1_2224", "context": "A patient with seropositive rheumatoid arthritis developed ascites while taking weekly doses of methotrexate (MTX).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient with seropositive rheumatoid arthritis [Treatment] taking weekly doses of methotrexate (MTX) [Effect] ascites"}, {"id": "18453852_1_2225", "context": "High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] healthy volunteers [Treatment] rifampicin and adjusted doses of lopinavir/ritonavir tablets [Effect] High incidence of adverse events"}, {"id": "14735388_2_2226", "context": "We report here a case of TEN after administration of ciprofloxacin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] administration [Subject] a case [Treatment] ciprofloxacin [Effect] TEN"}, {"id": "20120657_3_2227", "context": "Zidovudine induced pure red cell aplasia: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] Zidovudine [Effect] pure red cell aplasia"}, {"id": "17406804_1_2228", "context": "A case of recall pneumonitis induced by gemcitabine is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] A case [Treatment] gemcitabine [Effect] recall pneumonitis"}, {"id": "7893301_1_2229", "context": "Albuterol-induced hypokalemia and its potential cardiac toxicity are discussed briefly.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Albuterol [Effect] hypokalemia and its potential cardiac toxicity"}, {"id": "9653495_15_2230", "context": "In the absence of an ideal dose-intense FU monotherapy regimen, monthly FU with low-dose LV provides a simple and economical means by which to achieve adequate FU efficacy in the treatment of advanced colorectal cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] monthly FU with low-dose LV"}, {"id": "12503933_6_2231", "context": "OBJECTIVE: To report a patient developing fulminant liver failure while being treated with clarithromycin for pneumonia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] a patient [Treatment] clarithromycin [Effect] fulminant liver failure"}, {"id": "6529939_3_2232", "context": "The abnormal rhythm disappeared with the withdrawal of propranolol and when the drug was restarted a 2/1 S-A block was seen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] seen [Treatment] propranolol [Effect] 2/1 S-A block"}, {"id": "19826099_3_2233", "context": "The Naranjo probability scale indicated a probable relationship between apnea and exposure to lamotrigine through breast-feeding in this infant.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] a probable relationship [Subject] in this infant [Treatment] lamotrigine through breast-feeding [Effect] apnea"}, {"id": "16757971_2_2234", "context": "Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] temozolomide [Effect] Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma"}, {"id": "9920368_3_2235", "context": "Since amiodarone was first marketed in 1992 in Japan, the incidence of amiodarone-induced thyrotoxicosis (AIT) has been increasing.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] amiodarone [Effect] thyrotoxicosis (AIT)"}, {"id": "7619765_2_2236", "context": "The occurrence of a myocardial infarction is reported after chemotherapy containing etoposide, in a man with no risk factors for coronary heart disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a man with no risk factors for coronary heart disease [Treatment] chemotherapy containing etoposide [Effect] myocardial infarction"}, {"id": "889156_1_2237", "context": "The use of beclomethasone diproprionate inhaler complicated by the development of an eosinophilic pneumonia reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] beclomethasone diproprionate inhaler [Effect] eosinophilic pneumonia reaction"}, {"id": "7577414_1_2238", "context": "Nephrotic syndrome related to systemic lupus erythematosus after griseofulvin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] griseofulvin [Effect] Nephrotic syndrome related to systemic lupus erythematosus"}, {"id": "9554064_3_2239", "context": "Theoretical basal ganglia toxicologic mechanisms of methanol poisoning are reviewed, and the role of brain imaging studies will regard to diagnosis, prognosis and impact on management is discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] mechanisms [Treatment] methanol [Effect] poisoning"}, {"id": "8485005_3_2240", "context": "We report a case of drug-induced Kaposi's sarcoma (KS) on the sole of the right foot in a 71-year-old man, treated for 6 months with corticosteroid therapy (prednisolone 25 mg/day) for pericardial effusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case of; a 71-year-old man; for pericardial effusion [Treatment] 6 months with corticosteroid therapy (prednisolone 25 mg/day) [Effect] Kaposi's sarcoma (KS)"}, {"id": "16196187_3_2241", "context": "We present a case of acute epinephrine toxicity resulting in acute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed severe allergic reaction to intravenous immunoglobulin, and was subsequently given epinephrine by mistake intravenously rather than subcutaneously.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Subject] a young boy with combined variable immunodeficiency syndrome [Treatment] acute epinephrine; intravenous immunoglobulin, and was subsequently given epinephrine by mistake intravenously rather than subcutaneously [Effect] acute myocardial ischemia; severe allergic reaction"}, {"id": "8363533_1_2242", "context": "Albeit rare among Western patients, such lithium-associated thyroid dysfunctions appeared to be more likely to occur in Hong Kong Chinese.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] Hong Kong Chinese [Treatment] lithium [Effect] thyroid dysfunctions"}, {"id": "25671244_2_2243", "context": "Metaxalone has only recently been associated with serotonin syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Metaxalone [Effect] serotonin syndrome"}, {"id": "19235747_1_2244", "context": "Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is reported in up to 18.6% of patients treated with intravenous bisphosphonates and can result in significant morbidity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] 18.6% of patients [Treatment] intravenous bisphosphonates [Effect] osteonecrosis of the jaw (BRONJ)"}, {"id": "8691927_3_2245", "context": "Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] in [Subject] asthmatic children [Treatment] high-dose fluticasone propionate [Effect] Growth and adrenal suppression"}, {"id": "14674674_1_2246", "context": "A diagnosis of infliximab-induced lupus was made and the drug treatment was withdrawn.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] infliximab [Effect] lupus"}, {"id": "10510156_2_2247", "context": "AIMS: To identify the  human cytochrome P450 enzyme (s) involved in the in vitro metabolism of rosiglitazone, a potential oral antidiabetic agent for the treatment of type 2 diabetes-mellitus.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] potential oral [Treatment] rosiglitazone"}, {"id": "2011096_5_2248", "context": "Neurotoxicity can occur at any time using high-dose cytosine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occur [Treatment] high-dose cytosine [Effect] Neurotoxicity"}, {"id": "3677571_15_2249", "context": "The possibility of phenytoin hypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly fever, rash, and lymphadenopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Treatment] phenytoin [Effect] phenytoin hypersensitivity; fever, rash, and lymphadenopathy"}, {"id": "9360190_2_2250", "context": "Magnesium tocolysis as the cause of urinary calculus during pregnancy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Magnesium tocolysis [Effect] urinary calculus during pregnancy"}, {"id": "14601701_1_2251", "context": "Ocular ethambutol toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] Ocular ethambutol [Effect] toxicity"}, {"id": "8891729_1_2252", "context": "Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] fludarabine treatment [Effect] Fatal intravascular autoimmune hemolytic anemia"}, {"id": "14557583_1_2253", "context": "A 74-year-old patient with idiopathic Parkinson's disease was evaluated for unintended sleep episodes that occurred after long-term treatment with 400 mg/day of L-dopa.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 74-year-old patient with idiopathic Parkinson's disease [Treatment] long-term treatment with 400 mg/day of L-dopa [Effect] unintended sleep episodes"}, {"id": "6683487_2_2254", "context": "Thrombotic thrombocytopenic purpura (TTP) developed in a patient with seropositive rheumatoid arthritis (RA) after 2 1/2 months of treatment with penicillamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with seropositive rheumatoid arthritis (RA) [Treatment] 2 1/2 months of treatment with penicillamine [Effect] Thrombotic thrombocytopenic purpura (TTP)"}, {"id": "9337441_1_2255", "context": "Phenolphthalein-induced toxic epidermal necrolysis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Phenolphthalein [Effect] toxic epidermal necrolysis"}, {"id": "1536494_2_2256", "context": "We present a case of ethylenediamine-induced delayed hypersensitivity reaction in a 46-year-old woman who received parenteral aminophylline for an acute asthma exacerbation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a 46-year-old woman [Treatment] ethylenediamine [Effect] delayed hypersensitivity reaction [Potential therapeutic event] received [Subject] a 46-year-old woman [Treatment] parenteral aminophylline"}, {"id": "8730143_2_2257", "context": "Physicians should be aware of the potentially lethal side effects of dapsone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] dapsone [Effect] lethal side effects"}, {"id": "3753891_1_2258", "context": "Acute myocardial necrosis during administration of amsacrine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] amsacrine [Effect] Acute myocardial necrosis"}, {"id": "12699871_2_2259", "context": "Rapid identification of speech loss linked to FK506 may be important because reduction or cessation of the drug may be associated with reverse of speech loss.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] linked [Treatment] FK506 [Effect] speech loss"}, {"id": "667809_2_2260", "context": "Fatal pulmonary fibrosis following 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy [Effect] pulmonary fibrosis"}, {"id": "8862924_4_2261", "context": "The increasing prevalence of methamphetamine abuse and the severity of the associated ulcers should alert ophthalmologists to the problem of methamphetamine-related keratitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] methamphetamine abuse; methamphetamine [Effect] associated ulcers; keratitis"}, {"id": "15735923_5_2262", "context": "MDS was diagnosed 8.4 months after beginning TMZ.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] diagnosed [Treatment] 8.4 months after beginning TMZ [Effect] MDS"}, {"id": "8979664_3_2263", "context": "Uveitis associated with rifabutin therapy: a clinical alert.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] rifabutin therapy [Effect] Uveitis"}, {"id": "18698687_3_2264", "context": "We report a case of a patient with ciprofloxacin-induced SJS and acute onset of VBDS, and reviewed the related literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient [Treatment] ciprofloxacin [Effect] SJS; acute onset of VBDS"}, {"id": "8880251_3_2265", "context": "This case supports the assessment that MH and diabetes are associated diseases and that cresol could possibly trigger MH.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] trigger [Treatment] cresol [Effect] MH"}, {"id": "12150593_1_2266", "context": "Neonatal mydriasis: intravenous lidocaine adverse reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse reaction [Subject] Neonatal [Treatment] lidocaine [Effect] Neonatal mydriasis"}, {"id": "3417739_1_2267", "context": "Acute renal failure in a patient treated by continuous povidone-iodine mediastinal irrigation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient [Treatment] continuous povidone-iodine mediastinal irrigation [Effect] Acute renal failure"}, {"id": "7577414_2_2268", "context": "To our knowledge, this is the first case of griseofulvin-exacerbated lupus in which nephrotic syndrome has been observed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exacerbated [Subject] the first case [Treatment] griseofulvin [Effect] lupus; nephrotic syndrome"}, {"id": "12630660_6_2269", "context": "After reviewing the literature we suggest the CPM was a complication of lithium toxicity which affected the lateral geniculate nucleus which produced blindness.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] lithium [Effect] CPM; lithium toxicity; blindness"}, {"id": "1267457_1_2270", "context": "A 71-year-old man, who had a history of a previous bullous drug reaction to a sulfonamide, began receiving an ophthalmic preparation that contained sulfacetamide sodium.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reaction [Subject] A 71-year-old man [Treatment] sulfonamide [Effect] bullous"}, {"id": "9022114_4_2271", "context": "The authors report on two patients with corneal ulcers refractory to conventional treatment while the patients were undergoing oral colchicine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] undergoing [Subject] two patients [Treatment] oral colchicine therapy [Effect] corneal ulcers"}, {"id": "2937155_3_2272", "context": "Vancomycin-induced vasculitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Vancomycin [Effect] vasculitis"}, {"id": "8641617_2_2273", "context": "Based on our findings, it is thus concluded that cisplatin may cause C. difficile colitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] cisplatin [Effect] C. difficile colitis"}, {"id": "7249424_2_2274", "context": "Nephrotic syndrome associated with lithium therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] lithium therapy [Effect] Nephrotic syndrome"}, {"id": "10728450_1_2275", "context": "We report 2 patients who developed polyarteritis nodosa following vaccination against hepatitis B.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 2 patients [Treatment] vaccination against hepatitis B [Effect] polyarteritis nodosa"}, {"id": "7594371_3_2276", "context": "We recommend the cautious use of ketorolac in patients with underlying illnesses where NSAID-induced ototoxicity could result in adverse otologic consequences.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] where [Subject] patients with underlying illnesses [Treatment] ketorolac [Effect] NSAID-induced ototoxicity could result in adverse otologic consequences"}, {"id": "19660974_1_2277", "context": "Colitis as a manifestation of infliximab-associated disseminated cryptococcosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] infliximab [Effect] Colitis"}, {"id": "8276031_2_2278", "context": "A 15-month-old girl with rhinopharyngitis was treated with a nasal solution containing the imidazoline derivative naphazoline.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] A 15-month-old girl with rhinopharyngitis [Treatment] a nasal solution containing the imidazoline derivative naphazoline"}, {"id": "9804082_1_2279", "context": "Three diabetic cases of acute dizziness due to initial administration of voglibose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] Three diabetic cases [Treatment] initial administration of voglibose [Effect] acute dizziness"}, {"id": "14607011_1_2280", "context": "Fatal cold medication intoxication in an infant.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] infant [Treatment] cold medication [Effect] Fatal cold medication intoxication"}, {"id": "7779233_1_2281", "context": "Case study: a modified topical treatment regimen for sodium warfarin-induced necrotizing fasciitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] sodium warfarin [Effect] necrotizing fasciitis"}, {"id": "16211208_2_2282", "context": "Marked QT prolongation and torsades de pointes secondary to acute ischemia in an elderly man taking dofetilide for atrial fibrillation: a cautionary tale.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] an elderly man [Treatment] dofetilide [Effect] Marked QT prolongation and torsades de pointes secondary to acute ischemia"}, {"id": "18431096_1_2283", "context": "Methylphenidate and dextroamphetamine-induced peripheral vasculopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Methylphenidate and dextroamphetamine [Effect] peripheral vasculopathy"}, {"id": "8969033_3_2284", "context": "The reversal of heparin by protamine may cause severe hemodynamic deterioration, characterized by systemic hypotension, pulmonary hypertension, and bronchoconstriction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] The reversal of heparin by protamine [Effect] severe hemodynamic deterioration; systemic hypotension, pulmonary hypertension, and bronchoconstriction"}, {"id": "19826099_1_2285", "context": "OBJECTIVE: To report a case of severe apnea in an infant exposed to lamotrigine through breast-feeding.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] an infant [Treatment] exposed to lamotrigine through breast-feeding [Effect] severe apnea"}, {"id": "1316047_1_2286", "context": "Hemodynamic collapse following labetalol administration in preeclampsia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] labetalol [Effect] Hemodynamic collapse"}, {"id": "18801826_3_2287", "context": "We report a case of a 35-year old female who developed new onset type II diabetes mellitus with hyperosmolar hyperglycaemic coma and acute renal failure following treatment with a SGA for a first manic episode.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 35-year old female [Treatment] treatment with a SGA [Effect] type II diabetes mellitus with hyperosmolar hyperglycaemic coma and acute renal failure"}, {"id": "8503421_3_2288", "context": "We report the occurrence of renal failure due to cholesterol crystal embolization following thrombolytic therapy with intravenous recombinant tissue-type plasminogen activator (t-PA).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurrence [Treatment] thrombolytic therapy with intravenous recombinant tissue-type plasminogen activator (t-PA) [Effect] renal failure due to cholesterol crystal embolization"}, {"id": "9161656_8_2289", "context": "The asthma resolved within 24 hours following three albuterol inhalations.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Treatment] three albuterol inhalations"}, {"id": "2875665_2_2290", "context": "Administration of amantadine was associated with psychotic decompensations in two schizophrenic patients being maintained on concomitant neuroleptic medication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] two schizophrenic patients [Treatment] concomitant neuroleptic medication; amantadine [Effect] psychotic decompensations"}, {"id": "6998294_1_2291", "context": "Clinicians should be aware of fasting hypoglycemia as an unusual but potentially serious complication of disopyramide therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] disopyramide [Effect] fasting hypoglycemia"}, {"id": "1569260_1_2292", "context": "To the best of our knowledge, this is the first reported patient with captopril-induced pemphigus in whom no new lesions developed after subsequent treatment with enalapril.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patient [Treatment] captopril [Effect] pemphigus"}, {"id": "9494448_5_2293", "context": "Fortunately, a hypersensitivity reaction to one formulation of cyclosporine does not preclude use of a different formulation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Treatment] one formulation of cyclosporine [Effect] hypersensitivity reaction"}, {"id": "11302479_1_2294", "context": "She developed a severe urticarial rash 3 weeks following initiation of therapy with Enoxaparin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] Enoxaparin [Effect] urticarial rash"}, {"id": "9545161_3_2295", "context": "Fatal toxic epidermal necrolysis related to lamotrigine administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related to [Treatment] lamotrigine administration [Effect] Fatal toxic epidermal necrolysis"}, {"id": "11918514_3_2296", "context": "OBJECTIVE: To document a case of serotonin syndrome (SS) associated with mirtazapine monotherapy, review the previously reported cases of SS associated with this tetracyclic antidepressant, and discuss the possible pathogenic mechanisms leading to this serious adverse drug reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a case [Treatment] mirtazapine monotherapy [Effect] serotonin syndrome (SS)"}, {"id": "15331204_6_2297", "context": "CONCLUSION: Therapy with indapamide may induce diabetes in essential hypertension patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Subject] essential hypertension patients [Treatment] indapamide [Effect] diabetes"}, {"id": "11033836_2_2298", "context": "Placebo-controlled clinical trials of recombinant human interleukin-11 (rhIL-11, also known as oprelvekin [Neumega]) in patients with nonmyeloid malignancies have demonstrated significant efficacy in preventing postchemotherapy platelet nadirs of < or = 20,000/microL, and reducing the need for platelet transfusions while continuing chemotherapy without dose reductions.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] preventing [Subject] patients with nonmyeloid malignancies [Treatment] recombinant human interleukin-11 (rhIL-11, also known as oprelvekin [Neumega])"}, {"id": "115078_1_2299", "context": "A patient with rheumatoid arthritis developed an acute intrahepatic cholestasis after 100 mg of sodium aurothiomalate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient with rheumatoid arthritis [Treatment] 100 mg of sodium aurothiomalate [Effect] acute intrahepatic cholestasis"}, {"id": "17965530_2_2300", "context": "We concluded that the colonic ulcer and the sigmoidovesical fistula had been caused by the administration of calcium polystyrene sulfonate and sorbitol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] calcium polystyrene sulfonate and sorbitol [Effect] colonic ulcer and the sigmoidovesical fistula"}, {"id": "15606443_2_2301", "context": "Rosiglitazone, a thiazolidinedione antidiabetic medication used in the treatment of Type 2 diabetes mellitus, is predominantly metabolized by the cytochrome P450 (CYP) enzyme CYP2C8.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used [Treatment] Rosiglitazone; a thiazolidinedione antidiabetic medication"}, {"id": "17873198_1_2302", "context": "Interstitial lung disease (ILD) related to therapy with the drug gefitinib has been well reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] therapy with the drug gefitinib [Effect] Interstitial lung disease (ILD)"}, {"id": "19540093_1_2303", "context": "According to the Naranjo adverse drug reaction probability scale, tigecycline was the probable cause of her acute pancreatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] tigecycline [Effect] acute pancreatitis"}, {"id": "15479299_2_2304", "context": "We report a case of severe anemia, which responded well to steroid therapy, in a patient receiving IL-2 plus IFN-alpha for metastatic renal cell carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] a patient [Treatment] IL-2 plus IFN-alpha [Effect] severe anemia [Potential therapeutic event] responded [Treatment] steroid"}, {"id": "17420198_17_2305", "context": "The patient's movements resolved following diphenhydramine administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resolved [Treatment] diphenhydramine"}, {"id": "10679548_5_2306", "context": "The spectrum of nitrofurantoin lung injury continues to widen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] widen [Treatment] nitrofurantoin [Effect] lung injury"}, {"id": "12243603_10_2307", "context": "We describe a patient with a complex medication regimen who was admitted for rhabdomyolysis and accompanying acute renal failure, along with acute hepatitis, thought to be secondary to a drug interaction between atorvastatin and diltiazem.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Subject] a patient [Treatment] atorvastatin; diltiazem [Effect] rhabdomyolysis and accompanying acute renal failure, along with acute hepatitis"}, {"id": "11077455_4_2308", "context": "The current study investigated the visual fields and visual electrophysiology of eight patients with known vigabatrin-attributed visual field loss, three of whom were reported previously.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attributed [Subject] eight patients [Treatment] vigabatrin [Effect] visual field loss"}, {"id": "10840527_1_2309", "context": "Although the literature on the use of risperidone in elderly patients with dementia consists largely of uncontrolled trials, case reports, and chart reviews, it appears that this agent is effective for managing agitation in this population and does so with a low frequency of extrapyramidal symptoms (EPS).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] is [Subject] elderly patients with dementia [Treatment] use of risperidone"}, {"id": "18294121_4_2310", "context": "Temozolomide-induced desquamative skin rash in a patient with metastatic melanoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with metastatic melanoma [Treatment] Temozolomide [Effect] desquamative skin rash"}, {"id": "4066622_2_2311", "context": "The calcium channel blockers are a group of drugs that have recently become available for the treatment of angina.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] calcium channel blockers"}, {"id": "10723699_2_2312", "context": "We report on a young adolescent with benign intracranial hypertension which we attribute to the use of minocycline for acne.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attribute [Subject] a young adolescent [Treatment] minocycline [Effect] benign intracranial hypertension"}, {"id": "18795_1_2313", "context": "A 10-year-old asthmatic boy began to suffer from urticarial rash and moderately severe bronchospasm after 8 weeks' treatment with disodium cromoglycate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 10-year-old asthmatic boy [Treatment] 8 weeks' treatment with disodium cromoglycate [Effect] urticarial rash and moderately severe bronchospasm"}, {"id": "2796025_1_2314", "context": "Panic anxiety after abrupt discontinuation of mianserin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] abrupt discontinuation of mianserin [Effect] Panic anxiety"}, {"id": "17873198_4_2315", "context": "This case and other published evidence should alert physicians to the possibility of fatal erlotinib-induced ILD.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] This case [Treatment] erlotinib [Effect] ILD"}, {"id": "17987285_3_2316", "context": "Recent reports suggest that concomitant administration of CYP3A inhibitors with fentanyl may lead to dangerous drug interactions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] lead [Treatment] concomitant administration of CYP3A inhibitors with fentanyl [Effect] drug interactions"}, {"id": "21751666_4_2317", "context": "Post-exposure prophylaxis of H1N1 with oseltamivir was safe, effective and well tolerated to prevent H1N1 influenza A virus infection in newly transplanted renal allograft recipient receiving triple immunosuppression without any interaction with tacrolimus level.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prophylaxis [Subject] newly transplanted renal allograft recipient [Treatment] oseltamivir; without any interaction with tacrolimus level [Effect] safe, effective and well tolerated to prevent H1N1 influenza A virus infection"}, {"id": "8672829_3_2318", "context": "DISCUSSION: Central nervous system (CNS) toxicity has been described with ifosfamide, with most cases reported in the pediatric population.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] described [Subject] in the pediatric population [Treatment] ifosfamide [Effect] Central nervous system (CNS) toxicity"}, {"id": "12796597_2_2319", "context": "Despite the underlying hepatitis C, this case represents renal abnormalities consistent with IFNalpha therapy for CML.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] consistent [Subject] this case [Treatment] IFNalpha therapy [Effect] renal abnormalities"}, {"id": "11131346_4_2320", "context": "CONCLUSION: To the best of our knowledge, this is the first time colchicine intoxication in this age group has been described in the English literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] intoxication [Treatment] colchicine [Effect] colchicine intoxication"}, {"id": "85289_2_2321", "context": "We have seen a case of terminal malignant melanoma in which clinical manifestations, indicative of anterior spinal artery syndrome, developed following the injection of 0.3 ml of 10% phenol-glycerine into the cervical subarachnoid space at the C4--C5 level for the control of severe right arm pain.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] the injection of 0.3 ml of 10% phenol-glycerine into the cervical subarachnoid space at the C4--C5 level [Effect] terminal malignant melanoma in which clinical manifestations, indicative of anterior spinal artery syndrome"}, {"id": "10904571_2_2322", "context": "Colchicine-induced myopathy in renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Colchicine [Effect] myopathy"}, {"id": "7679525_4_2323", "context": "This report suggests that bleomycin lung toxicity may be reversible if treated aggressively.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Treatment] bleomycin [Effect] lung toxicity"}, {"id": "15840734_8_2324", "context": "DISCUSSION: NMS is a rare but potentially fatal reaction associated with neuroleptic drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] neuroleptic drugs [Effect] NMS"}, {"id": "1378497_3_2325", "context": "Scleroderma in association with the use of bleomycin: a report of 3 cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Subject] 3 cases [Treatment] bleomycin [Effect] Scleroderma"}, {"id": "19733945_1_2326", "context": "Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Linezolid [Effect] acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome"}, {"id": "16012330_5_2327", "context": "A 3-year-old boy diagnosed with acute lymphoblastic leukemia received induction chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] received [Subject] A 3-year-old boy diagnosed with acute lymphoblastic leukemia [Treatment] induction chemotherapy"}, {"id": "17438184_8_2328", "context": "Interferon and other immunostimulatory medications can lead to an exacerbation of this preexisting low-grade chronic inflammation that is quite similar to interferon-triggered sarcoidosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] lead [Treatment] Interferon and other immunostimulatory medications [Effect] exacerbation of this preexisting low-grade chronic inflammation"}, {"id": "2768785_1_2329", "context": "Intravenous cytarabine and methotrexate appear to act synergistically to enhance the potential for central nervous system toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] enhance [Treatment] Intravenous cytarabine and methotrexate [Effect] central nervous system toxicity"}, {"id": "12150593_3_2330", "context": "We suggest adding this side effect to the list of untoward effects of lidocaine and to the differential diagnosis of fixed dilated pupils in neonates treated with lidocaine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] neonates [Treatment] lidocaine [Effect] side effect"}, {"id": "17444802_14_2331", "context": "CONCLUSIONS: Topical INF alpha 2-beta is a valid choice for the treatment of CIN in patients for whom surgery is not possible.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] a valid choice [Subject] patients for whom surgery is not possible [Treatment] Topical INF alpha 2-beta"}, {"id": "9247841_4_2332", "context": "We report 3 patients who developed cutaneous vasculitis which is a rare and serious side-effect during antithyroid drug therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 3 patients [Treatment] during antithyroid drug therapy [Effect] cutaneous vasculitis"}, {"id": "1621023_3_2333", "context": "Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] depression and obsessive-compulsive disorder [Treatment] fluoxetine treatment [Effect] Prominent eye movements during NREM sleep and REM sleep behavior disorder"}, {"id": "10963515_1_2334", "context": "Allergic reaction to gemfibrozil manifesting as eosinophilic gastroenteritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Allergic reaction [Treatment] gemfibrozil [Effect] eosinophilic gastroenteritis"}, {"id": "16432996_14_2335", "context": "We suggest that sarcoidosis may develop in chronic hepatitis C patients during interferon alpha and/or ribavirin treatment, and diagnostic tests for this adverse effect should be performed during the follow-ups.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] chronic hepatitis C patients [Treatment] interferon alpha and/or ribavirin [Effect] sarcoidosis"}, {"id": "25417855_2_2336", "context": "Azole antifungals, prescribed prophylactically to avoid severe infections in immunosuppressed organ transplant recipients, can interact with drug substrates of CYP3A4.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] interact [Subject] immunosuppressed organ transplant recipients [Treatment] Azole antifungals; drug substrates of CYP3A4"}, {"id": "11576059_2_2337", "context": "We present the case of a 5-year-old girl who developed bilateral vocal cord paralysis following preoperative peritonsillar bupivacaine infiltration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a 5-year-old girl [Treatment] preoperative peritonsillar bupivacaine infiltration [Effect] bilateral vocal cord paralysis"}, {"id": "20338114_1_2338", "context": "One patient suffered coronary artery vasospasm, attributed to the use of topical 1:1000 epinephrine during surgery.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attributed [Subject] One patient [Treatment] topical 1:1000 epinephrine during surgery [Effect] coronary artery vasospasm"}, {"id": "16396068_1_2339", "context": "Trimethoprim-sulfamethoxazole-induced aseptic meningitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Trimethoprim-sulfamethoxazole [Effect] aseptic meningitis"}, {"id": "9256906_4_2340", "context": "We describe a patient with metastatic prostate cancer who developed nonoliguric renal failure during treatment with suramin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a patient with metastatic prostate cancer [Treatment] suramin [Effect] nonoliguric renal failure"}, {"id": "10656221_10_2341", "context": "In conclusion, this case strongly suggests that gliclazide can induce acute icteric liver necro-inflammation which may be misdiagnosed clinically as acute viral hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Subject] this case [Treatment] gliclazide [Effect] acute icteric liver necro-inflammation"}, {"id": "15685264_7_2342", "context": "After administration of Oxybutynin concomitantly with an increase in the dose of Dantrolene, she presented the clinical symptoms and laboratory finding of Carbamazepine intoxication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] After [Subject] she [Treatment] Oxybutynin concomitantly with an increase in the dose of Dantrolene; Carbamazepine [Effect] clinical symptoms and laboratory finding of Carbamazepine intoxication"}, {"id": "21597286_4_2343", "context": "A methotrexate overdosage was shown at 36 h after infusion associated with a severe renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] methotrexate [Effect] methotrexate overdosage was shown at 36 h after infusion; severe renal failure"}, {"id": "18717612_1_2344", "context": "Ceftriaxone-induced fixed drug eruption: first report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Ceftriaxone [Effect] fixed drug eruption"}, {"id": "7594371_4_2345", "context": "We report the case of a 20-year-old female with polyarteritis nodosa (PAN) who developed bilateral sensorineural hearing loss 25 minutes after receiving 30 mg of intravenous ketoralac.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 20-year-old female with polyarteritis nodosa (PAN) [Treatment] 30 mg of intravenous ketoralac [Effect] bilateral sensorineural hearing loss"}, {"id": "19915794_4_2346", "context": "We report an 82-year-old man who developed ventricular tachycardia and Torsades de Pointes (TdP) after oral administration of garenoxacin, a novel quinolone antibiotic agent that differs from the third-generation quinolones, for pneumonia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] an 82-year-old man [Treatment] oral administration of garenoxacin [Effect] ventricular tachycardia and Torsades de Pointes (TdP)"}, {"id": "12951892_1_2347", "context": "Lethargy in a newborn: lithium toxicity or lab error?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] toxicity [Subject] a newborn [Treatment] lithium [Effect] Lethargy"}, {"id": "18344455_1_2348", "context": "Simultaneous toxicities in a child on multiple anticonvulsants.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] on [Subject] a child [Treatment] multiple anticonvulsants. [Effect] Simultaneous toxicities"}, {"id": "17404582_3_2349", "context": "We report a 71-year male with castration-resistant metastatic prostate cancer who was treated with weekly docetaxel for 12 weeks and developed significant eye irritation and dryness during treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 71-year male with castration-resistant metastatic prostate cancer [Treatment] weekly docetaxel for 12 weeks [Effect] significant eye irritation and dryness"}, {"id": "1621023_2_2350", "context": "In addition, a 31-year-old man with obsessive-compulsive disorder developed RBD soon after starting fluoxetine therapy, which persisted at PSG study 19 months after fluoxetine discontinuation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 31-year-old man with obsessive-compulsive disorder [Treatment] starting fluoxetine therapy [Effect] RBD; which persisted at PSG study 19 months after fluoxetine discontinuation"}, {"id": "24791374_1_2351", "context": "Propafenone associated severe central nervous system and cardiovascular toxicity due to mirtazapine: a case of severe drug interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Treatment] Propafenone; mirtazapine [Effect] central nervous system and cardiovascular toxicity"}, {"id": "582099_2_2352", "context": "Neurotoxicity of intrathecal administration of amphotericin B.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] intrathecal administration of amphotericin B [Effect] Neurotoxicity"}, {"id": "7724306_6_2353", "context": "Parenteral pyridoxine, the specific antidote for INH-induced refractory seizures, should be readily available in every emergency department in the areas similarly experiencing increasing trends of TB.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] INH [Effect] refractory seizures"}, {"id": "9220046_3_2354", "context": "DISCUSSION: Rhabdomyolysis is a clinical syndrome resulting from the destruction of skeletal muscle that may progress to renal failure Several drugs have been associated with rhabdomyolysis, including lovastatin, a hydroxymethylglutaryl-coenzyme A reductase inhibitor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] lovastatin, a hydroxymethylglutaryl-coenzyme A reductase inhibitor [Effect] Rhabdomyolysis is a clinical syndrome resulting from the destruction of skeletal muscle that may progress to renal failure"}, {"id": "20367573_2_2355", "context": "Thrombocytosis associated with enoxaparin: A very rare cause in newborns.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] newborns [Treatment] enoxaparin [Effect] Thrombocytosis"}, {"id": "6837655_2_2356", "context": "The spectrum of renal lesions occurring during antituberculous therapy, particularly in association with rifampin, may be wider than previously suspected.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] antituberculous therapy, particularly in association with rifampin [Effect] The spectrum of renal lesions occurring"}, {"id": "16960880_3_2357", "context": "Native arterial thrombosis, though recognized as a severe complication of thrombin injection, has not been well described in the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] thrombin injection [Effect] Native arterial thrombosis"}, {"id": "21512888_8_2358", "context": "After treatment with levetiracetam, seizures recurred and intravenous loading with valproic acid was administered, but resulted in a rapid increase in international normalized ratio (INR) to 7.6.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] recurred [Treatment] levetiracetam [Effect] seizures [Potential therapeutic event] administered [Treatment] intravenous loading with valproic acid"}, {"id": "18396749_1_2359", "context": "Acute hepatitis with prolonged cholestasis and disappearance of interlobular bile ducts following tibolone and Hypericum perforatum (St. John's wort).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] tibolone and Hypericum perforatum (St. John's wort) [Effect] Acute hepatitis with prolonged cholestasis and disappearance of interlobular bile ducts"}, {"id": "8002140_3_2360", "context": "METHODS: Five cases of contact dermatitis due to budesonide, a nonhalogenated steroid, are described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Subject] Five cases [Treatment] budesonide [Effect] contact dermatitis"}, {"id": "1124417_3_2361", "context": "This sulfonamide like nephropathy should be differentiated from acetazolamide-related calcium phosphate nephrolithiasis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] acetazolamide [Effect] calcium phosphate nephrolithiasis."}, {"id": "17420198_18_2362", "context": "Aripiprazole was subsequently discontinued secondary to its lack of efficacy for OCD and the development of a movement disorder.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] Aripiprazole [Effect] a movement disorder"}, {"id": "12187348_1_2363", "context": "Gigantomastia induced by bucillamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] bucillamine [Effect] Gigantomastia"}, {"id": "20038831_2_2364", "context": "Hypersensitivity to carboplatin has been reported in up to 44% of patients receiving this antineoplastic agent, usually occurring after several courses of treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Subject] 44% of patients [Treatment] carboplatin; after several courses of treatment [Effect] Hypersensitivity"}, {"id": "8908396_1_2365", "context": "CONCLUSIONS: In our reported case, a local hyperproduction of TNF-alpha from macrophages that was induced by the injected insulin could explain the dedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of dexamethasone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] reported case [Treatment] injected insulin [Effect] local hyperproduction of TNF-alpha from macrophages; dedifferentiation of the adipocytes of the subcutaneous tissue"}, {"id": "11144696_9_2366", "context": "Both venlafaxine and trimipramine have been associated with seizures, mainly after overdose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] overdose; venlafaxine and trimipramine [Effect] seizures"}, {"id": "9291634_4_2367", "context": "Thirty-six patients with AL received, in a three-month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside (ARA-C); among them, along with myelosuppression, five experienced fever, infectious complications, gastrointestinal tract symptoms and severe myalgias.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] five [Treatment] chemotherapy; cytosine arabinoside (ARA-C) [Effect] fever, infectious complications, gastrointestinal tract symptoms and severe myalgias"}, {"id": "14674674_2_2368", "context": "Infliximab-induced lupus in Crohn's disease: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] Infliximab [Effect] lupus"}, {"id": "10660641_7_2369", "context": "The infection tended to subside with the AMPH administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] subside [Treatment] AMPH administration [Effect] infection tended"}, {"id": "17228132_2_2370", "context": "CONTEXT: Acute drug induced hepatitis has not been commonly associated with epidermal growth factor receptor (EGFR) inhibitors.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] epidermal growth factor receptor (EGFR) inhibitors [Effect] Acute drug induced hepatitis"}, {"id": "17873198_5_2371", "context": "We report a case of fatal pulmonary toxicity in a patient with advanced non-small cell lung cancer who received erlotinib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] received [Subject] a patient with advanced non-small cell lung cancer [Treatment] erlotinib [Effect] pulmonary toxicity"}, {"id": "16200540_4_2372", "context": "We describe a patient with idiopathic RLS who developed augmentation after 8 months of levodopa treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with idiopathic RLS [Treatment] after 8 months of levodopa treatment [Effect] augmentation"}, {"id": "12923827_3_2373", "context": "This communication describes a patient who developed Schneiderian first-rank symptoms in the course of treatment with fluvoxamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient [Treatment] fluvoxamine [Effect] Schneiderian first-rank symptoms"}, {"id": "3753891_2_2374", "context": "In addition to the recognized arrhythmic complications, the authors emphasize myocardial necrosis as a possible further manifestation of amsacrine-related cardiotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] amsacrine [Effect] myocardial necrosis; cardiotoxicity"}, {"id": "2857534_2_2375", "context": "The authors caution that treatment with alprazolam may be complicated by the induction of mania.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induction of [Treatment] treatment with alprazolam [Effect] mania"}, {"id": "17596682_2_2376", "context": "The use of rituximab has been uncommonly associated with delayed pulmonary toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] rituximab [Effect] delayed pulmonary toxicity"}, {"id": "18515982_6_2377", "context": "We believe that the acute renal failure in our patient was associated with anastrozole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] patient [Treatment] anastrozole [Effect] acute renal failure"}, {"id": "8656412_1_2378", "context": "On the fifth day of tocolysis with magnesium sulfate, nifedipine, terbutaline and betamethasone, edema developed in both labia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] On the fifth day of tocolysis with magnesium sulfate, nifedipine, terbutaline and betamethasone [Effect] edema; in both labia"}, {"id": "6159523_2_2379", "context": "Two patients with extrinsic asthma and coexistent insulin-dependent diabetes mellitus sustained an anaphylactoid reaction after the intravenous administration of 50% solution of dextrose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] Two patients with extrinsic asthma and coexistent insulin-dependent diabetes mellitus [Treatment] intravenous administration of 50% solution of dextrose [Effect] anaphylactoid reaction"}, {"id": "8936932_3_2380", "context": "Cardiac arrest after esmolol administration: a review of acute beta-blocker toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] esmolol [Effect] Cardiac arrest"}, {"id": "3680913_3_2381", "context": "We suggest that nicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the hepatic failure, and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] nicotinic acid [Effect] liver disease"}, {"id": "17277758_3_2382", "context": "METHODS: Two patients with exudative age-related macular degeneration were treated sequentially with an intravitreal injection of bevacizumab and developed signs of severe but painless infectious endophthalmitis 2 days later.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two patients [Treatment] intravitreal injection of bevacizumab; 2 days later [Effect] infectious endophthalmitis"}, {"id": "2586773_1_2383", "context": "Ibuprofen-induced meningitis: detection of intrathecal IgG synthesis and immune complexes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Ibuprofen [Effect] meningitis"}, {"id": "18020545_2_2384", "context": "Tardive oculogyric crisis during treatment with clozapine: report of three cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] three cases [Treatment] clozapine [Effect] Tardive oculogyric crisis"}, {"id": "11506739_1_2385", "context": "Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] low-dose IFN-alpha therapy [Effect] Myasthenia gravis"}, {"id": "12424571_2_2386", "context": "We herein report this rare case of acute onset of nephrotic syndrome during interferon-alpha retreatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] interferon-alpha [Effect] acute onset of nephrotic syndrome"}, {"id": "7393795_2_2387", "context": "Para-aminosalicylic acid-induced hypoglycaemia in a patient with diabetic nephropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with diabetic nephropathy [Treatment] Para-aminosalicylic acid [Effect] hypoglycaemia"}, {"id": "3970339_2_2388", "context": "Ischaemia following selfadministered intra-arterial injection of methylphenidate and diamorphine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] selfadministered intra-arterial injection of methylphenidate and diamorphine [Effect] Ischaemia"}, {"id": "9660541_2_2389", "context": "Mitomycin C-related hemolytic uremic syndrome in cancer patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] cancer patients [Treatment] Mitomycin C [Effect] hemolytic uremic syndrome"}, {"id": "7549443_1_2390", "context": "The second had acute cystitis and was treated by sulphonamide and the third developed myopia coincident with metronidazole treatment for trichomonas vaginalis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] the third [Treatment] metronidazole treatment [Effect] myopia [Potential therapeutic event] treated [Treatment] sulphonamide"}, {"id": "19669617_3_2391", "context": "Acute bilateral phrenic neuropathy following treatment with adalimumab.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] adalimumab [Effect] Acute bilateral phrenic neuropathy"}, {"id": "8921647_4_2392", "context": "Hypoxemia improved during continuous tolazoline infusion, but gastrointestinal bleeding occurred.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] Hypoxemia improved during continuous tolazoline infusion [Effect] gastrointestinal bleeding"}, {"id": "18176653_3_2393", "context": "BACKGROUND: NVP is a non-nucleoside reverse transcriptase inhibitor used in the treatment of Human Immunodeficiency Virus (HIV) infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] used [Treatment] NVP"}, {"id": "7393795_1_2394", "context": "A 62-year-old Indian with diabetic nephropathy controlled with metformin, developed miliary tuberculosis for which he was treated with rifampicin, isoniazid and ethambutol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 62-year-old Indian with diabetic nephropathy [Treatment] metformin [Effect] miliary tuberculosis [Potential therapeutic event] treated [Treatment] rifampicin, isoniazid and ethambutol"}, {"id": "8438851_1_2395", "context": "A patient with acute esophageal variceal bleeding developed fatal rhabdomyolysis during treatment with a continuous intravenous infusion of vasopressin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] A patient with acute esophageal variceal bleeding [Treatment] continuous intravenous infusion of vasopressin [Effect] fatal rhabdomyolysis"}, {"id": "6159523_7_2396", "context": "Preliminary results suggest that the higher concentrations of dextrose induce increased histamine release from blood cells, and that this phenomenon is more marked in diabetic, and particularly diabetic-allergic, individuals.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Subject] diabetic, and particularly diabetic-allergic, individuals [Treatment] higher concentrations of dextrose [Effect] increased histamine release from blood cells"}, {"id": "12243603_12_2397", "context": "All patients beginning HMG-CoA reductase inhibitor therapy should be counseled regarding the signs and symptoms of muscle injury; particular attention should be paid to those patients who are taking medications that may interact.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] regarding [Subject] All patients [Treatment] HMG-CoA reductase inhibitor [Effect] the signs and symptoms of muscle injury"}, {"id": "16498048_4_2398", "context": "Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves' disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Interferon-alpha [Effect] hyperthyroidism; Graves' disease"}, {"id": "16708747_1_2399", "context": "Acute severe intoxication with carbamazepine is associated with seizures, coma and respiratory depression.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] carbamazepine [Effect] Acute severe intoxication"}, {"id": "11022272_2_2400", "context": "CONCLUSION: We have introduced a case of anaphylaxis by calcitonin that suggest an IgE mediated hypersensitivity reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] by [Subject] a case [Treatment] calcitonin [Effect] anaphylaxis"}, {"id": "17188061_2_2401", "context": "PURPOSE: To describe transient structured visual hallucinations in a patient with vascular age-related macular degeneration (AMD), following an intravitreal Avastin-injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a patient with vascular age-related macular degeneration (AMD) [Treatment] an intravitreal Avastin-injection [Effect] transient structured visual hallucinations"}, {"id": "17556909_1_2402", "context": "Bortezomib-induced paralytic ileus is a potential gastrointestinal side effect of this first-in-class anticancer proteasome inhibitor.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Bortezomib [Effect] paralytic ileus"}, {"id": "19904536_15_2403", "context": "Fatal gemcitabine-induced pulmonary toxicity in metastatic   gallbladder adenocarcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] gemcitabine [Effect] pulmonary toxicity"}, {"id": "2611886_1_2404", "context": "It is suggested that the fatal stroke may have resulted from arterial spasm caused by ergotamine overdosage and possibly complicated by thrombosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] ergotamine overdosage [Effect] stroke; arterial spasm"}, {"id": "15770343_2_2405", "context": "During the anti-tuberculous therapy, visual loss can be related to ethambutol toxicity or the tuberculosis infection itself.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] ethambutol [Effect] visual loss"}, {"id": "24429012_1_2406", "context": "Elevated International Normalized Ratio in a patient concurrently using warfarin and vismodegib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] using [Subject] a patient [Treatment] warfarin and vismodegib [Effect] Elevated International Normalized Ratio"}, {"id": "8013261_3_2407", "context": "Occurrence of IDDM during interferon therapy for chronic viral hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] interferon therapy [Effect] IDDM"}, {"id": "3873709_2_2408", "context": "Pseudomembranous colitis readily occurs in at least certain population groups receiving trimethoprim-sulfamethoxazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurs [Subject] certain population groups [Treatment] trimethoprim-sulfamethoxazole [Effect] Pseudomembranous colitis"}, {"id": "8002140_4_2409", "context": "RESULTS: Budesonide use can cause contact dermatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Budesonide [Effect] contact dermatitis"}, {"id": "8340162_1_2410", "context": "Hypertension develops in most patients after transplantation when immunosuppression is based on cyclosporine and prednisone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] when [Subject] most patients [Treatment] after transplantation; immunosuppression is based on cyclosporine and prednisone [Effect] Hypertension"}, {"id": "9831311_3_2411", "context": "It was concluded that potassium loss occurred by a non-renal (intestinal) route in phosphate-induced hypokalemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] phosphate [Effect] potassium loss; hypokalemia"}, {"id": "16498048_5_2412", "context": "We have described three patients with hepatitis C for whom IFN-alpha and ribavirin were prescribed and who developed two successive phases of silent thyroiditis followed by hyperthryroidism relapse due to Graves' disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] three patients with hepatitis C [Treatment] IFN-alpha and ribavirin [Effect] two successive phases of silent thyroiditis followed by hyperthryroidism relapse due to Graves' disease"}, {"id": "3301251_2_2413", "context": "Hepatotoxicity associated with choline magnesium trisalicylate: case report and review of salicylate-induced hepatotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] case [Treatment] choline magnesium trisalicylate [Effect] Hepatotoxicity"}, {"id": "10891991_3_2414", "context": "CONCLUSIONS: The 3 cases presented here illustrate the development of reproductive endocrine disorders after the initiation of valproate therapy in women with epilepsy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] The 3 cases; women with epilepsy [Treatment] after the initiation of valproate therapy [Effect] reproductive endocrine disorders"}, {"id": "3346128_1_2415", "context": "A 43-year-old white man developed a shallow erosion of a psoriatic plaque after chronic administration of methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 43-year-old white man [Treatment] chronic administration of methotrexate [Effect] shallow erosion of a psoriatic plaque"}, {"id": "20126479_1_2416", "context": "CONCLUSIONS: SD-OCT and AO detected abnormalities that correlate topographically with visual field loss from hydroxychloroquine toxicity as demonstrated by HVF 10-2 and may be useful in the detection of subclinical abnormalities that precede symptoms or objective visual field loss.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Treatment] hydroxychloroquine [Effect] visual field loss"}, {"id": "18805724_2_2417", "context": "Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with rheumatoid arthritis [Treatment] Leflunomide [Effect] toxic epidermal necrolysis"}, {"id": "2295443_2_2418", "context": "Delayed bowel injury is an infrequently observed complication of chromic phosphate administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] chromic phosphate administration [Effect] Delayed bowel injury"}, {"id": "19034138_7_2419", "context": "Therefore, amantadine was permanently discontinued and the cornea cleared again.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] was [Treatment] amantadine [Effect] cornea cleared"}, {"id": "8530331_8_2420", "context": "CONCLUSION: We believe that risperidone is not a substitute for clozapine in treating psychosis in parkinsonian patients and should be used with caution.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treating [Subject] parkinsonian patients [Treatment] risperidone [Potential therapeutic event] treating [Subject] parkinsonian patients [Treatment] clozapine"}, {"id": "16767537_1_2421", "context": "Spontaneous splenic infarction associated with sumatriptan use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] sumatriptan [Effect] Spontaneous splenic infarction"}, {"id": "7606071_4_2422", "context": "DISCUSSION: Anaphylactoid reactions have been described previously with cisplatin administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] cisplatin [Effect] Anaphylactoid reactions"}, {"id": "20190474_3_2423", "context": "The current report describes a man who was prescribed zonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high-grade fever, eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus-6 immunoglobulin G titer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a man [Treatment] zonisamide for epilepsy [Effect] widespread skin rash, acute kidney injury, high-grade fever, eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus-6 immunoglobulin G titer"}, {"id": "11197768_3_2424", "context": "The toxicity of cadmium, zinc, and cadmium/zinc mixtures at concentrations ranging from 10000 to 10 microg/l was investigated.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] cadmium, zinc, and cadmium/zinc mixtures at concentrations ranging from 10000 to 10 microg/l [Effect] toxicity"}, {"id": "10475726_4_2425", "context": "We present a case of an elderly woman with a pre-existing history of ischaemic heart disease, who was treated with venlafaxine, and developed acute myocardial ischaemia within the first week of treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] an elderly woman with a pre-existing history of ischaemic heart disease [Treatment] venlafaxine [Effect] acute myocardial ischaemia within the first week of treatment"}, {"id": "15580406_1_2426", "context": "Here, we describe a case of Vogt-Koyanagi-Harada disease occurring 4 months after the start of interferon alpha treatment, probably induced by the immunomodulatory effects of interferon.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] a case [Treatment] 4 months after the start of interferon alpha [Effect] Vogt-Koyanagi-Harada disease"}, {"id": "17536204_3_2427", "context": "Capecitabine-induced headache responding to diltiazem.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Capecitabine [Effect] headache"}, {"id": "18171260_1_2428", "context": "Serotonin syndrome after concomitant treatment with linezolid and meperidine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] concomitant treatment with linezolid and meperidine [Effect] Serotonin syndrome"}, {"id": "8345435_3_2429", "context": "We report on a child with fatal valproate-related hepatotoxic effects despite this supplementation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] a child [Treatment] valproate [Effect] hepatotoxic effects"}, {"id": "7724306_2_2430", "context": "Acute isoniazid neurotoxicity in an urban hospital.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Treatment] isoniazid [Effect] Acute; neurotoxicity"}, {"id": "10555917_3_2431", "context": "In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] inhibition [Subject] a patient with systemic sclerosis [Treatment] D-penicillamine [Effect] vitro inhibition of hematopoiesis"}, {"id": "12243603_6_2432", "context": "Rhabdomyolysis has been reported in patients receiving hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors when coadministered with agents that may inhibit their metabolism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] patients [Treatment] hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors when coadministered with agents that may inhibit their metabolism [Effect] Rhabdomyolysis"}, {"id": "16540070_1_2433", "context": "A 55-year-old woman presented an episode of acute urticaria and labial angioedema 60 minutes after ingesting 500 mg of cloxacillin for a skin abscess.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] A 55-year-old woman; a skin abscess [Treatment] ingesting 500 mg of cloxacillin [Effect] acute urticaria and labial angioedema"}, {"id": "71813_2_2434", "context": "Acne provoked by gold seems not to have been described elsewhere.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] provoked [Treatment] gold [Effect] Acne"}, {"id": "17260498_2_2435", "context": "Taxanes are widely used chemotherapeutic agents with the potential to induce pulmonary injury through a variety of mechanisms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induce [Treatment] Taxanes [Effect] pulmonary injury"}, {"id": "17277758_4_2436", "context": "PURPOSE: To report two cases of acute endophthalmitis following intravitreal bevacizumab injection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] two cases [Treatment] intravitreal bevacizumab injection [Effect] acute endophthalmitis"}, {"id": "12621956_2_2437", "context": "This is a case report of subtle, mild hypothermia in a 54-year old female patient receiving risperidone for schizophrenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] a 54-year old female patient [Treatment] risperidone [Effect] mild hypothermia"}, {"id": "15866658_2_2438", "context": "Mycophenolate mofetil-induced neutropenia in liver transplantation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Mycophenolate mofetil [Effect] neutropenia in liver transplantation"}, {"id": "3579660_1_2439", "context": "Replicate brain magnetic resonance imaging examinations after six weeks and 11 months of penicillamine therapy documented the development of new brain lesions during this period, while liver biopsy specimen data disclosed that excellent hepatic decoppering had occurred.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] six weeks and 11 months of penicillamine therapy [Effect] new brain lesions [Potential therapeutic event] occurred [Treatment] six weeks and 11 months of penicillamine therapy [Effect] excellent hepatic decoppering"}, {"id": "4054170_1_2440", "context": "According to the literature, chlorambucil central nervous toxicity is found almost exclusively in childhood nephrotic syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] found [Subject] childhood nephrotic syndrome [Treatment] chlorambucil [Effect] central nervous toxicity"}, {"id": "9545161_2_2441", "context": "Administration of lamotrigine, especially in combination with valproic acid, may lead to the development of TEN.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] Administration of lamotrigine; with valproic acid [Effect] TEN"}, {"id": "17404582_1_2442", "context": "Docetaxel induced Meibomian duct inflammation and blockage is the likely cause of this presentation in a patient with no history of eyelid masses in the past.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with no history of eyelid masses in the past [Treatment] Docetaxel [Effect] Meibomian duct inflammation and blockage"}, {"id": "19660974_4_2443", "context": "We describe a unique case of disseminated cryptococcosis presenting as colitis that mimicked an exacerbation of Crohn's disease in a TNF-alpha inhibitor recipient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] recipient [Treatment] a TNF-alpha inhibitor [Effect] an exacerbation of Crohn's disease"}, {"id": "8438851_3_2444", "context": "Rhabdomyolysis associated with the use of intravenous vasopressin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] intravenous vasopressin [Effect] Rhabdomyolysis"}, {"id": "3926849_1_2445", "context": "Administration of intravenous nitroglycerin in a patient with idiopathic pulmonary hypertension resulted in an increase in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an increase in pulmonary vascular resistance.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] Administration [Subject] a patient with idiopathic pulmonary hypertension [Treatment] intravenous nitroglycerin [Effect] increase in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an increase in pulmonary vascular resistance"}, {"id": "11328247_5_2446", "context": "The increased libido disappeared after fluvoxamine was discontinued.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] fluvoxamine [Effect] increased libido"}, {"id": "9855339_2_2447", "context": "Coadministration of antidepressant agents such as nefazodone, or any other drug that inhibits the CYP3A4 isoenzyme subfamily, should be anticipated to interfere with tacrolimus metabolism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] interfere [Treatment] tacrolimus; Coadministration of antidepressant agents such as nefazodone, or any other drug that inhibits the CYP3A4 isoenzyme subfamily [Effect] tacrolimus metabolism"}, {"id": "7606071_3_2448", "context": "CONCLUSIONS: We conclude that a high dose combined with a short infusion time increases the risk of anaphylactoid reactions with the administration of intraperitoneal cisplatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] a high dose combined with a short infusion time; administration of intraperitoneal cisplatin [Effect] anaphylactoid reactions"}, {"id": "8742573_3_2449", "context": "Human insulin-induced lipoatrophy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Human insulin [Effect] lipoatrophy"}, {"id": "2332596_2_2450", "context": "Severe hepatotoxicity from phenobarbital occurred in an infant boy who had a complicated illness with chronic bilateral subdural hematomas and sepsis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] from [Subject] an infant boy who had a complicated illness with chronic bilateral subdural hematomas and sepsis. [Treatment] phenobarbital [Effect] Severe hepatotoxicity"}, {"id": "8053440_1_2451", "context": "Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] clindamycin and trimethoprim-sulfamethoxazole [Effect] Cholestatic liver disease with ductopenia (vanishing bile duct syndrome)"}, {"id": "16012330_11_2452", "context": "The authors suggest that in the absence of any proven benefit of itraconazole prophylaxis, and given the interaction of this drug with vincristine leading to severe and even potentially fatal toxicities, the combination use of these drugs should be avoided.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] leading [Treatment] itraconazole; vincristine [Effect] severe and even potentially fatal toxicities"}, {"id": "23042259_3_2453", "context": "The determinant role of individual pharmacogenetic profile in the occurrence of tacrolimus nephrotoxicity is presented and discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurrence [Treatment] tacrolimus [Effect] tacrolimus nephrotoxicity"}, {"id": "10555917_4_2454", "context": "These findings suggest that bicytopenia in this patient was caused by D-Pen and may be due to different sensitivities in the hematopoietic lineage.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] patient [Treatment] D-Pen [Effect] bicytopenia"}, {"id": "2320800_7_2455", "context": "We strongly suspect that this lethal anuria was mainly due to ifosfamide, occurring in a patient having received previous cisplatin chemotherapy and with poor kidney perfusion due to transient hypotension.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] a patient having received previous cisplatin chemotherapy and with poor kidney perfusion due to transient hypotension [Treatment] ifosfamide; having received previous cisplatin chemotherapy [Effect] lethal anuria"}, {"id": "12680486_2_2456", "context": "Clinicians have been aware of lithium toxicity for many years and traditionally have administered thiazide diuretics for lithium-induced polyuria and nephrogenic diabetes insipidus.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] administered [Treatment] thiazide diuretics"}, {"id": "19281746_2_2457", "context": "We report the first case of acute renal failure with hyperkalemia associated with the recently marketed direct renin inhibitor aliskiren.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] renin inhibitor aliskiren [Effect] acute renal failure with hyperkalemia"}, {"id": "2803154_3_2458", "context": "The authors describe a patient with hemiparesis who developed the syndrome of irreversible lithium-effectuated neurotoxicity (SILENT) while being treated with lithium for a manic episode.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with hemiparesis [Treatment] lithium for a manic episode [Effect] irreversible lithium-effectuated neurotoxicity (SILENT)"}, {"id": "8979664_2_2459", "context": "over the past 3 years there have been several reports of uveitis associated with rifabutin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] rifabutin therapy [Effect] uveitis"}, {"id": "9247841_1_2460", "context": "Propylthiouracil-induced cutaneous vasculitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Propylthiouracil [Effect] cutaneous vasculitis"}, {"id": "17876386_1_2461", "context": "It has been reported that fluoroquinolone antimicrobials prolong the corrected QT interval but rarely cause torsade de pointes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] prolong [Treatment] fluoroquinolone antimicrobials [Effect] corrected QT interval but rarely cause torsade de pointes"}, {"id": "11414270_1_2462", "context": "Succinylcholine-induced hyperkalemia in a patient with mucositis secondary to chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with mucositis [Treatment] Succinylcholine [Effect] hyperkalemia"}, {"id": "19745701_4_2463", "context": "To our knowledge, this is the first case of spontaneous remission of MTX-associated gastric LPD after discontinuation of MTX therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] the first case [Treatment] MTX [Effect] gastric LPD"}, {"id": "8651254_5_2464", "context": "We describe a patient with acute myeloblastic leukemia (AML) who developed nephrotic syndrome after receiving several courses of chemotherapy, including macrophage-colony-stimulating factor (M-CSF).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient with acute myeloblastic leukemia (AML) [Treatment] several courses of chemotherapy, including macrophage-colony-stimulating factor (M-CSF) [Effect] nephrotic syndrome"}, {"id": "7991279_1_2465", "context": "Actinomycin D associated hepatic veno-occlusive disease--a report of 2 cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Actinomycin D [Effect] hepatic veno-occlusive disease"}, {"id": "8604715_3_2466", "context": "Our patient developed both nephrogenic diabetes insipidus and renal tubular acidosis with a temporal pattern that demonstrated a link between foscarnet therapy and these abnormalities.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] patient [Treatment] foscarnet [Effect] nephrogenic diabetes insipidus and renal tubular acidosis"}, {"id": "1401493_1_2467", "context": "We report a case of acne fulminans occurring during treatment with 13-cis-retinoic acid for cystic acne.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] a case [Treatment] 13-cis-retinoic acid [Effect] acne fulminans"}, {"id": "12135176_2_2468", "context": "Verapamil is widely used for the termination of paroxysmal supraventricular tachycardia (PSVT) with little proarrhythmic effect.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] Verapamil [Effect] proarrhythmic effect"}, {"id": "20190474_1_2469", "context": "Acute kidney injury caused by zonisamide-induced hypersensitivity syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] zonisamide [Effect] hypersensitivity syndrome"}, {"id": "4004433_2_2470", "context": "Our findings suggest that hyperkalemia can develop with the use of low-dose heparin, within seven days of initiating heparin therapy, and that patients with diabetes mellitus or chronic renal insufficiency are especially predisposed to this complication.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] patients with diabetes mellitus or chronic renal insufficiency [Treatment] low-dose heparin, within seven days of initiating heparin therapy [Effect] hyperkalemia"}, {"id": "20120657_2_2471", "context": "We report a case of Zidovudine induced anaemia and bone marrow aplasia in a patient infected with HIV.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient infected with HIV [Treatment] Zidovudine [Effect] anaemia and bone marrow aplasia"}, {"id": "19390192_3_2472", "context": "We present the case of an adult Crohn's disease patient with a parvovirus B19 infection and leukopenia during long-term AZA therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] adult Crohn's disease patient [Treatment] long-term AZA therapy [Effect] a parvovirus B19 infection and leukopenia"}, {"id": "18094347_7_2473", "context": "Pathogenesis of methotrexate-induced papular eruption in psoriasis may involve immune mechanisms other than those of methotrexate-induced cutaneous vasculitis in collagen vascular disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] methotrexate [Effect] papular eruption in psoriasis; cutaneous vasculitis in collagen vascular disease"}, {"id": "9205466_2_2474", "context": "CASES: Two postmenopausal women treated with tamoxifen and progestational agents for breast carcinoma developed uterine enlargement and intermittent spotting.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two postmenopausal women [Treatment] tamoxifen and progestational [Effect] uterine enlargement and intermittent spotting"}, {"id": "19570088_1_2475", "context": "Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] transcatheter arterial infusion of cisplatin and embolization [Effect] Tumor lysis syndrome"}, {"id": "18821094_1_2476", "context": "Oxcarbazepine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Oxcarbazepine [Effect] Eosinophilia and Systemic Symptoms (DRESS)"}, {"id": "3579660_4_2477", "context": "Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] patients with Wilson's disease [Treatment] penicillamine therapy [Effect] Worsening of neurologic syndrome"}, {"id": "15494638_7_2478", "context": "Patient A reported right leg weakness (foot drop) during week 4 of CAP-XRT (1600 mg/m2).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] Patient A [Treatment] week 4 of CAP-XRT (1600 mg/m2) [Effect] right leg weakness"}, {"id": "3763264_2_2479", "context": "A child in whom a phenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein-losing enteropathy, myositis, and nephritis, is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A child [Treatment] phenobarbital [Effect] hypersensitivity drug reaction; which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein-losing enteropathy, myositis, and nephritis"}, {"id": "10229976_1_2480", "context": "Detection of activated eosinophils in nasal polyps of an aspirin-induced asthma patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] aspirin [Effect] asthma"}, {"id": "19540093_5_2481", "context": "We recommend that clinicians monitor patients for signs and symptoms of pancreatitis, including abdominal pain, during treatment with tigecycline.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] tigecycline [Effect] pancreatitis, including abdominal pain"}, {"id": "11568758_3_2482", "context": "We describe a patient who experienced a lichenoid eruption after the initiation of salsalate for relief of arthritic pain.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient [Treatment] the initiation of salsalate [Effect] lichenoid eruption"}, {"id": "12587815_2_2483", "context": "Concomitant administration of lithium with olanzapine may place patients at risk for NMS.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] administration [Subject] patients [Treatment] lithium; olanzapine [Effect] NMS"}, {"id": "20203465_3_2484", "context": "We report the case of an 87-year-old white woman with myasthenia gravis who presented with nausea, shortness of breath, azotemia, and hyperkalemia shortly after completing a course of intravenous immunoglobulin (IVIG).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] an 87-year-old white woman with myasthenia gravis [Treatment] intravenous immunoglobulin [Effect] nausea, shortness of breath, azotemia, and hyperkalemia"}, {"id": "17655517_8_2485", "context": "Linezolid should be discontinued immediately in patients experiencing these adverse effects.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] discontinued [Subject] patients [Treatment] Linezolid [Effect] adverse effects"}, {"id": "11077455_3_2486", "context": "PURPOSE: Symptomatic visual field constriction thought to be associated with vigabatrin has been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] vigabatrin [Effect] Symptomatic visual field constriction"}, {"id": "19857154_1_2487", "context": "Clinically significant adverse events from a drug interaction between quetiapine and atazanavir-ritonavir in two patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse events [Subject] two patients [Treatment] interaction between quetiapine and atazanavir-ritonavir [Effect] Clinically significant"}, {"id": "1477441_4_2488", "context": "OBJECTIVE: To report two cases of fixed drug eruption induced by methylphenidate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] two cases [Treatment] methylphenidate [Effect] fixed drug eruption"}, {"id": "17655517_2_2489", "context": "Linezolid is an oxazolidinone antibacterial agent indicated for serious gram-positive infections.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] indicated [Treatment] Linezolid"}, {"id": "17675030_1_2490", "context": "A search of the United States Food and Drug Administration's Adverse Event Reporting System identified nine cases of oxcarbazepine-associated angioedema in pediatric patients aged 16 years and younger.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] pediatric patients aged 16 years and younger [Treatment] oxcarbazepine [Effect] angioedema"}, {"id": "2140997_2_2491", "context": "Monitoring of liver function tests should be mandatory in patients receiving high doses of cyproterone acetate; the drug should be withdrawn immediately if abnormal liver function tests are found.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] abnormal [Subject] patients [Treatment] receiving high doses of cyproterone acetate [Effect] abnormal liver function"}, {"id": "6311654_3_2492", "context": "In six cases CT scans did not return to their original state after ACTH therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] six cases [Treatment] ACTH [Effect] CT scans did not return to their original state"}, {"id": "16204273_2_2493", "context": "This report describes a probable case of infliximab-induced membranous nephropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] infliximab [Effect] membranous nephropathy"}, {"id": "6683487_1_2494", "context": "Thrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] penicillamine [Effect] Thrombotic thrombocytopenic purpura"}, {"id": "10452772_3_2495", "context": "OBJECTIVE: The purpose of this study was to determine whether desensitization to NPH insulin, as well as standard insulin desensitization, could control allergic symptoms in a patient allergic to both NPH and regular insulin.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] control [Subject] a patient allergic to both NPH and regular insulin [Treatment] desensitization to NPH insulin, as well as standard insulin desensitization"}, {"id": "1261772_1_2496", "context": "Fulminant hepatic failure developed in a 24-year-old black woman who had been treated with propylthiouracil and propranolol for hyperthyroidism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 24-year-old black woman [Treatment] propylthiouracil and propranolol [Effect] Fulminant hepatic failure"}, {"id": "9195619_1_2497", "context": "However, as the use of hepatitis B vaccination is growing, adverse side effects, including mental nerve neuropathy, should be observed with an increased frequency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Treatment] hepatitis B vaccination [Effect] mental nerve neuropathy"}, {"id": "2292051_1_2498", "context": "Acute coronary events following cisplatin-based chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] cisplatin-based chemotherapy [Effect] Acute coronary events"}, {"id": "15494638_3_2499", "context": "Capecitabine (CAP) is a pro-drug of 5-FU and peripheral neuropathy associated with CAP has not been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] CAP [Effect] peripheral neuropathy"}, {"id": "15126179_3_2500", "context": "PURPOSE: To report a case of angiographically documented cystoid macula edema occurring after switching a pseudophakic patient from latanoprost to bimatoprost.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] switching [Subject] a pseudophakic patient [Treatment] from latanoprost to bimatoprost. [Effect] case of angiographically documented cystoid macula edema"}, {"id": "15013892_4_2501", "context": "The clinical picture was identical to that of chloroquine and hydroxychloroquine maculopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] identical [Treatment] chloroquine and hydroxychloroquine [Effect] maculopathy"}, {"id": "19299370_2_2502", "context": "CONCLUSION: A woman receiving enoxaparin every 12 hours developed signs and symptoms of hepatotoxicity after the second dose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A woman [Treatment] enoxaparin every 12 hours; after the second dose [Effect] signs and symptoms of hepatotoxicity"}, {"id": "1747495_2_2503", "context": "A case of liver damage following treatment with Danazol for fibrocystic breast disease is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] Danazol [Effect] liver damage"}, {"id": "2257522_1_2504", "context": "Antacid and sucralfate-induced hypophosphatemic osteomalacia: a case report and review of the literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] Antacid and sucralfate [Effect] hypophosphatemic osteomalacia"}, {"id": "16268429_3_2505", "context": "We report a case of senna-induced cholestatic hepatitis which was not diagnosed at presentation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] senna [Effect] cholestatic hepatitis"}, {"id": "788666_1_2506", "context": "Five patients are described in whom only gentamicin sulfate appeared responsible for acute renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] responsible [Subject] Five patients [Treatment] gentamicin sulfate [Effect] acute renal failure"}, {"id": "12852380_1_2507", "context": "However, in order to avoid neuropathic side effects, patients under thalidomide therapy should be monitored every 6 months with nerve conduction studies while taking the drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] under [Subject] patients [Treatment] thalidomide therapy [Effect] neuropathic side effects"}, {"id": "16200540_3_2508", "context": "Videopolysomnographic and pharmacokinetic studies with monitoring of plasma levodopa levels demonstrated marked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, tonic grouped discharges and flexor spasms, associated with painful dysesthesia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] demonstrated [Treatment] levodopa [Effect] marked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, tonic grouped discharges and flexor spasms, associated with painful dysesthesia"}, {"id": "3873709_1_2509", "context": "Antibiotic-associated colitis (pseudomembranous colitis) developed in four patients with spinal cord injury and taking oral trimethoprim-sulfamethoxazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] four patients with spinal cord injury [Treatment] oral trimethoprim-sulfamethoxazole [Effect] Antibiotic-associated colitis (pseudomembranous colitis)"}, {"id": "16641839_5_2510", "context": "We report the case of a 27-year-old Indian woman who developed maculopapular rash and angioedema secondary to carbamazepine administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 27-year-old Indian woman [Treatment] carbamazepine administration [Effect] maculopapular rash and angioedema"}, {"id": "16396068_3_2511", "context": "We reviewed the literature in an attempt to characterize the pattern and predictors of TMP/SMX-induced aseptic meningitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] TMP/SMX [Effect] aseptic meningitis"}, {"id": "12324937_4_2512", "context": "Mean time between initiation of gemcitabine therapy and onset of HUS was 7.4 +/- 3.5 months, or 21.9 +/- 10.9 doses of gemcitabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] onset [Treatment] 7.4 +/- 3.5 months, or 21.9 +/- 10.9 doses of gemcitabine [Effect] HUS"}, {"id": "8684546_1_2513", "context": "Aluminum intoxication, along with other factors, was considered to be the cause of TC development.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Aluminum intoxication [Effect] TC development"}, {"id": "11999915_1_2514", "context": "Agranulocytosis during clozapine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] clozapine therapy [Effect] Agranulocytosis"}, {"id": "14746605_1_2515", "context": "It was highly suspected that finasteride was associated with the anterior subcapsular opacity on the lens, and the patient therefore discontinued use of finasteride.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] the patient [Treatment] finasteride [Effect] anterior subcapsular opacity on the lens"}, {"id": "2811895_2_2516", "context": "Life-threatening cranial dystonia following trihexyphenidyl withdrawal.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] trihexyphenidyl withdrawal [Effect] cranial dystonia"}, {"id": "3982906_3_2517", "context": "The risk of cardiac decompensation in infants with supraventricular tachycardia and congestive cardiac failure should be kept in mind prior to administration of verapamil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Subject] infants with supraventricular tachycardia and congestive cardiac failure [Treatment] verapamil [Effect] cardiac decompensation"}, {"id": "18171260_5_2518", "context": "We describe serotonin syndrome after concomitant use of linezolid and meperidine in a 27-year-old man with acute leukemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a 27-year-old man with acute leukemia [Treatment] concomitant use of linezolid and meperidine [Effect] serotonin syndrome"}, {"id": "9191742_1_2519", "context": "Recent studies have shown that under experimental conditions ferrous sulfate may reduce the gastrointestinal absorption of orally administered levothyroxine sodium in patients with primary hypothyroidism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reduce [Subject] patients with primary hypothyroidism [Treatment] ferrous sulfate; orally administered levothyroxine sodium [Effect] reduce the gastrointestinal absorption of orally administered levothyroxine sodium"}, {"id": "19775485_2_2520", "context": "We report here a case of cardiovascular and neurological depression induced by oxymetalzoline in a toddler.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a toddler [Treatment] oxymetalzoline [Effect] cardiovascular and neurological depression"}, {"id": "10431414_3_2521", "context": "The association between heparin and priapism is often recognized; abnormal platelet aggregation could play a role in the pathogenesis of this side effect.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] heparin [Effect] priapism"}, {"id": "12078977_2_2522", "context": "Posterior leukoencephalopathy following cisplatin, bleomycin and vinblastine therapy for germ cell tumor of the ovary.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] cisplatin, bleomycin and vinblastine therapy for germ cell tumor of the ovary [Effect] Posterior leukoencephalopathy"}, {"id": "12086549_2_2523", "context": "OBJECTIVE: To report a case of cutaneous and hematologic toxicity in a patient treated with IL-2.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] case [Subject] a patient [Treatment] IL-2 [Effect] cutaneous and hematologic toxicity"}, {"id": "10707759_2_2524", "context": "Flecainide is a rare cause of hypersensitivity pneumonitis, and few cases have been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] Flecainide [Effect] hypersensitivity pneumonitis"}, {"id": "17536204_5_2525", "context": "The patient developed grade 3 capecitabine-induced headache.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] capecitabine [Effect] headache"}, {"id": "1951476_2_2526", "context": "We report a case of biopsy-proven acute tubulointerstitial nephritis associated with a second course of flurbiprofen, a nonsteroidal anti-inflammatory drug of the propionic acid class.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] a second course of flurbiprofen [Effect] biopsy-proven acute tubulointerstitial nephritis"}, {"id": "1378497_1_2527", "context": "Although an association between exposure to bleomycin and the development of scleroderma has been suspected, few cases are reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] few cases [Treatment] bleomycin [Effect] scleroderma"}, {"id": "10987357_2_2528", "context": "A 74-year-old man received oral administration of pilsicainide, a pure sodium channel blocker with slow recovery kinetics, to convert paroxysmal atrial fibrillation to sinus rhythm and developed loss of consciousness two days later.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 74-year-old man [Treatment] oral administration of pilsicainide; two days later [Effect] loss of consciousness"}, {"id": "11876387_1_2529", "context": "Aggressive endometrial carcinoma in a breast cancer patient treated with tamoxifen with normal transvaginal ultrasonography.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] breast cancer patient; with normal transvaginal ultrasonography [Treatment] tamoxifen [Effect] Aggressive endometrial carcinoma"}, {"id": "8792511_1_2530", "context": "Less common adverse events to dapsone include the idiosyncratic reactions of leukopenia and agranulocytosis, cutaneous eruptions, peripheral neuropathy, psychosis, toxic hepatitis, cholestatic jaundice, nephrotic syndrome, renal papillary necrosis, severe hypoalbuminemia without proteinuria, an infectious mononucleosis-like syndrome, and minor neurological and gastrointestinal complaints.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] include [Treatment] dapsone [Effect] the idiosyncratic reactions of leukopenia and agranulocytosis, cutaneous eruptions, peripheral neuropathy, psychosis, toxic hepatitis, cholestatic jaundice, nephrotic syndrome, renal papillary necrosis, severe hypoalbuminemia without proteinuria, an infectious mononucleosis-like syndrome, and minor neurological and gastrointestinal complaints"}, {"id": "10475726_2_2531", "context": "The association of venlafaxine treatment with ischaemic events could be explained by its unique pharmacological and haemodynamic properties.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] venlafaxine treatment [Effect] ischaemic events"}, {"id": "17060191_5_2532", "context": "This selective closure of the ductus arteriosus suggests that the affected twin was predisposed to hypoxia and thus was more susceptible to ductal closure in response to indomethacin exposure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] response [Treatment] indomethacin exposure [Effect] ductal closure"}, {"id": "8903300_3_2533", "context": "This pattern is suggestive of renal toxicity due to tobramycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Treatment] tobramycin [Effect] renal toxicity"}, {"id": "8742573_4_2534", "context": "OBJECTIVE: To evaluate the efficacy of the administration of insulin by a jet-injector device in stopping and reversing severe human insulin-induced lipoatrophy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] insulin [Effect] severe human; lipoatrophy"}, {"id": "2442958_2_2535", "context": "This is a unique autopsy case of hepatocellular carcinoma closely related to diethylstilbestrol (DES) therapy for prostatic cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] a unique autopsy case [Treatment] diethylstilbestrol (DES) [Effect] hepatocellular carcinoma"}, {"id": "12921505_2_2536", "context": "Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] for [Treatment] Argatroban"}, {"id": "1592841_1_2537", "context": "Falling backward in two elderly patients taking bupropion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] two elderly patients [Treatment] bupropion [Effect] Falling backward"}, {"id": "11881322_4_2538", "context": "METHODS: Three patients with apparent itraconazole-induced liver injury were studied.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] Three patients [Treatment] itraconazole [Effect] liver injury"}, {"id": "15907341_2_2539", "context": "Six patients developed peripheral neuropathy and five patients bone marrow depression, blood transfusions were given to three patients and in all five patients bone marrow function normalized after cessation of linezolid.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] normalized [Subject] all five patients [Treatment] cessation of linezolid [Adverse event] developed [Subject] Six patients [Treatment] linezolid [Effect] peripheral neuropathy [Adverse event] developed [Subject] five patients [Treatment] linezolid [Effect] bone marrow depression [Potential therapeutic event] given [Subject] three patients [Treatment] blood transfusions; cessation of linezolid"}, {"id": "12111771_5_2540", "context": "To our knowledge, four cases of interstitial pneumonitis associated with fludarabine have been reported in medical literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] fludarabine [Effect] interstitial pneumonitis"}, {"id": "20397038_1_2541", "context": "Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] after [Subject] a case of severe hydroxychloroquine retinopathy [Treatment] cessation of therapy; hydroxychloroquine [Effect] Normalization of generalized retinal function and progression of maculopathy"}, {"id": "20118434_2_2542", "context": "Interferon-induced psychosis as a \"psychiatric contraindication\" to hepatitis C treatment: a review and case-based discussion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Interferon [Effect] psychosis"}, {"id": "10524732_1_2543", "context": "Prolongation of the QT interval and ventricular tachyarrhymias have been described in patients on amiodarone therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] described [Subject] patients [Treatment] amiodarone therapy [Effect] Prolongation of the QT interval and ventricular tachyarrhymias"}, {"id": "17420198_9_2544", "context": "Aripiprazole, 5 mg daily, was initiated in November 2004 as an augmentation strategy for the diagnosis of OCD.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] augmentation [Treatment] Aripiprazole; 5 mg daily"}, {"id": "11250985_4_2545", "context": "Serious adverse events experienced by patients with chronic heart failure taking spironolactone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] experienced [Subject] patients with chronic heart failure [Treatment] spironolactone [Effect] Serious adverse events"}, {"id": "941054_2_2546", "context": "Review of the literature relating to methicillin-induced nephropathy suggests a hypersensitivity origin for this disorder, but immunologic and ultrastructural investigation to date has failed to elucidate pathogenesis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] methicillin [Effect] nephropathy; hypersensitivity"}, {"id": "16298824_2_2547", "context": "ARDS has been associated with the administration of other monoclonal antibodies, such as infliximab, gemtuzumab ozogamicin, and OKT3 and is believed to be directly mediated by release of proinflammatory cytokines.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] the administration of other monoclonal antibodies, such as infliximab, gemtuzumab ozogamicin, and OKT3 [Effect] ARDS"}, {"id": "12365708_3_2548", "context": "CASE REPORT: Soon after initiation of amiodarone HCl (200 mg/day), a 76-year-old man came to us with symptoms of visual \"shining,\" glare, color vision anomalies, and gradually decreased vision.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after initiation [Subject] a 76-year-old man [Treatment] amiodarone HCl [Effect] symptoms of visual \"shining,\" glare, color vision anomalies, and gradually decreased vision"}, {"id": "527355_1_2549", "context": "An insulin-dependent diabetic patient with nephropathy developed severe acidosis after treatment with acetazolamide for glaucoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] An insulin-dependent diabetic patient with nephropathy [Treatment] acetazolamide for glaucoma [Effect] severe acidosis"}, {"id": "15504988_1_2550", "context": "Severe hypo-alpha-lipoproteinemia during treatment with rosiglitazone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] rosiglitazone [Effect] hypo-alpha-lipoproteinemia"}, {"id": "2445709_2_2551", "context": "Peripheral neuropathy and cerebellar syndrome associated with amiodarone therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] amiodarone [Effect] Peripheral neuropathy and cerebellar syndrome"}, {"id": "18691992_4_2552", "context": "CONCLUSIONS: We report this case of the concomitant appearance of multiple skin cancers and nail changes associated with hydroxyurea use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] case [Treatment] hydroxyurea [Effect] multiple skin cancers and nail changes"}, {"id": "9847899_1_2553", "context": "As this relapse coincided with development of a strong delayed-type hypersensitivity response to tuberculin and improved after treatment with the anti-inflammatory agent oxpentifylline, it was probably caused by restoration of pathogen-specific cellular immunity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] tuberculin [Effect] a strong delayed-type hypersensitivity response [Potential therapeutic event] improved [Treatment] anti-inflammatory agent oxpentifylline"}, {"id": "16012330_1_2554", "context": "Itraconazole-related increased vincristine neurotoxicity: case report and review of literature.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] Itraconazole [Effect] increased vincristine neurotoxicity"}, {"id": "11837564_1_2555", "context": "A 62-year-old Caucasian man with atrial fibrillation who was taking warfarin reported an episode of hematochezia; his international normalized ratio (INR) was 1.74.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] episode [Subject] A 62-year-old Caucasian man with atrial fibrillation [Treatment] warfarin [Effect] hematochezia"}, {"id": "22233409_1_2556", "context": "Severe anaemia related to oseltamivir during treatment of chronic hepatitis C: a new drug interaction?", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] oseltamivir during treatment of chronic hepatitis C [Effect] anaemia"}, {"id": "10084639_1_2557", "context": "BACKGROUND: How to best treat psychotic patients who have had past clozapine-induced agranulocytosis or granulocytopenia remains a problem.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] psychotic patients [Treatment] clozapine [Effect] agranulocytosis or granulocytopenia"}, {"id": "15126179_1_2558", "context": "Cystoid macular edema in a low-risk patient after switching from latanoprost to bimatoprost.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] low-risk patient [Treatment] switching from latanoprost to bimatoprost [Effect] Cystoid macular edema"}, {"id": "7439122_3_2559", "context": "Physicians should therefore be aware of its occurrence and carefully monitor serum levels of CPK, GOT and GPT during the treatment of diabetes insipidus with clofibrate, especially in patients with associated hypothyroidism, latent or overt, which possibly favors the development of myopathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Subject] patients with associated hypothyroidism, latent or overt [Treatment] clofibrate [Effect] myopathy."}, {"id": "1951476_1_2560", "context": "Flurbiprofen-associated acute tubulointerstitial nephritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Flurbiprofen [Effect] acute tubulointerstitial nephritis"}, {"id": "9302445_1_2561", "context": "CONCLUSION: We believe this to be the first reported case of rhGH-induced hypercalcemia in an HIV-infected patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an HIV-infected patient [Treatment] rhGH [Effect] hypercalcemia"}, {"id": "7946029_2_2562", "context": "A case of basilar invagination which is thought to have arisen from the patient's intrauterine exposure to phenytoin is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] exposure [Treatment] phenytoin [Effect] basilar invagination"}, {"id": "1495728_1_2563", "context": "Methotrexate pneumonitis in nonsurgical treatment of ectopic pregnancy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Treatment] nonsurgical treatment [Effect] Methotrexate pneumonitis"}, {"id": "3767790_2_2564", "context": "Two patients who were receiving Tolazoline by infusion developed duodenal ulceration and subsequent intestinal perforation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] Two patients [Treatment] receiving Tolazoline by infusion [Effect] duodenal ulceration and subsequent intestinal perforation"}, {"id": "20098333_2_2565", "context": "We report the case of a 14-year-old female with acute promyelocytic leukemia who developed symptomatic cardiomyopathy only 4 months into treatment with a combination of daunomycin and all-trans retinoic acid (ATRA).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a 14-year-old female with acute promyelocytic leukemia [Treatment] 4 months into treatment with a combination of daunomycin and all-trans retinoic acid (ATRA) [Effect] symptomatic cardiomyopathy"}, {"id": "17228132_3_2566", "context": "Hepatotoxicity seen with erlotinib, a small molecule tyrosine kinase inhibitor to EGFR, is usually transient with mild elevation of transaminases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] seen [Treatment] erlotinib [Effect] Hepatotoxicity; transient with mild elevation of transaminases"}, {"id": "18585545_5_2567", "context": "RESULTS: A previously healthy 42-year-old woman presented with acute-onset delirium with psychotic features as a consequence of levofloxacin therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] as a consequence of [Subject] A previously healthy 42-year-old woman [Treatment] levofloxacin therapy [Effect] acute-onset delirium with psychotic features"}, {"id": "22791547_5_2568", "context": "Although limb dyskinesia after methylphenidate is a commonly reported side effect, to the authors' knowledge this is only the second reported case to develop both orofacial and limb dyskinesia in the acute period after the first dose of methylphenidate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Subject] the second reported case [Treatment] methylphenidate [Effect] orofacial and limb dyskinesia"}, {"id": "7995508_1_2569", "context": "Phenylpropanolamine-induced psychosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Phenylpropanolamine [Effect] psychosis"}, {"id": "3763264_1_2570", "context": "Graft versus host-like illness in a child with phenobarbital hypersensitivity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] hypersensitivity [Subject] a child [Treatment] phenobarbital [Effect] Graft versus host-like illness; hypersensitivity"}, {"id": "8597009_4_2571", "context": "The wide use of phenytoin during the recent tuberculosis epidemic makes it imperative to suspect this drug interaction in patients exhibiting clinical features that might be related to phenytoin toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suspect [Subject] patients [Treatment] phenytoin [Effect] phenytoin toxicity"}, {"id": "9660541_3_2572", "context": "We report a case of MMC-related hemolytic uremic syndrome, and discuss the etiologic parameters, clinical aspects, prognosis and treatment modalities of this severe syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] MMC [Effect] hemolytic uremic syndrome"}, {"id": "3947272_3_2573", "context": "Myasthenic patients receiving ampicillin should be closely monitored for possible acute exacerbations.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] Myasthenic patients [Treatment] ampicillin [Effect] acute exacerbations"}, {"id": "11999915_4_2574", "context": "The male patient was treated with 225-mg/day clozapine and the time to the diagnosis of agranulocytosis was 6 weeks.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] diagnosis [Subject] The male patient [Treatment] 225-mg/day clozapine [Effect] agranulocytosis"}, {"id": "2862137_2_2575", "context": "Alprazolam withdrawal delirium unresponsive to diazepam: case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] to [Treatment] diazepam"}, {"id": "4036917_3_2576", "context": "These findings support previous studies that showed that the use of aspirin during the antecedent illness may be a risk factor for the development of RS.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] development [Treatment] aspirin [Effect] RS"}, {"id": "16405935_1_2577", "context": "Chloroquine-induced bilateral ptosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Chloroquine [Effect] bilateral ptosis"}, {"id": "17364199_14_2578", "context": "DISCUSSION: To our knowledge this is the first reported case of tuberculous uveitis following treatment with etanercept.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] etanercept [Effect] tuberculous uveitis"}, {"id": "25538343_2_2579", "context": "Hyponatremia is a known adverse effect of duloxetine, and it can lead to potentially life-threatening complications.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] adverse [Treatment] duloxetine [Effect] Hyponatremia; potentially life-threatening complications"}, {"id": "19003750_1_2580", "context": "A 22-year-old drug-abuser injected flunitrazepam tablets dissolved in tap water into her left femoral artery and presented with clinical signs of acute ischaemia of the left leg.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] A 22-year-old drug-abuser [Treatment] injected flunitrazepam tablets dissolved in tap water into her left femoral artery [Effect] acute ischaemia of the left leg"}, {"id": "1348483_1_2581", "context": "A patient with Parkinson's disease, initially treated with bromocriptine and subsequently with cabergoline, developed progressive pleuropulmonary abnormalities during the latter therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A patient with Parkinson's disease [Treatment] initially treated with bromocriptine and subsequently with cabergoline [Effect] progressive pleuropulmonary abnormalities during the latter therapy"}, {"id": "16432996_3_2582", "context": "Although interferon gamma has been implicated in the pathogenesis of sarcoidosis, only a few cases of sarcoidosis associated with interferon alpha therapy have been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] pathogenesis [Treatment] interferon gamma [Effect] sarcoidosis [Adverse event] associated [Treatment] interferon alpha [Effect] sarcoidosis"}, {"id": "3143551_3_2583", "context": "Camptocormia, a new side effect of sodium valproate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] sodium valproate [Effect] Camptocormia"}, {"id": "15028964_2_2584", "context": "Many patients with cardiac arrhythmias require concomitant therapy with warfarin and amiodarone.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] require [Subject] Many patients with cardiac arrhythmias [Treatment] concomitant therapy with warfarin and amiodarone"}, {"id": "11373877_2_2585", "context": "We report the case histories of two patients with histologically confirmed adenocarcinoma of the prostate, both of whom had been treated with steroidal anti-androgen therapy in the form of cyproterone acetate prior to radical or palliative pelvic irradiation, and who subsequently developed femoral head avascular necrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] two patients with histologically confirmed adenocarcinoma of the prostate [Treatment] steroidal anti-androgen therapy in the form of cyproterone acetate prior to radical or palliative pelvic irradiation [Effect] femoral head avascular necrosis."}, {"id": "16284443_3_2586", "context": "Thus, the possible in vivo effects of insulin on adipocytes were clearly observed in this case of insulin-induced lipohypertrophy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] insulin [Effect] lipohypertrophy"}, {"id": "10599932_5_2587", "context": "After the addition of citalopram, a desmethylclomipramine plasma level increase and an 8-hydroacy-desmethylclomipramine plasma level decrease were observed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] After [Treatment] citalopram [Effect] desmethylclomipramine plasma level increase and an 8-hydroacy-desmethylclomipramine plasma level decrease"}, {"id": "16791713_3_2588", "context": "Here we present the case of a woman who received high doses of methylprednisolone (1 g iv daily) for active Graves' ophthalmopathy, and developed severe hypertension followed by myocardial infarction on the fifth day of treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] received [Subject] a woman [Treatment] high doses of methylprednisolone (1 g iv daily) [Effect] severe hypertension followed by myocardial infarction on the fifth day of treatment."}, {"id": "19875411_2_2589", "context": "Severe cardiomyopathy following treatment with the tumour necrosis factor-alpha inhibitor adalimumab for Crohn's disease.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] treatment with the tumour necrosis factor-alpha inhibitor adalimumab [Effect] cardiomyopathy"}, {"id": "7991279_2_2590", "context": "There are now reports of liver failure following treatment of childhood cancers with AMD.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] childhood cancers [Treatment] AMD [Effect] liver failure"}, {"id": "18362995_2_2591", "context": "Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] a patient with chronic myeloid leukaemia and chronic hepatitis B infection [Treatment] Imatinib mesylate [Effect] fatal acute hepatic failure"}, {"id": "11889149_3_2592", "context": "This phase 3, randomized, double-blind 1-yr study assessed the effects of combined RLX and ALN in 331 postmenopausal women with osteoporosis (femoral neck BMD T-score, less than -2).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] effects [Subject] 331 postmenopausal women with osteoporosis (femoral neck BMD T-score, less than -2) [Treatment] combined RLX and ALN"}, {"id": "8597009_1_2593", "context": "Phenytoin toxicity due to concomitant antituberculosis therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] concomitant antituberculosis therapy. [Effect] Phenytoin toxicity"}, {"id": "7900744_2_2594", "context": "Hemodialysis should be performed for rapid reversal of mannitol-induced ARF.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] mannitol [Effect] ARF [Potential therapeutic event] performed [Treatment] Hemodialysis"}, {"id": "18067642_2_2595", "context": "Amiodarone is well recognized as an anti-arrhythmic drug containing a high dose of iodine with considerable potential to cause thyroid dysfunction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] recognized [Treatment] Amiodarone [Effect] potential to cause thyroid dysfunction"}, {"id": "1359782_2_2596", "context": "Pulmonary infiltrates and skin pigmentation associated with sulfasalazine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] sulfasalazine [Effect] Pulmonary infiltrates and skin pigmentation"}, {"id": "998323_1_2597", "context": "Lithium treatment was terminated in 1975 because of lithium intoxication with a diabetes insipidus-like syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] because [Treatment] Lithium treatment [Effect] lithium intoxication with a diabetes insipidus-like syndrome"}, {"id": "7304798_2_2598", "context": "The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which L-dopa shortened the manic-depressive cycle length when administered in a double-blind trial.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] shortened [Subject] a woman with a history of bipolar affective disorder [Treatment] L-dopa [Effect] shortened the manic-depressive cycle length"}, {"id": "19402273_1_2599", "context": "Isoniazid causing breast tissue enlargement has been very rarely reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causing [Treatment] Isoniazid [Effect] breast tissue enlargement"}, {"id": "7393795_3_2600", "context": "The induction of hypoglycaemia with PAS in this patient suggests a potential role for PAS in the treatment of diabetes mellitus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induction [Subject] this patient [Treatment] PAS [Effect] hypoglycaemia"}, {"id": "8641617_1_2601", "context": "Although both patients recovered from the colitis after the administration of vancomycin, the first case demonstrated a relapse of the colitis after receiving a subsequent course of the same chemotherapy with cisplatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] recovered [Subject] both patients [Treatment] vancomycin [Adverse event] receiving [Treatment] a subsequent course of the same chemotherapy with cisplatin [Effect] a relapse of the colitis"}, {"id": "15190230_1_2602", "context": "Acute dystonia during pegylated interferon alpha therapy in a case with chronic hepatitis B infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] therapy [Treatment] pegylated interferon alpha [Effect] Acute dystonia"}, {"id": "7696938_3_2603", "context": "I saw two patients with kala-azar resistant to sodium stibogluconate who developed cardiac arrest after amphotericin infusion (in spite of tolerating a test dose).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] two patients with kala-azar resistant to sodium stibogluconate [Treatment] amphotericin infusion [Effect] cardiac arrest"}, {"id": "18515982_2_2604", "context": "CONCLUSIONS: Anastrozole may be the causative factor in patients with sclerosing glomerulonephritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causative [Subject] patients [Treatment] Anastrozole [Effect] sclerosing glomerulonephritis"}, {"id": "9399776_5_2605", "context": "We describe two cases of acute pancreatitis that occurred after long term mesalamine therapy for ulcerative colitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Subject] two cases [Treatment] mesalamine [Effect] acute pancreatitis"}, {"id": "1673494_1_2606", "context": "Amphotericin B (AmB) is effective, but its use is limited by toxicity: renal impairment, anaemia, fever, malaise, and hypokalaemia are common.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] by [Treatment] Amphotericin B (AmB) [Effect] toxicity: renal impairment, anaemia, fever, malaise, and hypokalaemia"}, {"id": "1977935_6_2607", "context": "We believe that a drug interaction between terfenadine and ketoconazole resulted in the elevated terfenadine levels in plasma and in the cardiotoxicity previously seen only in cases of terfenadine overdose.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Treatment] a drug interaction between terfenadine and ketoconazole [Effect] the elevated terfenadine levels in plasma and in the cardiotoxicity"}, {"id": "3405528_1_2608", "context": "A case of halothane induced hepatitis is reported in a middle aged woman who underwent gastric surgery for morbid obesity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a middle aged woman [Treatment] halothane; gastric surgery for morbid obesity [Effect] hepatitis"}, {"id": "448845_2_2609", "context": "Carbonic anhydrase inhibitors used in the treatment of glaucoma, seizure disorders, and hypertension are rarely associated with blood dyscrasias.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] rarely associated [Treatment] Carbonic anhydrase inhibitors [Effect] blood dyscrasias"}, {"id": "282937_1_2610", "context": "Administration of intrathecal Ara-C in the same dose over longer intervals within 3-5 days between consecutive doses resulted in mild, transient neurological symptoms (paresthesias) in only one of 30 patients so treated.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulted [Subject] one of 30 patients [Treatment] Administration of intrathecal Ara-C in the same dose over longer intervals within 3-5 days between consecutive doses [Effect] neurological symptoms"}, {"id": "12751276_2_2611", "context": "Anaphylaxis from isoniazid is a possible side effect to this commonly prescribed antibiotic.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] is [Treatment] isoniazid; commonly prescribed antibiotic [Effect] Anaphylaxis"}, {"id": "9920368_2_2612", "context": "Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking amiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin (TSH) receptor antibody (TRAb), or thyrotropin-binding inhibiting immunoglobulin (TBII).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with arrhythmogenic right ventricular dysplasia [Treatment] amiodarone for 4 years [Effect] thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin (TSH) receptor antibody (TRAb), or thyrotropin-binding inhibiting immunoglobulin (TBII)"}, {"id": "18094347_5_2613", "context": "Methotrexate-induced papular eruption following treatment of psoriasis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Methotrexate [Effect] papular eruption"}, {"id": "18533420_3_2614", "context": "Sexual dysfunction associated with intrathecal baclofen use: a report of two cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] two cases [Treatment] intrathecal baclofen [Effect] Sexual dysfunction"}, {"id": "11030530_2_2615", "context": "Patients treated with L-asparaginase may present with hemorrhagic and thrombotic cerebrovascular events.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] present [Subject] Patients [Treatment] L-asparaginase [Effect] hemorrhagic and thrombotic cerebrovascular events"}, {"id": "15611427_3_2616", "context": "Since imiquimod induces large amounts of type I interferon production from TLR7-expressing plasmacytoid dendritic cell precursors (PDCs), the natural interferon-producing cells of the peripheral blood, we asked whether PDCs are present in psoriatic skin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induces [Treatment] imiquimod [Effect] large amounts of type I interferon production"}, {"id": "16405935_2_2617", "context": "Ptosis occurring 24 h after chloroquine therapy, with full recovery 48 h after cessation of chloroquine, has not been described previously.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Treatment] chloroquine therapy [Effect] Ptosis; full recovery 48 h after cessation of chloroquine"}, {"id": "17494808_1_2618", "context": "Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] lenalidomide [Effect] Hypersensitivity pneumonitis-like syndrome"}, {"id": "11033734_2_2619", "context": "Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] pediatric cancer patients [Treatment] imipenem/cilastatin [Effect] seizures"}, {"id": "6260900_2_2620", "context": "One of these was clofazimine, an aniline aposafranine derivative known to produce a ceroid-like pigment in the tissues of patients treated with this drug or lepromatous leprosy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] produce [Subject] patients treated with this drug or lepromatous leprosy [Treatment] clofazimine [Effect] a ceroid-like pigment"}, {"id": "331881_1_2621", "context": "Deposits of plasma proteins in the skin during treatment with carbamazepine and diphenylhydantoin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment [Treatment] carbamazepine and diphenylhydantoin [Effect] Deposits of plasma proteins in the skin"}, {"id": "14690166_1_2622", "context": "2-Chloro-deoxyadenosine induces durable complete remission in Castleman's disease but may accelerate its transformation to non-Hodgkin's lymphoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] accelerate [Treatment] 2-Chloro-deoxyadenosine [Effect] non-Hodgkin's lymphoma"}, {"id": "10393393_1_2623", "context": "Hypersensitivity to aspirin can be manifested as acute asthma, urticaria and/or angioedema, or a systemic anaphylactoid reaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] manifested [Treatment] aspirin [Effect] acute asthma; urticaria; angioedema; systemic anaphylactoid reaction; Hypersensitivity"}, {"id": "19224802_1_2624", "context": "An exaggerated hypertensive response to glycopyrrolate therapy for bradycardia associated with high-dose dexmedetomidine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] high-dose dexmedetomidine [Effect] bradycardia [Adverse event] response [Treatment] glycopyrrolate [Effect] exaggerated hypertensive"}, {"id": "8530331_7_2625", "context": "Only one patient, the youngest, did well on risperidone therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] did well [Subject] the youngest [Treatment] risperidone"}, {"id": "7019786_3_2626", "context": "Two elderly women suffered an acute deterioration of renal function after treatment with cefoxitin sodium.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] Two elderly women [Treatment] treatment with cefoxitin sodium [Effect] acute deterioration of renal function"}, {"id": "19904536_14_2627", "context": "Physicians should suspect pulmonary toxicity in patients with respiratory distress after gemcitabine chemotherapy, mainly in elderly patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] patients with respiratory distress; mainly in elderly patients [Treatment] gemcitabine chemotherapy [Effect] pulmonary toxicity"}, {"id": "9022114_3_2628", "context": "Delay of corneal wound healing in patients treated with colchicine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] patients [Treatment] colchicine [Effect] Delay of corneal wound healing"}, {"id": "9920368_1_2629", "context": "Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Amiodarone [Effect] thyrotoxicosis"}, {"id": "18721173_1_2630", "context": "CONCLUSION: All doctors need to be aware of the need to review the indications for gabapentin use during periods of acute illness, especially with regard to renal impairment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] regard [Treatment] gabapentin [Effect] renal impairment"}, {"id": "21751692_4_2631", "context": "EA signs were observed in all 7 patients in association with propofol TIVA but did not recur in any of 123 subsequent anesthetics sessions during which low-dose ketamine was added to propofol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Subject] all 7 patients [Treatment] propofol TIVA; low-dose ketamine was added to propofol [Effect] EA signs"}, {"id": "9788533_8_2632", "context": "The cause of death was multiple drug intoxication following acute use of sertraline, the manner of death was suicide, and the mechanism of death is an unexplained drug interaction and/or toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] sertraline [Effect] multiple drug intoxication"}, {"id": "9362107_2_2633", "context": "On the next day, after a total dose of only 600 mg of danazol, gingival bleeding and purpura occurred.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] On the next day, after a total dose of only 600 mg of danazol [Effect] gingival bleeding and purpura"}, {"id": "1393348_4_2634", "context": "SLE receded after withdrawal of carbamazepine and treatment with anti-inflammatory drugs.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] after [Treatment] withdrawal of carbamazepine and treatment with anti-inflammatory drugs"}, {"id": "8828999_1_2635", "context": "a 67-year-old man with bipolar disorder developed a Creutzfeldt-Jakob like syndrome during lithium carbonate treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a 67-year-old man with bipolar disorder [Treatment] lithium carbonate [Effect] Creutzfeldt-Jakob like syndrome"}, {"id": "7679525_2_2636", "context": "A 42 year old man, treated for testicular carcinoma with combination chemotherapy that included bleomycin, developed life threatening interstitial pneumonitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 42 year old man [Treatment] combination chemotherapy that included bleomycin, [Effect] interstitial pneumonitis"}, {"id": "18446030_1_2637", "context": "Disseminated eruptive giant mollusca contagiosa in an adult psoriasis patient during efalizumab therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] an adult psoriasis patient [Treatment] efalizumab therapy [Effect] Disseminated eruptive giant mollusca contagiosa"}, {"id": "812008_2_2638", "context": "Significant clinical improvement of the porphyria followed withdrawal of the diphenylhydantoin.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] improvement [Treatment] withdrawal of the diphenylhydantoin"}, {"id": "18294121_5_2639", "context": "Temozolomide was restarted 2 months later; the patient again developed a fever.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] the patient [Treatment] Temozolomide [Effect] fever"}, {"id": "9337441_16_2640", "context": "The patient's previous rash and the temporal relation of this event and the ingestion of phenolphthalein, as well as the similarity of this case to other reports, point to phenolphthalein as the cause of TEN in this patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Subject] The patient's previous rash [Treatment] ingestion of phenolphthalein [Effect] TEN"}, {"id": "15592331_12_2641", "context": "Ciprofloxacin greatly elevates plasma concentrations of tizanidine and dangerously potentiates its hypotensive and sedative effects, mainly by inhibiting its CYP1A2-mediated metabolism, at least when administered 1 hour before tizanidine.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] elevates [Treatment] Ciprofloxacin [Effect] plasma concentrations of tizanidine and dangerously potentiates its hypotensive and sedative effects"}, {"id": "11328247_4_2642", "context": "RESULTS: The patient, a 27-year-old married Japanese woman with borderline personality disorder, developed an increased libido with the administration of fluvoxamine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] The patient, a 27-year-old married Japanese woman with borderline personality disorder [Treatment] administration of fluvoxamine [Effect] increased libido"}, {"id": "9403220_2_2643", "context": "Acute renal failure with severe tubulointerstitial changes in a patient with minimal change nephrotic syndrome treated with enalapril.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] a patient with minimal change nephrotic syndrome [Treatment] enalapril [Effect] Acute renal failure with severe tubulointerstitial changes"}, {"id": "19667003_2_2644", "context": "PURPOSE: A case of carbamazepine-induced hyperammonemia is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] A case [Treatment] carbamazepine [Effect] hyperammonemia"}, {"id": "7919557_4_2645", "context": "The cough continued for the duration of therapy with quinapril.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] continued [Treatment] quinapril [Effect] cough"}, {"id": "15685264_2_2646", "context": "OBJECTIVE: To report a case of Carbamazepine toxicity following the administration of Oxybutynin and Dantrolene.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] Carbamazepine; Oxybutynin and Dantrolene [Effect] Carbamazepine toxicity"}, {"id": "9362107_1_2647", "context": "Danazol induced thrombocytopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Danazol [Effect] thrombocytopenia"}, {"id": "16005413_5_2648", "context": "Four elderly LTCF residents treated with serotonergic antidepressants including selective serotonin reuptake inhibitor (SSRI) or mirtazapine and opioids.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] Four elderly LTCF residents [Treatment] serotonergic antidepressants including selective serotonin reuptake inhibitor (SSRI) or mirtazapine and opioids"}, {"id": "1772299_1_2649", "context": "Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] patient [Treatment] L-tryptophan [Effect] eosinophilia-myalgia syndrome"}, {"id": "8942269_2_2650", "context": "His impaired memory was found to be due to the atenolol he was on and he made a complete recovery on withdrawing the beta-blocker.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] he [Treatment] atenolol [Effect] impaired memory"}, {"id": "15388215_1_2651", "context": "Tiagabine overdose causes an unusual array of neurological symptoms, many similar to reported adverse effects during therapeutic use.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causes [Treatment] Tiagabine overdose [Effect] an unusual array of neurological symptoms"}, {"id": "8496127_2_2652", "context": "This paper reports on a 6.9-year-old autistic male who developed repeated episodes of acute dystonic reactions associated with pimozide administration at the doses of 0.096 mg/kg/day and 0.032 mg/kg/day and 32 hours following pimozide withdrawal, as well as during subsequent thioridazine administration.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] 6.9-year-old autistic male [Treatment] pimozide administration at the doses of 0.096 mg/kg/day and 0.032 mg/kg/day and 32 hours following pimozide withdrawal, as well as during subsequent thioridazine administration [Effect] repeated episodes of acute dystonic reactions"}, {"id": "9169264_1_2653", "context": "Cephalexin rash in infectious mononucleosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Treatment] Cephalexin [Effect] Cephalexin rash"}, {"id": "19122478_6_2654", "context": "He developed recurrent skin rash, fever, hypereosinophilia, and acute renal failure after rechallenge with chlorambucil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] rechallenge with chlorambucil [Effect] recurrent skin rash, fever, hypereosinophilia, and acute renal failure"}, {"id": "464813_1_2655", "context": "Lower extremity arterial insufficiency after long-term methysergide maleate therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] long-term methysergide maleate therapy [Effect] Lower extremity arterial insufficiency"}, {"id": "11788010_3_2656", "context": "Hepatolithiasis (intrahepatic stone) during octreotide therapy for acromegaly: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] octreotide [Effect] Hepatolithiasis (intrahepatic stone)"}, {"id": "16527771_1_2657", "context": "Acute unilateral total visual loss after retrogasserian phenol injection for the treatment of trigeminal neuralgia: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] retrogasserian phenol injection [Effect] Acute unilateral total visual loss"}, {"id": "19995222_4_2658", "context": "OBJECTIVE: Clozapine causes few extrapyramidal symptoms and is recommended as a treatment drug for severe tardive dyskinesia (TD).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causes [Treatment] Clozapine [Effect] few extrapyramidal symptoms"}, {"id": "22791547_1_2659", "context": "Methylphenidate-induced acute orofacial and extremity dyskinesia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Methylphenidate [Effect] acute orofacial and extremity dyskinesia"}, {"id": "7946029_1_2660", "context": "Basilar invagination and mid-line skeletal abnormalities due to in utero exposure to phenytoin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] utero exposure to phenytoin [Effect] Basilar invagination and mid-line skeletal abnormalities"}, {"id": "18682542_2_2661", "context": "DISCUSSION: To our knowledge, this is the first case report illustrating neuralgic amyotrophy triggered by exposure to the antibiotics vancomycin, tobramycin, and piperacillin/tazobactam.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] triggered [Treatment] antibiotics vancomycin, tobramycin, and piperacillin/tazobactam [Effect] neuralgic amyotrophy"}, {"id": "9840249_1_2662", "context": "Alveolar-interstitial pneumopathy after gold-salts compounds administration, requiring mechanical ventilation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] gold-salts compounds administration [Effect] Alveolar-interstitial pneumopathy"}, {"id": "15373932_10_2663", "context": "This study revealed that ketoconazole affected the disposition of rosiglitazone in humans, probably by the inhibition of CYP2C8 and CYP2C9, leading to increasing rosiglitazone concentrations that could increase the efficacy of rosiglitazone or its adverse events.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] leading to [Subject] humans [Treatment] ketoconazole [Effect] increasing rosiglitazone concentrations that could increase the efficacy of rosiglitazone or its adverse events"}, {"id": "25538343_4_2664", "context": "We report a case of duloxetine-induced hyponatremia in an elderly patient treated with thiazide diuretics.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an elderly patient [Treatment] duloxetine; thiazide diuretics [Effect] hyponatremia"}, {"id": "3892171_1_2665", "context": "Protamine-induced fatal anaphylaxis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Protamine [Effect] anaphylaxis"}, {"id": "9362107_3_2666", "context": "We diagnosed this case as danazol induced thrombocytopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] this case [Treatment] danazol [Effect] thrombocytopenia"}, {"id": "8530331_5_2667", "context": "One patient required nursing home placement and a feeding gastrostomy as a result of the worsening parkinsonism during risperidone treatment, but was able to return home and have the gastrostomy removed after switching from risperidone to clozapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment [Subject] One patient [Treatment] risperidone [Effect] required nursing home placement and a feeding gastrostomy as a result of the worsening parkinsonism [Potential therapeutic event] after [Subject] One patient [Treatment] switching from risperidone to clozapine [Effect] was able to return home and have the gastrostomy removed"}, {"id": "9776099_1_2668", "context": "NMS is a drug-related response to various medications, such as Haloperidol, which the patient was receiving.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] response [Subject] patient [Treatment] Haloperidol [Effect] NMS"}, {"id": "15770343_3_2669", "context": "In addition, ethambutol rarely causes visual loss during the early period or when given at lower doses.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causes [Treatment] ethambutol; during the early period or when given at lower doses [Effect] visual loss"}, {"id": "11215836_4_2670", "context": "The day after clozapine was stopped, while he was still receiving clomipramine 150 mg/d, he began behaving oddly, started sweating profusely, shivering, and became tremulous, agitated, and confused.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] stopped [Subject] he [Treatment] day after clozapine was stopped, while he was still receiving clomipramine 150 mg/d [Effect] behaving oddly, started sweating profusely, shivering, and became tremulous, agitated, and confused"}, {"id": "9494448_4_2671", "context": "CONCLUSIONS: Hypersensitivity reactions to cyclosporine are due to Cremophor EL.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] Cremophor EL [Effect] Hypersensitivity reactions to cyclosporine"}, {"id": "10656221_2_2672", "context": "There are few reports in the literature related to sulfonylurea-induced hepatotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] sulfonylurea [Effect] hepatotoxicity"}, {"id": "17406804_4_2673", "context": "Radiation recall pneumonitis induced by gemcitabine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] gemcitabine [Effect] Radiation recall pneumonitis"}, {"id": "8266863_1_2674", "context": "Four days after the initial injection of 3.6 mg of goserelin acetate, severe dyspnea developed due to worsening pleuritis carcinomatosa, which was considered as a flare-up.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] injection of 3.6 mg of goserelin acetate [Effect] severe dyspnea; worsening pleuritis carcinomatosa"}, {"id": "11675845_4_2675", "context": "Ropinirole was added to his current therapy for Parkinson disease, with a corresponding decrease in the dose of levodopa/carbidopa to allow levodopa sparing.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] added [Treatment] Ropinirole; a corresponding decrease in the dose of levodopa/carbidopa to allow levodopa sparing"}, {"id": "11703329_2_2676", "context": "Recognizing early signs of HMSN, such as areflexia and pes cavus deformity, can prevent severe neurotoxicity of polychemotherapy by avoiding vincristine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] by [Treatment] vincristine [Effect] severe neurotoxicity of polychemotherapy"}, {"id": "17285101_3_2677", "context": "This is the first report of pulmonary hypertension in an adult patient during lithium therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] an adult patient [Treatment] lithium therapy. [Effect] pulmonary hypertension"}, {"id": "15307435_2_2678", "context": "In this report, we present a case of hypoglycaemic coma associated with SP, an adverse reaction that is likely to be underreported and expected to occur with greater frequency as the use of SP increases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] SP [Effect] hypoglycaemic coma; an adverse reaction that is likely to be underreported and expected to occur with greater frequency as the use of SP increases"}, {"id": "7439122_2_2679", "context": "However, we have recently had four cases of clofibrate-induced myopathy in patients with diabetes insipidus due to hypothalamic lesions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] four cases; diabetes insipidus due to hypothalamic lesions [Treatment] clofibrate [Effect] myopathy"}, {"id": "9052919_2_2680", "context": "One patient had MRI T2 abnormalities compatible with cyclosporin neurotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] had [Subject] One patient [Treatment] cyclosporin [Effect] neurotoxicity; MRI T2 abnormalities"}, {"id": "21751666_1_2681", "context": "Post-exposure prophylaxis for H1N1 with oseltamivir in renal allograft recipient--safe and effective without any immunosuppresive drug interaction.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] Post-exposure prophylaxis [Subject] renal allograft recipient [Treatment] oseltamivir [Effect] safe and effective without any immunosuppresive drug interaction"}, {"id": "8140860_3_2682", "context": "Seven days after the introduction of amoxycillin (500 mg/8 h) for a probable respiratory infection, the patient developed spontaneous bruising, with an INR of 7.1.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] the patient [Treatment] Seven days after the introduction of amoxycillin (500 mg/8 h) [Effect] spontaneous bruising, with an INR of 7.1"}, {"id": "15383642_2_2683", "context": "To report a case in which significant hypotension occurred after initiation of tizanidine in a patient using the antihypertensive agent lisinopril.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient; a case [Treatment] initiation of tizanidine; lisinopril [Effect] hypotension"}, {"id": "23624139_3_2684", "context": "We herein describe a case of severe hyponatremia complicated by seizure and coma due to the intake of non-steroidal anti-inflammatory drugs (NSAIDs) in a patient on DDAVP replacement therapy for central diabetes insipidus (DI).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Subject] a patient; for central diabetes insipidus (DI) [Treatment] intake of non-steroidal anti-inflammatory drugs (NSAIDs); on DDAVP replacement therapy [Effect] severe hyponatremia; seizure and coma"}, {"id": "11213850_6_2685", "context": "Each subject was treated according to the following sequence: baseline; phase 1 (days 1-6): cisapride 10 mg 4 times/day; washout (days 7-13); phase 2 (days 14-44): fluoxetine 20 mg/day; and phase 3 (days 45-52): cisapride 10 mg 4 times/day (days 45-51) plus fluoxetine 20 mg/day (days 45-52).", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] Each subject [Treatment] baseline; phase 1 (days 1-6): cisapride 10 mg 4 times/day; washout (days 7-13); phase 2 (days 14-44): fluoxetine 20 mg/day; and phase 3 (days 45-52): cisapride 10 mg 4 times/day (days 45-51) plus fluoxetine 20 mg/day (days 45-52)"}, {"id": "412488_7_2686", "context": "These findings are consistent with an immune-complex form of glomerulopathy in which gold is neither the antigen nor a hapten in the glomerular deposits, and they suggest the hypothesis that antibodies to tubular epithelial antigens induced by gold therapy may be a causative factor in the renal disease associated with gold therapy in rheumatoid arthritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] gold therapy in rheumatoid arthritis [Effect] renal disease"}, {"id": "7304798_1_2687", "context": "Induction of rapid mood cycling during L-dopa treatment in a bipolar patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a bipolar patient [Treatment] L-dopa [Effect] rapid mood cycling"}, {"id": "11144696_2_2688", "context": "To report a patient having a first-time seizure after receiving venlafaxine and trimipramine for depression.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] patient [Treatment] venlafaxine and trimipramine [Effect] seizure"}, {"id": "282937_3_2689", "context": "Paraplegia following prophylactic intrathecal cytosine arabinoside (Ara-C) is described in a patient with acute myelogenous leukemia in remission who received doses of 100 mg/m2/d for 5 consecutive days.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a patient with acute myelogenous leukemia in remission [Treatment] prophylactic intrathecal cytosine arabinoside (Ara-C); doses of 100 mg/m2/d for 5 consecutive days [Effect] Paraplegia"}, {"id": "19402273_2_2690", "context": "Isoniazid induced gynaecomastia: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Isoniazid [Effect] gynaecomastia"}, {"id": "17671884_7_2691", "context": "One previous study of four transplant patients whose immediate post-transplantation immunosuppression utilized corticosteroids, cyclosporine, MMF, and anti-T-lymphocyte globulin noted anemia in 13% of them.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] noted [Subject] four transplant patients [Treatment] immediate post-transplantation immunosuppression utilized corticosteroids, cyclosporine, MMF, and anti-T-lymphocyte globulin [Effect] anemia"}, {"id": "1348483_2_2692", "context": "Pleuropulmonary changes during treatment of Parkinson's disease with a long-acting ergot derivative, cabergoline.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] cabergoline [Effect] Pleuropulmonary changes"}, {"id": "3982906_2_2693", "context": "However, each infant demonstrated hemodynamic decompensation shortly after verapamil administration and required cardiopulmonary resuscitation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] demonstrated [Subject] each infant [Treatment] verapamil [Effect] hemodynamic decompensation"}, {"id": "11160777_11_2694", "context": "Long-term studies are needed to determine whether the insulin-sensitizing effects of the glitazones can prevent or delay premature atherosclerotic cardiovascular disease, morbidity, and death.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prevent [Treatment] glitazones"}, {"id": "7663030_1_2695", "context": "Probable propafenone-induced transient global amnesia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] propafenone [Effect] transient global amnesia"}, {"id": "16119501_3_2696", "context": "The patient continued to have fever and autonomic instability without evidence of infection which entirely resolved within 24 hours of reinstitution of full preadmission dosing of oral baclofen.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] have [Treatment] 24 hours of reinstitution of full preadmission dosing of oral baclofen [Effect] fever and autonomic instability without evidence of infection which entirely resolved"}, {"id": "16629074_2_2697", "context": "Traumatic late flap dehiscence and Enterobacter keratitis following LASIK.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] LASIK [Effect] Traumatic late flap dehiscence and Enterobacter keratitis"}, {"id": "2305654_2_2698", "context": "We report on a patient with subarachnoid haemorrhage who developed an acute life-threatening pseudo-obstruction of the colon, a variant of adynamic ileus, while being treated with intravenous nimodipine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] patient with subarachnoid haemorrhage [Treatment] intravenous nimodipine [Effect] pseudo-obstruction of the colon"}, {"id": "12111771_1_2699", "context": "A 73-year-old woman presented with fever and cough 2 weeks after completing the third cycle of fludarabine for chronic lymphocytic leukemia (CLL).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] A 73-year-old woman [Treatment] 2 weeks after completing the third cycle of fludarabine for chronic lymphocytic leukemia (CLL) [Effect] fever and cough"}, {"id": "15729090_2_2700", "context": "We report a case of myoclonus induced by quetiapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] quetiapine [Effect] myoclonus"}, {"id": "1393348_1_2701", "context": "A 21-year-old woman suffering from bipolar affective disorder developed systemic lupus erythematosus (SLE) with characteristic laboratory findings, 18 months after starting carbamazepine maintenance treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 21-year-old woman suffering from bipolar affective disorder [Treatment] 18 months after starting carbamazepine maintenance treatment [Effect] systemic lupus erythematosus (SLE)"}, {"id": "7973922_2_2702", "context": "Acyclovir produces neurologic symptoms that resemble extension of viral infection into the central nervous system.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] produces [Treatment] Acyclovir [Effect] neurologic symptoms"}, {"id": "12086549_3_2703", "context": "Subcutaneous IL-2 is safe and well tolerated, with a mortality rate <3%.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] Subcutaneous IL-2 [Effect] mortality rate <3%"}, {"id": "19434733_3_2704", "context": "Two patients with HLH developed etoposide-related secondary acute myeloid leukemia (sAML) following therapy for HLH.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] Two patients with HLH [Treatment] etoposide [Effect] secondary acute myeloid leukemia (sAML)"}, {"id": "2250853_2_2705", "context": "We report a case of secondary glaucoma caused by epithelial downgrowth in which filtration surgery was performed with adjunctive use of subconjunctival 5-fluorouracil.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] filtration surgery was performed with adjunctive use of subconjunctival 5-fluorouracil [Effect] secondary glaucoma; epithelial downgrowth"}, {"id": "17189581_1_2706", "context": "Mild serotonin syndrome associated with concurrent linezolid and fluoxetine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] concurrent linezolid and fluoxetine [Effect] serotonin syndrome"}, {"id": "8530331_1_2707", "context": "Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Subject] six patients with Parkinson's disease and other akinetic-rigid syndromes [Treatment] Risperidone versus clozapine"}, {"id": "18691992_5_2708", "context": "Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] an elderly subject [Treatment] Hydroxyurea [Effect] concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas"}, {"id": "11889149_4_2709", "context": "Women (aged < or = 75 yr; > or = 2 yr since their last menstrual period) received placebo, RLX 60 mg/d, ALN 10 mg/d, or RLX 60 mg/d and ALN 10 mg/d combined.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] received [Subject] Women (aged < or = 75 yr; > or = 2 yr since their last menstrual period) [Treatment] RLX 60 mg/d, ALN 10 mg/d, or RLX 60 mg/d and ALN 10 mg/d combined"}, {"id": "8301877_2_2710", "context": "Myoclonus and seizures in a patient with parkinsonism: induction by levodopa and its confirmation on SEPs.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induction [Subject] a patient with parkinsonism [Treatment] levodopa [Effect] Myoclonus and seizures"}, {"id": "7663030_2_2711", "context": "OBJECTIVE: To describe a probable case of transient global amnesia caused by propafenone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] propafenone [Effect] transient global amnesia"}, {"id": "458006_2_2712", "context": "We report the development of squamous-cell carcinoma within a basal-cell epithelioma that was treated with intralesional injections of 5-FU.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Treatment] intralesional injections of 5-FU [Effect] squamous-cell carcinoma within a basal-cell epithelioma"}, {"id": "10745478_1_2713", "context": "This case report illustrates the use of continuous high-dose intracoronary nitroglycerin infusion through a 6 French coronary guiding catheter in the treatment of a patient with cocaine-induced refractory coronary vasospasm.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] cocaine [Effect] refractory coronary vasospasm [Potential therapeutic event] treatment [Treatment] use of continuous high-dose intracoronary nitroglycerin infusion through a 6 French coronary guiding catheter"}, {"id": "18585545_3_2714", "context": "Here, we describe levofloxacin-induced delirium with psychotic features in a relatively young, otherwise healthy female.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] relatively young, otherwise healthy female [Treatment] levofloxacin [Effect] delirium with psychotic features"}, {"id": "9876809_1_2715", "context": "Ticlopidine-induced phenytoin toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Ticlopidine [Effect] toxicity"}, {"id": "19540093_3_2716", "context": "Pancreatitis has been associated with the tetracycline class of antibiotics and concerns about tigecycline-induced acute pancreatitis have recently been raised.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] tigecycline [Effect] acute pancreatitis"}, {"id": "2811895_1_2717", "context": "Abrupt, accidental withdrawal of trihexyphenidyl triggered severe exacerbation of the cranial dystonia associated with inspiratory stridor and acute respiratory difficulties, prompting emergency admission.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] triggered [Treatment] Abrupt, accidental withdrawal of trihexyphenidyl [Effect] exacerbation of the cranial dystonia associated with inspiratory stridor and acute respiratory difficulties"}, {"id": "3397227_2_2718", "context": "We report two patients with anhedonic ejaculation (ejaculation without orgasm) associated with initiation of treatment with desipramine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] two patients [Treatment] desipramine [Effect] anhedonic ejaculation (ejaculation without orgasm)"}, {"id": "18191947_3_2719", "context": "We describe longitudinal diffusion-weighted MRI findings of sub-acute leukoencephalopathy following methotrexate therapy in a 24-year-old man diagnosed with pre-B-cell acute lymphoblastic leukemia (ALL), presenting with right-sided paralysis and aphasia after second consolidation with intrathecal triple-drug therapy given intrathecally.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a 24-year-old man [Treatment] methotrexate [Effect] longitudinal diffusion-weighted MRI findings of sub-acute leukoencephalopathy [Adverse event] after [Subject] a 24-year-old man [Treatment] second consolidation with intrathecal triple-drug therapy given intrathecally [Effect] presenting with right-sided paralysis and aphasia"}, {"id": "19915794_2_2720", "context": "Therefore, although garenoxacin reportedly causes fewer adverse reactions for cardiac rhythms than third-generation quinolone antibiotics, one must be cautious of the interference of other drugs during hypokalemia in order to prevent TdP.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] causes [Treatment] garenoxacin [Effect] adverse reactions for cardiac rhythms [Adverse event] prevent [Subject] hypokalemia [Treatment] garenoxacin [Effect] TdP"}, {"id": "12792223_1_2721", "context": "A 45-year-old woman with steroid-dependent Crohn's colitis, successfully managed with maintenance infliximab infusions and methotrexate, developed a lupus-like syndrome eight months after her initial infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 45-year-old woman with steroid-dependent Crohn's colitis [Treatment] maintenance infliximab infusions and methotrexate; eight months after her initial infusion [Effect] lupus-like syndrome"}, {"id": "6292681_1_2722", "context": "Severe neurotoxicity with methyl G: CALGB experience.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Treatment] methyl G [Effect] neurotoxicity"}, {"id": "3725284_2_2723", "context": "We report a case of a 60-year-old woman affected by squamous lung carcinoma, who developed paroxysmal supraventricular tachycardia during cisplatin and etoposide combination chemotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 60-year-old woman affected by squamous lung carcinoma [Treatment] cisplatin and etoposide combination [Effect] paroxysmal supraventricular tachycardia"}, {"id": "9177620_2_2724", "context": "The authors report a case of acute pancreatitis (AP) occurring in a patient under treatment with carbamazepine (CBZ) for post-traumatic petit mal epilepsy, and review the current literature of drug-induced AP.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurring [Subject] a patient [Treatment] carbamazepine [Effect] acute pancreatitis"}, {"id": "19707032_1_2725", "context": "Acute ocular ischemic change may be associated with intravitreal injection of bevacizumab in patients with vascular compromised diabetic retinopathy and/or underlying stenosis of the carotid artery.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] patients with vascular compromised diabetic retinopathy and/or underlying stenosis of the carotid artery [Treatment] intravitreal injection of bevacizumab [Effect] Acute ocular ischemic change"}, {"id": "17852449_2_2726", "context": "All-trans-retinoic acid (ATRA) has been proved to be an effective treatment for acute promyelocytic leukemia (APL), inducing remission in more than 90% of cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] proved [Subject] more than 90% of cases [Treatment] All-trans-retinoic acid (ATRA)"}, {"id": "18698687_2_2727", "context": "Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] ciprofloxacin [Effect] Vanishing bile duct and Stevens-Johnson syndrome"}, {"id": "9161656_5_2728", "context": "Antiasthmatic medications were prescribed, but the asthma symptoms did not improve.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] improve [Treatment] Antiasthmatic medications were prescribed"}, {"id": "12590235_1_2729", "context": "Both 6-MP and AZA are widely used and are known to cause hepatotoxicity in a proportion of patients.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] used [Subject] a proportion of patients [Treatment] 6-MP and AZA [Effect] hepatotoxicity"}, {"id": "11889149_2_2730", "context": "Both raloxifene (RLX) and alendronate (ALN) can treat and prevent new vertebral fractures, increase bone mineral density (BMD), and decrease biochemical markers of bone turnover in postmenopausal women with osteoporosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treat [Subject] postmenopausal women with osteoporosis [Treatment] Both raloxifene (RLX) and alendronate (ALN) [Effect] increase bone mineral density (BMD); decrease biochemical markers of bone turnover"}, {"id": "9840249_3_2731", "context": "We report a case of severe respiratory failure due to gold salt toxicity in a patient suffering from rheumatoid arthritis requiring mechanical ventilation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Subject] a patient suffering from rheumatoid arthritis [Treatment] gold salt [Effect] respiratory failure"}, {"id": "3628148_2_2732", "context": "We describe rupture of a cerebral arterial aneurysm in a 32 year old hypertensive woman following the introduction of nifedipine treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] a 32 year old hypertensive woman [Treatment] nifedipine treatment [Effect] rupture of a cerebral arterial aneurysm"}, {"id": "16882109_2_2733", "context": "Factors that suggested an association between the severe angioedematous reaction and BP topical application include the strong reaction to BP in the patch-test, the temporal relationship, the complete resolution of symptoms after the drug was withdrawn and the absence of other identified explanations.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] BP topical application [Effect] severe angioedematous reaction"}, {"id": "11889149_14_2734", "context": "RLX+ALN reduced bone turnover more than either drug alone, resulting in greater BMD increment, but whether this difference reflects better fracture risk reduction was not assessed in this study.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] reduced [Treatment] RLX; ALN [Effect] bone turnover more than either drug alone, resulting in greater BMD increment"}, {"id": "11881322_3_2735", "context": "Hepatotoxicity related to itraconazole: report of three cases.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Subject] three cases [Treatment] itraconazole [Effect] Hepatotoxicity"}, {"id": "2295443_3_2736", "context": "This report presents a case of colon perforation which occurred 4 months after treatment with intraperitoneal chromic phosphate for stage IB ovarian papillary serous cystadenocarcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurred [Treatment] intraperitoneal chromic phosphate [Effect] colon perforation"}, {"id": "9634122_1_2737", "context": "Flutamide withdrawal syndrome is characterized by a decrease in prostate-specific antigen (PSA) after flutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] withdrawal [Subject] subset of patients with progressing metastatic carcinoma of the prostate [Treatment] flutamide [Effect] decrease in prostate-specific antigen (PSA)"}, {"id": "7282702_2_2738", "context": "Bradycardia and congestive heart failure associated with ocular timolol maleate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] ocular timolol maleate [Effect] Bradycardia and congestive heart failure"}, {"id": "19707032_4_2739", "context": "CONCLUSIONS: Patients receiving intravitreal injections of bevacizumab should be evaluated for potential systemic risk factors such as carotid insufficiency, coagulopathy and poorly controlled diabetes mellitus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] risk [Treatment] intravitreal injections of bevacizumab [Effect] carotid insufficiency, coagulopathy and poorly controlled diabetes mellitus"}, {"id": "25671244_13_2740", "context": "Severe serotonin toxicity may result from metaxalone abuse in individuals using a selective serotonin reuptake inhibitor therapeutically.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] result [Treatment] metaxalone abuse; using a selective serotonin reuptake inhibitor therapeutically [Effect] serotonin toxicity"}, {"id": "18504683_2_2741", "context": "The purpose of this article is to present the first case-series of posterior reversible encephalopathy syndrome (PRES) associated with L-asparaginase treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] L-asparaginase treatment [Effect] posterior reversible encephalopathy syndrome (PRES)"}, {"id": "16029707_1_2742", "context": "Eruptive epidermoid cysts resulting from treatment with imiquimod.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Treatment] imiquimod [Effect] Eruptive epidermoid cysts"}, {"id": "12757344_1_2743", "context": "Carbamazepine-related hyponatremia following cardiopulmonary bypass.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] Carbamazepine [Effect] hyponatremia"}, {"id": "15379082_2_2744", "context": "Fulminant hepatic failure is a rare complication of disulfiram treatment for alcoholism.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complication [Treatment] disulfiram [Effect] Fulminant hepatic failure"}, {"id": "11049910_11_2745", "context": "Implications: Clinicians should be aware of the possibility of increased toxicity of ropivacaine when used together with inhibitors of CYP1A2.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increased [Treatment] ropivacaine; inhibitors of CYP1A2 [Effect] toxicity"}, {"id": "3379435_1_2746", "context": "Evidence obtained indicated that the Reye-like syndrome might be caused by calcium hopantenate possibly due to the induction of pantothenic acid deficiency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] calcium hopantenate [Effect] Reye-like syndrome"}, {"id": "3143551_5_2747", "context": "Hepatopathy subsided after the cessation of carbamazepine and lynestrenol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] carbamazepine; lynestrenol [Effect] Hepatopathy subsided"}, {"id": "8667442_2_2748", "context": "This article presents a patient with hypoparathyroidism who was treated with calcium carbonate and calcitriol resulting in two admissions to the hospital for milk-alkali syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] resulting [Subject] a patient with hypoparathyroidism [Treatment] calcium carbonate and calcitriol [Effect] two admissions to the hospital for milk-alkali syndrome"}, {"id": "16997047_3_2749", "context": "Recurrent hyponatremia associated with citalopram and mirtazapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] citalopram and mirtazapine [Effect] Recurrent hyponatremia"}, {"id": "24429012_2_2750", "context": "A case report of a sharp rise in International Normalized Ratio (INR) values during a patient's concomitant use of warfarin and the antineoplastic agent vismodegib is presented.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] a patient [Treatment] concomitant use of warfarin and the antineoplastic agent vismodegib [Effect] a sharp rise in International Normalized Ratio (INR) values"}, {"id": "18810448_1_2751", "context": "In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement (true thymic hyperplasia), mediastinal lymphadenopathy and pleurisy associated with systemic symptoms under Etanercept treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a case of juvenile idiopathic arthritis patient [Treatment] Etanercept [Effect] thymic enlargement (true thymic hyperplasia), mediastinal lymphadenopathy and pleurisy associated with systemic symptoms"}, {"id": "2445709_1_2752", "context": "A 52-year-old woman developed symmetric sensorimotor polyneuropathy and cerebellar syndrome after 24 months of amiodarone treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 52-year-old woman [Treatment] amiodarone [Effect] symmetric sensorimotor polyneuropathy; cerebellar syndrome"}, {"id": "18396749_3_2753", "context": "The case of a patient under tibolone therapy for two years who developed a mixed-type liver injury with prolonged cholestasis and features of the vanishing bile duct syndrome following a ten weeks treatment with St. John wort (Hypericum Perforatum) infusions is reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient under tibolone therapy [Treatment] under tibolone therapy; a ten weeks treatment with St. John wort (Hypericum Perforatum) infusions [Effect] a mixed-type liver injury with prolonged cholestasis and features of the vanishing bile duct syndrome"}, {"id": "18094347_6_2754", "context": "OBJECTIVE: To report a case of a diffuse papular eruption following treatment of psoriasis with methotrexate injections.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] methotrexate injections [Effect] diffuse papular eruption"}, {"id": "10099659_1_2755", "context": "Prolonged severe 5-fluorouracil-associated neurotoxicity in a patient with dihydropyrimidine dehydrogenase deficiency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a patient with dihydropyrimidine dehydrogenase deficiency [Treatment] 5-fluorouracil [Effect] neurotoxicity"}, {"id": "18343993_3_2756", "context": "Life-threatening interstitial lung disease associated with trastuzumab: case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] case [Treatment] trastuzumab [Effect] Life-threatening interstitial lung disease"}, {"id": "15694139_6_2757", "context": "Thalidomide neuropathy is often associated with proximal weakness and may progress even after discontinuation of treatment, in the phenomenon of 'coasting'.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Thalidomide [Effect] neuropathy; proximal weakness"}, {"id": "18607107_3_2758", "context": "RESULTS: Our patient developed Crohn's disease while on Copaxone treatment as a consequence of long-term immunosuppression.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] patient [Treatment] Copaxone [Effect] Crohn's disease; long-term immunosuppression"}, {"id": "19707032_2_2759", "context": "Acute vision loss after intravitreal injection of bevacizumab (avastin) associated with ocular ischemic syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] intravitreal injection of bevacizumab (avastin) [Effect] Acute vision loss; ocular ischemic syndrome"}, {"id": "2663536_1_2760", "context": "Development of persistent late onset asthma following treatment with captopril.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] captopril [Effect] persistent late onset asthma"}, {"id": "19717383_1_2761", "context": "Herein, we describe a patient with AIDS who presented to medical attention with pancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab (R-EPOCH) for diffuse large B-cell lymphoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] a patient with AIDS [Treatment] 48 months postchemotherapy with etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab (R-EPOCH) [Effect] medical attention with pancytopenia"}, {"id": "8038468_2_2762", "context": "However, prolongation of 5-FU half-life and an increase in INR have been reported with the concurrent use of 5-FU and warfarin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] reported [Treatment] the concurrent use of 5-FU and warfarin [Effect] prolongation of 5-FU half-life and an increase in INR"}, {"id": "7718983_1_2763", "context": "Graves' hyperthyroidism following transient thyrotoxicosis during interferon therapy for chronic hepatitis type C.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] interferon [Effect] Graves' hyperthyroidism following transient thyrotoxicosis"}, {"id": "17083900_2_2764", "context": "We report a case of acute generalized exanthematous pustulosis (AGEP) in a 50-year-old woman that was attributed to the ingestion of nimesulide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] attributed [Subject] a 50-year-old woman [Treatment] ingestion of nimesulide [Effect] acute generalized exanthematous pustulosis (AGEP)"}, {"id": "18191947_2_2765", "context": "This case demonstrates the value of DWI in evaluation and diagnosis of sub-acute toxic leukoencephalopathy in patients being treated with methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] patients [Treatment] methotrexate [Effect] sub-acute toxic leukoencephalopathy"}, {"id": "15785053_3_2766", "context": "We report the first histopathologically documented case of oral mucosa pigmentation after OLP treatment with topical tacrolimus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treatment [Treatment] topical tacrolimus [Effect] oral mucosa pigmentation"}, {"id": "16298824_5_2767", "context": "Progressive hypoxemia mandated endotracheal intubation 1 week after rituximab administration and led to death 4 weeks after admission.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] rituximab administration [Effect] Progressive hypoxemia; led to death"}, {"id": "21751542_4_2768", "context": "Angiotensin converting enzyme blockers and their influence on the endothelial dysfunction, but the risk of hyperpotassemia are showed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] showed [Treatment] Angiotensin converting enzyme blockers [Effect] hyperpotassemia"}, {"id": "24846936_2_2769", "context": "This is the first report of a fatal outcome from serotonin toxicity, precipitated by an interaction between methylene blue and venlafaxine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] precipitated [Treatment] methylene blue; venlafaxine [Effect] serotonin toxicity"}, {"id": "19904536_10_2770", "context": "A helicoidal CT scan showed diffuse and severe interstitial pneumonitis, and lung biopsy confirmed accelerated usual interstitial pneumonia consistent with drug-induced toxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] drug [Effect] diffuse and severe interstitial pneumonitis; accelerated usual interstitial pneumonia; toxicity"}, {"id": "10614572_3_2771", "context": "We report a case of severe hypotension associated with intravenous valproate used to treat status epilepticus in an 11-year-old girl.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] an 11-year-old girl [Treatment] intravenous valproate [Effect] hypotension"}, {"id": "11489400_1_2772", "context": "Relief by naloxone of morphine-induced spasm of the sphincter of Oddi in a post-cholecystectomy patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] Relief [Subject] post-cholecystectomy patient. [Treatment] naloxone [Adverse event] induced [Subject] post-cholecystectomy patient. [Treatment] morphine [Effect] spasm of the sphincter of Oddi"}, {"id": "17610180_2_2773", "context": "The results of the ultrasound examination combined with clinical anamnesis allowed diagnosis of gastric mucosa foveolar hyperplasia due to prolonged PGE1 therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] prolonged PGE1 therapy [Effect] gastric mucosa foveolar hyperplasia"}, {"id": "6683487_4_2774", "context": "To our knowledge, no prior cases of penicillamine-induced TTP in RA have been reported.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] penicillamine [Effect] TTP"}, {"id": "6529939_1_2775", "context": "Alternating sinus rhythm and intermittent sinoatrial block induced by propranolol.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] propranolol [Effect] Alternating sinus rhythm and intermittent sinoatrial block"}, {"id": "9701106_5_2776", "context": "The noted increase in the theophylline level after zafirlukast administration is in contrast to the original reports by the manufacturer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] zafirlukast administration [Effect] increase in the theophylline level"}, {"id": "6947095_2_2777", "context": "The cause is presumed to be secondary to hypercoagulability due to asparaginase-induced antithrombin III deficiency.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] asparaginase [Effect] antithrombin III deficiency"}, {"id": "10749332_5_2778", "context": "Troglitazone-induced fulminant hepatic failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Troglitazone [Effect] fulminant hepatic failure"}, {"id": "2320800_2_2779", "context": "A sixty-year-old woman with advanced breast cancer, previously treated with cisplatin, developed an irreversible lethal renal failure with anuria, the day after 5 g/m2 bolus ifosfamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A sixty-year-old woman with advanced breast cancer, previously treated with cisplatin [Treatment] the day after 5 g/m2 bolus ifosfamide [Effect] an irreversible lethal renal failure with anuria"}, {"id": "10467499_2_2780", "context": "With the negative viral serologies, the clinical picture was most consistent with an infectious mononucleosis-like syndrome produced by the minocycline ingestion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] produced [Treatment] minocycline ingestion [Effect] infectious mononucleosis-like syndrome"}, {"id": "15920338_2_2781", "context": "High-grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] tamoxifen [Effect] High-grade endometrial stromal sarcoma"}, {"id": "16207263_2_2782", "context": "We report here two cases of dyserythropoietic anaemia associated with long-term linezolid use that share striking similarities to chloramphenicol-associated myelotoxicity.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] long-term linezolid [Effect] dyserythropoietic anaemia"}, {"id": "16503727_2_2783", "context": "Dipyrone-induced granulocytopenia: a case for awareness.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] Dipyrone [Effect] granulocytopenia"}, {"id": "22233409_4_2784", "context": "We report the case of a patient with chronic hepatitis C infection who developed severe anaemia during antiviral treatment with peginterferon alfa/ribavirin when oseltamivir was added to treat influenza.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] a patient with chronic hepatitis C infection [Treatment] peginterferon alfa/ribavirin; oseltamivir [Effect] severe anaemia"}, {"id": "8641617_3_2785", "context": "Both patients were then treated with a carboplatin alternative to cisplatin in the following courses, which resulted in neither a relapse of the colitis nor a recurrence of the malignancies up to this time.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] resulted [Subject] Both patients [Treatment] carboplatin [Effect] neither a relapse of the colitis nor a recurrence of the malignancies"}, {"id": "18344455_2_2786", "context": "It is rare to develop simultaneous toxicities while on anticonvulsants.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] develop [Treatment] anticonvulsants [Effect] toxicities"}, {"id": "16211208_1_2787", "context": "Because of serious side effects of an increase in the QT interval causing torsades de pointes, dofetilide must be initiated with close monitoring of the QT interval in an inpatient setting.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] increase [Treatment] dofetilide [Effect] QT interval causing torsades de pointes"}, {"id": "8651254_2_2788", "context": "It should be emphasized that the recurrence of nephrotic syndrome was observed after the following chemotherapy, including M-CSF, whereas the bone marrow still remained completely remitted.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] chemotherapy, including M-CSF [Effect] nephrotic syndrome; the bone marrow still remained completely remitted"}, {"id": "8604715_4_2789", "context": "We present a patient with human immunodeficiency virus infection under treatment with foscarnet for CMV retinitis who complained of thirst and polyuria.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] complained [Subject] a patient with human immunodeficiency virus infection [Treatment] foscarnet [Effect] thirst and polyuria"}, {"id": "8672829_6_2790", "context": "This represents the first report of nonconvulsive status epilepticus induced by ifosfamide.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] ifosfamide [Effect] nonconvulsive status epilepticus"}, {"id": "17536204_2_2791", "context": "BACKGROUND: Headaches have been reported as a potential side effect of capecitabine therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Treatment] capecitabine [Effect] Headaches"}, {"id": "18795_3_2792", "context": "When DSCG was withdrawn, urticaria vanished and the child remained symptom-free.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] remained [Subject] the child [Treatment] DSCG was withdrawn [Effect] urticaria vanished; symptom-free"}, {"id": "8345435_1_2793", "context": "Hepatotoxic effects in a child receiving valproate and carnitine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] a child [Treatment] valproate and carnitine [Effect] Hepatotoxic effects"}, {"id": "7718983_5_2794", "context": "We report a case of Graves' hyperthyroidism induced by long-term interferon (IFN) therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] long-term interferon (IFN) therapy [Effect] Graves' hyperthyroidism"}, {"id": "9211543_1_2795", "context": "Bleomycin and cyclophosphamide toxicity simulating metastatic nodules to the lungs in childhood cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] simulating [Subject] childhood cancer [Treatment] Bleomycin and cyclophosphamide toxicity [Effect] metastatic nodules to the lungs"}, {"id": "17266059_1_2796", "context": "The patient presented with fulminant microangiopathic hemolytic anemia and thrombocytopenia within 48 hr of initiating therapy with trimethoprim-sulfamethoxazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] presented [Subject] The patient [Treatment] within 48 hr of initiating therapy with trimethoprim-sulfamethoxazole [Effect] fulminant microangiopathic hemolytic anemia and thrombocytopenia"}, {"id": "1792646_2_2797", "context": "Pneumocystis pneumonia should be considered in asthmatic patients taking methotrexate who present with fever, pulmonary infiltrates, and hypoxia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] asthmatic patients [Treatment] methotrexate [Effect] Pneumocystis pneumonia; fever, pulmonary infiltrates, and hypoxia"}, {"id": "16298824_1_2798", "context": "Acute respiratory distress syndrome after rituximab infusion.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] rituximab infusion [Effect] Acute respiratory distress syndrome"}, {"id": "17406804_3_2799", "context": "CONCLUSION: Gemcitabine-induced recall pneumonitis is a rarely reported phenomenon and should be taken into account even after extended time interval to the previous radiotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Gemcitabine [Effect] recall pneumonitis"}, {"id": "6519218_1_2800", "context": "In a 61-year-old man receiving chronic low-dosage amiodarone an interstitial pneumopathy was observed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] observed [Subject] a 61-year-old man [Treatment] chronic low-dosage amiodarone [Effect] interstitial pneumopathy"}, {"id": "12126225_2_2801", "context": "A 75-year-old man developed bilateral lower leg edema 6 months after switching from troglitazone to pioglitazone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 75-year-old man [Treatment] 6 months after switching from troglitazone to pioglitazone [Effect] bilateral lower leg edema"}, {"id": "10475726_1_2802", "context": "An acute ischaemic event associated with the use of venlafaxine: a case report and proposed pathophysiological mechanisms.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] a case [Treatment] venlafaxine [Effect] An acute ischaemic event"}, {"id": "21751666_5_2803", "context": "Oseltamivir was effective for post-exposure prophylaxis of H1N1 in close contact.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] post-exposure prophylaxis [Treatment] Oseltamivir"}, {"id": "19365885_1_2804", "context": "Herein, we present a patient with severe and prolonged hypoglycemia after long-acting octreotide treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a patient [Treatment] long-acting octreotide treatment [Effect] severe and prolonged hypoglycemia"}, {"id": "25417855_1_2805", "context": "Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Subject] a renal transplant patient [Treatment] pharmacokinetic drug-drug interaction between everolimus and voriconazole [Effect] Worsening pneumonitis"}, {"id": "11576059_1_2806", "context": "Vocal cord paralysis as a consequence of peritonsillar infiltration with bupivacaine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] consequence [Treatment] peritonsillar infiltration with bupivacaine [Effect] Vocal cord paralysis"}, {"id": "1267457_3_2807", "context": "The sulfonamides are the best verified drug-trigger for erythema multiforme and Stevens-Johnson syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] drug-trigger [Treatment] sulfonamides [Effect] erythema multiforme and Stevens-Johnson syndrome"}, {"id": "576675_2_2808", "context": "Edema associated with ibuprofen therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] ibuprofen [Effect] Edema"}, {"id": "3365032_1_2809", "context": "A patient is presented with typical hyperthyroidism, who developed a severe proximal muscle weakness and a raised creatine phosphokinase after treatment for hyperthyroidism with propylthiouracil (100 mg orally, three times a day).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A patient is presented with typical hyperthyroidism [Treatment] treatment for hyperthyroidism with propylthiouracil (100 mg orally, three times a day) [Effect] severe proximal muscle weakness and a raised creatine phosphokinase"}, {"id": "12243603_7_2810", "context": "Atorvastatin is the most potent of this class of agents currently available and is commonly used in the treatment of hyperlipidemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treatment [Treatment] Atorvastatin [Effect] most potent"}, {"id": "2935070_2_2811", "context": "However, there are few reports in the literature of ampicillin as a cause of acute interstitial nephritis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] ampicillin [Effect] acute interstitial nephritis"}, {"id": "2956288_3_2812", "context": "Optic neuropathy in ethambutol-treated renal tuberculosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Treatment] ethambutol [Effect] Optic neuropathy"}, {"id": "7779233_2_2813", "context": "This case study describes an atypical case of refractory, sodium warfarin-induced necrotizing fasciitis and myonecrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] sodium warfarin [Effect] necrotizing fasciitis and myonecrosis"}, {"id": "8384030_4_2814", "context": "OBJECTIVE: To report a case of possible foscarnet-induced severe hypomagnesemia and other electrolyte disorders.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] foscarnet [Effect] severe hypomagnesemia and other electrolyte disorders"}, {"id": "7673653_3_2815", "context": "However, the occurrence and management of akathisia induced by fluvoxamine have not been described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] fluvoxamine [Effect] akathisia"}, {"id": "17009081_3_2816", "context": "Nephrotic syndrome associated with interferon-beta-1b therapy for multiple sclerosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated with [Treatment] interferon-beta-1b therapy [Effect] Nephrotic syndrome"}, {"id": "17438184_3_2817", "context": "OBSERVATIONS: A 48-year-old woman presented with disfiguring facial edema 10 weeks after she began antiviral therapy with peginterferon alfa-2a and ribavirin for chronic hepatitis C infection.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 48-year-old woman [Treatment] 10 weeks; antiviral therapy with peginterferon alfa-2a and ribavirin [Effect] disfiguring facial edema"}, {"id": "4095247_3_2818", "context": "Two of these patients, who also received the anti-emetic prochlorperazine, lost consciousness for 48-72 h and then fully recovered.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] lost [Subject] Two of these patients [Treatment] anti-emetic prochlorperazine [Effect] lost consciousness for 48-72 h and then fully recovered"}, {"id": "16986159_1_2819", "context": "We present a depressive patient who developed mild parkinsonian signs and camptocormia after the introduction of olanzapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] depressive patient [Treatment] introduction of olanzapine [Effect] mild parkinsonian signs and camptocormia"}, {"id": "7379406_3_2820", "context": "The case report discussed is, to our knowledge, the third of its kind regarding bone fluorosis resulting from use of this nicotinic derivative.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] use [Treatment] nicotinic derivative [Effect] bone fluorosis"}, {"id": "17266059_3_2821", "context": "We report a case of Thrombotic Thrombocytopenic Purpura occurring as an allergic response to trimethoprim-sulfamethoxazole therapy (Bactrim, Septra) in a Jehovah's Witness patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] to [Subject] Jehovah's Witness patient [Treatment] trimethoprim-sulfamethoxazole [Effect] Thrombotic Thrombocytopenic Purpura; allergic response"}, {"id": "11144696_3_2822", "context": "A 25-year-old white woman with chronic depression was treated with venlafaxine 150 mg/d and trimipramine 50 mg/d.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] treated [Subject] A 25-year-old white woman with chronic depression [Treatment] venlafaxine 150 mg/d and trimipramine 50 mg/d"}, {"id": "12078977_1_2823", "context": "A 31-year-old female developed multiple episodes of grand mal seizures after combination chemotherapy with cisplatin, vinblastine and bleomycin for germ cell ovarian cancer stage Ic.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A 31-year-old female [Treatment] combination chemotherapy with cisplatin, vinblastine and bleomycin [Effect] multiple episodes of grand mal seizures"}, {"id": "8604715_1_2824", "context": "Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] foscarnet [Effect] Nephrogenic diabetes insipidus and renal tubular acidosis"}, {"id": "16765687_1_2825", "context": "PURPOSE: Topiramate-induced angle-closure glaucoma (TiACG) is believed to be related to its sulfonamide moiety.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Topiramate [Effect] angle-closure glaucoma (TiACG)"}, {"id": "18344455_4_2826", "context": "These toxicities resolved after the cessation of anticonvulsants, and her seizures were managed acutely with scheduled lorazepam.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] managed [Treatment] lorazepam"}, {"id": "2728526_4_2827", "context": "This article reports the occurrence of rifampin-associated thrombocytopenia in an indigent patient after a four-month lapse in therapy for pulmonary tuberculosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] an indigent patient [Treatment] rifampin; after a four-month lapse in therapy for pulmonary tuberculosis [Effect] thrombocytopenia"}, {"id": "6721543_1_2828", "context": "Drug-induced psychosis resulted from the administration of quinacrine hydrochloride at a dosage of 100 mg twice daily for the treatment of discoid lupus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] administration of quinacrine hydrochloride at a dosage of 100 mg twice daily [Effect] psychosis resulted"}, {"id": "10688731_3_2829", "context": "We report a case of a scleroderma-like reaction induced by long-term administration of UFT.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a case [Treatment] long-term administration of UFT [Effect] a scleroderma-like reaction"}, {"id": "16109609_4_2830", "context": "We report four cases of hemodynamically significant pericardial effusion in patients with refractory lymphoma who were receiving gemcitabine, all of whom had a history of mediastinal radiation without subcarinal blocking.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] in [Subject] had a history of mediastinal radiation without subcarinal blocking [Treatment] gemcitabine [Effect] hemodynamically significant pericardial effusion"}, {"id": "10679548_1_2831", "context": "Both had impaired lung function and abnormal computed tomographic scans, and their condition improved when nitrofurantoin was withdrawn and corticosteroid treatment commenced.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] improved [Subject] Both had impaired lung function and abnormal computed tomographic scans [Treatment] nitrofurantoin was withdrawn and corticosteroid treatment commenced"}, {"id": "18691992_6_2832", "context": "OBJECTIVE: The purpose of this study was to report the concomitant occurrence of multiple squamous cell carcinomas and diffuse nail hyperpigmentation associated with hydroxyurea treatment, and to describe a successful therapeutic approach using imiquimod 5%.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] hydroxyurea [Effect] multiple squamous cell carcinomas and diffuse nail hyperpigmentation"}, {"id": "17319250_2_2833", "context": "We present a case report of a patient who developed a prolonged QT while being treated with oral methadone for a chronic pain syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] a patient [Treatment] oral methadone [Effect] prolonged QT"}, {"id": "19897274_3_2834", "context": "In this article, we describe a Japanese patient with severe interstitial pneumonia probably caused by sorafenib treatment for metastatic renal cell carcinoma.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Subject] a Japanese patient [Treatment] sorafenib [Effect] severe interstitial pneumonia"}, {"id": "15494638_17_2835", "context": "Neurotoxicity occurs most often with intermittent high dose 5-FU as bolus injection or 24- to 48-h infusions.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] occurs [Treatment] intermittent high dose 5-FU as bolus injection or 24- to 48-h infusions [Effect] Neurotoxicity"}, {"id": "14998226_7_2836", "context": "Lovastatin also reportedly has caused increases in INR when coadministered with warfarin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] Lovastatin [Effect] increases in INR"}, {"id": "14998226_10_2837", "context": "Pravastatin does not appear to interact with warfarin but has caused an increased INR when combined with the anticoagulant fluindione.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] Pravastatin; combined with the anticoagulant fluindion [Effect] increased INR"}, {"id": "8120934_2_2838", "context": "Bromocriptine-induced schizophrenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Bromocriptine [Effect] schizophrenia"}, {"id": "17873198_2_2839", "context": "Pulmonary toxicity associated with erlotinib.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] erlotinib [Effect] Pulmonary toxicity"}, {"id": "2442958_1_2840", "context": "Multicentric hepatocellular carcinoma following phosphate diethylstilbestrol therapy for prostatic cancer.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Treatment] phosphate diethylstilbestrol [Effect] Multicentric hepatocellular carcinoma"}, {"id": "16025424_1_2841", "context": "Rapid onset of quetiapine-induced diabetic ketoacidosis in an elderly patient: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] an elderly patient [Treatment] quetiapine [Effect] diabetic ketoacidosis"}, {"id": "3815268_1_2842", "context": "A 57-year-old woman developed pulmonary sarcoidosis during therapy with interferon beta for advanced renal cell carcinoma metastatic to mediastinal lymph nodes.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] 57-year-old woman [Treatment] interferon beta for advanced renal cell carcinoma metastatic to mediastinal lymph nodes [Effect] pulmonary sarcoidosis"}, {"id": "9013348_2_2843", "context": "Mesalamine-induced hypersensitivity pneumonitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Mesalamine [Effect] hypersensitivity pneumonitis"}, {"id": "11737689_2_2844", "context": "A girl with cystic fibrosis and cyclic neutropenia developed an erythematous papular eruption without fever or neutrophilia 7 months after commencing therapy with G-CSF.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] A girl with cystic fibrosis and cyclic neutropenia [Treatment] 7 months after commencing therapy with G-CSF. [Effect] erythematous papular eruption without fever or neutrophilia"}, {"id": "71813_3_2845", "context": "Lichen planus and acne provoked by gold.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] provoked [Treatment] gold [Effect] Lichen planus and acne"}, {"id": "12153007_2_2846", "context": "To the best of our knowledge only two previous cases of AML have been linked to treatment of HCL with purine analogs, both with 2-chlorodeoxyadenosine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] linked [Treatment] purine analogs, both with 2-chlorodeoxyadenosine [Effect] AML"}, {"id": "12656748_3_2847", "context": "There are no previous reports in the literature about the emergence of CML during treatment with hydroxyurea.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] treatment with hydroxyurea [Effect] CML"}, {"id": "10614572_1_2848", "context": "Intravenous valproate associated with significant hypotension in the treatment of status epilepticus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] Intravenous valproate [Effect] significant hypotension"}, {"id": "17876386_2_2849", "context": "Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Treatment] moxifloxacin [Effect] Torsade de pointes"}, {"id": "25417855_3_2850", "context": "We report serious adverse effects due to interaction between orally administered voriconazole and everolimus in a renal transplant recipient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due to [Subject] a renal transplant recipient [Treatment] interaction between orally administered voriconazole and everolimus [Effect] serious adverse effects"}, {"id": "2554727_1_2851", "context": "Horner's syndrome and demyelinating peripheral neuropathy caused by high-dose cytosine arabinoside.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] high-dose cytosine arabinoside [Effect] Horner's syndrome and demyelinating peripheral neuropathy"}, {"id": "16097572_1_2852", "context": "Fatal radiation myelopathy after high-dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma: a review of the literature and implications for practice.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] high-dose busulfan; melphalan [Effect] radiation myelopathy"}, {"id": "8053440_4_2853", "context": "This is the first description, to our knowledge, of ductopenia apparently caused by clindamycin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] caused [Treatment] clindamycin [Effect] ductopenia"}, {"id": "7781845_1_2854", "context": "Mefloquine-associated hypoglycaemia in a cachectic AIDS patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] cachectic AIDS patient [Treatment] Mefloquine [Effect] hypoglycaemia"}, {"id": "19226083_17_2855", "context": "Patients who commonly require linezolid as an antimicrobial are those with complex infections where other antibiotic treatment has failed.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] require [Subject] Patients; complex infections [Treatment] linezolid as an antimicrobial"}, {"id": "6245286_2_2856", "context": "In three of these patients the infection was clinically unsuspected; in the fourth, cutaneous herpes zoster developed after administration of 300 mg of cytarabine daily for the preceding five days.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] three of these patients [Treatment] 300 mg of cytarabine daily for the preceding five days [Effect] cutaneous herpes zoster"}, {"id": "17655517_9_2857", "context": "Patients receiving linezolid for more than 28 days should be monitored for signs of peripheral and optic neuropathy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] monitored [Subject] Patients [Treatment] linezolid for more than 28 days [Effect] peripheral and optic neuropathy"}, {"id": "3941210_1_2858", "context": "Atrioventricular block complicating amiodarone-induced hypothyroidism in a patient with pre-excitation and rate-dependent bilateral bundle branch block.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Subject] a patient with pre-excitation and rate-dependent bilateral bundle branch block [Treatment] amiodarone [Effect] hypothyroidism"}, {"id": "7249424_1_2859", "context": "Lithium is known to cause acute renal failure and tubulo-interstitial disease, but the recently described association with proteinuria or nephrotic syndrome is little recognized.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] association [Treatment] Lithium [Effect] acute renal failure and tubulo-interstitial disease; proteinuria or nephrotic syndrome"}, {"id": "17509184_1_2860", "context": "A 40-year-old man with advanced HIV infection and Mycobacterium avium complex infection experienced rapid cognitive decline after commencement of ethambutol, and symptoms fully resolved with cessation.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] 40-year-old man with advanced HIV infection and Mycobacterium avium complex infection [Treatment] commencement of ethambutol [Effect] rapid cognitive decline"}, {"id": "19892516_2_2861", "context": "Ciprofloxacin-induced hemorrhagic vasculitis is a rare side effect.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] Ciprofloxacin [Effect] hemorrhagic vasculitis"}, {"id": "15028964_7_2862", "context": "Given that significant thyroid disorders may be only mildly symptomatic and thus may escape clinical detection, we suggest that thyroid function should be tested in any patient with otherwise unexplained changes in warfarin dose requirements, particularly if concomitantly treated with amiodarone.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] changes [Treatment] warfarin; with amiodarone [Effect] significant thyroid disorders"}, {"id": "10367184_1_2863", "context": "Myotonia associated with sarcoidosis: marked exacerbation with pravastatin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] sarcoidosis [Treatment] pravastatin [Effect] exacerbation; Myotonia"}, {"id": "7668127_5_2864", "context": "This observation questions the suitability of aspirin as prophylaxis for vascular disease in patients with meningiomas.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] prophylaxis [Subject] patients with meningiomas [Treatment] aspirin"}, {"id": "8360712_2_2865", "context": "Delayed neurotoxicity of intraventricular interleukin-2: a case report.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] of [Subject] a case report [Treatment] intraventricular interleukin-2 [Effect] Delayed neurotoxicity"}, {"id": "7776854_4_2866", "context": "We stress the potential of benzarone to cause hepatotoxicity, which usually resembles severe chronic active hepatitis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] cause [Treatment] benzarone [Effect] hepatotoxicity; severe chronic active hepatitis"}, {"id": "3579660_3_2867", "context": "We describe a patient with Wilson's disease who presented with neurologic disease, was treated with D-penicillamine, and suffered sudden neurologic deterioration coincident with therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] suffered [Subject] a patient with Wilson's disease who presented with neurologic disease [Treatment] D-penicillamine [Effect] sudden neurologic deterioration"}, {"id": "16889287_3_2868", "context": "We report the case of a 21-year-old female patient with dapsone hypersensitivity syndrome.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] with [Subject] a 21-year-old female patient [Treatment] dapsone [Effect] hypersensitivity syndrome"}, {"id": "22233409_5_2869", "context": "The adverse events related to ribavirin and drug-drug interactions during therapy for hepatitis C are discussed.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] related [Treatment] ribavirin [Effect] adverse events"}, {"id": "2309833_3_2870", "context": "Insulin-dependent diabetes mellitus developed in a young woman 8 weeks after the initiation of danazol for treatment of pelvic endometriosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] a young woman [Treatment] 8 weeks after the initiation of danazol [Effect] Insulin-dependent diabetes mellitus"}, {"id": "417679_1_2871", "context": "Four cases of fat embolism are described in infants receiving prolonged intravenous infusion of fat (Intralipid 20%).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] receiving [Subject] Four cases; infants [Treatment] prolonged intravenous infusion of fat (Intralipid 20%) [Effect] fat embolism"}, {"id": "18176653_1_2872", "context": "Oral adverse effects due to the use of Nevirapine.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] due [Treatment] Nevirapine [Effect] adverse effects"}, {"id": "19299370_4_2873", "context": "PURPOSE: A case of probable enoxaparin-induced hepatotoxicity is described.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] enoxaparin [Effect] hepatotoxicity"}, {"id": "15383642_9_2874", "context": "Tizanidine was used again after her BP had stabilized, but did not produce similar problems.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] produce [Treatment] Tizanidine [Effect] problems"}, {"id": "424824_3_2875", "context": "It is suggested therefore that methotrexate be added to the list of agents capable of inducing diffuse interstitial pulmonary fibrosis.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] inducing [Treatment] methotrexate [Effect] diffuse interstitial pulmonary fibrosis"}, {"id": "8816294_1_2876", "context": "The delayed encephalopathy developed 9 and 22 months respectively after the first dose of intrathecal methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Treatment] intrathecal methotrexate [Effect] delayed encephalopathy"}, {"id": "3565435_2_2877", "context": "Severe systemic hypersensitivity reaction to ibuprofen occurring after prolonged therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] ibuprofen; prolonged therapy [Effect] Severe systemic hypersensitivity reaction"}, {"id": "11250985_2_2878", "context": "In patients with chronic heart failure, spironolactone added to conventional treatment may lead to serious and, occasionally, fatal hyperkalaemia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] lead [Subject] patients with chronic heart failure [Treatment] spironolactone [Effect] serious and, occasionally, fatal hyperkalaemia"}, {"id": "10516999_2_2879", "context": "We report a case of acute hyperphosphatemia secondary to rectal administration of sodium phosphate and sodium biphosphate (Fleet enema).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Treatment] rectal administration of sodium phosphate and sodium biphosphate (Fleet enema) [Effect] acute hyperphosphatemia"}, {"id": "12365708_4_2880", "context": "Visual changes secondary to initiation of amiodarone: a case report and review involving ocular management in cardiac polypharmacy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] secondary [Subject] a case [Treatment] amiodarone [Effect] Visual changes"}, {"id": "14674674_3_2881", "context": "This is the first case, to our knowledge, of onset of prolonged infliximab-induced lupus.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] infliximab [Effect] lupus"}, {"id": "17420198_19_2882", "context": "A patient with developmental disabilities who had no history of movement disorders developed EPS following initiation of aripiprazole.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] following [Subject] A patient with developmental disabilities who had no history of movement disorders [Treatment] initiation of aripiprazole [Effect] EPS"}, {"id": "15307435_1_2883", "context": "Case report: life-threatening hypoglycaemia associated with sulfadoxine-pyrimethamine, a commonly used antimalarial drug.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] associated [Subject] Case [Treatment] sulfadoxine-pyrimethamine [Effect] life-threatening hypoglycaemia"}, {"id": "12811715_2_2884", "context": "Diphenhydramine-induced wide complex dysrhythmia responds to treatment with sodium bicarbonate.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] to [Treatment] treatment with sodium bicarbonate"}, {"id": "228648_1_2885", "context": "Prenatal cytomegalovirus (CMV) infection associated with severe brain damage was detected in an infant whose mother had been treated with prednisolone and azathioprine for systemic lupus erythematosus (SLE).", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] treated [Subject] an infant whose mother had been treated with prednisolone and azathioprine for systemic lupus erythematosus (SLE) [Treatment] prednisolone and azathioprine [Effect] Prenatal cytomegalovirus (CMV) infection associated with severe brain damage"}, {"id": "20178709_2_2886", "context": "Methotrexate may rarely provoke serositis, even with low doses and after just a few weeks of therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] provoke [Treatment] Methotrexate [Effect] serositis"}, {"id": "21597286_6_2887", "context": "Prescription analyses by pharmacists and literature research have permitted us to suggest that a drug-drug interaction between methotrexate and proton pump inhibitors (PPI) was responsible for this renal failure.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] responsible [Treatment] methotrexate and proton pump inhibitors (PPI) [Effect] renal failure"}, {"id": "18795_2_2888", "context": "Asthma and urticaria during disodium cromoglycate treatment.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Treatment] disodium cromoglycate treatment [Effect] Asthma and urticaria"}, {"id": "10679548_7_2889", "context": "We suggest that the previous classification of nitrofurantoin induced lung injury into \"acute\" and \"chronic\" injury is an oversimplification in view of the wide variety of pathological entities that have subsequently emerged.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] nitrofurantoin [Effect] lung injury"}, {"id": "2369419_2_2890", "context": "Hepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking methotrexate.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] taking [Subject] a woman with rheumatoid arthritis [Treatment] methotrexate [Effect] Hepatitis with bridging fibrosis and reversible hepatic insufficiency"}, {"id": "16116136_4_2891", "context": "Primary CNS lymphoma regressed on withdrawal of MM.", "question": "What are the events?", "question_type": "Events", "answers": "[Potential therapeutic event] regressed [Treatment] withdrawal of MM [Effect] Primary CNS lymphoma"}, {"id": "6498095_2_2892", "context": "Pemphigus foliaceus induced by rifampicin.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] induced [Treatment] rifampicin [Effect] Pemphigus foliaceus"}, {"id": "2931445_3_2893", "context": "L-T4 stimulated lymphocyte transformation in this patient.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] stimulated [Subject] this patient [Treatment] L-T4 [Effect] lymphocyte transformation"}, {"id": "12126225_1_2894", "context": "A 53-year-old man developed lower leg edema 4 weeks after rosiglitazone was increased from 4 mg once/day to 4 mg twice/day.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Subject] A 53-year-old man [Treatment] 4 weeks after rosiglitazone was increased from 4 mg once/day to 4 mg twice/day [Effect] lower leg edema"}, {"id": "3143551_2_2895", "context": "A mentally retarded 23-year-old woman with myoclonic astatic epilepsy developed an abnormal posture of extreme forward flexion, called camptocormia, during valproate monotherapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] during [Subject] A mentally retarded 23-year-old woman with myoclonic astatic epilepsy [Treatment] valproate [Effect] abnormal posture of extreme forward flexion, called camptocormia,"}, {"id": "12086549_1_2896", "context": "After 5 days of treatment with IL-2, the patient developed a hemorrhagic lesion that progressed to toxic epidermal necrolysis, as well as grade 4 pancytopenia.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] developed [Subject] patient [Treatment] 5 days of treatment with IL-2 [Effect] a hemorrhagic lesion that progressed to toxic epidermal necrolysis, as well as grade 4 pancytopenia"}, {"id": "9399776_1_2897", "context": "Acute pancreatitis after long-term 5-aminosalicylic acid therapy.", "question": "What are the events?", "question_type": "Events", "answers": "[Adverse event] after [Treatment] long-term 5-aminosalicylic acid therapy [Effect] Acute pancreatitis"}]}